action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
,,32111,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,c1cnc(N2CCN(Cc3cccc4c3Cc3ccccc3-4)CC2)nc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '14.63', 'le': '0.26', 'lle': '1.64', 'sei': '15.53'}",CHEMBL303519,,CHEMBL303519,5.01,0,http://www.openphacts.org/units/Nanomolar,108659,=,1,1,=,,IC50,nM,,9800.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9800.0
,,33282,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '20.25', 'le': '0.37', 'lle': '3.83', 'sei': '17.60'}",CHEMBL292943,,CHEMBL292943,7.30,0,http://www.openphacts.org/units/Nanomolar,108665,=,1,1,=,,IC50,nM,,50.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50.0
,,38258,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cncc(CN3CCN(c4ccccc4F)CC3)c2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '20.80', 'le': '0.38', 'lle': '3.25', 'sei': '39.25'}",CHEMBL61682,,CHEMBL61682,7.60,0,http://www.openphacts.org/units/Nanomolar,108652,=,1,1,=,,IC50,nM,,25.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,25.0
,,39387,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1-c1cccc(CN2CCN(c3ncccn3)CC2)c1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '17.88', 'le': '0.33', 'lle': '2.97', 'sei': '15.53'}",CHEMBL64487,,CHEMBL64487,6.44,0,http://www.openphacts.org/units/Nanomolar,108663,=,1,1,=,,IC50,nM,,360.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,360.0
,,39391,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,c1cnc(N2CCN(Cc3cccc(-c4ccsc4)c3)CC2)nc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '19.39', 'le': '0.37', 'lle': '2.99', 'sei': '20.22'}",CHEMBL64597,,CHEMBL64597,6.52,0,http://www.openphacts.org/units/Nanomolar,108662,=,1,1,=,,IC50,nM,,300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,300.0
,,40505,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cncc(CN3CCN(c4ccc(F)cc4)CC3)c2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '19.58', 'le': '0.36', 'lle': '2.80', 'sei': '36.94'}",CHEMBL291824,,CHEMBL291824,7.16,0,http://www.openphacts.org/units/Nanomolar,108653,=,1,1,=,,IC50,nM,,70.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,70.0
,,47823,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '20.98', 'le': '0.38', 'lle': '3.71', 'sei': '22.66'}",CHEMBL59942,,CHEMBL59942,7.31,0,http://www.openphacts.org/units/Nanomolar,108671,=,1,1,=,,IC50,nM,,49.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,49.0
,,50520,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cncc(CN3CCN(c4ccccn4)CC3)c2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '20.73', 'le': '0.38', 'lle': '3.62', 'sei': '22.39'}",CHEMBL61657,,CHEMBL61657,7.22,0,http://www.openphacts.org/units/Nanomolar,108654,=,1,1,=,,IC50,nM,,60.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,60.0
,,55514,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cncc(CN3CCN(c4ncccn4)CC3)c2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '19.81', 'le': '0.36', 'lle': '3.92', 'sei': '15.33'}",CHEMBL302183,,CHEMBL302183,6.92,0,http://www.openphacts.org/units/Nanomolar,108651,=,1,1,=,,IC50,nM,,120.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,120.0
,,57998,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,c1cnc(N2CCN(Cc3cccc4c3-c3ccccc3C4)CC2)nc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '16.46', 'le': '0.30', 'lle': '2.27', 'sei': '17.48'}",CHEMBL304692,,CHEMBL304692,5.64,0,http://www.openphacts.org/units/Nanomolar,108670,=,1,1,=,,IC50,nM,,2300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2300.0
,,59201,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '19.72', 'le': '0.38', 'lle': '2.90', 'sei': '18.33'}",CHEMBL555670,,CHEMBL267014,6.44,0,http://www.openphacts.org/units/Nanomolar,108668,=,1,1,=,,IC50,nM,,360.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,360.0
,,63216,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccccc1-c1cccc(CN2CCN(c3ncccn3)CC2)c1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '18.95', 'le': '0.35', 'lle': '3.00', 'sei': '20.47'}",CHEMBL291380,,CHEMBL291380,6.60,0,http://www.openphacts.org/units/Nanomolar,108666,=,1,1,=,,IC50,nM,,250.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,250.0
,,64549,[],CHEMBL671342,Binding affinity of compound to Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Nc1cccc(-c2ccc(CCN3CCN(CC(=O)c4ccccc4)CC3)cc2)n1,,,CHEMBL1131962,Bioorg Med Chem Lett,1999.0,,CHEMBL40391,,CHEMBL40391,,0,http://www.openphacts.org/units/Nanomolar,155829,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,65943,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)c1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '17.50', 'le': '0.32', 'lle': '2.84', 'sei': '15.21'}",CHEMBL64671,,CHEMBL64671,6.31,0,http://www.openphacts.org/units/Nanomolar,108664,=,1,1,=,,IC50,nM,,490.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,490.0
,,67125,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1cccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)c1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '20.35', 'le': '0.37', 'lle': '3.49', 'sei': '21.98'}",CHEMBL62829,,CHEMBL62829,7.09,0,http://www.openphacts.org/units/Nanomolar,108657,=,1,1,=,,IC50,nM,,81.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,81.0
,,67130,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C\C(=O)O,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '18.29', 'le': '0.34', 'lle': '2.24', 'sei': '21.70'}",CHEMBL64119,,CHEMBL1179189,6.21,0,http://www.openphacts.org/units/Nanomolar,108667,=,1,1,=,,IC50,nM,,620.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,620.0
,,68341,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cncc(CN3CCN(c4ccccc4)CC3)c2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '21.98', 'le': '0.40', 'lle': '3.43', 'sei': '39.43'}",CHEMBL302904,,CHEMBL302904,7.64,0,http://www.openphacts.org/units/Nanomolar,108656,=,1,1,=,,IC50,nM,,23.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,23.0
,,69658,[],CHEMBL671073,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(-c2cncc(CN3CCN(c4cnccn4)CC3)c2)cc1,,,CHEMBL1130912,Bioorg Med Chem Lett,1998.0,"{'bei': '18.16', 'le': '0.33', 'lle': '3.35', 'sei': '14.06'}",CHEMBL60957,,CHEMBL60957,6.35,0,http://www.openphacts.org/units/Nanomolar,108655,=,1,1,=,,IC50,nM,,450.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,450.0
,,188330,[],CHEMBL672303,Inhibitory concentration against binding of Dopamine receptor D2 by displacement of [3H]spiperone,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC[C@H]1CCCN1CCc1ccccc1)C1CCCCC1,,,CHEMBL1133417,Bioorg Med Chem Lett,2000.0,,CHEMBL82652,,CHEMBL82652,,0,http://www.openphacts.org/units/Nanomolar,289090,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM l-1,UO_0000065,,1000.0
,,190680,[],CHEMBL672303,Inhibitory concentration against binding of Dopamine receptor D2 by displacement of [3H]spiperone,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1cccc(C(=O)NC[C@@H]2CCCN2CCc2ccccc2)c1,,,CHEMBL1133417,Bioorg Med Chem Lett,2000.0,,CHEMBL356304,,CHEMBL356304,,0,http://www.openphacts.org/units/Nanomolar,289095,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM l-1,UO_0000065,,1000.0
,,193080,[],CHEMBL672303,Inhibitory concentration against binding of Dopamine receptor D2 by displacement of [3H]spiperone,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC[C@@H]1CCCN1CCc1ccccc1)c1ccccc1,,,CHEMBL1133417,Bioorg Med Chem Lett,2000.0,,CHEMBL147279,,CHEMBL147279,,0,http://www.openphacts.org/units/Nanomolar,289093,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM l-1,UO_0000065,,1000.0
,,203695,[],CHEMBL672303,Inhibitory concentration against binding of Dopamine receptor D2 by displacement of [3H]spiperone,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC[C@@H]1CCCN1CCc1ccccc1)C1CCCCC1,,,CHEMBL1133417,Bioorg Med Chem Lett,2000.0,,CHEMBL82884,,CHEMBL82884,,0,http://www.openphacts.org/units/Nanomolar,289091,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM l-1,UO_0000065,,1000.0
,,204966,[],CHEMBL672303,Inhibitory concentration against binding of Dopamine receptor D2 by displacement of [3H]spiperone,B,,,BAO_0000190,BAO_0000357,single protein format,CSc1cccc(C(=O)NC[C@H]2CCCN2CCc2ccccc2)c1,,,CHEMBL1133417,Bioorg Med Chem Lett,2000.0,,CHEMBL148249,,CHEMBL148249,,0,http://www.openphacts.org/units/Nanomolar,289094,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM l-1,UO_0000065,,1000.0
,,209687,[],CHEMBL672303,Inhibitory concentration against binding of Dopamine receptor D2 by displacement of [3H]spiperone,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN(CCC)C1CCc2cccc(O)c2C1,,,CHEMBL1133417,Bioorg Med Chem Lett,2000.0,,CHEMBL56,8-OH-DPAT,CHEMBL56,,0,http://www.openphacts.org/units/Nanomolar,289089,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM l-1,UO_0000065,,1000.0
,,217956,[],CHEMBL672303,Inhibitory concentration against binding of Dopamine receptor D2 by displacement of [3H]spiperone,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC[C@H]1CCCN1CCc1ccccc1)c1ccccc1,,,CHEMBL1133417,Bioorg Med Chem Lett,2000.0,,CHEMBL147226,,CHEMBL147226,,0,http://www.openphacts.org/units/Nanomolar,289092,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM l-1,UO_0000065,,1000.0
,,268104,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '19.89', 'le': '0.41', 'lle': '2.27', 'sei': '110.91'}",CHEMBL1204116,,CHEMBL302075,7.19,0,http://www.openphacts.org/units/Nanomolar,244361,=,1,1,=,,IC50,nM,,65.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,65.0
,,270782,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '21.26', 'le': '0.41', 'lle': '3.23', 'sei': '22.50'}",CHEMBL42,CLOZAPINE,CHEMBL42,6.95,0,http://www.openphacts.org/units/Nanomolar,244353,=,1,1,=,,IC50,nM,,113.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,113.0
,,272116,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Cl.c1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccn3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '22.43', 'le': '0.41', 'lle': '3.57', 'sei': '33.97'}",CHEMBL1203260,,CHEMBL126318,6.58,0,http://www.openphacts.org/units/Nanomolar,244347,=,1,1,=,,IC50,nM,,263.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,263.0
,,272119,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.c1ccc([C@H]2C[C@@H]2CN2CCN(c3cccnc3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,,CHEMBL1202203,,CHEMBL126317,,0,http://www.openphacts.org/units/Nanomolar,244346,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,272122,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '19.41', 'le': '0.38', 'lle': '2.29', 'sei': '103.31'}",CHEMBL1202222,,CHEMBL126792,6.70,0,http://www.openphacts.org/units/Nanomolar,244339,=,1,1,=,,IC50,nM,,202.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,202.0
,,273255,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Cc1ccc(N2CCN(CC3CC3c3ccccc3)CC2)c(C)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '22.53', 'le': '0.41', 'lle': '2.99', 'sei': '111.45'}",CHEMBL2092961,,CHEMBL2109988,7.22,0,http://www.openphacts.org/units/Nanomolar,244352,=,1,1,=,,IC50,nM,,60.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,60.0
,,274429,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.COc1cc(Cl)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '21.77', 'le': '0.42', 'lle': '3.50', 'sei': '49.46'}",CHEMBL1202211,,CHEMBL126032,7.77,0,http://www.openphacts.org/units/Nanomolar,244358,=,1,1,=,,IC50,nM,,17.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,17.0
,,277005,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Clc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1Cl,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '24.08', 'le': '0.50', 'lle': '3.78', 'sei': '134.24'}",CHEMBL1202213,,CHEMBL341310,8.70,0,http://www.openphacts.org/units/Nanomolar,244363,=,1,1,=,,IC50,nM,,2.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.0
,,277008,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Clc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(Cl)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '19.91', 'le': '0.41', 'lle': '2.27', 'sei': '111.02'}",CHEMBL125455,,CHEMBL125455,7.19,0,http://www.openphacts.org/units/Nanomolar,244360,=,1,1,=,,IC50,nM,,64.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,64.0
,,278120,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.COc1ccccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '25.74', 'le': '0.47', 'lle': '4.68', 'sei': '52.84'}",CHEMBL1202216,,CHEMBL126509,8.30,0,http://www.openphacts.org/units/Nanomolar,244332,=,1,1,=,,IC50,nM,,5.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.0
,,278123,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.COc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '20.99', 'le': '0.39', 'lle': '3.15', 'sei': '43.07'}",CHEMBL1202217,,CHEMBL125910,6.77,0,http://www.openphacts.org/units/Nanomolar,244333,=,1,1,=,,IC50,nM,,171.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,171.0
,,282922,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Oc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3Cl)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '20.99', 'le': '0.43', 'lle': '3.30', 'sei': '29.65'}",CHEMBL1202202,,CHEMBL126126,7.92,0,http://www.openphacts.org/units/Nanomolar,244342,=,1,1,=,,IC50,nM,,12.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,12.0
,,285300,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '22.34', 'le': '0.44', 'lle': '3.97', 'sei': '20.72'}",CHEMBL54,HALOPERIDOL,CHEMBL54,8.40,0,http://www.openphacts.org/units/Nanomolar,244338,=,1,1,=,,IC50,nM,,4.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.0
,,286421,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Clc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '20.91', 'le': '0.41', 'lle': '2.57', 'sei': '105.49'}",CHEMBL1202221,,CHEMBL126182,6.84,0,http://www.openphacts.org/units/Nanomolar,244335,=,1,1,=,,IC50,nM,,146.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,146.0
,,286424,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '20.22', 'le': '0.39', 'lle': '2.34', 'sei': '101.99'}",CHEMBL1202220,,CHEMBL419610,6.61,0,http://www.openphacts.org/units/Nanomolar,244334,=,1,1,=,,IC50,nM,,246.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,246.0
,,286427,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Cl.c1ccc([C@H]2C[C@@H]2CN2CCN(c3ncccn3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '20.77', 'le': '0.38', 'lle': '3.72', 'sei': '18.96'}",CHEMBL1203257,,CHEMBL126847,6.12,0,http://www.openphacts.org/units/Nanomolar,244344,=,1,1,=,,IC50,nM,,766.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,766.0
,,286430,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccc3Cl)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '22.87', 'le': '0.45', 'lle': '3.49', 'sei': '121.70'}",CHEMBL1202219,,CHEMBL126322,7.89,0,http://www.openphacts.org/units/Nanomolar,244341,=,1,1,=,,IC50,nM,,13.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,13.0
,,287574,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Cc1cc(Cl)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '20.22', 'le': '0.39', 'lle': '2.32', 'sei': '106.37'}",CHEMBL1202210,,CHEMBL338183,6.89,0,http://www.openphacts.org/units/Nanomolar,244356,=,1,1,=,,IC50,nM,,128.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,128.0
,,290110,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccc3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '25.41', 'le': '0.46', 'lle': '3.82', 'sei': '114.69'}",CHEMBL341497,,CHEMBL341497,7.43,0,http://www.openphacts.org/units/Nanomolar,244330,=,1,1,=,,IC50,nM,,37.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,37.0
,,290113,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Clc1ccccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '25.40', 'le': '0.49', 'lle': '4.03', 'sei': '128.10'}",CHEMBL1202215,,CHEMBL126633,8.30,0,http://www.openphacts.org/units/Nanomolar,244331,=,1,1,=,,IC50,nM,,5.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.0
,,290116,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1Cl,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '18.49', 'le': '0.38', 'lle': '1.76', 'sei': '103.12'}",CHEMBL1202212,,CHEMBL126429,6.68,0,http://www.openphacts.org/units/Nanomolar,244362,=,1,1,=,,IC50,nM,,208.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,208.0
,,290119,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Cc1cc(F)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '22.09', 'le': '0.41', 'lle': '3.11', 'sei': '110.61'}",CHEMBL1202209,,CHEMBL339674,7.17,0,http://www.openphacts.org/units/Nanomolar,244355,=,1,1,=,,IC50,nM,,68.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,68.0
,,290122,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.COc1c(Cl)cc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1Cl,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '16.97', 'le': '0.35', 'lle': '1.71', 'sei': '42.28'}",CHEMBL1202204,,CHEMBL337951,6.64,0,http://www.openphacts.org/units/Nanomolar,244348,=,1,1,=,,IC50,nM,,228.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,228.0
,,290125,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.c1ccc([C@H]2C[C@@H]2CN2CCN(c3ccncc3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,,CHEMBL1202207,,CHEMBL340065,,0,http://www.openphacts.org/units/Nanomolar,244345,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,292540,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '19.46', 'le': '0.40', 'lle': '2.11', 'sei': '108.51'}",CHEMBL1204116,,CHEMBL302075,7.03,0,http://www.openphacts.org/units/Nanomolar,244359,=,1,1,=,,IC50,nM,,93.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,93.0
,,292549,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.COc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3Cl)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '20.84', 'le': '0.43', 'lle': '3.22', 'sei': '51.91'}",CHEMBL1202206,,CHEMBL129556,8.15,0,http://www.openphacts.org/units/Nanomolar,244343,=,1,1,=,,IC50,nM,,7.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.0
,,293714,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(C)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '22.27', 'le': '0.41', 'lle': '2.91', 'sei': '110.13'}",CHEMBL1202208,,CHEMBL126493,7.14,0,http://www.openphacts.org/units/Nanomolar,244350,=,1,1,=,,IC50,nM,,73.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,73.0
,,296390,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Cc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(C)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '22.92', 'le': '0.42', 'lle': '3.12', 'sei': '113.38'}",CHEMBL1204119,,CHEMBL338337,7.35,0,http://www.openphacts.org/units/Nanomolar,244351,=,1,1,=,,IC50,nM,,45.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,45.0
,,297672,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.COc1ccc(Cl)cc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '23.26', 'le': '0.45', 'lle': '4.03', 'sei': '52.84'}",CHEMBL1202205,,CHEMBL126604,8.30,0,http://www.openphacts.org/units/Nanomolar,244349,=,1,1,=,,IC50,nM,,5.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.0
,,300303,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.COc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '18.99', 'le': '0.35', 'lle': '2.50', 'sei': '38.98'}",CHEMBL1202224,,CHEMBL337983,6.12,0,http://www.openphacts.org/units/Nanomolar,244336,=,1,1,=,,IC50,nM,,752.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,752.0
,,300306,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Clc1cc(Cl)cc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '20.74', 'le': '0.43', 'lle': '2.57', 'sei': '115.66'}",CHEMBL1202225,,CHEMBL129324,7.50,0,http://www.openphacts.org/units/Nanomolar,244337,=,1,1,=,,IC50,nM,,32.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,32.0
,,300309,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3cccc(Cl)c3)CC2)cc1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '21.03', 'le': '0.41', 'lle': '2.85', 'sei': '111.91'}",CHEMBL1202223,,CHEMBL126793,7.25,0,http://www.openphacts.org/units/Nanomolar,244340,=,1,1,=,,IC50,nM,,56.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,56.0
,,303809,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,Br.Br.COc1cc(F)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '23.50', 'le': '0.44', 'lle': '4.24', 'sei': '50.92'}",CHEMBL1202214,,CHEMBL126269,8.00,0,http://www.openphacts.org/units/Nanomolar,244357,=,1,1,=,,IC50,nM,,10.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10.0
,,303812,[],CHEMBL671074,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,,,BAO_0000190,BAO_0000357,single protein format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,,,CHEMBL1133592,J Med Chem,2000.0,"{'bei': '16.31', 'le': '0.38', 'lle': '3.38', 'sei': '11.92'}",CHEMBL22242,REMOXIPRIDE,CHEMBL22242,6.06,0,http://www.openphacts.org/units/Nanomolar,244354,=,1,1,=,,IC50,nM,,880.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,880.0
,Not Determined,349023,[],CHEMBL671076,Binding affinity towards human Dopamine receptor D2; Not tested,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)N=C(N1CCN(C)CC1)c1ccccc1N2,,,CHEMBL1132638,J Med Chem,1999.0,,CHEMBL73074,,CHEMBL73074,,0,http://www.openphacts.org/units/Nanomolar,127984,,1,0,,,IC50,nM,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,
,Not Determined,350289,[],CHEMBL671076,Binding affinity towards human Dopamine receptor D2; Not tested,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)C(N1CCN(C)CC1)=Nc1ccccc1N2,,,CHEMBL1132638,J Med Chem,1999.0,,CHEMBL72794,,CHEMBL72794,,0,http://www.openphacts.org/units/Nanomolar,127985,,1,0,,,IC50,nM,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,
,,351725,[],CHEMBL884444,Compound was tested in vitro for its binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,"{'bei': '22.17', 'le': '0.43', 'lle': '3.50', 'sei': '25.89'}",CHEMBL831,LOXAPINE,CHEMBL831,7.27,0,http://www.openphacts.org/units/Nanomolar,127979,=,1,1,=,,IC50,nM,,54.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,54.0
,,353143,[],CHEMBL671075,Binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3ccccc3Nc3ccc(Cl)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,"{'bei': '22.85', 'le': '0.44', 'lle': '3.75', 'sei': '24.19'}",CHEMBL415300,ISOCLOZAPINE,CHEMBL415300,7.47,0,http://www.openphacts.org/units/Nanomolar,127975,=,1,1,=,,IC50,nM,,34.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,34.0
,,356184,[],CHEMBL671075,Binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3ccccc3Nc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,"{'bei': '15.56', 'le': '0.31', 'lle': '3.55', 'sei': '9.23'}",CHEMBL72292,,CHEMBL72292,6.85,0,http://www.openphacts.org/units/Nanomolar,127971,=,1,1,=,,IC50,nM,,140.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,140.0
,,360335,[],CHEMBL671075,Binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,"{'bei': '20.15', 'le': '0.39', 'lle': '2.87', 'sei': '21.33'}",CHEMBL42,CLOZAPINE,CHEMBL42,6.58,0,http://www.openphacts.org/units/Nanomolar,127970,=,1,1,=,,IC50,nM,,260.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,260.0
,Not Determined,362892,[],CHEMBL671076,Binding affinity towards human Dopamine receptor D2; Not tested,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3cc(OS(=O)(=O)C(F)(F)F)ccc3Nc3ccccc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,,CHEMBL310712,,CHEMBL310712,,0,http://www.openphacts.org/units/Nanomolar,127973,,1,0,,,IC50,nM,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,
,Not Determined,364585,[],CHEMBL671076,Binding affinity towards human Dopamine receptor D2; Not tested,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3cc(OS(C)(=O)=O)ccc3Nc3ccccc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,,CHEMBL70609,,CHEMBL70609,,0,http://www.openphacts.org/units/Nanomolar,127972,,1,0,,,IC50,nM,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,
,Not Determined,366049,[],CHEMBL671076,Binding affinity towards human Dopamine receptor D2; Not tested,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3ccccc3Nc3ccc(OS(C)(=O)=O)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,,CHEMBL307163,,CHEMBL307163,,0,http://www.openphacts.org/units/Nanomolar,127974,,1,0,,,IC50,nM,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,
,,369930,[],CHEMBL857158,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CNCC1CC2c3ccccc3Cc3ccccc3N2O1,,,CHEMBL1135380,Bioorg Med Chem Lett,2002.0,"{'bei': '20.58', 'le': '0.38', 'lle': '2.71', 'sei': '23.55'}",CHEMBL81485,,CHEMBL81485,5.77,0,http://www.openphacts.org/units/Nanomolar,147845,=,1,1,=,,IC50,nM,,1698.24,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.77
,,370265,[],CHEMBL671075,Binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,"{'bei': '15.84', 'le': '0.33', 'lle': '3.57', 'sei': '10.13'}",CHEMBL70319,,CHEMBL70319,7.52,0,http://www.openphacts.org/units/Nanomolar,127976,=,1,1,=,,IC50,nM,,30.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30.0
,Not Determined,370280,[],CHEMBL671076,Binding affinity towards human Dopamine receptor D2; Not tested,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3ccccc3Nc3ccc(O)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,,CHEMBL308090,,CHEMBL308090,,0,http://www.openphacts.org/units/Nanomolar,127983,,1,0,,,IC50,nM,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,
,Not Determined,370291,[],CHEMBL671076,Binding affinity towards human Dopamine receptor D2; Not tested,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3cc(O)ccc3Nc3ccccc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,,CHEMBL70377,,CHEMBL70377,,0,http://www.openphacts.org/units/Nanomolar,127982,,1,0,,,IC50,nM,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,
,,371618,[],CHEMBL671075,Binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL1132638,J Med Chem,1999.0,"{'bei': '22.11', 'le': '0.44', 'lle': '3.88', 'sei': '20.50'}",CHEMBL54,HALOPERIDOL,CHEMBL54,8.31,0,http://www.openphacts.org/units/Nanomolar,127969,=,1,1,=,,IC50,nM,,4.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.9
,,371638,[],CHEMBL671075,Binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3ccccc3Sc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,"{'bei': '16.70', 'le': '0.35', 'lle': '3.93', 'sei': '12.28'}",CHEMBL73589,,CHEMBL73589,7.64,0,http://www.openphacts.org/units/Nanomolar,127980,=,1,1,=,,IC50,nM,,23.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,23.0
,,372649,[],CHEMBL857158,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,,,CHEMBL1135380,Bioorg Med Chem Lett,2002.0,"{'bei': '20.58', 'le': '0.38', 'lle': '2.66', 'sei': '38.57'}",CHEMBL83658,,CHEMBL83658,6.06,1,http://www.openphacts.org/units/Nanomolar,147852,=,1,1,=,,IC50,nM,,870.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.06
,,374575,[],CHEMBL884444,Compound was tested in vitro for its binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3ccccc3Oc3ccc(OS(C)(=O)=O)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,,CHEMBL306474,,CHEMBL306474,,0,http://www.openphacts.org/units/Nanomolar,127978,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,376927,[],CHEMBL857158,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1,,,CHEMBL1135380,Bioorg Med Chem Lett,2002.0,"{'bei': '16.28', 'le': '0.30', 'lle': '1.23', 'sei': '31.95'}",CHEMBL313189,,CHEMBL313189,5.02,0,http://www.openphacts.org/units/Nanomolar,147856,=,1,1,=,,IC50,nM,,9549.93,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.02
,,378666,[],CHEMBL671075,Binding affinity towards human Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3ccccc3Oc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1,,,CHEMBL1132638,J Med Chem,1999.0,"{'bei': '16.50', 'le': '0.33', 'lle': '3.93', 'sei': '10.20'}",CHEMBL430798,,CHEMBL430798,7.28,0,http://www.openphacts.org/units/Nanomolar,127981,=,1,1,=,,IC50,nM,,52.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,52.0
,,386983,[],CHEMBL857158,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN2c3ccccc3Cc3ccccc3C2C1,,,CHEMBL1135380,Bioorg Med Chem Lett,2002.0,"{'bei': '19.48', 'le': '0.35', 'lle': '2.07', 'sei': '79.48'}",CHEMBL6437,MIANSERIN,CHEMBL6437,5.15,0,http://www.openphacts.org/units/Nanomolar,147857,=,1,1,=,,IC50,nM,,7079.46,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.15
,,442275,[],CHEMBL672304,Inhibitory concentration against Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,,,CHEMBL1128756,Bioorg Med Chem Lett,1995.0,,CHEMBL603,ZAFIRLUKAST,CHEMBL603,,0,http://www.openphacts.org/units/Nanomolar,43613,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,450225,[],CHEMBL663736,Compound was tested for its affinity towards dopaminergic (D2) receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1N1CCN(C(=O)COc2ccc3[nH]cc(CCN)c3c2)CC1,,,CHEMBL1128860,Bioorg Med Chem Lett,1995.0,,CHEMBL120055,,CHEMBL120055,,0,http://www.openphacts.org/units/Nanomolar,312115,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,450234,[],CHEMBL672304,Inhibitory concentration against Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cnccc2n1-c1ccc(OCc2cccc(/C=C/c3ccc4ccc(Cl)cc4n3)c2)cc1,,,CHEMBL1128756,Bioorg Med Chem Lett,1995.0,,CHEMBL28902,,CHEMBL28902,,0,http://www.openphacts.org/units/Nanomolar,43612,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,455492,[],CHEMBL663736,Compound was tested for its affinity towards dopaminergic (D2) receptor,B,,,BAO_0000190,BAO_0000357,single protein format,NCCc1c[nH]c2ccc(OCC(=O)N3CCN(c4cccc5ccccc45)CC3)cc12,,,CHEMBL1128860,Bioorg Med Chem Lett,1995.0,,CHEMBL160581,,CHEMBL160581,,0,http://www.openphacts.org/units/Nanomolar,312110,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,458242,[],CHEMBL672304,Inhibitory concentration against Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2cnccc2n1-c1ccc(OCc2cccc(/C=C/c3nc4cc(F)ccc4s3)c2)cc1,,,CHEMBL1128756,Bioorg Med Chem Lett,1995.0,,CHEMBL31714,,CHEMBL31714,,0,http://www.openphacts.org/units/Nanomolar,43610,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,464479,[],CHEMBL671650,Inhibitory concentration against binding of [3H]spiperone to human D2 dopaminergic receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc2c(c1)CCN2,,,CHEMBL1129926,Bioorg Med Chem Lett,1997.0,"{'bei': '44.29', 'le': '0.82', 'lle': '4.63', 'sei': '18.56'}",CHEMBL19331,,CHEMBL19331,5.99,0,http://www.openphacts.org/units/Nanomolar,24510,=,1,1,=,,IC50,nM,,1030.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.03
,,471335,[],CHEMBL671650,Inhibitory concentration against binding of [3H]spiperone to human D2 dopaminergic receptor,B,,,BAO_0000190,BAO_0000357,single protein format,OC[C@H]1O[C@H](Oc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)[C@H](O)[C@H](O)[C@H]1O,,,CHEMBL1129926,Bioorg Med Chem Lett,1997.0,"{'bei': '12.96', 'le': '0.25', 'lle': '5.91', 'sei': '3.70'}",CHEMBL2303762,,CHEMBL2303762,5.62,0,http://www.openphacts.org/units/Nanomolar,24519,=,1,1,=,,IC50,nM,,2420.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.42
,,474590,[],CHEMBL670114,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1,,,CHEMBL1131565,J Med Chem,1998.0,"{'bei': '18.52', 'le': '0.35', 'lle': '3.30', 'sei': '16.04'}",CHEMBL349034,,CHEMBL349034,7.10,0,http://www.openphacts.org/units/Nanomolar,324112,=,1,1,=,,IC50,nM,,79.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,79.0
,,489046,[],CHEMBL670114,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CC[C@H]2CC[C@H](Nc3ncccn3)CC2)CC1,,,CHEMBL1131565,J Med Chem,1998.0,"{'bei': '20.24', 'le': '0.38', 'lle': '4.33', 'sei': '14.96'}",CHEMBL164792,,CHEMBL164792,8.00,0,http://www.openphacts.org/units/Nanomolar,324115,=,1,1,=,,IC50,nM,,9.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.9
,,513661,[],CHEMBL672502,Binding affinity against Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1,,,CHEMBL1135009,Bioorg Med Chem Lett,2002.0,"{'bei': '19.36', 'le': '0.36', 'lle': '2.92', 'sei': '20.00'}",CHEMBL331077,,CHEMBL331077,5.72,0,http://www.openphacts.org/units/Nanomolar,226249,=,1,1,=,,IC50,nM,,1905.46,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-5.72
,,521455,[],CHEMBL672502,Binding affinity against Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,,,CHEMBL1135009,Bioorg Med Chem Lett,2002.0,"{'bei': '20.58', 'le': '0.38', 'lle': '2.66', 'sei': '38.57'}",CHEMBL83658,,CHEMBL83658,6.06,0,http://www.openphacts.org/units/Nanomolar,226246,=,1,1,=,,IC50,nM,,870.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-6.06
,,537459,[],CHEMBL672502,Binding affinity against Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1,,,CHEMBL1135009,Bioorg Med Chem Lett,2002.0,"{'bei': '24.51', 'le': '0.48', 'lle': '4.00', 'sei': '51.30'}",CHEMBL315772,,CHEMBL315772,8.06,0,http://www.openphacts.org/units/Nanomolar,226248,=,1,1,=,,IC50,nM,,8.71,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-8.06
,,552603,[],CHEMBL672502,Binding affinity against Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3cccnc3Cc3ccccc3N2O1,,,CHEMBL1135009,Bioorg Med Chem Lett,2002.0,,CHEMBL331188,,CHEMBL331188,,0,http://www.openphacts.org/units/Nanomolar,226247,<,1,1,<,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-6.0
,,575546,[],CHEMBL671744,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.Cl.Cn1c(=O)c2c(ncn2CCCN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n(C)c1=O,,,CHEMBL1128457,J Med Chem,1995.0,"{'bei': '14.48', 'le': '0.27', 'lle': '4.86', 'sei': '10.79'}",CHEMBL553331,,CHEMBL1194812,7.37,0,http://www.openphacts.org/units/Nanomolar,249001,=,1,1,=,,IC50,nM,,43.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,43.0
,,576832,[],CHEMBL671744,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,,,CHEMBL1128457,J Med Chem,1995.0,"{'bei': '15.36', 'le': '0.28', 'lle': '-0.01', 'sei': '24.42'}",CHEMBL305660,EBASTINE,CHEMBL305660,7.21,0,http://www.openphacts.org/units/Nanomolar,249012,=,1,1,=,,IC50,nM,,61.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,61.0
,,590449,[],CHEMBL671744,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1c(=O)c2c(ncn2CCCN2CCC(C(c3ccccc3)c3ccccc3)CC2)n(C)c1=O.O=C(O)/C=C/C(=O)O,,,CHEMBL1128457,J Med Chem,1995.0,"{'bei': '15.66', 'le': '0.29', 'lle': '4.02', 'sei': '11.35'}",CHEMBL338611,,CHEMBL1184199,7.39,0,http://www.openphacts.org/units/Nanomolar,248997,=,1,1,=,,IC50,nM,,41.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,41.0
,,599009,[],CHEMBL666193,Compound was tested for inhibitory activity against Dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N)c(Cl)cc1C(=O)NC1C2CC3CN(C2)CC31.Cl,,,CHEMBL1130509,Bioorg Med Chem Lett,1997.0,,CHEMBL558226,,CHEMBL319673,,0,http://www.openphacts.org/units/Nanomolar,119302,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,610010,[],CHEMBL672301,Compound was selective with respect to binding at the Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N)c(Cl)cc1C(=O)NCC12CC3CN(CC3C1)C2,,,CHEMBL1130509,Bioorg Med Chem Lett,1997.0,,CHEMBL67555,,CHEMBL67555,,0,http://www.openphacts.org/units/Nanomolar,119304,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,640447,[],CHEMBL671343,Binding affinity against Dopamine receptor D2 was determined using [ [3H]-spiperone radioligand,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,,,CHEMBL1128281,J Med Chem,1995.0,"{'bei': '16.32', 'le': '0.31', 'lle': '2.13', 'sei': '10.74'}",CHEMBL14376,ILOPERIDONE,CHEMBL14376,6.96,0,http://www.openphacts.org/units/Nanomolar,14604,=,1,1,=,,IC50,nM,,110.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,110.0
,,692315,[],CHEMBL672300,In vitro receptor binding affinity against Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,NC1CCc2cc(O)c(O)cc2[C@H]1c1ccccc1,,,CHEMBL1128439,J Med Chem,1995.0,,CHEMBL110362,,CHEMBL110362,,0,http://www.openphacts.org/units/Nanomolar,208762,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.0
,,719167,[],CHEMBL671063,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,F,,,BAO_0000190,BAO_0000019,assay format,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL225230,R-N-PROPYLNORAPOMORPHINE,CHEMBL225230,,0,http://www.openphacts.org/units/Nanomolar,251223,=,1,1,=,,IC50,nM,,0.000001,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.000001
,,720521,[],CHEMBL663737,Tested for binding affinity for Dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C2CCC1CC(NC(=O)c1cnn3ccccc13)C2,,,CHEMBL1127772,Bioorg Med Chem Lett,1994.0,,CHEMBL355149,,CHEMBL355149,,0,http://www.openphacts.org/units/Nanomolar,315747,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,722356,[],CHEMBL671743,Antagonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]spiperone,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL267044,LEVOSULPIRIDE,CHEMBL267044,,0,http://www.openphacts.org/units/Nanomolar,251217,=,1,1,=,,IC50,nM,,2E-8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2E-8
,,734564,[],CHEMBL663738,Tested for binding affinity for Dopamine D2 receptors,B,,,BAO_0000190,BAO_0000357,single protein format,CN1C2CCC1CC(OC(=O)c1cnn3ccccc13)C2,,,CHEMBL1127772,Bioorg Med Chem Lett,1994.0,,CHEMBL350972,,CHEMBL350972,,0,http://www.openphacts.org/units/Nanomolar,315743,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,735583,[],CHEMBL671063,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,F,,,BAO_0000190,BAO_0000019,assay format,NC1CCc2cc(O)c(O)cc2C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL26736,,CHEMBL26736,,0,http://www.openphacts.org/units/Nanomolar,251222,=,1,1,=,,IC50,nM,,4E-8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4E-8
,,735584,[],CHEMBL671063,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,F,,,BAO_0000190,BAO_0000019,assay format,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL225230,R-N-PROPYLNORAPOMORPHINE,CHEMBL225230,,0,http://www.openphacts.org/units/Nanomolar,251216,=,1,1,=,,IC50,nM,,1E-9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1E-9
,,738351,[],CHEMBL671743,Antagonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]spiperone,F,,,BAO_0000190,BAO_0000019,assay format,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL267930,SPIPERONE,CHEMBL267930,,0,http://www.openphacts.org/units/Nanomolar,251218,=,1,1,=,,IC50,nM,,3E-10,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3E-10
,,738352,[],CHEMBL671743,Antagonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]spiperone,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL1255588,,CHEMBL1255588,,0,http://www.openphacts.org/units/Nanomolar,251215,=,1,1,=,,IC50,nM,,5E-9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5E-9
,,739473,[],CHEMBL671063,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,F,,,BAO_0000190,BAO_0000019,assay format,NCCc1c[nH]c2ccc(O)cc12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL39,SEROTONIN,CHEMBL39,,0,http://www.openphacts.org/units/Nanomolar,251219,=,1,1,=,,IC50,nM,,0.0003,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.0003
,,742214,[],CHEMBL671743,Antagonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]spiperone,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)[C@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL479587,(-)-BUTACLAMOL,CHEMBL479587,,0,http://www.openphacts.org/units/Nanomolar,251214,>,1,1,>,,IC50,nM,,0.00001,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.00001
,,746137,[],CHEMBL671063,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,F,,,BAO_0000190,BAO_0000019,assay format,NCCc1ccc(O)c(O)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL59,DOPAMINE,CHEMBL59,,0,http://www.openphacts.org/units/Nanomolar,251221,=,1,1,=,,IC50,nM,,0.000008,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.000008
,,752300,[],CHEMBL671063,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,F,,,BAO_0000190,BAO_0000019,assay format,NC[C@H](O)c1ccc(O)c(O)c1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1122967,J Med Chem,1985.0,,CHEMBL1437,NOREPINEPHRINE,CHEMBL1437,,0,http://www.openphacts.org/units/Nanomolar,251220,=,1,1,=,,IC50,nM,,0.00008,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.00008
,,833646,[],CHEMBL670073,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2C1,,,CHEMBL1129704,Bioorg Med Chem Lett,1996.0,"{'bei': '18.65', 'le': '0.35', 'lle': '3.85', 'sei': '12.23'}",CHEMBL11425,,CHEMBL11425,7.17,0,http://www.openphacts.org/units/Nanomolar,8969,=,1,1,=,,IC50,nM,,67.61,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-7.17
,,836046,[],CHEMBL670678,Compound was evaluated for the binding affinity towards Dopamine receptor D2 by displacement of [3H]SCH-23390.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c1CC1(CCCN1CCCCN1C(=O)CC3(CCCC3)CC1=O)CO2,,,CHEMBL1129704,Bioorg Med Chem Lett,1996.0,"{'bei': '13.53', 'le': '0.25', 'lle': '2.01', 'sei': '10.09'}",CHEMBL11265,,CHEMBL11265,5.96,0,http://www.openphacts.org/units/Nanomolar,8965,=,1,1,=,,IC50,nM,,1096.48,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-5.96
,,837255,[],CHEMBL670073,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)CC1COc2cccc(OC)c2C1,,,CHEMBL1129704,Bioorg Med Chem Lett,1996.0,"{'bei': '12.59', 'le': '0.24', 'lle': '1.30', 'sei': '9.73'}",CHEMBL417608,,CHEMBL417608,5.75,0,http://www.openphacts.org/units/Nanomolar,8968,=,1,1,=,,IC50,nM,,1778.28,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-5.75
,,852693,[],CHEMBL670073,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2c1CC(CNCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2,,,CHEMBL1129704,Bioorg Med Chem Lett,1996.0,"{'bei': '18.16', 'le': '0.34', 'lle': '4.20', 'sei': '11.09'}",CHEMBL416523,,CHEMBL416523,7.53,0,http://www.openphacts.org/units/Nanomolar,8961,=,1,1,=,,IC50,nM,,29.51,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-7.53
,,852699,[],CHEMBL670073,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN(CCC)CC1COc2cccc(OC)c2C1,,,CHEMBL1129704,Bioorg Med Chem Lett,1996.0,"{'bei': '20.15', 'le': '0.38', 'lle': '2.22', 'sei': '25.76'}",CHEMBL11262,,CHEMBL11262,5.59,0,http://www.openphacts.org/units/Nanomolar,8970,=,1,1,=,,IC50,nM,,2570.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-5.59
,,864198,[],CHEMBL670073,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1,,,CHEMBL1129704,Bioorg Med Chem Lett,1996.0,"{'bei': '18.08', 'le': '0.34', 'lle': '3.80', 'sei': '13.54'}",CHEMBL11592,,CHEMBL11592,8.00,0,http://www.openphacts.org/units/Nanomolar,8964,=,1,1,=,,IC50,nM,,10.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,Log IC50,,UO_0000065,,-8.0
,,949648,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(CCOC(=O)NC2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '12.09', 'le': '0.22', 'lle': '0.08', 'sei': '9.58'}",CHEMBL116463,,CHEMBL116463,6.26,0,http://www.openphacts.org/units/Nanomolar,216610,=,1,1,=,,IC50,nM,,551.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,551.0
,,951006,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc(CCOC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '11.22', 'le': '0.21', 'lle': '-0.10', 'sei': '9.99'}",CHEMBL326263,,CHEMBL326263,5.65,0,http://www.openphacts.org/units/Nanomolar,216626,=,1,1,=,,IC50,nM,,2240.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2240.0
,,960153,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(CCNC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '10.62', 'le': '0.20', 'lle': '-0.31', 'sei': '12.36'}",CHEMBL113956,,CHEMBL113956,5.54,0,http://www.openphacts.org/units/Nanomolar,216612,=,1,1,=,,IC50,nM,,2890.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2890.0
,,962620,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCN(c2ccccc2)C12CCN(Cc1cccc(Oc3ccccc3)c1)CC2,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '15.16', 'le': '0.28', 'lle': '1.86', 'sei': '13.99'}",CHEMBL115280,,CHEMBL115280,6.27,0,http://www.openphacts.org/units/Nanomolar,216628,=,1,1,=,,IC50,nM,,538.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,538.0
,,969067,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3nsnc3c1)CC2,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '18.21', 'le': '0.35', 'lle': '4.29', 'sei': '11.26'}",CHEMBL325750,,CHEMBL325750,6.91,0,http://www.openphacts.org/units/Nanomolar,216629,=,1,1,=,,IC50,nM,,123.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,123.0
,,970267,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cc4c(cc3Cl)OCO4)CC2)C1=O,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '12.05', 'le': '0.23', 'lle': '3.21', 'sei': '7.63'}",CHEMBL115222,,CHEMBL115222,5.67,0,http://www.openphacts.org/units/Nanomolar,216631,=,1,1,=,,IC50,nM,,2120.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2120.0
,,975320,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(OCCc1ccc(F)cc1)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '11.24', 'le': '0.21', 'lle': '-0.43', 'sei': '17.03'}",CHEMBL325516,,CHEMBL325516,5.58,0,http://www.openphacts.org/units/Nanomolar,216625,=,1,1,=,,IC50,nM,,2620.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2620.0
,,978919,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CN2CCC(n3c(O)nc4ccccc43)CC2)c(Cl)c1,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '17.76', 'le': '0.35', 'lle': '1.78', 'sei': '15.30'}",CHEMBL114484,,CHEMBL114484,6.32,0,http://www.openphacts.org/units/Nanomolar,216594,=,1,1,=,,IC50,nM,,480.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,480.0
,,985302,[],CHEMBL671072,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3c(c1)OCO3)CC2,,,CHEMBL1134625,J Med Chem,2001.0,"{'bei': '17.11', 'le': '0.32', 'lle': '3.91', 'sei': '11.57'}",CHEMBL326962,,CHEMBL326962,6.25,0,http://www.openphacts.org/units/Nanomolar,216630,=,1,1,=,,IC50,nM,,557.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,557.0
,,992177,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(/C=C/c1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,,CHEMBL112457,,CHEMBL1180057,,0,http://www.openphacts.org/units/Nanomolar,213083,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,993234,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,C(=C/c1ccccc1)\CN(c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,,CHEMBL115506,,CHEMBL1180160,,0,http://www.openphacts.org/units/Nanomolar,213086,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,994555,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,"{'bei': '16.63', 'le': '0.30', 'lle': '1.85', 'sei': '16.47'}",CHEMBL116233,,CHEMBL1180187,5.33,0,http://www.openphacts.org/units/Nanomolar,213085,=,1,1,=,,IC50,nM,,4700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4700.0
,,995828,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C/C=C/c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,,CHEMBL112413,,CHEMBL1180053,,0,http://www.openphacts.org/units/Nanomolar,213075,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,995831,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C(=O)C#Cc1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,"{'bei': '15.97', 'le': '0.29', 'lle': '2.15', 'sei': '22.55'}",CHEMBL111964,,CHEMBL1180033,5.31,0,http://www.openphacts.org/units/Nanomolar,213078,=,1,1,=,,IC50,nM,,4900.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4900.0
,,999625,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,C(#Cc1ccccc1)CNC1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,,CHEMBL115934,,CHEMBL1180175,,0,http://www.openphacts.org/units/Nanomolar,213082,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1000647,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,C(=C/c1ccccc1)\CNC1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,,CHEMBL111909,,CHEMBL580142,,0,http://www.openphacts.org/units/Nanomolar,213074,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1003118,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,C(#Cc1ccccc1)CN(c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,"{'bei': '15.90', 'le': '0.28', 'lle': '0.84', 'sei': '93.37'}",CHEMBL113282,,CHEMBL1180091,6.05,0,http://www.openphacts.org/units/Nanomolar,213080,=,1,1,=,,IC50,nM,,890.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,890.0
,,1008266,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C#Cc1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,"{'bei': '14.76', 'le': '0.27', 'lle': '1.08', 'sei': '24.73'}",CHEMBL112170,,CHEMBL1180044,5.82,0,http://www.openphacts.org/units/Nanomolar,213077,=,1,1,=,,IC50,nM,,1500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1500.0
,,1013958,[],CHEMBL671344,Compound was tested for the binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1,,,CHEMBL1125775,J Med Chem,1991.0,,CHEMBL305187,IFENPRODIL,CHEMBL305187,,0,http://www.openphacts.org/units/Nanomolar,195903,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,1014480,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C(=O)/C=C/c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,"{'bei': '15.39', 'le': '0.28', 'lle': '1.33', 'sei': '21.86'}",CHEMBL325063,,CHEMBL1183940,5.15,0,http://www.openphacts.org/units/Nanomolar,213084,=,1,1,=,,IC50,nM,,7100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7100.0
,,1015877,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CC#Cc1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,"{'bei': '16.92', 'le': '0.31', 'lle': '1.76', 'sei': '83.14'}",CHEMBL112957,,CHEMBL1180083,5.39,0,http://www.openphacts.org/units/Nanomolar,213081,=,1,1,=,,IC50,nM,,4100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4100.0
,,1018648,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,C(=C/c1ccccc1)\CN(C/C=C/c1ccccc1)C1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,,CHEMBL320801,,CHEMBL1183846,,0,http://www.openphacts.org/units/Nanomolar,213076,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1019807,[],CHEMBL667743,Displacement of [3H]-spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(C#Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1.O=C(O)/C=C/C(=O)O,,,CHEMBL1127992,Bioorg Med Chem Lett,1994.0,"{'bei': '17.59', 'le': '0.32', 'lle': '2.78', 'sei': '17.32'}",CHEMBL113449,,CHEMBL1180095,5.60,0,http://www.openphacts.org/units/Nanomolar,213079,=,1,1,=,,IC50,nM,,2500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2500.0
,,1029543,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)NCCN2CCN(Cc3ccccc3OC)CC2)c1.Cl.Cl.O,,,CHEMBL1131412,J Med Chem,1998.0,,CHEMBL2373204,,CHEMBL356581,,0,http://www.openphacts.org/units/Nanomolar,283097,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,1031902,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)NCCN2CCN(Cc3ccc(Cl)cc3)CC2)c1.Cl.Cl.O,,,CHEMBL1131412,J Med Chem,1998.0,,CHEMBL2373207,,CHEMBL359051,,0,http://www.openphacts.org/units/Nanomolar,283096,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,1031904,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '20.31', 'le': '0.39', 'lle': '2.92', 'sei': '21.50'}",CHEMBL42,CLOZAPINE,CHEMBL42,6.64,0,http://www.openphacts.org/units/Nanomolar,283087,=,1,1,=,,IC50,nM,,230.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,230.0
,,1033105,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1N1CCN(CCC(=O)NC2CCc3c(cccc3OC)C2)CC1,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '14.45', 'le': '0.27', 'lle': '3.23', 'sei': '11.32'}",CHEMBL359002,,CHEMBL359002,6.12,0,http://www.openphacts.org/units/Nanomolar,283091,=,1,1,=,,IC50,nM,,761.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,761.0
,,1042628,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1C(=O)NCCN1CCN(c2ccccc2OC)CC1,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '16.49', 'le': '0.31', 'lle': '3.83', 'sei': '11.27'}",CHEMBL356358,,CHEMBL356358,6.09,0,http://www.openphacts.org/units/Nanomolar,283098,=,1,1,=,,IC50,nM,,810.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,810.0
,,1042630,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-c2csc(CCN3CCN(c4ccccc4OC)CC3)n2)c1.Cl,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '14.80', 'le': '0.29', 'lle': '1.87', 'sei': '16.02'}",CHEMBL2373205,,CHEMBL144494,6.06,0,http://www.openphacts.org/units/Nanomolar,283094,=,1,1,=,,IC50,nM,,870.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,870.0
,,1044111,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(OC)c(C(=O)NCCN2CCN(c3ccccc3OC)CC2)c1,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '16.53', 'le': '0.31', 'lle': '4.34', 'sei': '10.43'}",CHEMBL144811,,CHEMBL144811,6.60,0,http://www.openphacts.org/units/Nanomolar,283085,=,1,1,=,,IC50,nM,,250.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,250.0
,,1050214,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1N1CCN(CCCC2CCCc3c(OC)cccc32)CC1,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '19.51', 'le': '0.36', 'lle': '2.97', 'sei': '30.87'}",CHEMBL26929,,CHEMBL26929,7.70,0,http://www.openphacts.org/units/Nanomolar,283093,=,1,1,=,,IC50,nM,,20.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,20.0
,,1051372,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(-c2csc(CN3CCN(c4ccccc4OC)CC3)n2)c1.Cl.Cl.Cl.O,,,CHEMBL1131412,J Med Chem,1998.0,,CHEMBL2373206,,CHEMBL144868,,0,http://www.openphacts.org/units/Nanomolar,283095,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,1052610,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)C(CCCN1CCN(c3ccccc3OC)CC1)CCC2,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '17.29', 'le': '0.32', 'lle': '2.09', 'sei': '27.36'}",CHEMBL424125,,CHEMBL424125,6.82,0,http://www.openphacts.org/units/Nanomolar,283092,=,1,1,=,,IC50,nM,,150.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,150.0
,,1055092,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2c(c1)CC(NC(=O)CCN1CCN(c3ccccc3OC)CC1)CC2.Cl.Cl,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '14.61', 'le': '0.27', 'lle': '3.30', 'sei': '11.45'}",CHEMBL2373210,,CHEMBL147897,6.19,0,http://www.openphacts.org/units/Nanomolar,283090,=,1,1,=,,IC50,nM,,650.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,650.0
,,1055094,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '22.31', 'le': '0.44', 'lle': '3.96', 'sei': '20.69'}",CHEMBL54,HALOPERIDOL,CHEMBL54,8.39,0,http://www.openphacts.org/units/Nanomolar,283086,=,1,1,=,,IC50,nM,,4.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.1
,,1060036,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)NCCN2CCN(c3ccccc3OC)CC2)c1,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '16.66', 'le': '0.31', 'lle': '3.89', 'sei': '11.39'}",CHEMBL286725,,CHEMBL286725,6.16,0,http://www.openphacts.org/units/Nanomolar,283105,=,1,1,=,,IC50,nM,,700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,700.0
,,1061304,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,,,CHEMBL1131412,J Med Chem,1998.0,,CHEMBL357448,,CHEMBL357448,,0,http://www.openphacts.org/units/Nanomolar,283100,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,1062791,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)CCCN2CCN(c3ccccc3OC)CC2)c1,,,CHEMBL1131412,J Med Chem,1998.0,"{'bei': '21.40', 'le': '0.40', 'lle': '4.40', 'sei': '18.77'}",CHEMBL26677,,CHEMBL26677,7.89,0,http://www.openphacts.org/units/Nanomolar,283102,=,1,1,=,,IC50,nM,,13.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,13.0
,,1064014,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1,,,CHEMBL1131412,J Med Chem,1998.0,,CHEMBL93403,,CHEMBL93403,,0,http://www.openphacts.org/units/Nanomolar,283104,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,1066332,[],CHEMBL670113,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(C(=O)NCCN2CCN(c3ccccn3)CC2)c1,,,CHEMBL1131412,J Med Chem,1998.0,,CHEMBL147483,,CHEMBL147483,,0,http://www.openphacts.org/units/Nanomolar,283103,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,1066775,[],CHEMBL666192,Binding affinity towards dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc([Si]2(c3ccc(F)cc3)CCC(N3CCN(c4ccccc4)CC3)C2)cc1,,,CHEMBL1127235,Bioorg Med Chem Lett,1994.0,"{'bei': '16.11', 'le': None, 'lle': None, 'sei': None}",CHEMBL134423,,CHEMBL134423,7.00,0,http://www.openphacts.org/units/Nanomolar,256805,=,1,1,=,,IC50,nM,,100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100.0
,,1086475,[],CHEMBL666192,Binding affinity towards dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc([Si]2(c3ccc(F)cc3)CCC(N3CCN(c4ccccc4)CC3)C2)cc1,,,CHEMBL1127235,Bioorg Med Chem Lett,1994.0,"{'bei': '15.77', 'le': None, 'lle': None, 'sei': None}",CHEMBL134423,,CHEMBL134423,6.85,0,http://www.openphacts.org/units/Nanomolar,256798,=,1,1,=,,IC50,nM,,140.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,140.0
,,1098055,[],CHEMBL670685,Ability to displace [3H]YM-0915 from Dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCC(COc2nc3ccccc3c3c2CCCN3)CC1,,,CHEMBL1145012,J Med Chem,2003.0,"{'bei': '16.11', 'le': '0.30', 'lle': '1.38', 'sei': '14.63'}",CHEMBL35226,,CHEMBL35226,5.47,0,http://www.openphacts.org/units/Nanomolar,53680,=,1,1,=,,IC50,nM,,3400.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,M,UO_0000065,,0.0000034
,,1152337,[],CHEMBL672501,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1,,,CHEMBL1135381,Bioorg Med Chem Lett,2002.0,"{'bei': '23.82', 'le': '0.44', 'lle': '3.90', 'sei': '47.36'}",CHEMBL84931,,CHEMBL84931,7.44,0,http://www.openphacts.org/units/Nanomolar,152192,=,1,1,=,,IC50,nM,,36.31,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.44
,,1154938,[],CHEMBL672501,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1,,,CHEMBL1135381,Bioorg Med Chem Lett,2002.0,"{'bei': '24.51', 'le': '0.48', 'lle': '4.00', 'sei': '51.30'}",CHEMBL315772,,CHEMBL315772,8.06,1,http://www.openphacts.org/units/Nanomolar,152175,=,1,1,=,,IC50,nM,,8.71,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.06
,,1154953,[],CHEMBL672501,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1,,,CHEMBL1135381,Bioorg Med Chem Lett,2002.0,"{'bei': '19.22', 'le': '0.36', 'lle': '2.67', 'sei': '40.42'}",CHEMBL314107,,CHEMBL314107,6.35,0,http://www.openphacts.org/units/Nanomolar,152191,=,1,1,=,,IC50,nM,,446.68,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.35
,,1164433,[],CHEMBL672501,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,,,CHEMBL1135381,Bioorg Med Chem Lett,2002.0,"{'bei': '20.58', 'le': '0.38', 'lle': '2.66', 'sei': '38.57'}",CHEMBL83658,,CHEMBL83658,6.06,1,http://www.openphacts.org/units/Nanomolar,152173,=,1,1,=,,IC50,nM,,870.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.06
,,1165701,[],CHEMBL672501,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2,,,CHEMBL1135381,Bioorg Med Chem Lett,2002.0,"{'bei': '23.54', 'le': '0.43', 'lle': '3.55', 'sei': '46.21'}",CHEMBL85735,,CHEMBL85735,7.26,0,http://www.openphacts.org/units/Nanomolar,152178,=,1,1,=,,IC50,nM,,54.95,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.26
,,1174794,[],CHEMBL672501,Binding affinity for human cloned Dopamine receptor D2L,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN2c3ccccc3Cc3ccccc3C2C1,,,CHEMBL1135381,Bioorg Med Chem Lett,2002.0,"{'bei': '19.48', 'le': '0.35', 'lle': '2.07', 'sei': '79.48'}",CHEMBL6437,MIANSERIN,CHEMBL6437,5.15,1,http://www.openphacts.org/units/Nanomolar,152189,=,1,1,=,,IC50,nM,,7079.46,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.15
,,1442592,[],CHEMBL833053,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,,,CHEMBL1137093,Bioorg Med Chem Lett,2004.0,"{'bei': '18.63', 'le': '0.38', 'lle': '2.30', 'sei': '24.38'}",CHEMBL611207,,CHEMBL611207,7.20,0,http://www.openphacts.org/units/Nanomolar,373798,=,1,1,=,,IC50,nM,,63.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,63.0
,,1443828,[],CHEMBL833053,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,,,CHEMBL1137093,Bioorg Med Chem Lett,2004.0,"{'bei': '18.40', 'le': '0.37', 'lle': '2.21', 'sei': '24.08'}",CHEMBL611207,,CHEMBL611207,7.11,0,http://www.openphacts.org/units/Nanomolar,373766,=,1,1,=,,IC50,nM,,77.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,77.0
,,1444387,[],CHEMBL833053,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,,,CHEMBL1137093,Bioorg Med Chem Lett,2004.0,"{'bei': '15.72', 'le': '0.32', 'lle': '1.18', 'sei': '20.57'}",CHEMBL608530,,CHEMBL608530,6.08,0,http://www.openphacts.org/units/Nanomolar,373767,=,1,1,=,,IC50,nM,,837.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,837.0
,,1444403,[],CHEMBL833053,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,,,CHEMBL1137093,Bioorg Med Chem Lett,2004.0,"{'bei': '15.34', 'le': '0.31', 'lle': '1.03', 'sei': '20.08'}",CHEMBL608530,,CHEMBL608530,5.93,0,http://www.openphacts.org/units/Nanomolar,373797,=,1,1,=,,IC50,nM,,1173.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1173.0
,,1508803,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL301242,,CHEMBL301242,7.84,0,http://www.openphacts.org/units/Nanomolar,391188,=,1,1,=,,IC50,nM,,14.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,14.6
,,1508820,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL59725,,CHEMBL59725,7.02,0,http://www.openphacts.org/units/Nanomolar,391213,=,1,1,=,,IC50,nM,,94.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,94.7
,,1508837,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL139926,,CHEMBL139926,6.93,0,http://www.openphacts.org/units/Nanomolar,391240,=,1,1,=,,IC50,nM,,118.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,118.0
,,1508943,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL302374,,CHEMBL302374,7.26,0,http://www.openphacts.org/units/Nanomolar,391326,=,1,1,=,,IC50,nM,,55.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,55.4
,,1508958,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL262724,,CHEMBL262724,7.12,0,http://www.openphacts.org/units/Nanomolar,391352,=,1,1,=,,IC50,nM,,76.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,76.7
,,1509077,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL69451,,CHEMBL69451,7.04,0,http://www.openphacts.org/units/Nanomolar,391004,=,1,1,=,,IC50,nM,,92.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,92.0
,,1509093,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL71327,,CHEMBL71327,7.79,0,http://www.openphacts.org/units/Nanomolar,391029,=,1,1,=,,IC50,nM,,16.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,16.1
,Not Active,1509260,[],CHEMBL874196,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor; IA=inactive,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL304605,,CHEMBL304605,,0,http://www.openphacts.org/units/Nanomolar,391070,,1,0,,,IC50,nM,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,
,,1509275,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C\CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL71865,,CHEMBL71865,8.13,0,http://www.openphacts.org/units/Nanomolar,391092,=,1,1,=,,IC50,nM,,7.49,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.49
,,1509424,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL180060,,CHEMBL180060,6.79,0,http://www.openphacts.org/units/Nanomolar,391093,=,1,1,=,,IC50,nM,,162.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,162.0
,,1509433,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL370713,,CHEMBL370713,7.21,0,http://www.openphacts.org/units/Nanomolar,391122,=,1,1,=,,IC50,nM,,61.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,61.8
,,1509442,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL194493,,CHEMBL194493,7.86,0,http://www.openphacts.org/units/Nanomolar,391143,=,1,1,=,,IC50,nM,,13.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,13.8
,,1509451,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL195057,,CHEMBL195057,8.08,0,http://www.openphacts.org/units/Nanomolar,391163,=,1,1,=,,IC50,nM,,8.29,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8.29
,,1509561,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL366904,,CHEMBL366904,6.96,0,http://www.openphacts.org/units/Nanomolar,391189,=,1,1,=,,IC50,nM,,111.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,111.0
,,1509573,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL175734,,CHEMBL175734,6.59,0,http://www.openphacts.org/units/Nanomolar,391214,=,1,1,=,,IC50,nM,,254.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,254.0
,,1509585,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL180010,,CHEMBL180010,7.09,1,http://www.openphacts.org/units/Nanomolar,391241,=,1,1,=,,IC50,nM,,80.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,80.9
,,1510960,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL300780,,CHEMBL300780,5.89,1,http://www.openphacts.org/units/Nanomolar,391162,=,1,1,=,,IC50,nM,,1280.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1280.0
,,1510976,[],CHEMBL827419,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,,,CHEMBL1139520,J Med Chem,2005.0,,CHEMBL301242,,CHEMBL301242,7.45,0,http://www.openphacts.org/units/Nanomolar,391188,=,1,1,=,,IC50,nM,,35.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,35.6
,,1600487,[],CHEMBL872217,Inhibitory concentration against dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL1140446,J Med Chem,2005.0,"{'bei': '24.62', 'le': '0.48', 'lle': '4.33', 'sei': '26.06'}",CHEMBL42,CLOZAPINE,CHEMBL42,8.05,0,http://www.openphacts.org/units/Nanomolar,400213,=,1,1,=,,IC50,nM,,9.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.0
,,1611110,[],CHEMBL881984,Percent inhibition against Dopamine receptor D2 at 1 uM,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,,,CHEMBL1140374,J Med Chem,2005.0,"{'bei': '22.27', 'le': '0.41', 'lle': '3.21', 'sei': '34.30'}",CHEMBL1255588,,CHEMBL1255588,8.05,1,http://www.openphacts.org/units/Nanomolar,403324,=,1,1,=,,IC50,nM,,8.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8.9
,,1617742,[],CHEMBL872217,Inhibitory concentration against dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc2c(N3CCNCC3)cccc2c1,,,CHEMBL1140446,J Med Chem,2005.0,,CHEMBL277120,,CHEMBL277120,,0,http://www.openphacts.org/units/Nanomolar,405326,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,1617764,[],CHEMBL872217,Inhibitory concentration against dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Cc2cc(CCN3CCN(c4cccc5ccccc45)CC3)ccc2N1,,,CHEMBL1140446,J Med Chem,2005.0,"{'bei': '19.80', 'le': '0.36', 'lle': '3.66', 'sei': '20.68'}",CHEMBL54786,,CHEMBL54786,7.36,0,http://www.openphacts.org/units/Nanomolar,405337,=,1,1,=,,IC50,nM,,44.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,44.0
,,1617788,[],CHEMBL872217,Inhibitory concentration against dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,,,CHEMBL1140446,J Med Chem,2005.0,"{'bei': '20.10', 'le': '0.40', 'lle': '4.49', 'sei': '17.13'}",CHEMBL708,ZIPRASIDONE,CHEMBL708,8.30,0,http://www.openphacts.org/units/Nanomolar,405348,=,1,1,=,,IC50,nM,,5.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.0
,,1617862,[],CHEMBL872217,Inhibitory concentration against dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21,,,CHEMBL1140446,J Med Chem,2005.0,"{'bei': '16.66', 'le': '0.32', 'lle': '3.11', 'sei': '23.00'}",CHEMBL69584,,CHEMBL69584,6.16,0,http://www.openphacts.org/units/Nanomolar,405360,=,1,1,=,,IC50,nM,,690.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,690.0
,,1617912,[],CHEMBL872217,Inhibitory concentration against dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,,,CHEMBL1140446,J Med Chem,2005.0,"{'bei': '18.50', 'le': '0.34', 'lle': '3.64', 'sei': '25.11'}",CHEMBL107742,,CHEMBL107742,6.73,0,http://www.openphacts.org/units/Nanomolar,405371,=,1,1,=,,IC50,nM,,188.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,188.0
,,1617936,[],CHEMBL872217,Inhibitory concentration against dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1,,,CHEMBL1140446,J Med Chem,2005.0,"{'bei': '19.11', 'le': '0.35', 'lle': '3.86', 'sei': '25.93'}",CHEMBL320597,,CHEMBL320597,6.95,0,http://www.openphacts.org/units/Nanomolar,405382,=,1,1,=,,IC50,nM,,113.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,113.0
,,1654241,[],CHEMBL869386,Inhibition of human dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cc(Cl)ccc1/C=C/C(=O)N1CCN(Cc2ccc(F)cc2)C[C@H]1C,,,CHEMBL1141202,Bioorg Med Chem Lett,2005.0,,CHEMBL198949,,CHEMBL198949,,0,http://www.openphacts.org/units/Nanomolar,408008,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.0
,,1676515,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN2CCC[C@@H]12,,,CHEMBL1149398,J Med Chem,2006.0,,CHEMBL34291,,CHEMBL34291,,0,http://www.openphacts.org/units/Nanomolar,423712,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1676699,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,Cn1nc(C(=O)OC[C@@H]2CCN3CCC[C@@H]23)c2ccccc21,,,CHEMBL1149398,J Med Chem,2006.0,,CHEMBL383577,,CHEMBL383577,,0,http://www.openphacts.org/units/Nanomolar,423730,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1676700,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(OC[C@@H]1CCN2CCC[C@@H]12)c1[nH]nc2ccccc12,,,CHEMBL1149398,J Med Chem,2006.0,,CHEMBL201878,,CHEMBL201878,,0,http://www.openphacts.org/units/Nanomolar,423729,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1676701,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(OC[C@@H]1CCN2CCC[C@@H]12)c1c[nH]c2ccccc12,,,CHEMBL1149398,J Med Chem,2006.0,,CHEMBL201946,,CHEMBL201946,,0,http://www.openphacts.org/units/Nanomolar,423726,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1676714,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N)c(Cl)cc1C(=O)OC[C@@H]1CCN2CCC[C@@H]12,,,CHEMBL1149398,J Med Chem,2006.0,,CHEMBL201621,,CHEMBL201621,,0,http://www.openphacts.org/units/Nanomolar,423716,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1676715,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN2CCC[C@@H]12,,,CHEMBL1149398,J Med Chem,2006.0,"{'bei': '15.62', 'le': '0.31', 'lle': '2.74', 'sei': '7.81'}",CHEMBL201019,,CHEMBL201019,5.28,0,http://www.openphacts.org/units/Nanomolar,423714,=,1,1,=,,IC50,nM,,5300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5300.0
,,1676716,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N)c(Cl)cc1C(=O)NC[C@H]1CCN2CCC[C@H]12,,,CHEMBL1149398,J Med Chem,2006.0,"{'bei': '16.70', 'le': '0.34', 'lle': '3.27', 'sei': '8.00'}",CHEMBL37333,,CHEMBL37333,5.41,0,http://www.openphacts.org/units/Nanomolar,423713,=,1,1,=,,IC50,nM,,3900.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3900.0
,,1676739,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N)c(Cl)cc1C(=O)N[C@@H]1C2CC3CN(C2)CC31,,,CHEMBL1149398,J Med Chem,2006.0,,CHEMBL2448165,,CHEMBL2448165,,0,http://www.openphacts.org/units/Nanomolar,423733,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1676740,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,,,CHEMBL1149398,J Med Chem,2006.0,"{'bei': '14.26', 'le': '0.28', 'lle': '3.28', 'sei': '7.72'}",CHEMBL1729,CISAPRIDE,CHEMBL1729,6.64,0,http://www.openphacts.org/units/Nanomolar,423731,=,1,1,=,,IC50,nM,,227.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,227.0
,,1676741,[],CHEMBL858805,Binding affinity to dopamine receptor D2,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NC[C@@H]1CCN2CCC[C@@H]12)c1cc(Cl)cn2ccnc12,,,CHEMBL1149398,J Med Chem,2006.0,,CHEMBL202434,,CHEMBL202434,,0,http://www.openphacts.org/units/Nanomolar,423722,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,1682742,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H](C(=O)c1ccc(C)cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL372312,,CHEMBL372312,,0,http://www.openphacts.org/units/Nanomolar,429286,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682796,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(CC(=O)c1ccc(Cl)c(Cl)c1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL377498,,CHEMBL377498,,0,http://www.openphacts.org/units/Nanomolar,429312,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682797,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(CC(=O)c1ccc(C)cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL202939,,CHEMBL202939,,0,http://www.openphacts.org/units/Nanomolar,429311,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682798,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccc(-c2cccs2)cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL369997,,CHEMBL369997,,0,http://www.openphacts.org/units/Nanomolar,429309,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682799,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccc2ccccc2c1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL204759,,CHEMBL204759,,0,http://www.openphacts.org/units/Nanomolar,429304,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682800,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1cccc(C)c1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL204254,,CHEMBL204254,,0,http://www.openphacts.org/units/Nanomolar,429303,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682801,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccccc1C)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL203403,,CHEMBL203403,,0,http://www.openphacts.org/units/Nanomolar,429302,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682802,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccc(C(F)(F)F)cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL204490,,CHEMBL204490,,0,http://www.openphacts.org/units/Nanomolar,429300,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682803,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccc(NC(C)=O)cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL379679,,CHEMBL379679,,0,http://www.openphacts.org/units/Nanomolar,429299,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682804,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccc(OC)cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL381127,,CHEMBL381127,,0,http://www.openphacts.org/units/Nanomolar,429297,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682805,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccc([N+](=O)[O-])cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL379446,,CHEMBL379446,,0,http://www.openphacts.org/units/Nanomolar,429296,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682806,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccc(O)cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL203563,,CHEMBL203563,,0,http://www.openphacts.org/units/Nanomolar,429295,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1682807,[],CHEMBL859254,Inhibitory activity against dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CCCC(C(=O)c1ccc(Br)cc1)N1CCCC1,,,CHEMBL1138144,J Med Chem,2006.0,,CHEMBL202420,,CHEMBL202420,,0,http://www.openphacts.org/units/Nanomolar,429290,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1739442,[],CHEMBL869737,Binding affinity to D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1coc2ccc(N3C[C@@]4(CN5CCC4CC5)OC3=O)cc12,,,CHEMBL1138068,J Med Chem,2006.0,,CHEMBL2113241,,CHEMBL2113241,,0,http://www.openphacts.org/units/Nanomolar,505173,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nmol/L,UO_0000065,,10000.0
,,1749541,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL377050,,CHEMBL377050,,0,http://www.openphacts.org/units/Nanomolar,532958,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749542,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(O)c(/C(CCN2CCN(c3ccccn3)CC2)=N/O)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213106,,CHEMBL213106,,0,http://www.openphacts.org/units/Nanomolar,532957,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749543,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(OCc2ccccc2)c(/C(CCN2CCN(c3ccccn3)CC2)=N/O)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212075,,CHEMBL212075,,0,http://www.openphacts.org/units/Nanomolar,532956,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749544,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1F,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL214190,,CHEMBL214190,,0,http://www.openphacts.org/units/Nanomolar,532955,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749594,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL385350,,CHEMBL385350,,0,http://www.openphacts.org/units/Nanomolar,532942,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749595,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1Cl,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL214954,,CHEMBL214954,,0,http://www.openphacts.org/units/Nanomolar,532943,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749596,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccccc1Cl,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL385230,,CHEMBL385230,,0,http://www.openphacts.org/units/Nanomolar,532944,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749597,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1/C(CCN1CCN(c2ccccn2)CC1)=N/O,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL215849,,CHEMBL215849,,0,http://www.openphacts.org/units/Nanomolar,532945,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749598,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccccc1/C(CCN1CCN(c2ccccn2)CC1)=N\O,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL214440,,CHEMBL214440,,0,http://www.openphacts.org/units/Nanomolar,532946,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749599,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(F)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212188,,CHEMBL212188,,0,http://www.openphacts.org/units/Nanomolar,532947,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749600,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(Cl)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212189,,CHEMBL212189,,0,http://www.openphacts.org/units/Nanomolar,532948,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749601,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(/C(CCN2CCN(c3ccccn3)CC2)=N/O)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212298,,CHEMBL212298,,0,http://www.openphacts.org/units/Nanomolar,532949,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749602,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccc(/C(CCN2CCN(c3ccccn3)CC2)=N/O)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212847,,CHEMBL212847,,0,http://www.openphacts.org/units/Nanomolar,532950,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749603,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212902,,CHEMBL212902,,0,http://www.openphacts.org/units/Nanomolar,532951,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749604,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL384529,,CHEMBL384529,,0,http://www.openphacts.org/units/Nanomolar,532952,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749605,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1cc(F)cc(F)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL214343,,CHEMBL214343,,0,http://www.openphacts.org/units/Nanomolar,532953,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749610,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(C)cc(/C(CCN2CCN(c3ccccn3)CC2)=N/O)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211985,,CHEMBL211985,,0,http://www.openphacts.org/units/Nanomolar,532954,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749611,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL385826,,CHEMBL385826,,0,http://www.openphacts.org/units/Nanomolar,532959,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749612,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212782,,CHEMBL212782,,0,http://www.openphacts.org/units/Nanomolar,532960,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749613,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213572,,CHEMBL213572,,0,http://www.openphacts.org/units/Nanomolar,532961,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749614,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212831,,CHEMBL212831,,0,http://www.openphacts.org/units/Nanomolar,532962,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749615,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL261957,,CHEMBL261957,,0,http://www.openphacts.org/units/Nanomolar,532963,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749616,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)O/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL376639,,CHEMBL376639,,0,http://www.openphacts.org/units/Nanomolar,532964,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749617,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,C=CCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213700,,CHEMBL213700,,0,http://www.openphacts.org/units/Nanomolar,532965,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749618,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#CCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL376955,,CHEMBL376955,,0,http://www.openphacts.org/units/Nanomolar,532966,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749619,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2cccc(OC)c2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL411545,,CHEMBL411545,,0,http://www.openphacts.org/units/Nanomolar,532975,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749620,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2ccccc2OC)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212607,,CHEMBL212607,,0,http://www.openphacts.org/units/Nanomolar,532974,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749621,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2ccccc2C#N)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL386867,,CHEMBL386867,,0,http://www.openphacts.org/units/Nanomolar,532973,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749622,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2ccccc2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213246,,CHEMBL213246,,0,http://www.openphacts.org/units/Nanomolar,532972,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749623,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccnc1N1CCN(CC/C(=N\O)c2ccccc2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL215670,,CHEMBL215670,,0,http://www.openphacts.org/units/Nanomolar,532967,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749624,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1cccnc1N1CCN(CC/C(=N/O)c2ccccc2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL438961,,CHEMBL438961,,0,http://www.openphacts.org/units/Nanomolar,532968,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749625,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ncccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211972,,CHEMBL211972,,0,http://www.openphacts.org/units/Nanomolar,532969,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749626,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(/CCN1CCN(c2ncccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212804,,CHEMBL212804,,0,http://www.openphacts.org/units/Nanomolar,532970,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749627,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2nccs2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212545,,CHEMBL212545,,0,http://www.openphacts.org/units/Nanomolar,532971,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749628,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)c(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL215569,,CHEMBL215569,,0,http://www.openphacts.org/units/Nanomolar,533012,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749629,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)c(Cl)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213558,,CHEMBL213558,,0,http://www.openphacts.org/units/Nanomolar,533011,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749630,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)c(Cl)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL378324,,CHEMBL378324,,0,http://www.openphacts.org/units/Nanomolar,533010,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749631,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2ccc(OC)cc2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL214203,,CHEMBL214203,,0,http://www.openphacts.org/units/Nanomolar,532976,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749632,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2cccc(OCC)c2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL215704,,CHEMBL215704,,0,http://www.openphacts.org/units/Nanomolar,532977,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749633,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccc2OC(C)C)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL2113243,,CHEMBL2113243,,0,http://www.openphacts.org/units/Nanomolar,532978,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749634,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccc2OC(C)C)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL2113244,,CHEMBL2113244,,0,http://www.openphacts.org/units/Nanomolar,532979,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749635,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2ncccc2C#N)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213398,,CHEMBL213398,,0,http://www.openphacts.org/units/Nanomolar,532980,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749636,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2ncccc2C)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL379597,,CHEMBL379597,,0,http://www.openphacts.org/units/Nanomolar,532981,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749637,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2ncccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL377023,,CHEMBL377023,,0,http://www.openphacts.org/units/Nanomolar,532982,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749638,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C(\CCN1CCN(c2nccs2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL377388,,CHEMBL377388,,0,http://www.openphacts.org/units/Nanomolar,532983,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749639,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1Cl,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212073,,CHEMBL212073,,0,http://www.openphacts.org/units/Nanomolar,532984,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749640,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccccc1Cl,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212290,,CHEMBL212290,,0,http://www.openphacts.org/units/Nanomolar,532985,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749641,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1C,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL437687,,CHEMBL437687,,0,http://www.openphacts.org/units/Nanomolar,532986,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749642,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccccc1C,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213486,,CHEMBL213486,,0,http://www.openphacts.org/units/Nanomolar,532987,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749643,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(Br)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212872,,CHEMBL212872,,0,http://www.openphacts.org/units/Nanomolar,533001,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749644,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Br)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL377585,,CHEMBL377585,,0,http://www.openphacts.org/units/Nanomolar,533000,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749645,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212236,,CHEMBL212236,,0,http://www.openphacts.org/units/Nanomolar,532999,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749646,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212235,,CHEMBL212235,,0,http://www.openphacts.org/units/Nanomolar,532998,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749647,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL427048,,CHEMBL427048,,0,http://www.openphacts.org/units/Nanomolar,532997,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749648,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(F)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL426510,,CHEMBL426510,,0,http://www.openphacts.org/units/Nanomolar,532988,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749649,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(F)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213164,,CHEMBL213164,,0,http://www.openphacts.org/units/Nanomolar,532989,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749650,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(Cl)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212784,,CHEMBL212784,,0,http://www.openphacts.org/units/Nanomolar,532990,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749651,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(Cl)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211930,,CHEMBL211930,,0,http://www.openphacts.org/units/Nanomolar,532991,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749652,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212861,,CHEMBL212861,,0,http://www.openphacts.org/units/Nanomolar,532992,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749653,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212903,,CHEMBL212903,,0,http://www.openphacts.org/units/Nanomolar,532993,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749654,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(C#N)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL437493,,CHEMBL437493,,0,http://www.openphacts.org/units/Nanomolar,532994,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749655,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(C#N)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211836,,CHEMBL211836,,0,http://www.openphacts.org/units/Nanomolar,532995,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749656,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212969,,CHEMBL212969,,0,http://www.openphacts.org/units/Nanomolar,532996,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749657,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(/CCN1CCN(c2ccccn2)CC1)c1cc(F)cc(F)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213518,,CHEMBL213518,,0,http://www.openphacts.org/units/Nanomolar,533047,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749658,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL45244,"PD-168,077",CHEMBL45244,,0,http://www.openphacts.org/units/Nanomolar,533046,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749659,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL209645,,CHEMBL209645,,0,http://www.openphacts.org/units/Nanomolar,533031,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749660,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCO/N=C1/c2ccccc2CCC1CN1CCN(c2ccccn2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212901,,CHEMBL212901,,0,http://www.openphacts.org/units/Nanomolar,533044,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749661,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/c1cccnc1)C(O)CN1CCN(c2ccccn2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL378302,,CHEMBL378302,,0,http://www.openphacts.org/units/Nanomolar,533043,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749662,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/c1ccc(Cl)cc1)C(COC(C)C)CN1CCN(c2ccccn2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211360,,CHEMBL211360,,0,http://www.openphacts.org/units/Nanomolar,533042,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749663,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/c1ccc(Cl)cc1)C(CNOC)CN1CCN(c2ccccn2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212288,,CHEMBL212288,,0,http://www.openphacts.org/units/Nanomolar,533041,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749664,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/c1ccc(Cl)cc1)C(C)CN1CCN(c2ccccn2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213004,,CHEMBL213004,,0,http://www.openphacts.org/units/Nanomolar,533040,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749665,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COC(CN1CCN(c2ccccn2)CC1)/C(=N\O)c1cccc(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212028,,CHEMBL212028,,0,http://www.openphacts.org/units/Nanomolar,533039,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749666,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COC(CN1CCN(c2ccccn2)CC1)/C(=N/O)c1cccc(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211623,,CHEMBL211623,,0,http://www.openphacts.org/units/Nanomolar,533038,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749667,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(/C(=N/O)C(O)CN2CCN(c3ccccn3)CC2)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL215723,,CHEMBL215723,,0,http://www.openphacts.org/units/Nanomolar,533037,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749668,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(/C(=N\O)C(O)CN2CCN(c3ccccn3)CC2)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211463,,CHEMBL211463,,0,http://www.openphacts.org/units/Nanomolar,533036,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749669,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/c1ccc(Cl)cc1)C(CN1CCN(c2ccccn2)CC1)OC,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212490,,CHEMBL212490,,0,http://www.openphacts.org/units/Nanomolar,533035,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749670,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\c1ccc(Cl)cc1)C(CN1CCN(c2ccccn2)CC1)OC,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213208,,CHEMBL213208,,0,http://www.openphacts.org/units/Nanomolar,533034,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749671,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/c1ccc(Cl)cc1)C(O)CN1CCN(c2ccccn2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL441529,,CHEMBL441529,,0,http://www.openphacts.org/units/Nanomolar,533033,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749672,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\c1ccc(Cl)cc1)C(O)CN1CCN(c2ccccn2)CC1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL214247,,CHEMBL214247,,0,http://www.openphacts.org/units/Nanomolar,533032,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749673,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213828,,CHEMBL213828,,0,http://www.openphacts.org/units/Nanomolar,533030,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749674,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(/CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211415,,CHEMBL211415,,0,http://www.openphacts.org/units/Nanomolar,533029,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749675,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL209447,,CHEMBL209447,,0,http://www.openphacts.org/units/Nanomolar,533028,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749676,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212891,,CHEMBL212891,,0,http://www.openphacts.org/units/Nanomolar,533027,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749677,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL378427,,CHEMBL378427,,0,http://www.openphacts.org/units/Nanomolar,533026,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749678,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212595,,CHEMBL212595,,0,http://www.openphacts.org/units/Nanomolar,533025,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749679,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cc(F)cc(F)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211732,,CHEMBL211732,,0,http://www.openphacts.org/units/Nanomolar,533002,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749680,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cc(F)cc(F)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL215705,,CHEMBL215705,,0,http://www.openphacts.org/units/Nanomolar,533003,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749681,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cc(C)cc(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL377794,,CHEMBL377794,,0,http://www.openphacts.org/units/Nanomolar,533004,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749682,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cc(C)cc(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212393,,CHEMBL212393,,0,http://www.openphacts.org/units/Nanomolar,533005,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749683,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)cc1Cl,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL209759,,CHEMBL209759,,0,http://www.openphacts.org/units/Nanomolar,533006,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749684,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)cc1Cl,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211829,,CHEMBL211829,,0,http://www.openphacts.org/units/Nanomolar,533007,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749685,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(F)c(Cl)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL378576,,CHEMBL378576,,0,http://www.openphacts.org/units/Nanomolar,533008,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749686,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(F)c(Cl)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211902,,CHEMBL211902,,0,http://www.openphacts.org/units/Nanomolar,533009,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749687,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)c(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL215450,,CHEMBL215450,,0,http://www.openphacts.org/units/Nanomolar,533013,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749688,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(C)c(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212444,,CHEMBL212444,,0,http://www.openphacts.org/units/Nanomolar,533014,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749689,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(C)c(C)c1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL215678,,CHEMBL215678,,0,http://www.openphacts.org/units/Nanomolar,533015,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749690,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccnc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212291,,CHEMBL212291,,0,http://www.openphacts.org/units/Nanomolar,533016,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749691,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCN(c2ccccn2)CC1C)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL212292,,CHEMBL212292,,0,http://www.openphacts.org/units/Nanomolar,533017,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749692,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCN(c2ccccn2)CC1C)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL214197,,CHEMBL214197,,0,http://www.openphacts.org/units/Nanomolar,533018,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749693,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCC(c2ccccn2)CC1)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL210101,,CHEMBL210101,,0,http://www.openphacts.org/units/Nanomolar,533019,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749694,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCC(c2ccccn2)CC1)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL437532,,CHEMBL437532,,0,http://www.openphacts.org/units/Nanomolar,533020,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749695,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCC(c2cccc[n+]2[O-])CC1)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL213097,,CHEMBL213097,,0,http://www.openphacts.org/units/Nanomolar,533021,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749696,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(/CCN1CCC(c2cccc[n+]2[O-])CC1)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL379546,,CHEMBL379546,,0,http://www.openphacts.org/units/Nanomolar,533022,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749697,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CO/N=C(\CCN1CCCC(c2ccccn2)C1)c1ccc(Cl)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL211831,,CHEMBL211831,,0,http://www.openphacts.org/units/Nanomolar,533023,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749698,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(/CN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL209472,,CHEMBL209472,,0,http://www.openphacts.org/units/Nanomolar,533024,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1749801,[],CHEMBL866136,Antagonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,,,CHEMBL1145336,J Med Chem,2006.0,,CHEMBL214314,,CHEMBL214314,,0,http://www.openphacts.org/units/Nanomolar,532941,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,1791312,[],CHEMBL854872,Inhibition of D2(L),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(N2CCCC2)nc2ccc(NC(=O)COc3ccc(Cl)cc3)cc12,,,CHEMBL1137582,Bioorg Med Chem Lett,2007.0,,CHEMBL216228,,CHEMBL216228,,0,http://www.openphacts.org/units/Nanomolar,618531,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,100.0
,,1920682,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL300780,,CHEMBL300780,5.89,0,http://www.openphacts.org/units/Nanomolar,654381,=,1,1,=,,IC50,nM,,1280.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1280.0
,,1920684,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL244989,,CHEMBL244989,6.75,1,http://www.openphacts.org/units/Nanomolar,654393,=,1,1,=,,IC50,nM,,179.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,179.0
,,1920685,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL394541,,CHEMBL394541,6.76,1,http://www.openphacts.org/units/Nanomolar,654392,=,1,1,=,,IC50,nM,,175.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,175.0
,,1920686,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL244774,,CHEMBL244774,7.64,1,http://www.openphacts.org/units/Nanomolar,654390,=,1,1,=,,IC50,nM,,22.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,22.9
,,1920687,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL244773,,CHEMBL244773,6.43,1,http://www.openphacts.org/units/Nanomolar,654389,=,1,1,=,,IC50,nM,,368.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,368.0
,,1920688,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL398175,,CHEMBL398175,5.89,1,http://www.openphacts.org/units/Nanomolar,654388,=,1,1,=,,IC50,nM,,1300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1300.0
,,1920689,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL244562,,CHEMBL244562,7.39,1,http://www.openphacts.org/units/Nanomolar,654387,=,1,1,=,,IC50,nM,,41.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,41.0
,,1920690,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL241973,,CHEMBL241973,6.97,0,http://www.openphacts.org/units/Nanomolar,654386,=,1,1,=,,IC50,nM,,107.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,107.0
,,1920691,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL110365,,CHEMBL110365,6.65,0,http://www.openphacts.org/units/Nanomolar,654385,=,1,1,=,,IC50,nM,,224.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,224.0
,,1920692,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL180010,,CHEMBL180010,7.09,0,http://www.openphacts.org/units/Nanomolar,654384,=,1,1,=,,IC50,nM,,80.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,80.9
,,1920693,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC[C@H]1C[C@@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL231156,,CHEMBL231156,6.17,0,http://www.openphacts.org/units/Nanomolar,654402,=,1,1,=,,IC50,nM,,672.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,672.0
,,1920694,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL390253,,CHEMBL390253,7.05,1,http://www.openphacts.org/units/Nanomolar,654399,=,1,1,=,,IC50,nM,,88.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,88.3
,Not Determined,1920737,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL304605,,CHEMBL304605,,0,,654383,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,1920776,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL396024,,CHEMBL396024,,0,,654395,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,1920777,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL242644,,CHEMBL242644,,0,,654396,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,1920778,[],CHEMBL895651,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(=O)OC(CCNC(=O)c1ccc(-c2ccccn2)cc1)CN1CCN(c2cccc(Cl)c2Cl)CC1,,,CHEMBL1148745,J Med Chem,2007.0,,CHEMBL242434,,CHEMBL242434,,0,,654398,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,1969327,[],CHEMBL896533,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=[N+]([O-])c1cc(O)c2c(c1)S(=O)(=O)N=C(Nc1ccccc1Oc1ccccc1)N2,,,CHEMBL1149534,Bioorg Med Chem Lett,2007.0,,CHEMBL399203,,CHEMBL399203,,0,http://www.openphacts.org/units/Nanomolar,658073,>,1,1,>,,IC50,nM,,3200.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,3.2
,,2055980,[],CHEMBL925073,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1,,,CHEMBL1140623,Bioorg Med Chem Lett,2007.0,"{'bei': '12.89', 'le': '0.24', 'lle': '0.34', 'sei': '9.77'}",CHEMBL250689,,CHEMBL250689,6.00,0,http://www.openphacts.org/units/Nanomolar,682773,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,2056003,[],CHEMBL925073,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C,,,CHEMBL1140623,Bioorg Med Chem Lett,2007.0,"{'bei': '11.69', 'le': '0.23', 'lle': '2.08', 'sei': '6.54'}",CHEMBL249854,,CHEMBL249854,6.19,0,http://www.openphacts.org/units/Nanomolar,682813,=,1,1,=,,IC50,nM,,640.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,640.0
,,2077456,[],CHEMBL945905,Binding affinity to human dopaminergic D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1,,,CHEMBL1141467,J Med Chem,2008.0,,CHEMBL220808,SARIZOTAN,CHEMBL220808,,0,http://www.openphacts.org/units/Nanomolar,688824,<,1,1,<,,IC50,nM,,6.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6.0
,,2089360,[],CHEMBL946008,Binding affinity to dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CCCN2CCN(Cc3ccccc3)CC2)cc1,,,CHEMBL1142308,Bioorg Med Chem,2008.0,,CHEMBL273041,,CHEMBL273041,,0,http://www.openphacts.org/units/Nanomolar,693887,>,1,1,>,,IC50,nM,,100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100.0
,,2138442,[],CHEMBL920904,Binding affinity at dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(N2CCN(CCCC(=O)NCc3nc4ccccc4c(=O)n3-c3ccccc3)CC2)c1C,,,CHEMBL1144677,Bioorg Med Chem,2008.0,"{'bei': '10.13', 'le': '0.19', 'lle': '0.94', 'sei': '7.32'}",CHEMBL259415,,CHEMBL259415,5.16,0,http://www.openphacts.org/units/Nanomolar,706362,=,1,1,=,,IC50,nM,,6900.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6900.0
,,2138450,[],CHEMBL920904,Binding affinity at dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(N2CCN(CCCC(=O)NCc3nc4cc(F)ccc4c(=O)n3-c3ccccc3)CC2)c1C,,,CHEMBL1144677,Bioorg Med Chem,2008.0,"{'bei': '11.04', 'le': '0.20', 'lle': '1.46', 'sei': '8.26'}",CHEMBL261102,,CHEMBL261102,5.82,0,http://www.openphacts.org/units/Nanomolar,706379,=,1,1,=,,IC50,nM,,1500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1500.0
,,2138458,[],CHEMBL920904,Binding affinity at dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)NCc1nc2cc(F)ccc2c(=O)n1-c1ccccc1,,,CHEMBL1144677,Bioorg Med Chem,2008.0,"{'bei': '9.13', 'le': '0.17', 'lle': '0.42', 'sei': '7.35'}",CHEMBL261019,,CHEMBL261019,5.18,0,http://www.openphacts.org/units/Nanomolar,706387,=,1,1,=,,IC50,nM,,6600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6600.0
,,2138466,[],CHEMBL920904,Binding affinity at dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc(N2CCN(CCCC(=O)NCc3nc4ccc(F)cc4c(=O)n3-c3ccccc3)CC2)c1C,,,CHEMBL1144677,Bioorg Med Chem,2008.0,"{'bei': '10.23', 'le': '0.19', 'lle': '1.04', 'sei': '7.66'}",CHEMBL261434,,CHEMBL261434,5.40,0,http://www.openphacts.org/units/Nanomolar,706396,=,1,1,=,,IC50,nM,,4000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4000.0
,,2138474,[],CHEMBL920904,Binding affinity at dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccccc2)CC1,,,CHEMBL1144677,Bioorg Med Chem,2008.0,"{'bei': '9.96', 'le': '0.18', 'lle': '1.53', 'sei': '6.62'}",CHEMBL259776,,CHEMBL259776,5.28,0,http://www.openphacts.org/units/Nanomolar,706400,=,1,1,=,,IC50,nM,,5300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5300.0
,,2138482,[],CHEMBL920904,Binding affinity at dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccccc2)CC1,,,CHEMBL1144677,Bioorg Med Chem,2008.0,"{'bei': '11.04', 'le': '0.20', 'lle': '1.86', 'sei': '7.53'}",CHEMBL260907,,CHEMBL260907,6.00,0,http://www.openphacts.org/units/Nanomolar,706403,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,2138490,[],CHEMBL920904,Binding affinity at dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3cc(F)ccc3c(=O)n2-c2ccc(OC)cc2)CC1,,,CHEMBL1144677,Bioorg Med Chem,2008.0,"{'bei': '10.15', 'le': '0.19', 'lle': '1.67', 'sei': '6.55'}",CHEMBL259199,,CHEMBL259199,5.82,0,http://www.openphacts.org/units/Nanomolar,706418,=,1,1,=,,IC50,nM,,1500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1500.0
,,2138498,[],CHEMBL920904,Binding affinity at dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccc(OC)cc2)CC1,,,CHEMBL1144677,Bioorg Med Chem,2008.0,"{'bei': '11.95', 'le': '0.22', 'lle': '2.70', 'sei': '7.71'}",CHEMBL406221,,CHEMBL406221,6.85,0,http://www.openphacts.org/units/Nanomolar,706420,=,1,1,=,,IC50,nM,,140.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,140.0
,,2148241,[],CHEMBL928141,Displacement of [3H]spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1,,,CHEMBL1142222,Proc Natl Acad Sci U S A,2007.0,,CHEMBL250699,,CHEMBL250699,,0,http://www.openphacts.org/units/Nanomolar,695710,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2227393,[],CHEMBL1005621,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC,,,CHEMBL1156607,Bioorg Med Chem Lett,2008.0,,CHEMBL392158,FALLYPRIDE,CHEMBL392158,8.30,0,http://www.openphacts.org/units/Nanomolar,796060,=,1,1,=,,IC50,nM,,5.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.0
,,2227394,[],CHEMBL1005621,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCCl)cc(OC)c1OC,,,CHEMBL1156607,Bioorg Med Chem Lett,2008.0,,CHEMBL502017,,CHEMBL502017,7.77,0,http://www.openphacts.org/units/Nanomolar,796061,=,1,1,=,,IC50,nM,,17.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,17.1
,,2248547,[],CHEMBL959903,Antagonist activity at human dopamine D2L receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,,,CHEMBL1139353,J Med Chem,2009.0,,CHEMBL496739,,CHEMBL496739,6.23,0,http://www.openphacts.org/units/Nanomolar,775853,=,1,1,=,,IC50,nM,,584.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,584.0
,,2248548,[],CHEMBL959904,Antagonist activity at human dopamine D2S receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,,,CHEMBL1139353,J Med Chem,2009.0,,CHEMBL496739,,CHEMBL496739,5.91,0,http://www.openphacts.org/units/Nanomolar,775853,=,1,1,=,,IC50,nM,,1240.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1240.0
,,2348168,[],CHEMBL965249,Binding affinity to human dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc2[nH]cc(C3CCN(CCCCCCCN4CCC(c5c[nH]c6ccc(NC(=O)c7ccc(F)cc7)cc56)CC4)CC3)c2c1)c1ccc(F)cc1,,,CHEMBL1150432,J Med Chem,2008.0,"{'bei': '7.98', 'le': '0.15', 'lle': '-4.29', 'sei': '6.39'}",CHEMBL503468,,CHEMBL503468,6.16,0,http://www.openphacts.org/units/Nanomolar,793781,=,1,1,=,,IC50,nM,,700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.7
,,2362396,[],CHEMBL1033065,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O[C@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,,,CHEMBL1140093,J Med Chem,2008.0,,CHEMBL3084502,,CHEMBL3084502,7.32,0,http://www.openphacts.org/units/Nanomolar,747141,=,1,1,=,,IC50,nM,,48.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,48.3
,,2362401,[],CHEMBL1033065,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,,,CHEMBL1140093,J Med Chem,2008.0,,CHEMBL445102,,CHEMBL445102,8.35,0,http://www.openphacts.org/units/Nanomolar,747462,=,1,1,=,,IC50,nM,,4.46,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.46
,,2362402,[],CHEMBL1033065,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12,,,CHEMBL1140093,J Med Chem,2008.0,,CHEMBL3084515,,CHEMBL3084515,8.72,0,http://www.openphacts.org/units/Nanomolar,747302,=,1,1,=,,IC50,nM,,1.92,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.92
,,2362403,[],CHEMBL1033065,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12,,,CHEMBL1140093,J Med Chem,2008.0,,CHEMBL3084512,,CHEMBL3084512,7.58,0,http://www.openphacts.org/units/Nanomolar,747299,=,1,1,=,,IC50,nM,,26.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,26.2
,,2362404,[],CHEMBL1033065,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,,,CHEMBL1140093,J Med Chem,2008.0,,CHEMBL3084503,,CHEMBL3084503,6.68,0,http://www.openphacts.org/units/Nanomolar,747142,=,1,1,=,,IC50,nM,,210.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,210.0
,,2376486,[],CHEMBL980770,Displacement of radioligand from dopamine D2S receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,,,CHEMBL1139415,Bioorg Med Chem Lett,2008.0,"{'bei': '10.25', 'le': '0.20', 'lle': '-1.18', 'sei': '7.01'}",CHEMBL461571,,CHEMBL461571,5.45,0,http://www.openphacts.org/units/Nanomolar,722289,=,1,1,=,,IC50,nM,,3550.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,3.55
,,2397884,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL522460,,CHEMBL522460,5.29,0,http://www.openphacts.org/units/Nanomolar,804977,=,1,1,=,,IC50,nM,,5100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.1
,,2397885,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c2c(F)cccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL486758,,CHEMBL486758,,0,http://www.openphacts.org/units/Nanomolar,803961,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2397886,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c2cc(F)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL485755,,CHEMBL485755,5.44,0,http://www.openphacts.org/units/Nanomolar,803962,=,1,1,=,,IC50,nM,,3600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,3.6
,,2397887,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c2ccc(F)cc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL485953,,CHEMBL485953,,0,http://www.openphacts.org/units/Nanomolar,803963,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2397888,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL521030,,CHEMBL521030,5.64,0,http://www.openphacts.org/units/Nanomolar,803964,=,1,1,=,,IC50,nM,,2300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.3
,,2397889,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c2cc(Br)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL487984,,CHEMBL487984,5.57,0,http://www.openphacts.org/units/Nanomolar,804060,=,1,1,=,,IC50,nM,,2700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.7
,,2397890,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4c(F)cccc43)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL487788,,CHEMBL487788,5.96,0,http://www.openphacts.org/units/Nanomolar,804061,=,1,1,=,,IC50,nM,,1100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.1
,,2397891,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4ccc(F)cc43)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL487985,,CHEMBL487985,5.72,0,http://www.openphacts.org/units/Nanomolar,804062,=,1,1,=,,IC50,nM,,1900.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.9
,,2397892,[],CHEMBL939457,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4cc(Cl)ccc43)CC2)CC1,,,CHEMBL1152245,Bioorg Med Chem Lett,2008.0,,CHEMBL487986,,CHEMBL487986,,0,http://www.openphacts.org/units/Nanomolar,804063,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2401860,[],CHEMBL953137,Displacement of radiolabeled (+)butaclamol from human dopamine D2S receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,,,CHEMBL1140203,J Med Chem,2008.0,"{'bei': '22.30', 'le': '0.41', 'lle': '3.22', 'sei': '34.34'}",CHEMBL1255588,,CHEMBL1255588,8.06,0,http://www.openphacts.org/units/Nanomolar,1311174,=,1,1,=,,IC50,nM,,8.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,10'-9M,UO_0000065,,8.7
,,2485599,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,"{'bei': '13.78', 'le': '0.25', 'lle': '1.64', 'sei': '12.60'}",CHEMBL522460,,CHEMBL522460,5.58,0,http://www.openphacts.org/units/Nanomolar,772797,=,1,1,=,,IC50,nM,,2650.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.65
,Not Determined,2485634,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4cc(Cl)ccc43)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL491208,,CHEMBL491208,,0,,772796,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,2485635,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(C2CCN(Cc3ccccc3[N+](=O)[O-])CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL514689,,CHEMBL514689,,0,,772005,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,2485636,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3[N+](=O)[O-])CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,"{'bei': '13.65', 'le': '0.25', 'lle': '2.41', 'sei': '6.80'}",CHEMBL478034,,CHEMBL478034,5.95,0,http://www.openphacts.org/units/Nanomolar,772004,=,1,1,=,,IC50,nM,,1130.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.13
,Not Determined,2485637,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(C2CCN(Cc3ccccc3Cl)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL515489,,CHEMBL515489,,0,,772003,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,2485638,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3Cl)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,"{'bei': '13.38', 'le': '0.26', 'lle': '1.41', 'sei': '12.84'}",CHEMBL477821,,CHEMBL477821,5.69,0,http://www.openphacts.org/units/Nanomolar,771919,=,1,1,=,,IC50,nM,,2060.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.06
,Not Determined,2485639,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2cc(Cl)ccc2n1C1CCN(C2CCN(Cc3ccccc3C(F)(F)F)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL518747,,CHEMBL518747,,0,,771918,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,2485640,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCOC(=O)N1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL491209,,CHEMBL491209,,0,http://www.openphacts.org/units/Nanomolar,772798,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2485641,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2ccc(F)cc2n1C1CCN(C2CCN(Cc3ccccc3C(F)(F)F)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL491818,,CHEMBL491818,,0,http://www.openphacts.org/units/Nanomolar,772879,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2485642,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2cc(F)ccc2n1C1CCN(C2CCN(Cc3ccccc3C(F)(F)F)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,"{'bei': '11.69', 'le': '0.22', 'lle': '0.78', 'sei': '12.58'}",CHEMBL489576,,CHEMBL489576,5.57,0,http://www.openphacts.org/units/Nanomolar,772878,=,1,1,=,,IC50,nM,,2690.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.69
,,2485643,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(F)cccc2n1C1CCN(C2CCN(Cc3ccccc3C(F)(F)F)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL521914,,CHEMBL521914,,0,http://www.openphacts.org/units/Nanomolar,772803,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2485644,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccc(F)cc43)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL490797,,CHEMBL490797,,0,http://www.openphacts.org/units/Nanomolar,772802,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2485645,[],CHEMBL983581,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4c(F)cccc43)CC2)CC1,,,CHEMBL1142444,Bioorg Med Chem Lett,2008.0,,CHEMBL490598,,CHEMBL490598,,0,http://www.openphacts.org/units/Nanomolar,772800,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,2529739,[],CHEMBL985708,Binding affinity to dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(CCOC)c1nc(C)nc2c(-c3ccc(OC)cc3C)c(C)nn12,,,CHEMBL1138477,J Med Chem,2009.0,,CHEMBL475306,,CHEMBL475306,,0,http://www.openphacts.org/units/Nanomolar,808335,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,2529760,[],CHEMBL985708,Binding affinity to dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCC(CC)Nc1nc(C)nc2c(-c3cc(F)c(OC)cc3Cl)c(C)nn12,,,CHEMBL1138477,J Med Chem,2009.0,,CHEMBL484158,,CHEMBL484158,,0,http://www.openphacts.org/units/Nanomolar,809258,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,2529761,[],CHEMBL985708,Binding affinity to dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COCCN(CCOC)c1nc(C)nc2c(-c3cc(C)c(OC)cc3C)c(C)nn12,,,CHEMBL1138477,J Med Chem,2009.0,,CHEMBL483993,,CHEMBL483993,,0,http://www.openphacts.org/units/Nanomolar,809187,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,2529762,[],CHEMBL985708,Binding affinity to dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@@H](C)Nc1nc(C)nc2c(-c3c(C)cc(OC)cc3OC)c(C)nn12,,,CHEMBL1138477,J Med Chem,2009.0,,CHEMBL506214,,CHEMBL506214,,0,http://www.openphacts.org/units/Nanomolar,809178,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,2565589,[],CHEMBL979061,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Fc1ccc(-c2noc(C3CCN(c4cnc5ccc(Cl)cc5c4)CC3)n2)c(Cl)c1,,,CHEMBL1155906,Bioorg Med Chem Lett,2008.0,,CHEMBL468176,,CHEMBL468176,,0,http://www.openphacts.org/units/Nanomolar,768922,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,50.0
,,2573324,[],CHEMBL982014,Inhibition of human dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,,,CHEMBL1155111,J Med Chem,2008.0,"{'bei': '21.64', 'le': '0.40', 'lle': '2.98', 'sei': '33.34'}",CHEMBL1255588,,CHEMBL1255588,7.82,0,http://www.openphacts.org/units/Nanomolar,743111,=,1,1,=,,IC50,nM,,15.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,15.0
,,2573831,[],CHEMBL988377,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(Oc2cccnc2Cl)nc1)c1c[nH]c2ccccc12,,,CHEMBL1155132,Bioorg Med Chem Lett,2008.0,,CHEMBL516452,,CHEMBL516452,,0,http://www.openphacts.org/units/Nanomolar,743229,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,2573844,[],CHEMBL988377,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(Oc2cccnc2)nc1)c1c[nH]c2ccccc12,,,CHEMBL1155132,Bioorg Med Chem Lett,2008.0,,CHEMBL479952,,CHEMBL479952,,0,http://www.openphacts.org/units/Nanomolar,743230,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,2573845,[],CHEMBL988377,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2c(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c[nH]c2c1,,,CHEMBL1155132,Bioorg Med Chem Lett,2008.0,,CHEMBL519103,,CHEMBL519103,,0,http://www.openphacts.org/units/Nanomolar,743146,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,2573846,[],CHEMBL988377,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc2[nH]cc(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c2c1,,,CHEMBL1155132,Bioorg Med Chem Lett,2008.0,,CHEMBL480699,,CHEMBL480699,,0,http://www.openphacts.org/units/Nanomolar,743145,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,2573847,[],CHEMBL988377,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc2[nH]cc(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c2c1,,,CHEMBL1155132,Bioorg Med Chem Lett,2008.0,,CHEMBL480127,,CHEMBL480127,,0,http://www.openphacts.org/units/Nanomolar,743144,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,2573848,[],CHEMBL988377,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(cc1C(F)(F)F)N(C(=O)Nc1ccc(Oc3cccnc3C)nc1)CC2,,,CHEMBL1155132,Bioorg Med Chem Lett,2008.0,,CHEMBL14460,SB-243213,CHEMBL14460,,0,http://www.openphacts.org/units/Nanomolar,742887,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,2912690,[],CHEMBL1044818,Antagonist activity at dopamine D2 receptor expressed in HEK293 cells by by [35S]GTPgammaS binding assay in presence of quinpirole,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCn2cc(CCCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1,,,CHEMBL1154108,Bioorg Med Chem,2009.0,,CHEMBL582945,,CHEMBL582945,5.80,0,http://www.openphacts.org/units/Nanomolar,846583,=,1,1,=,,IC50,nM,,1570.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.57
,,2912692,[],CHEMBL1044818,Antagonist activity at dopamine D2 receptor expressed in HEK293 cells by by [35S]GTPgammaS binding assay in presence of quinpirole,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCc2cn(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1,,,CHEMBL1154108,Bioorg Med Chem,2009.0,,CHEMBL574700,,CHEMBL574700,6.32,0,http://www.openphacts.org/units/Nanomolar,846584,=,1,1,=,,IC50,nM,,480.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,480.0
,,2927565,[],CHEMBL1046708,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2NC1,,,CHEMBL1154177,Bioorg Med Chem Lett,2009.0,,CHEMBL21343,,CHEMBL21343,,0,http://www.openphacts.org/units/Nanomolar,848804,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,2927566,[],CHEMBL1046708,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1,,,CHEMBL1154177,Bioorg Med Chem Lett,2009.0,"{'bei': '13.53', 'le': '0.25', 'lle': '1.29', 'sei': '8.47'}",CHEMBL584554,,CHEMBL584554,5.80,0,http://www.openphacts.org/units/Nanomolar,848803,=,1,1,=,,IC50,nM,,1590.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1590.0
,,2998124,[],CHEMBL1049085,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,NCCn1cc(S(=O)(=O)c2ccccc2)c2cccnc21,,,CHEMBL1155250,Bioorg Med Chem,2009.0,,CHEMBL576315,,CHEMBL576315,,0,http://www.openphacts.org/units/Nanomolar,854522,<,1,1,<,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5000.0
,,2998125,[],CHEMBL1049085,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCn1cc(S(=O)(=O)c2cccc(F)c2)c2cccnc21,,,CHEMBL1155250,Bioorg Med Chem,2009.0,,CHEMBL571858,,CHEMBL571858,,0,http://www.openphacts.org/units/Nanomolar,854590,<,1,1,<,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5000.0
,,2998126,[],CHEMBL1049085,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCn1cc(S(=O)(=O)c2cccc(Cl)c2)c2cccnc21,,,CHEMBL1155250,Bioorg Med Chem,2009.0,,CHEMBL584046,,CHEMBL584046,,0,http://www.openphacts.org/units/Nanomolar,854482,<,1,1,<,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5000.0
,,2998127,[],CHEMBL1049085,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,NCCn1cc(S(=O)(=O)c2cccc(Cl)c2)c2cccnc21,,,CHEMBL1155250,Bioorg Med Chem,2009.0,,CHEMBL565745,,CHEMBL565745,,0,http://www.openphacts.org/units/Nanomolar,854499,<,1,1,<,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5000.0
,,2998128,[],CHEMBL1049085,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCn1cc(S(=O)(=O)c2cccc3ccccc23)c2cccnc21,,,CHEMBL1155250,Bioorg Med Chem,2009.0,,CHEMBL565552,,CHEMBL565552,,0,http://www.openphacts.org/units/Nanomolar,854419,<,1,1,<,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5000.0
,,3073819,[],CHEMBL1050444,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)Cc1nc(-c2ccc(C(C)(C)C)cc2)n(-c2cccc(O)c2)n1,,,CHEMBL1152515,Bioorg Med Chem,2009.0,,CHEMBL595449,,CHEMBL595449,,0,http://www.openphacts.org/units/Nanomolar,874735,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3189929,[],CHEMBL1101348,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1[nH]c(-c2ccccc2)cc1C(=O)NCCCN1CCN(c2cccc(Cl)c2Cl)CC1,,,CHEMBL1154983,Bioorg Med Chem Lett,2010.0,"{'bei': '12.66', 'le': '0.25', 'lle': '0.73', 'sei': '11.62'}",CHEMBL1086626,,CHEMBL1086626,5.97,0,http://www.openphacts.org/units/Nanomolar,892907,=,1,1,=,,IC50,nM,,1071.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1071.0
,,3189930,[],CHEMBL1101348,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(-c2ccccc2)n1C,,,CHEMBL1154983,Bioorg Med Chem Lett,2010.0,"{'bei': '11.52', 'le': '0.23', 'lle': '0.34', 'sei': '13.81'}",CHEMBL1086754,,CHEMBL1086754,5.59,0,http://www.openphacts.org/units/Nanomolar,892908,=,1,1,=,,IC50,nM,,2542.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2542.0
,,3189931,[],CHEMBL1101348,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCCn1c(-c2ccccc2)cc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C,,,CHEMBL1154983,Bioorg Med Chem Lett,2010.0,"{'bei': '10.57', 'le': '0.21', 'lle': '-0.69', 'sei': '13.40'}",CHEMBL1086756,,CHEMBL1086756,5.43,0,http://www.openphacts.org/units/Nanomolar,892910,=,1,1,=,,IC50,nM,,3736.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3736.0
,,3262969,[],CHEMBL1108779,Inhibition of dopamine D2 (receptor),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCC2CCN(C(=O)c3ccccc3)CC2)C1,,,CHEMBL1156954,Bioorg Med Chem Lett,2010.0,,CHEMBL1092929,,CHEMBL1092929,,0,http://www.openphacts.org/units/Nanomolar,902033,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3262970,[],CHEMBL1108779,Inhibition of dopamine D2 (receptor),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCC2CCN(C(=O)c3ccccc3F)CC2)C1,,,CHEMBL1156954,Bioorg Med Chem Lett,2010.0,,CHEMBL1089881,,CHEMBL1089881,,0,http://www.openphacts.org/units/Nanomolar,902203,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3262971,[],CHEMBL1108779,Inhibition of dopamine D2 (receptor),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCC2CCN(C(=O)c3cc(F)ccc3F)CC2)C1,,,CHEMBL1156954,Bioorg Med Chem Lett,2010.0,,CHEMBL1092921,,CHEMBL1092921,,0,http://www.openphacts.org/units/Nanomolar,902280,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3262972,[],CHEMBL1108779,Inhibition of dopamine D2 (receptor),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCC2CCN(C(=O)c3ccccc3Cl)CC2)C1,,,CHEMBL1156954,Bioorg Med Chem Lett,2010.0,,CHEMBL1088874,,CHEMBL1088874,,0,http://www.openphacts.org/units/Nanomolar,902356,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3262973,[],CHEMBL1108779,Inhibition of dopamine D2 (receptor),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3ccccc3)CC2)C1,,,CHEMBL1156954,Bioorg Med Chem Lett,2010.0,,CHEMBL1093469,,CHEMBL1093469,,0,http://www.openphacts.org/units/Nanomolar,902607,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3262974,[],CHEMBL1108779,Inhibition of dopamine D2 (receptor),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3ccccc3Cl)CC2)C1,,,CHEMBL1156954,Bioorg Med Chem Lett,2010.0,,CHEMBL1092238,,CHEMBL1092238,,0,http://www.openphacts.org/units/Nanomolar,902748,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3262975,[],CHEMBL1108779,Inhibition of dopamine D2 (receptor),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3ccccc3F)CC2)C1,,,CHEMBL1156954,Bioorg Med Chem Lett,2010.0,,CHEMBL1093802,,CHEMBL1093802,,0,http://www.openphacts.org/units/Nanomolar,902821,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3262976,[],CHEMBL1108779,Inhibition of dopamine D2 (receptor),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCN(CCN2CCN(C(=O)c3cc(F)ccc3F)CC2)C1,,,CHEMBL1156954,Bioorg Med Chem Lett,2010.0,,CHEMBL1089793,,CHEMBL1089793,,0,http://www.openphacts.org/units/Nanomolar,902822,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3380879,[],CHEMBL1212473,Displacement of [3H]spiperone from human recombinant dopamine D2S receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,C/C(=N\OC(=O)Nc1ccccc1)c1cccc(-c2cccs2)c1,,,CHEMBL1208724,Bioorg Med Chem Lett,2010.0,,CHEMBL1210154,,CHEMBL1210154,,0,http://www.openphacts.org/units/Nanomolar,928039,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423702,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(c1cccc(N2CCN(C)CC2)c1)S(=O)(=O)c1ccc2ccccc2c1,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1222134,,CHEMBL1222134,,0,http://www.openphacts.org/units/Nanomolar,935548,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423703,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(c1cccc(N2CCN(C)CC2)c1)S(=O)(=O)c1ccccc1,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1222138,,CHEMBL1222138,,0,http://www.openphacts.org/units/Nanomolar,935552,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423705,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(c1cccc(N2CCN(C)CC2)c1)S(=O)(=O)c1cccc2ccccc12,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1222234,,CHEMBL1222234,,0,http://www.openphacts.org/units/Nanomolar,935678,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423707,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2cccc(N(C)S(=O)(=O)c3ccc4ccccc4c3)c2)CC1,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1222362,,CHEMBL1222362,,0,http://www.openphacts.org/units/Nanomolar,935858,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423709,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(c1cccc(N2CCN(C)CC2)c1)S(=O)(=O)c1ccc2ccccc2c1,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1222363,,CHEMBL1222363,,0,http://www.openphacts.org/units/Nanomolar,935859,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423711,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN(c1cccc(N2CCN(C)CC2)c1)S(=O)(=O)c1ccc2ccccc2c1,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1222364,,CHEMBL1222364,,0,http://www.openphacts.org/units/Nanomolar,935860,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423713,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2cccc(N(CC3CC3)S(=O)(=O)c3ccc4ccccc4c3)c2)CC1,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1221449,,CHEMBL1221449,,0,http://www.openphacts.org/units/Nanomolar,934525,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423715,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2cccc(N(Cc3ccccc3)S(=O)(=O)c3ccc4ccccc4c3)c2)CC1,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1221452,,CHEMBL1221452,,0,http://www.openphacts.org/units/Nanomolar,934528,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3423717,[],CHEMBL1227606,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2cccc(NS(=O)(=O)c3ccc4ccccc4c3)c2)CC1,,,CHEMBL1221248,Bioorg Med Chem Lett,2010.0,,CHEMBL1221497,,CHEMBL1221497,,0,http://www.openphacts.org/units/Nanomolar,934602,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,3437296,[],CHEMBL1247748,Binding affinity to human recombinant dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12,,,CHEMBL1240532,Science,2010.0,,CHEMBL1082723,CIPARGAMIN,CHEMBL1082723,,0,http://www.openphacts.org/units/Nanomolar,954993,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,3550715,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(Cl)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276708,,CHEMBL1276708,7.49,0,http://www.openphacts.org/units/Nanomolar,970935,=,1,1,=,,IC50,nM,,32.36,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.49
,,3550716,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(OC)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276709,,CHEMBL1276709,7.15,0,http://www.openphacts.org/units/Nanomolar,970936,=,1,1,=,,IC50,nM,,70.79,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.15
,,3550717,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1Br,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276738,,CHEMBL1276738,8.10,0,http://www.openphacts.org/units/Nanomolar,971012,=,1,1,=,,IC50,nM,,7.943,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.1
,,3550718,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Br,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276739,,CHEMBL1276739,7.96,0,http://www.openphacts.org/units/Nanomolar,971013,=,1,1,=,,IC50,nM,,10.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.96
,,3550719,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(I)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL23464,,CHEMBL23464,9.17,0,http://www.openphacts.org/units/Nanomolar,971014,=,1,1,=,,IC50,nM,,0.6761,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,9.17
,,3550720,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1C,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276763,,CHEMBL1276763,8.30,0,http://www.openphacts.org/units/Nanomolar,971093,=,1,1,=,,IC50,nM,,5.012,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.3
,,3550721,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(Cl)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276764,,CHEMBL1276764,6.96,0,http://www.openphacts.org/units/Nanomolar,971094,=,1,1,=,,IC50,nM,,109.65,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.96
,,3550722,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276765,,CHEMBL1276765,6.91,0,http://www.openphacts.org/units/Nanomolar,971095,=,1,1,=,,IC50,nM,,123.03,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.91
,,3550723,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(I)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276325,,CHEMBL1276325,9.54,0,http://www.openphacts.org/units/Nanomolar,969924,=,1,1,=,,IC50,nM,,0.2884,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,9.54
,,3550724,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(SC)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276326,,CHEMBL1276326,8.96,0,http://www.openphacts.org/units/Nanomolar,969925,=,1,1,=,,IC50,nM,,1.096,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.96
,,3550725,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276327,,CHEMBL1276327,8.89,0,http://www.openphacts.org/units/Nanomolar,969926,=,1,1,=,,IC50,nM,,1.288,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.89
,,3550726,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276350,,CHEMBL1276350,8.57,0,http://www.openphacts.org/units/Nanomolar,970005,=,1,1,=,,IC50,nM,,2.692,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.57
,,3550727,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276351,,CHEMBL1276351,7.17,0,http://www.openphacts.org/units/Nanomolar,970006,=,1,1,=,,IC50,nM,,67.61,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.17
,,3550728,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(Cl)ccc1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276238,,CHEMBL1276238,6.59,0,http://www.openphacts.org/units/Nanomolar,969418,=,1,1,=,,IC50,nM,,257.04,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.59
,,3550729,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Cl)c1Cl,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276352,,CHEMBL1276352,7.70,0,http://www.openphacts.org/units/Nanomolar,970007,=,1,1,=,,IC50,nM,,19.95,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.7
,,3550730,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Cl)c1Br,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276374,,CHEMBL1276374,8.25,0,http://www.openphacts.org/units/Nanomolar,970085,=,1,1,=,,IC50,nM,,5.623,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.25
,,3550731,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(Br)ccc1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276268,,CHEMBL1276268,7.34,0,http://www.openphacts.org/units/Nanomolar,969482,=,1,1,=,,IC50,nM,,45.71,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.34
,,3550732,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL22242,REMOXIPRIDE,CHEMBL22242,8.92,0,http://www.openphacts.org/units/Nanomolar,970086,=,1,1,=,,IC50,nM,,1.202,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.92
,,3550733,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276375,,CHEMBL1276375,8.38,0,http://www.openphacts.org/units/Nanomolar,970087,=,1,1,=,,IC50,nM,,4.169,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.38
,,3550734,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Cl)ccc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276399,,CHEMBL1276399,7.19,0,http://www.openphacts.org/units/Nanomolar,970164,=,1,1,=,,IC50,nM,,64.57,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.19
,,3550735,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276400,,CHEMBL1276400,8.06,0,http://www.openphacts.org/units/Nanomolar,970165,=,1,1,=,,IC50,nM,,8.71,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.06
,,3550736,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(F)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276401,,CHEMBL1276401,6.44,0,http://www.openphacts.org/units/Nanomolar,970166,=,1,1,=,,IC50,nM,,363.08,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.44
,,3550737,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(Cl)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276426,,CHEMBL1276426,7.41,0,http://www.openphacts.org/units/Nanomolar,970240,=,1,1,=,,IC50,nM,,38.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.41
,,3550738,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(Cl)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276427,,CHEMBL1276427,7.24,0,http://www.openphacts.org/units/Nanomolar,970241,=,1,1,=,,IC50,nM,,57.54,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.24
,,3550739,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1c(Cl)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276428,,CHEMBL1276428,7.92,0,http://www.openphacts.org/units/Nanomolar,970242,=,1,1,=,,IC50,nM,,12.02,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.92
,,3550740,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276459,,CHEMBL1276459,8.08,0,http://www.openphacts.org/units/Nanomolar,970317,=,1,1,=,,IC50,nM,,8.318,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.08
,,3550741,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(Br)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276460,,CHEMBL1276460,7.77,0,http://www.openphacts.org/units/Nanomolar,970318,=,1,1,=,,IC50,nM,,16.98,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.77
,,3550742,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(Br)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276461,,CHEMBL1276461,7.59,0,http://www.openphacts.org/units/Nanomolar,970319,=,1,1,=,,IC50,nM,,25.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.59
,,3550743,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Br)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276494,,CHEMBL1276494,8.85,0,http://www.openphacts.org/units/Nanomolar,970396,=,1,1,=,,IC50,nM,,1.413,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.85
,,3550744,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Br)c1[N+](=O)[O-],,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276495,,CHEMBL1276495,6.73,0,http://www.openphacts.org/units/Nanomolar,970397,=,1,1,=,,IC50,nM,,186.21,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.73
,,3550745,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(I)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276496,,CHEMBL1276496,8.52,0,http://www.openphacts.org/units/Nanomolar,970398,=,1,1,=,,IC50,nM,,3.02,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.52
,,3550746,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(C)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276527,,CHEMBL1276527,7.59,0,http://www.openphacts.org/units/Nanomolar,970474,=,1,1,=,,IC50,nM,,25.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.59
,,3550747,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(C)c(C)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276528,,CHEMBL1276528,8.11,0,http://www.openphacts.org/units/Nanomolar,970475,=,1,1,=,,IC50,nM,,7.762,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.11
,,3550748,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276529,,CHEMBL1276529,8.54,0,http://www.openphacts.org/units/Nanomolar,970476,=,1,1,=,,IC50,nM,,2.884,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.54
,,3550749,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1F,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276559,,CHEMBL1276559,8.82,0,http://www.openphacts.org/units/Nanomolar,970552,=,1,1,=,,IC50,nM,,1.514,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.82
,,3550750,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276560,,CHEMBL1276560,9.04,0,http://www.openphacts.org/units/Nanomolar,970553,=,1,1,=,,IC50,nM,,0.912,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,9.04
,,3550751,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Br,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276561,,CHEMBL1276561,8.64,0,http://www.openphacts.org/units/Nanomolar,970554,=,1,1,=,,IC50,nM,,2.291,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.64
,,3550752,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276585,,CHEMBL1276585,9.30,0,http://www.openphacts.org/units/Nanomolar,970630,=,1,1,=,,IC50,nM,,0.5012,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,9.3
,,3550753,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(OC)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276586,,CHEMBL1276586,6.69,0,http://www.openphacts.org/units/Nanomolar,970631,=,1,1,=,,IC50,nM,,204.17,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.69
,,3550754,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(OC)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276587,,CHEMBL1276587,7.17,0,http://www.openphacts.org/units/Nanomolar,970632,=,1,1,=,,IC50,nM,,67.61,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.17
,,3550755,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1O,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL283099,,CHEMBL283099,8.00,0,http://www.openphacts.org/units/Nanomolar,970707,=,1,1,=,,IC50,nM,,10.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.0
,,3550756,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276615,,CHEMBL1276615,8.49,0,http://www.openphacts.org/units/Nanomolar,970708,=,1,1,=,,IC50,nM,,3.236,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.49
,,3550757,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Br)c(C)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276616,,CHEMBL1276616,8.26,0,http://www.openphacts.org/units/Nanomolar,970709,=,1,1,=,,IC50,nM,,5.495,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.26
,,3550758,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(C)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276645,,CHEMBL1276645,8.28,0,http://www.openphacts.org/units/Nanomolar,970784,=,1,1,=,,IC50,nM,,5.248,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.28
,,3550759,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1c(Br)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276646,,CHEMBL1276646,7.77,0,http://www.openphacts.org/units/Nanomolar,970785,=,1,1,=,,IC50,nM,,16.98,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.77
,,3550760,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1CC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276647,,CHEMBL1276647,8.75,0,http://www.openphacts.org/units/Nanomolar,970786,=,1,1,=,,IC50,nM,,1.778,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.75
,,3550761,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL282925,,CHEMBL282925,8.89,0,http://www.openphacts.org/units/Nanomolar,970859,=,1,1,=,,IC50,nM,,1.288,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.89
,,3550762,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)cccc1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL282024,,CHEMBL282024,7.28,0,http://www.openphacts.org/units/Nanomolar,970860,=,1,1,=,,IC50,nM,,52.48,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.28
,,3550763,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276677,,CHEMBL1276677,7.40,0,http://www.openphacts.org/units/Nanomolar,970861,=,1,1,=,,IC50,nM,,39.81,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.4
,,3550764,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cccc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276269,,CHEMBL1276269,6.50,0,http://www.openphacts.org/units/Nanomolar,969483,=,1,1,=,,IC50,nM,,316.23,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.5
,,3550765,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(Br)ccc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276710,,CHEMBL1276710,7.25,0,http://www.openphacts.org/units/Nanomolar,970937,=,1,1,=,,IC50,nM,,56.23,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.25
,,3550766,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(C)c(Cl)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276711,,CHEMBL1276711,7.96,0,http://www.openphacts.org/units/Nanomolar,970938,=,1,1,=,,IC50,nM,,10.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.96
,,3550767,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Cl)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276712,,CHEMBL1276712,8.77,0,http://www.openphacts.org/units/Nanomolar,970939,=,1,1,=,,IC50,nM,,1.698,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.77
,,3550768,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(F)c(Br)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276740,,CHEMBL1276740,8.15,0,http://www.openphacts.org/units/Nanomolar,971015,=,1,1,=,,IC50,nM,,7.079,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.15
,,3550769,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1c(C)c(Br)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276741,,CHEMBL1276741,7.96,0,http://www.openphacts.org/units/Nanomolar,971016,=,1,1,=,,IC50,nM,,10.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.96
,,3550770,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc(C)cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276742,,CHEMBL1276742,7.72,0,http://www.openphacts.org/units/Nanomolar,971017,=,1,1,=,,IC50,nM,,19.05,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.72
,,3550771,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCCc1c(C)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276766,,CHEMBL1276766,6.85,0,http://www.openphacts.org/units/Nanomolar,971096,=,1,1,=,,IC50,nM,,141.25,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.85
,,3550772,[],CHEMBL1285353,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCN1CCC[C@H]1CNC(=O)c1cc([N+](=O)[O-])cc(O)c1OC,,,CHEMBL1275273,Eur J Med Chem,2010.0,,CHEMBL1276767,,CHEMBL1276767,5.52,0,http://www.openphacts.org/units/Nanomolar,971097,=,1,1,=,,IC50,nM,,3019.95,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.52
,,3555060,[],CHEMBL1285527,Binding affinity to dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@@H]1CC[C@H](c2c[nH]c3ccc(C#N)cc23)C1,,,CHEMBL1275372,J Med Chem,2010.0,,CHEMBL1275709,,CHEMBL1275709,,0,http://www.openphacts.org/units/Nanomolar,968381,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30000.0
,,3555061,[],CHEMBL1285527,Binding affinity to dopamine D2,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)[C@H]1CC[C@@H](c2c[nH]c3ccc(F)cc23)C1,,,CHEMBL1275372,J Med Chem,2010.0,,CHEMBL1275791,,CHEMBL1275791,,0,http://www.openphacts.org/units/Nanomolar,968576,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30000.0
,,3557033,[],CHEMBL1286197,Inhibition of human dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2,,,CHEMBL1275331,J Med Chem,2010.0,,CHEMBL1278088,,CHEMBL1278088,,0,http://www.openphacts.org/units/Nanomolar,972655,>,1,1,>,,IC50,nM,,100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.1
,,3557049,[],CHEMBL1286325,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2,,,CHEMBL1275331,J Med Chem,2010.0,,CHEMBL1278088,,CHEMBL1278088,,0,http://www.openphacts.org/units/Nanomolar,972655,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,10'-6 mol/L,UO_0000065,,1.0
,,5121963,[],CHEMBL1647768,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2ccc3c(c2)N(S(=O)(=O)c2ccc4ccccc4c2)CCC3=O)CC1,,,CHEMBL1641464,Bioorg Med Chem Lett,2011.0,,CHEMBL1642116,,CHEMBL1642116,,0,http://www.openphacts.org/units/Nanomolar,1317371,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,5121964,[],CHEMBL1647768,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(c2cccc3c2C(=O)CCN3S(=O)(=O)c2ccc3ccccc3c2)CC1,,,CHEMBL1641464,Bioorg Med Chem Lett,2011.0,,CHEMBL1642117,,CHEMBL1642117,,0,http://www.openphacts.org/units/Nanomolar,1317372,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,5121965,[],CHEMBL1647768,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CC(=O)c2ccc(N3CCN(C)CC3)cc2N1S(=O)(=O)c1ccc2ccccc2c1,,,CHEMBL1641464,Bioorg Med Chem Lett,2011.0,"{'bei': '15.27', 'le': '0.29', 'lle': '3.11', 'sei': '11.27'}",CHEMBL1642118,,CHEMBL1642118,6.87,0,http://www.openphacts.org/units/Nanomolar,1317373,=,1,1,=,,IC50,nM,,136.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,136.0
,,5121966,[],CHEMBL1647768,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC1CC(=O)c2c(N3CCN(C)CC3)cccc2N1S(=O)(=O)c1ccc2ccccc2c1,,,CHEMBL1641464,Bioorg Med Chem Lett,2011.0,,CHEMBL1642123,,CHEMBL1642123,,0,http://www.openphacts.org/units/Nanomolar,1317378,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,5121967,[],CHEMBL1647768,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCC1CC(=O)c2c(N3CCN(C)CC3)cccc2N1S(=O)(=O)c1ccc2ccccc2c1,,,CHEMBL1641464,Bioorg Med Chem Lett,2011.0,,CHEMBL1642126,,CHEMBL1642126,,0,http://www.openphacts.org/units/Nanomolar,1317381,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,5121968,[],CHEMBL1647768,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(N2CCN(C)CC2)c2c(c1)N(S(=O)(=O)c1ccc3ccccc3c1)C(C)CC2=O,,,CHEMBL1641464,Bioorg Med Chem Lett,2011.0,"{'bei': '12.40', 'le': '0.24', 'lle': '1.68', 'sei': '9.43'}",CHEMBL1642128,,CHEMBL1642128,5.75,0,http://www.openphacts.org/units/Nanomolar,1317383,=,1,1,=,,IC50,nM,,1784.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1784.0
,,5165969,[],CHEMBL1663583,Inhibition of human dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,,,CHEMBL1649335,Bioorg Med Chem,2010.0,"{'bei': '21.91', 'le': '0.40', 'lle': '3.08', 'sei': '33.75'}",CHEMBL1255588,,CHEMBL1255588,7.92,0,http://www.openphacts.org/units/Nanomolar,1323897,=,1,1,=,,IC50,nM,,12.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,12.0
,Not Determined,6200157,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774383,,CHEMBL1774383,,0,,1422311,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200158,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774384,,CHEMBL1774384,,0,,1422312,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200159,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774385,,CHEMBL1774385,,0,,1422313,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200160,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774386,,CHEMBL1774386,,0,,1422314,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200161,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4ccccc4OC)CC3)cc2c1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774532,,CHEMBL1774532,,0,,1422502,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200162,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774534,,CHEMBL1774534,,0,,1422504,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200163,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774535,,CHEMBL1774535,,0,,1422505,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200164,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774536,,CHEMBL1774536,,0,,1422506,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200165,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774537,,CHEMBL1774537,,0,,1422507,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200166,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774539,,CHEMBL1774539,,0,,1422509,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200167,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2[nH]c(C(=O)NCCC(F)CN3CCN(c4ccccc4OC)CC3)cc2c1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774540,,CHEMBL1774540,,0,,1422510,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200168,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2[nH]c(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774541,,CHEMBL1774541,,0,,1422511,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200169,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774542,,CHEMBL1774542,,0,,1422512,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,6200170,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(CCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2c(c1)Cc1ccccc1-2,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1773087,,CHEMBL1773087,,0,,1422523,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,6200320,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774533,,CHEMBL1774533,5.80,0,http://www.openphacts.org/units/Nanomolar,1422503,=,1,1,=,,IC50,nM,,1600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1600.0
,,6200321,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL1774538,,CHEMBL1774538,6.38,0,http://www.openphacts.org/units/Nanomolar,1422508,=,1,1,=,,IC50,nM,,421.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,421.0
,,6200322,[],CHEMBL1777184,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,F,,,BAO_0000190,BAO_0000219,cell-based format,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,,,CHEMBL1772985,J Med Chem,2011.0,,CHEMBL26,SULPIRIDE,CHEMBL26,7.99,0,http://www.openphacts.org/units/Nanomolar,1422528,=,1,1,=,,IC50,nM,,10.28,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10.28
,,6201130,[],CHEMBL1781414,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)CCc1ccc(OC)c(OCCc2ccccc2)c1.Cl,,,CHEMBL1777734,Bioorg Med Chem Lett,2011.0,,CHEMBL521582,,CHEMBL190883,,0,http://www.openphacts.org/units/Nanomolar,1424992,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,6291240,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '10.98', 'le': '0.22', 'lle': '2.13', 'sei': '5.07'}",CHEMBL1807825,,CHEMBL1807825,5.40,0,http://www.openphacts.org/units/Nanomolar,1444249,=,1,1,=,,IC50,nM,,3981.07,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.4
,,6291241,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '11.77', 'le': '0.24', 'lle': '2.16', 'sei': '5.75'}",CHEMBL1807824,,CHEMBL1807824,5.60,0,http://www.openphacts.org/units/Nanomolar,1444248,=,1,1,=,,IC50,nM,,2511.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.6
,,6291242,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '12.06', 'le': '0.25', 'lle': '2.53', 'sei': '5.55'}",CHEMBL1807823,,CHEMBL1807823,5.40,0,http://www.openphacts.org/units/Nanomolar,1444247,=,1,1,=,,IC50,nM,,3981.07,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.4
,,6291243,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3cccc4ccccc34)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,,CHEMBL1807822,,CHEMBL1807822,,0,http://www.openphacts.org/units/Nanomolar,1444246,<,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,6291244,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '14.10', 'le': '0.28', 'lle': '3.52', 'sei': '5.88'}",CHEMBL1807821,,CHEMBL1807821,6.10,0,http://www.openphacts.org/units/Nanomolar,1444245,=,1,1,=,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,6291245,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '13.44', 'le': '0.27', 'lle': '2.25', 'sei': '7.08'}",CHEMBL1807820,,CHEMBL1807820,6.70,0,http://www.openphacts.org/units/Nanomolar,1444244,=,1,1,=,,IC50,nM,,199.53,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.7
,,6291246,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '13.40', 'le': '0.27', 'lle': '2.51', 'sei': '6.56'}",CHEMBL1807819,,CHEMBL1807819,6.20,0,http://www.openphacts.org/units/Nanomolar,1444243,=,1,1,=,,IC50,nM,,630.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.2
,,6291247,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3ccccc3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,,CHEMBL1807818,,CHEMBL1807818,,0,http://www.openphacts.org/units/Nanomolar,1444242,<,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,6291248,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCOCCc3ccccc3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,,CHEMBL1807817,,CHEMBL1807817,,0,http://www.openphacts.org/units/Nanomolar,1444241,<,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,6291249,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '15.07', 'le': '0.31', 'lle': '4.10', 'sei': '6.44'}",CHEMBL82663,SIBENADET,CHEMBL82663,7.00,0,http://www.openphacts.org/units/Nanomolar,1444240,=,1,1,=,,IC50,nM,,100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.0
,,6291250,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '10.78', 'le': '0.20', 'lle': '0.64', 'sei': '8.28'}",CHEMBL1346,DARIFENACIN,CHEMBL1346,4.60,0,http://www.openphacts.org/units/Nanomolar,1443854,=,1,1,=,,IC50,nM,,25118.86,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,4.6
,,6291252,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,,CHEMBL1256786,FORMOTEROL,CHEMBL1256786,,0,http://www.openphacts.org/units/Nanomolar,1443852,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,6292044,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '12.22', 'le': '0.25', 'lle': '2.41', 'sei': '6.47'}",CHEMBL1807826,,CHEMBL1807826,6.30,0,http://www.openphacts.org/units/Nanomolar,1444250,=,1,1,=,,IC50,nM,,501.19,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.3
,,6292045,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,,CHEMBL1807827,,CHEMBL1807827,,0,http://www.openphacts.org/units/Nanomolar,1444251,<,1,1,>,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,6292046,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '12.03', 'le': '0.26', 'lle': '2.27', 'sei': '5.96'}",CHEMBL1807828,,CHEMBL1807828,5.80,0,http://www.openphacts.org/units/Nanomolar,1444252,=,1,1,=,,IC50,nM,,1584.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.8
,,6292047,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '12.39', 'le': '0.27', 'lle': '2.22', 'sei': '6.57'}",CHEMBL1807829,,CHEMBL1807829,6.40,0,http://www.openphacts.org/units/Nanomolar,1444253,=,1,1,=,,IC50,nM,,398.11,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.4
,,6292048,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCC[S+]([O-])CCCNCCc3cccc(Cl)c3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,,CHEMBL1807830,,CHEMBL1807830,,0,http://www.openphacts.org/units/Nanomolar,1444254,<,1,1,>,,IC50,nM,,3162.28,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.5
,,6292049,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '11.87', 'le': '0.25', 'lle': '3.89', 'sei': '4.64'}",CHEMBL1807831,,CHEMBL1807831,6.10,0,http://www.openphacts.org/units/Nanomolar,1444255,=,1,1,=,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,6292050,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '11.80', 'le': '0.24', 'lle': '2.69', 'sei': '5.16'}",CHEMBL1807832,,CHEMBL1807832,5.50,0,http://www.openphacts.org/units/Nanomolar,1444256,=,1,1,=,,IC50,nM,,3162.28,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.5
,,6292051,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '12.03', 'le': '0.26', 'lle': '2.27', 'sei': '5.96'}",CHEMBL1807869,,CHEMBL1807869,5.80,0,http://www.openphacts.org/units/Nanomolar,1444297,=,1,1,=,,IC50,nM,,1584.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.8
,,6292052,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '12.45', 'le': '0.26', 'lle': '2.47', 'sei': '6.16'}",CHEMBL1807870,,CHEMBL1807870,6.00,0,http://www.openphacts.org/units/Nanomolar,1444298,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,6292053,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '11.62', 'le': '0.26', 'lle': '1.82', 'sei': '6.16'}",CHEMBL1807871,,CHEMBL1807871,6.00,0,http://www.openphacts.org/units/Nanomolar,1444299,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,6292054,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,,CHEMBL1807872,,CHEMBL1807872,,0,http://www.openphacts.org/units/Nanomolar,1444300,<,1,1,>,,IC50,nM,,2511.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.6
,,6292055,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '11.39', 'le': '0.24', 'lle': '2.24', 'sei': '5.35'}",CHEMBL1807873,,CHEMBL1807873,5.70,0,http://www.openphacts.org/units/Nanomolar,1444301,=,1,1,=,,IC50,nM,,1995.26,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.7
,,6292056,[],CHEMBL1810621,Binding affinity to dopamine 2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1,,,CHEMBL1806408,Bioorg Med Chem Lett,2011.0,"{'bei': '12.57', 'le': '0.25', 'lle': '3.10', 'sei': '5.72'}",CHEMBL1807874,,CHEMBL1807874,5.60,0,http://www.openphacts.org/units/Nanomolar,1444302,=,1,1,=,,IC50,nM,,2511.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.6
,,6338259,[],CHEMBL1827739,Inhibition of dopamine D2 receptor by competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c(C)n1-c1ccccc1.Cl.Cl.Cl.Cl,,,CHEMBL1821711,J Med Chem,2011.0,"{'bei': '12.79', 'le': '0.26', 'lle': '1.69', 'sei': '11.31'}",CHEMBL3216758,,CHEMBL1852516,6.04,0,http://www.openphacts.org/units/Nanomolar,1453764,=,1,1,=,,IC50,nM,,908.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,908.0
,,6338260,[],CHEMBL1827739,Inhibition of dopamine D2 receptor by competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c(C)n1-c1ccccc1.Cl.Cl.Cl.Cl,,,CHEMBL1821711,J Med Chem,2011.0,"{'bei': '12.05', 'le': '0.24', 'lle': '1.12', 'sei': '10.98'}",CHEMBL3216098,,CHEMBL1852341,5.86,0,http://www.openphacts.org/units/Nanomolar,1453767,=,1,1,=,,IC50,nM,,1369.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1369.0
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599581,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CCNC(=O)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL1231530,BETAMIPRON,CHEMBL1231530,,0,,1539551,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599670,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Brc1c(NC2=NCCN2)ccc2nccnc12,,,CHEMBL1909046,,,,CHEMBL844,BRIMONIDINE,CHEMBL844,,0,,1539559,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599778,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl,,,CHEMBL1909046,,,,CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE,CHEMBL1098,,0,,1539567,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7599877,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1458880,CADMIUM DICHLORIDE,CHEMBL1458880,,0,,1539575,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600144,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C,,,CHEMBL1909046,,,,CHEMBL211501,ANTIMYCIN A,CHEMBL211501,,0,,1539503,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600343,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN,,,CHEMBL1909046,,,,CHEMBL3084803,ASTROMICIN,CHEMBL3084803,,0,,1539511,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600462,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1095699,AZASERINE,CHEMBL1095699,,0,,1539519,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600605,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NCC(CC(=O)O)c1ccc(Cl)cc1,,,CHEMBL1909046,,,,CHEMBL701,BACLOFEN,CHEMBL701,,0,,1539527,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600737,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-],,,CHEMBL1909046,,,,CHEMBL221753,BENZETHONIUM CHLORIDE,CHEMBL1182210,,0,,1539535,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7600809,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-],,,CHEMBL1909046,,,,CHEMBL12089,BERBERINE CHLORIDE,CHEMBL295124,,0,,1539543,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7601603,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,ClC(Cl)(Cl)Cl,,,CHEMBL1909046,,,,CHEMBL44814,CARBON TETRACHLORIDE,CHEMBL44814,,0,,1539586,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602406,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO,,,CHEMBL1909046,,,,CHEMBL415690,BETADEX,CHEMBL415690,,0,,1539544,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602520,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL264374,BEZAFIBRATE,CHEMBL264374,,0,,1539552,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602606,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1,,,CHEMBL1909046,,,,CHEMBL1077,BROMFENAC,CHEMBL1077,,0,,1539560,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602716,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1,,,CHEMBL1909046,,,,CHEMBL894,BUPROPION,CHEMBL894,,0,,1539568,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7602812,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,,,CHEMBL1909046,,,,CHEMBL319244,CAFFEIC ACID PHENETHYL ESTER,CHEMBL319244,,0,,1539576,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7603072,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)N1c2ccccc2C=Cc2ccccc21,,,CHEMBL1909046,,,,CHEMBL108,CARBAMAZEPINE,CHEMBL108,,0,,1539584,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7603086,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc(=O)n(-c2ccccc2)n1C,,,CHEMBL1909046,,,,CHEMBL277474,ANTIPYRINE,CHEMBL277474,,0,,1539504,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7603285,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NCC(O)COc1ccc(CC(N)=O)cc1,,,CHEMBL1909046,,,,CHEMBL24,ATENOLOL,CHEMBL24,,0,,1539512,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7603409,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21,,,CHEMBL1909046,,,,CHEMBL1598608,AZASETRON,CHEMBL1598608,,0,,1539520,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7603552,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1,,,CHEMBL1909046,,,,CHEMBL1201346,BALSALAZIDE,CHEMBL1201346,,0,,1539528,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7603656,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34,,,CHEMBL1909046,,,,CHEMBL31184,BENZO[DEF]CHRYSENE,CHEMBL31184,,0,,1539536,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7604398,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cn1c(=O)c2c(ncn2C)n(C)c1=O,,,CHEMBL1909046,,,,CHEMBL113,CAFFEINE,CHEMBL113,,0,,1539577,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7605320,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,,,CHEMBL1909046,,,,CHEMBL135,ESTRADIOL,CHEMBL135,,0,,1539545,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7605434,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCC[C@@H](CC)COC(=O)c1ccccc1C(=O)OC[C@@H](CC)CCCC,,,CHEMBL1909046,,,,CHEMBL402794,BIS(2-ETHYLHEXYL)PHTHALATE,CHEMBL402794,,0,,1539553,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7605519,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1,,,CHEMBL1909046,,,,CHEMBL253376,BROMHEXINE,CHEMBL253376,,0,,1539561,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7605623,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,,,CHEMBL1909046,,,"{'bei': '16.84', 'le': '0.32', 'lle': '4.40', 'sei': '9.32'}",CHEMBL49,BUSPIRONE,CHEMBL49,6.49,0,http://www.openphacts.org/units/Nanomolar,1539569,=,15,1,=,,IC50,nM,,323.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.323
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7605980,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)n1ccn(C)c1=S,,,CHEMBL1909046,,,,CHEMBL508102,CARBIMAZOLE,CHEMBL508102,,0,,1539585,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7605992,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O,,,CHEMBL1909046,,,,CHEMBL1256017,ARCAINE SULFATE,CHEMBL102740,,0,,1539505,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7606188,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,,,CHEMBL1909046,,,,CHEMBL1487,ATORVASTATIN,CHEMBL1487,,0,,1539513,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7606315,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cn1cnc([N+](=O)[O-])c1Sc1ncnc2[nH]cnc12,,,CHEMBL1909046,,,,CHEMBL1542,AZATHIOPRINE,CHEMBL1542,,0,,1539521,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7606459,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1,,,CHEMBL1909046,,,,CHEMBL521589,BAMBUTEROL,CHEMBL521589,,0,,1539529,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7606559,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,c1ccc2c(c1)c1cccc3ccc4cccc2c4c31,,,CHEMBL1909046,,,,CHEMBL1371125,BENZO[E]PYRENE,CHEMBL1371125,,0,,1539537,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7608227,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,,,CHEMBL1909046,,,,CHEMBL282575,ESTRADIOL BENZOATE,CHEMBL282575,,0,,1539546,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7608354,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,,,CHEMBL1909046,,,,CHEMBL942,BISACODYL,CHEMBL942,,0,,1539554,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7608437,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)C(Br)C(=O)NC(N)=O,,,CHEMBL1909046,,,,CHEMBL1515611,BROMISOVALUM,CHEMBL1515611,,0,,1539562,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7608536,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CS(=O)(=O)OCCCCOS(C)(=O)=O,,,CHEMBL1909046,,,,CHEMBL820,BUSULFAN,CHEMBL820,,0,,1539570,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7608637,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1,,,CHEMBL1909046,,,,CHEMBL65,CAMPTOTHECIN,CHEMBL65,,0,,1539578,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7608778,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3,,,CHEMBL1909046,,,,CHEMBL566534,ARTEMETHER,CHEMBL566534,,0,,1539506,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7608972,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C1[C@@H]2CCC3[C@@](CC[C@@H]4[C@H](C(=O)O)C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@]34C)(C2)[C@@H]1O.[K+].[K+],,,CHEMBL1909046,,,,CHEMBL499815,ATRACTYLOSIDE,CHEMBL2219524,,0,,1539514,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7609100,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1,,,CHEMBL1909046,,,,CHEMBL564201,6-AZAURIDINE,CHEMBL564201,,0,,1539522,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7609243,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1,,,CHEMBL1909046,,,,CHEMBL270299,BAY-11-7085,CHEMBL270299,,0,,1539530,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7609346,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)c1ccc(N)cc1,,,CHEMBL1909046,,,,CHEMBL278172,BENZOCAINE,CHEMBL278172,,0,,1539538,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7610092,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,,CHEMBL1909046,,,,CHEMBL1016,CANDESARTAN,CHEMBL1016,,0,,1539579,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7610869,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12,,,CHEMBL1909046,,,,CHEMBL26260,BETA-NAPHTHOFLAVONE,CHEMBL26260,,0,,1539547,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7611001,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(c1ccc(O)cc1)c1ccc(O)cc1,,,CHEMBL1909046,,,,CHEMBL418971,BISPHENOL A,CHEMBL418971,,0,,1539555,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7611089,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Brc1ccccc1,,,CHEMBL1909046,,,,CHEMBL16068,BROMOBENZENE,CHEMBL16068,,0,,1539563,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7611187,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCOC(=O)c1ccc(N)cc1,,,CHEMBL1909046,,,,CHEMBL127516,BUTAMBEN,CHEMBL127516,,0,,1539571,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7611435,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4,,,CHEMBL1909046,,,,CHEMBL567597,ARTEMISININ,CHEMBL567597,,0,,1539507,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7611632,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2,,,CHEMBL1909046,,,,CHEMBL517712,ATROPINE,CHEMBL517712,,0,,1539515,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7611762,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL529,AZITHROMYCIN,CHEMBL529,,0,,1539523,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7611901,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,,,CHEMBL1909046,,,,CHEMBL1586,BECLOMETHASONE,CHEMBL1586,,0,,1539531,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7612006,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL541,BENZOIC ACID,CHEMBL541,,0,,1539539,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7612751,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@]12C(=O)OC(=O)[C@]1(C)[C@H]1CC[C@@H]2O1,,,CHEMBL1909046,,,,CHEMBL48449,CANTHARIDIN,CHEMBL48449,,0,,1539580,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7613673,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNCCc1ccccn1,,,CHEMBL1909046,,,,CHEMBL24441,BETAHISTINE,CHEMBL24441,,0,,1539548,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7613800,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,,,CHEMBL1909046,,,,CHEMBL290106,BITHIONOL,CHEMBL290106,,0,,1539556,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7613895,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,,,CHEMBL1909046,,,"{'bei': '13.44', 'le': '0.28', 'lle': '5.61', 'sei': '7.45'}",CHEMBL493,BROMOCRIPTINE,CHEMBL493,8.80,0,http://www.openphacts.org/units/Nanomolar,1539564,=,15,1,=,,IC50,nM,,1.582,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.001582
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7614005,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12,,,CHEMBL1909046,,,,CHEMBL990,BUTENAFINE,CHEMBL990,,0,,1539572,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7614250,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(C(=O)N2CCCC2=O)cc1,,,CHEMBL1909046,,,,CHEMBL36994,ANIRACETAM,CHEMBL36994,,0,,1539500,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7614379,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,,,CHEMBL1909046,,,,CHEMBL196,ASCORBIC ACID,CHEMBL196,,0,,1539508,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7614565,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1366,AURANOFIN,CHEMBL1366,,0,,1539516,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7614710,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O,,,CHEMBL1909046,,,,CHEMBL1537,AZLOCILLIN,CHEMBL1537,,0,,1539524,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7614847,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O,,,CHEMBL1909046,,,,CHEMBL838,BENAZEPRIL,CHEMBL838,,0,,1539532,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7614947,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1,,,CHEMBL1909046,,,"{'bei': '15.73', 'le': '0.36', 'lle': '-0.48', 'sei': '20.29'}",CHEMBL508112,BENZOTHIAZYL DISULFIDE,CHEMBL508112,5.23,0,http://www.openphacts.org/units/Nanomolar,1539540,=,15,1,=,,IC50,nM,,5866.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.866
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7615723,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,,,CHEMBL1909046,,,,CHEMBL294199,CAPSAICIN,CHEMBL294199,,0,,1539581,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7616647,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,,,CHEMBL1909046,,,,CHEMBL632,BETAMETHASONE,CHEMBL632,,0,,1539549,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7616748,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-],,,CHEMBL1909046,,,,CHEMBL4649901,,CHEMBL403664,,0,,1539557,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7616841,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,,,CHEMBL1909046,,,,CHEMBL1370,BUDESONIDE,CHEMBL1370,,0,,1539565,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7616953,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12,,,CHEMBL1909046,,,,CHEMBL1255834,BW-723C86,CHEMBL1255834,,0,,1539573,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7617208,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(C2C(=O)c3ccccc3C2=O)cc1,,,CHEMBL1909046,,,,CHEMBL712,ANISINDIONE,CHEMBL712,,0,,1539501,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7617336,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)Oc1ccccc1C(=O)O,,,CHEMBL1909046,,,,CHEMBL25,ASPIRIN,CHEMBL25,,0,,1539509,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7617520,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1,,,CHEMBL1909046,,,,CHEMBL1489,AZACITIDINE,CHEMBL1489,,0,,1539517,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7617666,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O,,,CHEMBL1909046,,,,CHEMBL158,AZTREONAM,CHEMBL158,,0,,1539525,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7617803,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1,,,CHEMBL1909046,,,,CHEMBL340978,BENOXAPROFEN,CHEMBL340978,,0,,1539533,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7617877,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2,,,CHEMBL1909046,,,,CHEMBL1201203,BENZTROPINE,CHEMBL1201203,,0,,1539541,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7618661,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,,,CHEMBL1909046,,,,CHEMBL1560,CAPTOPRIL,CHEMBL1560,,0,,1539582,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7618939,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,,,CHEMBL1909046,,,"{'bei': '11.66', 'le': '0.21', 'lle': '-0.01', 'sei': '12.63'}",CHEMBL296419,ASTEMIZOLE,CHEMBL296419,5.34,0,http://www.openphacts.org/units/Nanomolar,1539510,=,15,1,=,,IC50,nM,,4521.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,4.521
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7619601,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O,,,CHEMBL1909046,,,,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,CHEMBL1201207,,0,,1539550,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7619701,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1,,,CHEMBL1909046,,,,CHEMBL357995,BOPINDOLOL,CHEMBL357995,,0,,1539558,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7619798,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1,,,CHEMBL1909046,,,,CHEMBL188921,BUFLOMEDIL,CHEMBL188921,,0,,1539566,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7619900,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1476898,CADMIUM ACETATE,CHEMBL1476898,,0,,1539574,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7620164,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1,,,CHEMBL1909046,,,,CHEMBL423192,ANISOMYCIN,CHEMBL423192,,0,,1539502,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7620516,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O,,,CHEMBL1909046,,,,CHEMBL515914,AZARIBINE,CHEMBL515914,,0,,1539518,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7620662,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1,,,CHEMBL1909046,,,,CHEMBL1200558,BACITRACIN,CHEMBL1200558,,0,,1539526,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7620799,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1,,,CHEMBL1909046,,,,CHEMBL388590,BENZBROMARONE,CHEMBL388590,,0,,1539534,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7620854,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OCc1ccccc1,,,CHEMBL1909046,,,,CHEMBL720,BENZYL ALCOHOL,CHEMBL720,,0,,1539542,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7621654,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[N+](C)(C)CCOC(N)=O.[Cl-],,,CHEMBL1909046,,,,CHEMBL14,CARBACHOL,CHEMBL965,,0,,1539583,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7621791,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccc2c3c(cccc13)C(=O)NC2=O,,,CHEMBL1909046,,,,CHEMBL338790,,CHEMBL338790,,0,,1539441,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7622978,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,,,CHEMBL1909046,,,,CHEMBL63560,(R)-BICALUTAMIDE,CHEMBL63560,,0,,1539417,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7623067,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,c1ccc(Cn2ccnc2)cc1,,,CHEMBL1909046,,,,CHEMBL14192,BENZYLIMIDAZOLE,CHEMBL14192,,0,,1539425,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7623152,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2,,,CHEMBL1909046,,,,CHEMBL30327,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",CHEMBL30327,,0,,1539433,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7623481,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1[nH]c2ccccc2c2ccccc12,,,CHEMBL1909046,,,,CHEMBL45245,,CHEMBL45245,,0,,1539450,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7623597,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC,,,CHEMBL1909046,,,,CHEMBL502620,ACLARUBICIN,CHEMBL502620,,0,,1539458,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7623718,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1ncnc2[nH]ncc12,,,CHEMBL1909046,,,,CHEMBL1467,ALLOPURINOL,CHEMBL1467,,0,,1539466,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7623807,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)c1nc(N(C)C)nc(N(C)C)n1,,,CHEMBL1909046,,,,CHEMBL1455,ALTRETAMINE,CHEMBL1455,,0,,1539474,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7623932,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN,,,CHEMBL1909046,,,,CHEMBL1370561,AMINOPHYLLINE,CHEMBL190,,0,,1539482,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7624109,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2,,,CHEMBL1909046,,,"{'bei': '21.35', 'le': '0.42', 'lle': '3.27', 'sei': '18.17'}",CHEMBL1113,AMOXAPINE,CHEMBL1113,6.70,0,http://www.openphacts.org/units/Nanomolar,1539490,=,15,1,=,,IC50,nM,,200.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.2
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7624223,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12,,,CHEMBL1909046,,,,CHEMBL87285,ANDROSTERONE,CHEMBL87285,,0,,1539499,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7624740,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@@H](Cc1ccc(F)cc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1235242,,CHEMBL1235242,,0,,1539442,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7625692,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,,,CHEMBL1909046,,,,CHEMBL1399,ANASTROZOLE,CHEMBL1399,,0,,1539498,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7625922,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1onc(O)c1CC(N)C(=O)O,,,CHEMBL1909046,,,,CHEMBL13378,"(R,S)-AMPA",CHEMBL13378,,0,,1539418,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7626008,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,S=C=Nc1cccc2ccccc12,,,CHEMBL1909046,,,,CHEMBL1381098,1-NAPHTHYLISOTHIOCYANATE,CHEMBL1381098,,0,,1539426,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7626103,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)Nc1cccc(O)c1,,,CHEMBL1909046,,,,CHEMBL9419,METACETAMOL,CHEMBL9419,,0,,1539434,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7626433,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL3215298,ABAMECTIN,CHEMBL3215298,,0,,1539451,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7626552,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN1C[C@]2(COC)[C@H](O)C[C@@H](OC)[C@@]34[C@@H]5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)[C@@H]5[C@@](OC(C)=O)([C@@H]([C@H](OC)[C@H]23)[C@H]14)[C@@H](O)[C@@H]6OC,,,CHEMBL1909046,,,,CHEMBL2103747,ACONITINE,CHEMBL2103747,,0,,1539459,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7626674,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=CCO,,,CHEMBL1909046,,,,CHEMBL234926,ALLYL ALCOHOL,CHEMBL234926,,0,,1539467,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7626764,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC12CC3CC(CC(C3)C1)C2,,,CHEMBL1909046,,,,CHEMBL660,AMANTADINE,CHEMBL660,,0,,1539475,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7626891,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1,,,CHEMBL1909046,,,,CHEMBL376180,AMINOPTERIN,CHEMBL376180,,0,,1539483,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7627044,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,,,CHEMBL1909046,,,,CHEMBL1082,AMOXICILLIN,CHEMBL1082,,0,,1539491,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7627684,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cn[nH]c1,,,CHEMBL1909046,,,,CHEMBL1308,FOMEPIZOLE,CHEMBL1308,,0,,1539443,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7628719,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NC[C@H](O)COc1cccc2[nH]ccc12,,,CHEMBL1909046,,,,CHEMBL117405,,CHEMBL117405,,0,,1539419,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7628801,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C(Cl)Cl,,,CHEMBL1909046,,,,CHEMBL156455,"1,1-DICHLOROETHENE",CHEMBL156455,,0,,1539427,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7628899,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)c1cccc(N)c1,,,CHEMBL1909046,,,,CHEMBL81977,3-AMINOBENZAMIDE,CHEMBL81977,,0,,1539435,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7629144,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCCCCCCc1ccc(O)cc1,,,CHEMBL1909046,,,,CHEMBL153062,4-NONYLPHENOL,CHEMBL153062,,0,,1539444,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7629230,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O,,,CHEMBL1909046,,,,CHEMBL1566,ACARBOSE,CHEMBL1566,,0,,1539452,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7629348,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc2c(ncn2COCCO)c(=O)[nH]1,,,CHEMBL1909046,,,,CHEMBL184,ACYCLOVIR,CHEMBL184,,0,,1539460,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7629471,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O,,,CHEMBL1909046,,,,CHEMBL1110,ALOSETRON,CHEMBL1110,,0,,1539468,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7629561,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1,,,CHEMBL1909046,,,,CHEMBL153479,AMBROXOL,CHEMBL153479,,0,,1539476,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7629689,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccc(C(=O)O)c(O)c1,,,CHEMBL1909046,,,,CHEMBL1169,AMINOSALICYLIC ACID,CHEMBL1169,,0,,1539484,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7629841,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,,,CHEMBL1909046,,,,CHEMBL267345,AMPHOTERICIN B,CHEMBL267345,,0,,1539492,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7631253,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1,,,CHEMBL1909046,,,,CHEMBL1909048,,CHEMBL1909048,,0,,1539420,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7631340,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N=C(Nc1ccccc1)Nc1ccccc1,,,CHEMBL1909046,,,,CHEMBL77675,,CHEMBL77675,,0,,1539428,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7631435,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3,,,CHEMBL1909046,,,,CHEMBL40583,3-METHYLCHOLANTHRENE,CHEMBL40583,,0,,1539436,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7631678,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCCCCCc1ccc(O)cc1,,,CHEMBL1909046,,,,CHEMBL195437,4-OCTYLPHENOL,CHEMBL195437,,0,,1539445,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7631783,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1,,,CHEMBL1909046,,,,CHEMBL642,ACEBUTOLOL,CHEMBL642,,0,,1539453,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7631902,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2,,,CHEMBL1909046,,,,CHEMBL1697694,AFLATOXIN,CHEMBL1697694,,0,,1539461,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7632021,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO,,,CHEMBL1909046,,,,CHEMBL1230813,ALFADEX,CHEMBL1230813,,0,,1539469,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7632113,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NCCCNCCSP(=O)(O)O,,,CHEMBL1909046,,,,CHEMBL1006,AMIFOSTINE,CHEMBL1006,,0,,1539477,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7632383,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,,,CHEMBL1909046,,,,CHEMBL174,AMPICILLIN,CHEMBL174,,0,,1539493,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7633598,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1,,,CHEMBL1909046,,,"{'bei': '7.28', 'le': '0.21', 'lle': '-2.24', 'sei': '11.01'}",CHEMBL633,AMIODARONE,CHEMBL633,4.70,0,http://www.openphacts.org/units/Nanomolar,1539485,=,15,1,=,,IC50,nM,,19952.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,19.952
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7633963,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1,,,CHEMBL1909046,,,,CHEMBL437002,,CHEMBL437002,,0,,1539421,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7634052,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)N1c2ccccc2CCc2ccccc21,,,CHEMBL1909046,,,,CHEMBL41543,,CHEMBL41543,,0,,1539429,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7634147,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O,,,CHEMBL1909046,,,,CHEMBL291338,"3,3',4',5-TETRACHLOROSALICYLANILIDE",CHEMBL291338,,0,,1539437,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7634367,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccc(Cc2ccc(N)cc2)cc1,,,CHEMBL1909046,,,,CHEMBL85728,"4,4'-METHYLENEDIANILINE",CHEMBL85728,,0,,1539446,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7634483,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl,,,CHEMBL1909046,,,,CHEMBL93645,ACECLOFENAC,CHEMBL93645,,0,,1539454,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7634603,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O,,,CHEMBL1909046,,,,CHEMBL2105617,AJMALINE,CHEMBL2105617,,0,,1539462,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7634714,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,,,CHEMBL1909046,,,"{'bei': '15.13', 'le': '0.28', 'lle': '6.28', 'sei': '7.37'}",CHEMBL1403281,ERGOCRYPTINE,CHEMBL1403281,8.71,0,http://www.openphacts.org/units/Nanomolar,1539470,=,15,1,=,,IC50,nM,,1.95,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.00195
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7634822,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,,,CHEMBL1909046,,,,CHEMBL177,AMIKACIN,CHEMBL177,,0,,1539478,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7635071,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1,,,CHEMBL1909046,,,,CHEMBL1365675,AMITRAZ,CHEMBL1365675,,0,,1539486,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7635119,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21,,,CHEMBL1909046,,,,CHEMBL1566249,AMPIROXICAM,CHEMBL1566249,,0,,1539494,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7636697,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1,,,CHEMBL1909046,,,,CHEMBL1909049,,CHEMBL1909049,,0,,1539422,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7636791,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,,,CHEMBL1909046,,,,CHEMBL1395,METHYLTESTOSTERONE,CHEMBL1395,,0,,1539430,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7636884,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1544,LIOTHYRONINE,CHEMBL1544,,0,,1539438,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7637105,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F,,,CHEMBL1909046,,,,CHEMBL917,FLOXURIDINE,CHEMBL917,,0,,1539447,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7637219,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,,,CHEMBL1909046,,,,CHEMBL189171,ACEMETACIN,CHEMBL189171,,0,,1539455,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7637339,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1,,,CHEMBL1909046,,,,CHEMBL1483,ALBENDAZOLE,CHEMBL1483,,0,,1539463,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7637433,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12,,,CHEMBL1909046,,,,CHEMBL283196,ALPHA-NAPHTHOFLAVONE,CHEMBL283196,,0,,1539471,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7637553,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N=C(N)NC(=O)c1nc(Cl)c(N)nc1N,,,CHEMBL1909046,,,,CHEMBL945,AMILORIDE,CHEMBL945,,0,,1539479,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7637786,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCC=C1c2ccccc2CCc2ccccc21,,,CHEMBL1909046,,,"{'bei': '21.61', 'le': '0.39', 'lle': '1.83', 'sei': '185.07'}",CHEMBL629,AMITRIPTYLINE,CHEMBL629,6.00,0,http://www.openphacts.org/units/Nanomolar,1539487,=,15,1,=,,IC50,nM,,1009.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.009
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7637853,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1,,,CHEMBL1909046,,,,CHEMBL116,AMPRENAVIR,CHEMBL116,,0,,1539495,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7638002,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1,,,CHEMBL1909046,,,,CHEMBL426123,,CHEMBL426123,,0,,1539415,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7639508,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1,,,CHEMBL1909046,,,,CHEMBL1909050,,CHEMBL1909050,,0,,1539423,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7639601,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2,,,CHEMBL1909046,,,,CHEMBL311469,2-ACETYLAMINOFLUORENE,CHEMBL311469,,0,,1539431,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7639701,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CCCc1cccs1,,,CHEMBL1909046,,,,CHEMBL1230333,,CHEMBL1230333,,0,,1539439,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7639921,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Sc1ncnc2nc[nH]c12,,,CHEMBL1909046,,,,CHEMBL1425,MERCAPTOPURINE,CHEMBL1425,,0,,1539448,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7640036,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)Nc1ccc(O)cc1,,,CHEMBL1909046,,,,CHEMBL112,ACETAMINOPHEN,CHEMBL112,,0,,1539456,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7640157,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NCCCC(O)(P(=O)(O)O)P(=O)(O)O,,,CHEMBL1909046,,,,CHEMBL870,ALENDRONIC ACID,CHEMBL870,,0,,1539464,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7640247,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,,,CHEMBL1909046,,,,CHEMBL47,VITAMIN E,CHEMBL47,,0,,1539472,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7640369,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NCCCCCC(=O)O,,,CHEMBL1909046,,,,CHEMBL1046,AMINOCAPROIC ACID,CHEMBL1046,,0,,1539480,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7640563,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,,,CHEMBL1909046,,,,CHEMBL1491,AMLODIPINE,CHEMBL1491,,0,,1539488,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7640653,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1cc(-c2ccncc2)c[nH]c1=O,,,CHEMBL1909046,,,,CHEMBL12856,INAMRINONE,CHEMBL12856,,0,,1539496,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7642286,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1,,,CHEMBL1909046,,,,CHEMBL558551,,CHEMBL558551,,0,,1539416,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7642372,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nn1nnc2ccccc21,,,CHEMBL1909046,,,,CHEMBL101168,,CHEMBL101168,,0,,1539424,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7642462,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]8COCC(C)O)O[C@@H]7COCC(C)O)O[C@@H]6COCC(C)O)O[C@@H]5COCC(C)O)O[C@@H]4COCC(C)O)O[C@@H]3COCC(C)O,,,CHEMBL1909046,,,,CHEMBL577294,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,CHEMBL577294,,0,,1539432,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7642568,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1,,,CHEMBL1909046,,,,CHEMBL1909051,,CHEMBL1909051,,0,,1539440,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7642789,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc(CC(=O)O)ccc2c1,,,CHEMBL1909046,,,,CHEMBL1105,6-METHOXY-2-NAPHTHYLACETIC ACID,CHEMBL1105,,0,,1539449,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7642904,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)Nc1nnc(S(N)(=O)=O)s1,,,CHEMBL1909046,,,,CHEMBL20,ACETAZOLAMIDE,CHEMBL20,,0,,1539457,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7643026,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL1601669,ALFACALCIDOL,CHEMBL1601669,,0,,1539465,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7643117,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,,,CHEMBL1909046,,,,CHEMBL661,ALPRAZOLAM,CHEMBL661,,0,,1539473,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7643241,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC1(c2ccc(N)cc2)CCC(=O)NC1=O,,,CHEMBL1909046,,,,CHEMBL488,AMINOGLUTETHIMIDE,CHEMBL488,,0,,1539481,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7643428,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC1(CCC(C)C)C(=O)NC(=O)NC1=O,,,CHEMBL1909046,,,,CHEMBL267894,AMOBARBITAL,CHEMBL267894,,0,,1539489,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7643519,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL461727,AMYGDALIN,CHEMBL461727,,0,,1539497,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7644196,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,,,CHEMBL1909046,,,,CHEMBL106,FLUCONAZOLE,CHEMBL106,,0,,1539770,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7645212,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1cc(Cl)c(OCC#CI)cc1Cl,,,CHEMBL1909046,,,,CHEMBL1289,HALOPROGIN,CHEMBL1289,,0,,1539827,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7645319,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,,CHEMBL1909046,,,,CHEMBL389621,HYDROCORTISONE,CHEMBL389621,,0,,1539835,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7645449,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=P1(NCCCl)OCCCN1CCCl,,,CHEMBL1909046,,,,CHEMBL1024,IFOSFAMIDE,CHEMBL1024,,0,,1539843,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7645755,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1,,,CHEMBL1909046,,,,CHEMBL1902981,EPERISONE,CHEMBL1902981,,0,,1539731,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7645821,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,,,CHEMBL1909046,,,,CHEMBL2220427,ERYTHROMYCIN PROPIONATE,CHEMBL2220427,,0,,1539739,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7645933,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL241694,ETHISTERONE,CHEMBL241694,,0,,1539747,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7646062,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC12CCC(CC1)C(C)(C)O2,,,CHEMBL1909046,,,,CHEMBL485259,EUCALYPTOL,CHEMBL485259,,0,,1539755,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7646559,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C,,,CHEMBL1909046,,,,CHEMBL1501,FLUOCINONIDE,CHEMBL1501,,0,,1539779,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7646621,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,,,CHEMBL1909046,,,,CHEMBL806,FLUTAMIDE,CHEMBL806,,0,,1539787,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7646761,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-],,,CHEMBL1909046,,,,CHEMBL1200993,GALLAMINE TRIETHIODIDE,CHEMBL360055,,0,,1539795,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7646894,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H](N)C[C@@H]2N)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL3039597,GENTAMICIN,CHEMBL3039597,,0,,1539803,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7647000,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NCC(=O)O,,,CHEMBL1909046,,,,CHEMBL773,GLYCINE,CHEMBL773,,0,,1539811,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7647134,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O,,,CHEMBL1909046,,,,CHEMBL562,GRISEOFULVIN,CHEMBL562,,0,,1539819,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7647712,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,,,CHEMBL1909046,,,"{'bei': '12.65', 'le': '0.23', 'lle': '-1.28', 'sei': '20.11'}",CHEMBL305660,EBASTINE,CHEMBL305660,5.94,0,http://www.openphacts.org/units/Nanomolar,1539723,=,15,1,=,,IC50,nM,,1149.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.1491
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7648329,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C(=O)O)c1cccc(Oc2ccccc2)c1,,,CHEMBL1909046,,,,CHEMBL1297,FENOPROFEN,CHEMBL1297,,0,,1539763,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7648471,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(=O)[nH]cc1F,,,CHEMBL1909046,,,,CHEMBL1463,FLUCYTOSINE,CHEMBL1463,,0,,1539771,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7649471,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4,,,CHEMBL1909046,,,,CHEMBL433257,HARRINGTONINE,CHEMBL433257,,0,,1539828,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7649583,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,,,CHEMBL1909046,,,,CHEMBL1535,HYDROXYCHLOROQUINE,CHEMBL1535,,0,,1539836,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7650053,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNC[C@H](O)c1ccc(O)c(O)c1,,,CHEMBL1909046,,,,CHEMBL679,EPINEPHRINE,CHEMBL679,,0,,1539732,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7650131,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1,,,CHEMBL1909046,,,,CHEMBL768,ESMOLOL,CHEMBL768,,0,,1539740,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7650240,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC1(C)CC(=O)NC1=O,,,CHEMBL1909046,,,,CHEMBL696,ETHOSUXIMIDE,CHEMBL696,,0,,1539748,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7650371,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=CCc1ccc(O)c(OC)c1,,,CHEMBL1909046,,,,CHEMBL42710,EUGENOL,CHEMBL42710,,0,,1539756,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7650861,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12,,,CHEMBL1909046,,,,CHEMBL177756,FLUORESCEIN,CHEMBL177756,,0,,1539780,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7650923,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21,,,CHEMBL1909046,,,,CHEMBL2220442,FLUVASTATIN,CHEMBL2220442,,0,,1539788,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7651067,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OC[C@H]1OC2C3[C@@H](CO)OC(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)C(OC1[C@H](O)[C@H]2O)O[C@@H]9CO)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)[C@H](O)[C@H]3O,,,CHEMBL1909046,,,,CHEMBL407030,,CHEMBL407030,,0,,1539796,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7651190,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-],,,CHEMBL1909046,,,"{'bei': '14.76', 'le': '0.27', 'lle': '1.04', 'sei': '57.93'}",CHEMBL64894,GENTIAN VIOLET,CHEMBL459265,5.50,0,http://www.openphacts.org/units/Nanomolar,1539804,=,15,1,=,,IC50,nM,,3178.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,3.178
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7651326,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CO,,,CHEMBL1909046,,,,CHEMBL252557,GLYCOLIC ACID,CHEMBL252557,,0,,1539812,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7651460,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccccc1OCC(O)CO,,,CHEMBL1909046,,,,CHEMBL980,GUAIFENESIN,CHEMBL980,,0,,1539820,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7651883,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,,,CHEMBL1909046,,,,CHEMBL941,IMATINIB,CHEMBL941,,0,,1539844,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7651970,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,,,CHEMBL1909046,,,"{'bei': '12.82', 'le': '0.28', 'lle': '-0.91', 'sei': '18.09'}",CHEMBL808,ECONAZOLE,CHEMBL808,4.89,0,http://www.openphacts.org/units/Nanomolar,1539724,=,15,1,=,,IC50,nM,,12807.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,12.807
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7652648,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(/C=C/C(=O)O)ccc1O,,,CHEMBL1909046,,,,CHEMBL32749,FERULATE,CHEMBL32749,,0,,1539764,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7652791,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL1568,FLUDARABINE,CHEMBL1568,,0,,1539772,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7653789,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,,,CHEMBL1909046,,,,CHEMBL496,HEXACHLOROPHENE,CHEMBL496,,0,,1539829,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7653906,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1062,HYDROXYPROGESTERONE,CHEMBL1062,,0,,1539837,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7654236,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1=NN(c2ccccc2)C(=O)C1,,,CHEMBL1909046,,,,CHEMBL290916,EDARAVONE,CHEMBL290916,,0,,1539725,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7654357,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1,,,CHEMBL1909046,,,,CHEMBL417,EPIRUBICIN,CHEMBL417,,0,,1539733,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7654437,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O,,,CHEMBL1909046,,,,CHEMBL193482,ESTRIOL,CHEMBL193482,,0,,1539741,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7654550,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OCCO,,,CHEMBL1909046,,,,CHEMBL457299,MACROGOL,CHEMBL457299,,0,,1539749,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7654681,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O,,,CHEMBL1909046,,,,CHEMBL880,FAMCICLOVIR,CHEMBL880,,0,,1539757,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7655170,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1200600,FLUOROMETHOLONE,CHEMBL1200600,,0,,1539781,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7655230,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)P(=O)(O)O,,,CHEMBL1909046,,,,CHEMBL666,FOSCARNET,CHEMBL666,,0,,1539789,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7655374,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1,,,CHEMBL1909046,,,,CHEMBL182,GANCICLOVIR,CHEMBL182,,0,,1539797,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7655470,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)=CCC/C(C)=C/CO,,,CHEMBL1909046,,,,CHEMBL25719,GERANIOL,CHEMBL25719,,0,,1539805,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7655613,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12,,,CHEMBL1909046,,,,CHEMBL441687,GLYCYRRHIZIN,CHEMBL441687,,0,,1539813,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7655739,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N=C(N)N/N=C/c1c(Cl)cccc1Cl,,,CHEMBL1909046,,,,CHEMBL420,GUANABENZ,CHEMBL420,,0,,1539821,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7656181,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)Cn1cnc2c(N)nc3ccccc3c21,,,CHEMBL1909046,,,,CHEMBL1282,IMIQUIMOD,CHEMBL1282,,0,,1539845,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7656926,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,,,CHEMBL1909046,,,,CHEMBL914,FEXOFENADINE,CHEMBL914,,0,,1539765,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7657069,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1201010,FLUDROCORTISONE ACETATE,CHEMBL1201010,,0,,1539773,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7658038,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2,,,CHEMBL1909046,,,,CHEMBL1319362,HOMATROPINE HYDROBROMIDE,CHEMBL1618018,,0,,1539830,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7658164,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)NO,,,CHEMBL1909046,,,,CHEMBL467,HYDROXYUREA,CHEMBL467,,0,,1539838,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7658473,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,,,CHEMBL1909046,,,,CHEMBL50588,EMETINE,CHEMBL50588,,0,,1539726,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7658599,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12,,,CHEMBL1909046,,,,CHEMBL1536,ERGOCALCIFEROL,CHEMBL1536,,0,,1539734,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7658676,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O,,,CHEMBL1909046,,,,CHEMBL1405,ESTRONE,CHEMBL1405,,0,,1539742,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7658791,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1200623,ETHYLESTRENOL,CHEMBL1200623,,0,,1539750,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7658929,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1,,,CHEMBL1909046,,,,CHEMBL902,FAMOTIDINE,CHEMBL902,,0,,1539758,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659417,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1[nH]cc(F)c(=O)[nH]1,,,CHEMBL1909046,,,,CHEMBL185,FLUOROURACIL,CHEMBL185,,0,,1539782,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659481,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1,,,CHEMBL1909046,,,,CHEMBL1103,FURAZOLIDONE,CHEMBL1103,,0,,1539790,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659625,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL1909046,,,,CHEMBL31,GATIFLOXACIN,CHEMBL31,,0,,1539798,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659721,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1,,,CHEMBL1909046,,,,CHEMBL427216,GLICLAZIDE,CHEMBL427216,,0,,1539806,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659864,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CNCP(=O)(O)O,,,CHEMBL1909046,,,,CHEMBL95764,GLYPHOSATE,CHEMBL95764,,0,,1539814,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7659981,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N=C(N)NCCN1CCCCCCC1,,,CHEMBL1909046,,,,CHEMBL765,GUANETHIDINE,CHEMBL765,,0,,1539822,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7660467,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O,,,CHEMBL1909046,,,,CHEMBL1527608,DOXOFYLLINE,CHEMBL1527608,,0,,1539718,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7661164,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,,,CHEMBL1909046,,,,CHEMBL710,FINASTERIDE,CHEMBL710,,0,,1539766,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7661307,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2,,,CHEMBL1909046,,,,CHEMBL407,FLUMAZENIL,CHEMBL407,,0,,1539774,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7662268,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2,,,CHEMBL1909046,,,,CHEMBL1255901,HUPERZINE A,CHEMBL1255901,,0,,1539831,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7662401,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)Cc1ccc(C(C)C(=O)O)cc1,,,CHEMBL1909046,,,,CHEMBL521,IBUPROFEN,CHEMBL521,,0,,1539839,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7662705,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,,,CHEMBL1909046,,,,CHEMBL578,ENALAPRIL,CHEMBL578,,0,,1539727,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7662831,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,,,CHEMBL1909046,,,"{'bei': '14.77', 'le': '0.28', 'lle': '6.26', 'sei': '7.02'}",CHEMBL1385840,ERGOCORNINE,CHEMBL1385840,8.30,0,http://www.openphacts.org/units/Nanomolar,1539735,=,15,1,=,,IC50,nM,,5.032,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.005032
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7662911,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl,,,CHEMBL1909046,,,,CHEMBL456,ETHACRYNIC ACID,CHEMBL456,,0,,1539743,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7663025,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1200624,ETHYNODIOL DIACETATE,CHEMBL1200624,,0,,1539751,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7663166,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)Cc1ccc(-c2ccccc2)cc1,,,CHEMBL1909046,,,,CHEMBL413965,FELBINAC,CHEMBL413965,,0,,1539759,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7663669,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL41,FLUOXETINE,CHEMBL41,,0,,1539783,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7663739,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,,,CHEMBL1909046,,,,CHEMBL35,FUROSEMIDE,CHEMBL35,,0,,1539791,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7663883,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,,,CHEMBL1909046,,,,CHEMBL888,GEMCITABINE,CHEMBL888,,0,,1539799,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7663979,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O,,,CHEMBL1909046,,,,CHEMBL1481,GLIMEPIRIDE,CHEMBL1481,,0,,1539807,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7664121,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL306043,GOLD SODIUM THIOMALATE,CHEMBL306043,,0,,1539815,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7664234,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl,,,CHEMBL1909046,,,,CHEMBL862,GUANFACINE,CHEMBL862,,0,,1539823,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7664720,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,,,CHEMBL1909046,,,,CHEMBL53463,DOXORUBICIN,CHEMBL53463,,0,,1539719,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7665422,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O,,,CHEMBL1909046,,,,CHEMBL1493,FLAVOXATE,CHEMBL1493,,0,,1539767,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7665550,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1,,,CHEMBL1909046,,,"{'bei': '15.95', 'le': '0.29', 'lle': '1.06', 'sei': '99.59'}",CHEMBL30008,FLUNARIZINE,CHEMBL30008,6.45,0,http://www.openphacts.org/units/Nanomolar,1539775,=,15,1,=,,IC50,nM,,352.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.352
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7666557,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NNc1nncc2ccccc12,,,CHEMBL1909046,,,,CHEMBL276832,HYDRALAZINE,CHEMBL276832,,0,,1539832,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7666689,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O,,,CHEMBL1909046,,,,CHEMBL1117,IDARUBICIN,CHEMBL1117,,0,,1539840,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7666999,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21,,,CHEMBL1909046,,,,CHEMBL826,ENOXACIN,CHEMBL826,,0,,1539728,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7667105,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,,,CHEMBL1909046,,,"{'bei': '19.23', 'le': '0.36', 'lle': '4.73', 'sei': '9.15'}",CHEMBL119443,ERGONOVINE,CHEMBL119443,6.26,0,http://www.openphacts.org/units/Nanomolar,1539736,=,15,1,=,,IC50,nM,,552.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.552
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7667202,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@@H](CO)NCCN[C@@H](CC)CO,,,CHEMBL1909046,,,,CHEMBL44884,ETHAMBUTOL,CHEMBL44884,,0,,1539744,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7667312,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(O)(P(=O)(O)O)P(=O)(O)O,,,CHEMBL1909046,,,,CHEMBL871,ETIDRONIC ACID,CHEMBL871,,0,,1539752,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7667449,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,,,CHEMBL1909046,,,,CHEMBL1480,FELODIPINE,CHEMBL1480,,0,,1539760,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7667819,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,,,CHEMBL1909046,,,,CHEMBL1512,FLUNISOLIDE,CHEMBL1512,,0,,1539776,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7667938,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,,CHEMBL1909046,,,"{'bei': '20.09', 'le': '0.40', 'lle': '4.48', 'sei': '29.35'}",CHEMBL726,FLUPHENAZINE,CHEMBL726,8.79,0,http://www.openphacts.org/units/Nanomolar,1539784,=,15,1,=,,IC50,nM,,1.616,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.001616
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7668046,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NCC1(CC(=O)O)CCCCC1,,,CHEMBL1909046,,,,CHEMBL940,GABAPENTIN,CHEMBL940,,0,,1539792,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7668190,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1,,,CHEMBL1909046,,,,CHEMBL457,GEMFIBROZIL,CHEMBL457,,0,,1539800,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7668285,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,,,CHEMBL1909046,,,,CHEMBL1073,GLIPIZIDE,CHEMBL1073,,0,,1539808,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7668425,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1201469,GRAMICIDIN,CHEMBL1201469,,0,,1539816,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7668532,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1,,,CHEMBL1909046,,,,CHEMBL434063,,CHEMBL434063,,0,,1539824,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7669030,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,,,CHEMBL1909046,,,,CHEMBL1433,DOXYCYCLINE ANHYDROUS,CHEMBL1433,,0,,1539720,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7669736,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1,,,CHEMBL1909046,,,,CHEMBL6273,FLEROXACIN,CHEMBL6273,,0,,1539768,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7670872,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NN,,,CHEMBL1909046,,,,CHEMBL1237174,HYDRAZINE,CHEMBL1237174,,0,,1539833,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7671004,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O,,,CHEMBL1909046,,,,CHEMBL252556,IDEBENONE,CHEMBL252556,,0,,1539841,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7671311,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1,,,CHEMBL1909046,,,,CHEMBL15511,ENROFLOXACIN,CHEMBL15511,,0,,1539729,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7671399,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21,,,CHEMBL1909046,,,"{'bei': '14.38', 'le': '0.27', 'lle': '6.38', 'sei': '7.08'}",CHEMBL442,ERGOTAMINE,CHEMBL442,8.37,0,http://www.openphacts.org/units/Nanomolar,1539737,=,15,1,=,,IC50,nM,,4.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.0043
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7671520,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCO,,,CHEMBL1909046,,,,CHEMBL545,ALCOHOL,CHEMBL545,,0,,1539745,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7671630,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3,,,CHEMBL1909046,,,,CHEMBL622,ETODOLAC,CHEMBL622,,0,,1539753,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7671767,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1,,,CHEMBL1909046,,,,CHEMBL37161,FENBENDAZOLE,CHEMBL37161,,0,,1539761,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7672125,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1,,,CHEMBL1909046,,,,CHEMBL1614641,FLUNOXAPROFEN,CHEMBL1614641,,0,,1539777,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7672189,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,,,CHEMBL1909046,,,,CHEMBL1201012,FLURANDRENOLIDE,CHEMBL1201012,,0,,1539785,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7672327,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1200431,GADOPENTETATE DIMEGLUMINE,CHEMBL1200431,,0,,1539793,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7672471,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O,,,CHEMBL1909046,,,,CHEMBL34139,GENACONAZOLE,CHEMBL34139,,0,,1539801,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7672565,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1372,OXIGLUTATIONE,CHEMBL1372,,0,,1539809,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7672698,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2,,,CHEMBL1909046,,,,CHEMBL289469,GRANISETRON,CHEMBL289469,,0,,1539817,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7672798,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1,,,CHEMBL1909046,,,,CHEMBL1200845,HALCINONIDE,CHEMBL1200845,,0,,1539825,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7673299,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,,,CHEMBL1909046,,,"{'bei': '22.71', 'le': '0.42', 'lle': '4.94', 'sei': '14.83'}",CHEMBL1108,DROPERIDOL,CHEMBL1108,8.62,0,http://www.openphacts.org/units/Nanomolar,1539721,=,15,1,=,,IC50,nM,,2.407,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.002407
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7674030,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1,,,CHEMBL1909046,,,,CHEMBL1454946,FLUBENDAZOLE,CHEMBL1454946,,0,,1539769,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7675068,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL1909046,,,"{'bei': '21.77', 'le': '0.43', 'lle': '3.75', 'sei': '20.18'}",CHEMBL54,HALOPERIDOL,CHEMBL54,8.18,0,http://www.openphacts.org/units/Nanomolar,1539826,=,15,1,=,,IC50,nM,,6.592,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.006592
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675150,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,,,CHEMBL1909046,,,,CHEMBL435,HYDROCHLOROTHIAZIDE,CHEMBL435,,0,,1539834,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675278,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I,,,CHEMBL1909046,,,,CHEMBL788,IDOXURIDINE,CHEMBL788,,0,,1539842,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675600,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1,,,CHEMBL1909046,,,,CHEMBL56337,EPALRESTAT,CHEMBL56337,,0,,1539730,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675664,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL532,ERYTHROMYCIN,CHEMBL532,,0,,1539738,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675792,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL691,ETHINYL ESTRADIOL,CHEMBL691,,0,,1539746,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7675914,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,,,CHEMBL1909046,,,,CHEMBL44657,ETOPOSIDE,CHEMBL44657,,0,,1539754,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7676044,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1,,,CHEMBL1909046,,,,CHEMBL672,FENOFIBRATE,CHEMBL672,,0,,1539762,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7676413,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,,,CHEMBL1909046,,,,CHEMBL989,FLUOCINOLONE ACETONIDE,CHEMBL989,,0,,1539778,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7676474,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,,,CHEMBL1909046,,,,CHEMBL563,FLURBIPROFEN,CHEMBL563,,0,,1539786,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7676614,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2,,,CHEMBL1909046,,,,CHEMBL659,GALANTAMINE,CHEMBL659,,0,,1539794,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7676757,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,,,CHEMBL1909046,,,,CHEMBL44,GENISTEIN,CHEMBL44,,0,,1539802,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7676860,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1,,,CHEMBL1909046,,,,CHEMBL472,GLYBURIDE,CHEMBL472,,0,,1539810,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7676993,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1,,,CHEMBL1909046,,,,CHEMBL583,GREPAFLOXACIN,CHEMBL583,,0,,1539818,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7677572,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O,,,CHEMBL1909046,,,,CHEMBL1752,DYPHYLLINE,CHEMBL1752,,0,,1539722,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7678387,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909056,COBALT(II) ACETYLACETONATE,CHEMBL1909056,,0,,1539649,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7678523,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1,,,CHEMBL1909046,,,,CHEMBL428880,CROMOLYN,CHEMBL428880,,0,,1539657,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7678606,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL139835,CYPROTERONE ACETATE,CHEMBL139835,,0,,1539665,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7678716,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1,,,CHEMBL1909046,,,,CHEMBL157548,DANOFLOXACIN,CHEMBL157548,,0,,1539673,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7678811,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1,,,CHEMBL1909046,,,,CHEMBL1201353,DEXCHLORPHENIRAMINE,CHEMBL1201353,,0,,1539681,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7678941,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COP(=O)(OC)OC=C(Cl)Cl,,,CHEMBL1909046,,,,CHEMBL167911,DICHLORVOS,CHEMBL167911,,0,,1539689,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7679332,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCOC(c1ccccc1)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL657,DIPHENHYDRAMINE,CHEMBL657,,0,,1539706,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7679370,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O,,,CHEMBL1909046,,,,CHEMBL1754,DOXAPRAM,CHEMBL1754,,0,,1539714,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680142,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,1539624,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7680224,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1,,,CHEMBL1909046,,,"{'bei': '19.97', 'le': '0.39', 'lle': '1.77', 'sei': '55.06'}",CHEMBL1626,CLEMASTINE,CHEMBL1626,6.87,0,http://www.openphacts.org/units/Nanomolar,1539632,=,15,1,=,,IC50,nM,,136.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.136
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7680407,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1cccc(Cl)c1NC1=NCCN1,,,CHEMBL1909046,,,,CHEMBL134,CLONIDINE,CHEMBL134,,0,,1539641,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7681115,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1,,,CHEMBL1909046,,,,CHEMBL248702,DEXFENFLURAMINE,CHEMBL248702,,0,,1539682,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7681315,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1CC[C@@]2(OC1)O[C@H]1[C@@H](O)[C@H]3[C@@H]4CC[C@H]5C[C@@H](O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)C(O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,,,CHEMBL1909046,,,,CHEMBL404811,DIGITONIN,CHEMBL404811,,0,,1539698,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7681661,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL1130,DOXIFLURIDINE,CHEMBL1130,,0,,1539717,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7681779,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1ccccc1O,,,CHEMBL1909046,,,,CHEMBL280998,CATECHOL,CHEMBL280998,,0,,1539592,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7681873,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1,,,CHEMBL1909046,,,,CHEMBL515,CHLORAMBUCIL,CHEMBL515,,0,,1539600,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7681953,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12,,,CHEMBL1909046,,,,CHEMBL404520,CHLORTETRACYCLINE,CHEMBL404520,,0,,1539608,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682096,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc(C2CCCCC2)n(O)c(=O)c1,,,CHEMBL1909046,,,,CHEMBL1413,CICLOPIROX,CHEMBL1413,,0,,1539616,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682723,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C(C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C,,,CHEMBL1909046,,,,CHEMBL47244,PICROTOXININ,CHEMBL47244,,0,,1539650,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682860,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C/C=C/C(=O)N(CC)c1ccccc1C,,,CHEMBL1909046,,,,CHEMBL1200709,CROTAMITON,CHEMBL1200709,,0,,1539658,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7682937,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(N)nc(NC2CC2)n1,,,CHEMBL1909046,,,,CHEMBL1231107,CYROMAZINE,CHEMBL1231107,,0,,1539666,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7683046,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1,,,CHEMBL1909046,,,,CHEMBL1201216,DAPIPRAZOLE,CHEMBL1201216,,0,,1539674,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7683263,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,,,CHEMBL1909046,,,,CHEMBL139,DICLOFENAC,CHEMBL139,,0,,1539690,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7683641,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1,,,CHEMBL1909046,,,"{'bei': '17.72', 'le': '0.33', 'lle': '1.29', 'sei': '23.36'}",CHEMBL936,DIPHENIDOL,CHEMBL936,5.48,0,http://www.openphacts.org/units/Nanomolar,1539707,=,15,1,=,,IC50,nM,,3290.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,3.29
,,7684451,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,,,CHEMBL1909046,,,"{'bei': '13.57', 'le': '0.27', 'lle': '2.97', 'sei': '7.35'}",CHEMBL1729,CISAPRIDE,CHEMBL1729,6.33,0,http://www.openphacts.org/units/Nanomolar,1539625,=,15,1,=,,IC50,nM,,473.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.473
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684517,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,,,CHEMBL1909046,,,,CHEMBL49080,CLENBUTEROL,CHEMBL49080,,0,,1539633,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7684705,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,,,CHEMBL1909046,,,,CHEMBL1771,CLOPIDOGREL,CHEMBL1771,,0,,1539642,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7685402,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1,,,CHEMBL1909046,,,,CHEMBL175,DEXIBUPROFEN,CHEMBL175,,0,,1539683,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7685542,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O,,,CHEMBL1909046,,,,CHEMBL1466,DICUMAROL,CHEMBL1466,,0,,1539691,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7685604,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL254219,DIGITOXIN,CHEMBL254219,,0,,1539699,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7685844,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC,,,CHEMBL1909046,,,,CHEMBL707,DOXAZOSIN,CHEMBL707,,0,,1539715,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7686051,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21,,,CHEMBL1909046,,,,CHEMBL1201195,CEFMETAZOLE,CHEMBL1201195,,0,,1539593,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7686148,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl,,,CHEMBL1909046,,,,CHEMBL130,CHLORAMPHENICOL,CHEMBL130,,0,,1539601,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7686227,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl,,,CHEMBL1909046,,,,CHEMBL1055,CHLORTHALIDONE,CHEMBL1055,,0,,1539609,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7686363,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,,,CHEMBL1909046,,,,CHEMBL7002,CIGLITAZONE,CHEMBL7002,,0,,1539617,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7687008,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2,,,CHEMBL1909046,,,,CHEMBL107,COLCHICINE,CHEMBL107,,0,,1539651,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7687146,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1,,,CHEMBL1909046,,,,CHEMBL1480987,CYCLANDELATE,CHEMBL1480987,,0,,1539659,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7687223,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1,,,CHEMBL1909046,,,,CHEMBL803,CYTARABINE,CHEMBL803,,0,,1539667,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7687327,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,,,CHEMBL1909046,,,,CHEMBL178,DAUNORUBICIN,CHEMBL178,,0,,1539675,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7687912,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,,,CHEMBL1909046,,,,CHEMBL932,DIPYRIDAMOLE,CHEMBL932,,0,,1539708,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7688708,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL11359,CISPLATIN,CHEMBL2068237,,0,,1539626,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7688791,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,1539634,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7688979,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NCC(O)c1ccccc1Cl,,,CHEMBL1909046,,,,CHEMBL1902627,CLORPRENALINE,CHEMBL1902627,,0,,1539643,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7689670,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1,,,CHEMBL1909046,,,,CHEMBL75435,DEXKETOPROFEN,CHEMBL75435,,0,,1539684,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7689808,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1,,,CHEMBL1909046,,,,CHEMBL1123,DICYCLOMINE,CHEMBL1123,,0,,1539692,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7689874,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL1751,DIGOXIN,CHEMBL1751,,0,,1539700,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7690089,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCC=C1c2ccccc2COc2ccccc21,,,CHEMBL1909046,,,,CHEMBL1628227,DOXEPIN,CHEMBL1628227,,0,,1539716,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7690326,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1,,,CHEMBL1909046,,,,CHEMBL1730,CEFOTAXIME,CHEMBL1730,,0,,1539594,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7690423,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1,,,CHEMBL1909046,,,,CHEMBL451,CHLORDIAZEPOXIDE,CHEMBL451,,0,,1539602,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7690505,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1[nH]c2cc(Cl)ccc2o1,,,CHEMBL1909046,,,,CHEMBL1371,CHLORZOXAZONE,CHEMBL1371,,0,,1539610,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7690628,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1,,,CHEMBL1909046,,,,CHEMBL34431,CILOSTAMIDE,CHEMBL34431,,0,,1539618,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7691270,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,,,CHEMBL1909046,,,,CHEMBL2221249,COLISTIN,CHEMBL2221249,,0,,1539652,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7691408,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCN(C(c2ccccc2)c2ccccc2)CC1,,,CHEMBL1909046,,,,CHEMBL648,CYCLIZINE,CHEMBL648,,0,,1539660,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7691495,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2,,,CHEMBL1909046,,,,CHEMBL504760,CAMPHOR,CHEMBL504760,,0,,1539668,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7691599,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(O)c(=O)ccn1C,,,CHEMBL1909046,,,,CHEMBL70927,DEFERIPRONE,CHEMBL70927,,0,,1539676,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7692197,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+],,,CHEMBL1909046,,,,CHEMBL487894,DIPYRONE SODIUM,CHEMBL461522,,0,,1539709,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7692965,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,,,CHEMBL1909046,,,,CHEMBL549,CITALOPRAM,CHEMBL549,,0,,1539627,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7693064,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1159650,CLOBETASOL PROPIONATE,CHEMBL1159650,,0,,1539635,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7693251,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O,,,CHEMBL1909046,,,,CHEMBL12131,CLOSANTEL,CHEMBL12131,,0,,1539644,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7693970,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,,,CHEMBL1909046,,,,CHEMBL52440,DEXTROMETHORPHAN,CHEMBL52440,,0,,1539685,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7694092,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1,,,CHEMBL1909046,,,,CHEMBL1460,DIDANOSINE,CHEMBL1460,,0,,1539693,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7694167,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O,,,CHEMBL1909046,,,"{'bei': '14.44', 'le': '0.27', 'lle': '6.11', 'sei': '7.47'}",CHEMBL1255837,DIHYDROERGOCRISTINE MESYLATE,CHEMBL601773,8.83,0,http://www.openphacts.org/units/Nanomolar,1539701,=,15,1,=,,IC50,nM,,1.474,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.001474
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7694620,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,,,CHEMBL1909046,,,,CHEMBL118,CELECOXIB,CHEMBL118,,0,,1539595,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7694727,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL110691,CHLORMADINONE ACETATE,CHEMBL110691,,0,,1539603,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7694812,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,,,CHEMBL1909046,,,,CHEMBL1042,CHOLECALCIFEROL,CHEMBL1042,,0,,1539611,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7694932,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,,,CHEMBL1909046,,,,CHEMBL799,CILOSTAZOL,CHEMBL799,,0,,1539619,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7695585,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909057,COPPER(II) OXIDE,CHEMBL1909057,,0,,1539653,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7695707,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1C[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C(=O)[C@@H](C)C1,,,CHEMBL1909046,,,,CHEMBL123292,CYCLOHEXIMIDE,CHEMBL123292,,0,,1539661,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7695809,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-],,,CHEMBL1909046,,,,CHEMBL1687,TUBOCURARINE CHLORIDE,CHEMBL339427,,0,,1539669,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7695913,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNCCCN1c2ccccc2CCc2ccccc21,,,CHEMBL1909046,,,,CHEMBL72,DESIPRAMINE,CHEMBL72,,0,,1539677,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7696510,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)C(=S)SSC(=S)N(CC)CC,,,CHEMBL1909046,,,"{'bei': '15.64', 'le': '0.40', 'lle': '1.02', 'sei': '71.57'}",CHEMBL964,DISULFIRAM,CHEMBL964,4.64,0,http://www.openphacts.org/units/Nanomolar,1539710,=,15,1,=,,IC50,nM,,23018.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,23.018
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7696563,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1351,CARBOPLATIN,CHEMBL1351,,0,,1539587,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7697289,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CC(O)(CC(=O)O)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1261,CITRIC ACID,CHEMBL1261,,0,,1539628,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7697391,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,,,CHEMBL1909046,,,,CHEMBL565,CLOFIBRATE,CHEMBL565,,0,,1539636,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7697556,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,,,CHEMBL1909046,,,"{'bei': '14.25', 'le': '0.27', 'lle': '-0.47', 'sei': '27.58'}",CHEMBL104,CLOTRIMAZOLE,CHEMBL104,4.91,0,http://www.openphacts.org/units/Nanomolar,1539645,=,15,1,=,,IC50,nM,,12186.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,12.186
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7698312,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I,,,CHEMBL1909046,,,,CHEMBL1201220,DIATRIZOIC ACID,CHEMBL1201220,,0,,1539686,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7698430,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl,,,CHEMBL1909046,,,,CHEMBL1873703,DIELDRIN,CHEMBL1873703,,0,,1539694,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7698480,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,,CHEMBL1909046,,,"{'bei': '13.79', 'le': '0.26', 'lle': '5.97', 'sei': '6.81'}",CHEMBL1732,DIHYDROERGOTAMINE,CHEMBL1732,8.05,0,http://www.openphacts.org/units/Nanomolar,1539702,=,15,1,=,,IC50,nM,,8.88,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.00888
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7698954,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1,,,CHEMBL1909046,,,,CHEMBL1727,CEPHALEXIN,CHEMBL1727,,0,,1539596,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7699060,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,ClC(Cl)Cl,,,CHEMBL1909046,,,,CHEMBL44618,CHLOROFORM,CHEMBL44618,,0,,1539604,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7699147,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C,,,CHEMBL1909046,,,,CHEMBL205596,CHOLIC ACID,CHEMBL205596,,0,,1539612,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7699266,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN/C(=N\CCSCc1nc[nH]c1C)NC#N,,,CHEMBL1909046,,,,CHEMBL30,CIMETIDINE,CHEMBL30,,0,,1539620,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7699917,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,,CHEMBL1909046,,,,CHEMBL1499,CORTISONE,CHEMBL1499,,0,,1539654,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7700037,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=P1(N(CCCl)CCCl)NCCCO1,,,CHEMBL1909046,,,,CHEMBL88,CYCLOPHOSPHAMIDE,CHEMBL88,,0,,1539662,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7700139,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)/N=N/c1[nH]cnc1C(N)=O,,,CHEMBL1909046,,,,CHEMBL476,DACARBAZINE,CHEMBL476,,0,,1539670,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7700238,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,,,CHEMBL1909046,,,,CHEMBL1172,DESLORATADINE,CHEMBL1172,,0,,1539678,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7700813,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,,,CHEMBL1909046,,,,CHEMBL926,DOBUTAMINE,CHEMBL926,,0,,1539711,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7700889,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909054,CARBOXYMETHYLCELLULOSE,CHEMBL1909054,,0,,1539588,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7701609,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O,,,CHEMBL1909046,,,,CHEMBL510139,CITRININ,CHEMBL510139,,0,,1539629,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7701711,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(Oc1ccc(Cl)cc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL683,CLOFIBRIC ACID,CHEMBL683,,0,,1539637,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7701818,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O,,,CHEMBL1909046,,,,CHEMBL891,CLOXACILLIN,CHEMBL891,,0,,1539646,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7702595,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21,,,CHEMBL1909046,,,,CHEMBL12,DIAZEPAM,CHEMBL12,,0,,1539687,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7702710,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1,,,CHEMBL1909046,,,"{'bei': '18.17', 'le': '0.33', 'lle': '0.05', 'sei': '12.05'}",CHEMBL411,DIETHYLSTILBESTROL,CHEMBL411,4.88,0,http://www.openphacts.org/units/Nanomolar,1539695,=,15,1,=,,IC50,nM,,13321.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,13.321
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7702775,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1,,,CHEMBL1909046,,,,CHEMBL23,DILTIAZEM,CHEMBL23,,0,,1539703,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7703255,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1,,,CHEMBL1909046,,,,CHEMBL1477,CERIVASTATIN,CHEMBL1477,,0,,1539597,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7703362,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc(O)cc(C)c1Cl,,,CHEMBL1909046,,,,CHEMBL398440,CHLOROXYLENOL,CHEMBL398440,,0,,1539605,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7703450,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO,,,CHEMBL1909046,,,,CHEMBL1567463,CHOLINE ALFOSCERATE,CHEMBL1567463,,0,,1539613,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7703567,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C/C=C/c1ccccc1,,,CHEMBL1909046,,,,CHEMBL293492,CINNAMALDEHYDE,CHEMBL293492,,0,,1539621,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7704222,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1650,CORTISONE ACETATE,CHEMBL1650,,0,,1539655,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7704343,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,,CHEMBL1909046,,,,CHEMBL160,CYCLOSPORINE,CHEMBL160,,0,,1539663,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7704446,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O,,,CHEMBL1909046,,,,CHEMBL1554,DACTINOMYCIN,CHEMBL1554,,0,,1539671,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7704525,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,,,CHEMBL1909046,,,,CHEMBL1766,DESOXIMETASONE,CHEMBL1766,,0,,1539679,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7705109,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,,,CHEMBL1909046,,,,CHEMBL3545252,DOCETAXEL,CHEMBL92,,0,,1539712,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7705191,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,,,CHEMBL1909046,,,,CHEMBL460499,CARMOFUR,CHEMBL460499,,0,,1539589,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7705864,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1,,,CHEMBL1909046,,,"{'bei': '16.58', 'le': '0.30', 'lle': '1.00', 'sei': '94.29'}",CHEMBL43064,CINNARIZINE,CHEMBL43064,6.11,0,http://www.openphacts.org/units/Nanomolar,1539622,=,15,1,=,,IC50,nM,,776.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.776
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7705937,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,,,CHEMBL1909046,,,,CHEMBL1619,CLADRIBINE,CHEMBL1619,,0,,1539630,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7706026,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,,,CHEMBL1909046,,,,CHEMBL954,ENCLOMIPHENE,CHEMBL954,,0,,1539638,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7706147,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL1909046,,,"{'bei': '19.62', 'le': '0.38', 'lle': '2.69', 'sei': '20.77'}",CHEMBL42,CLOZAPINE,CHEMBL42,6.41,0,http://www.openphacts.org/units/Nanomolar,1539647,=,15,1,=,,IC50,nM,,387.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.387
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7706949,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1,,,CHEMBL1909046,,,,CHEMBL181,DIAZOXIDE,CHEMBL181,,0,,1539688,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7707012,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1200545,DIFLORASONE DIACETATE,CHEMBL1200545,,0,,1539696,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7707093,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O,,,CHEMBL1909046,,,,CHEMBL1200406,DIMENHYDRINATE,CHEMBL1200406,,0,,1539704,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7707590,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1,,,CHEMBL1909046,,,,CHEMBL502896,CETRAXATE HYDROCHLORIDE,CHEMBL1187445,,0,,1539598,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7707687,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,,CHEMBL1909046,,,"{'bei': '22.79', 'le': '0.47', 'lle': '2.38', 'sei': '112.15'}",CHEMBL71,CHLORPROMAZINE,CHEMBL71,7.27,0,http://www.openphacts.org/units/Nanomolar,1539606,=,15,1,=,,IC50,nM,,54.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.054
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7707814,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[N+](C)(C)CCO.[Cl-],,,CHEMBL1909046,,,,CHEMBL282468,CHOLINE CHLORIDE,CHEMBL282468,,0,,1539614,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7708344,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21,,,CHEMBL1909046,,,"{'bei': '20.28', 'le': '0.40', 'lle': '1.85', 'sei': '98.52'}",CHEMBL415,CLOMIPRAMINE,CHEMBL415,6.38,0,http://www.openphacts.org/units/Nanomolar,1539639,=,15,1,=,,IC50,nM,,413.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.413
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708476,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909055,COBALTOUS CHLORIDE,CHEMBL1909055,,0,,1539648,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708612,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1ccc2ccccc2o1,,,CHEMBL1909046,,,,CHEMBL6466,COUMARIN,CHEMBL6466,,0,,1539656,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7708732,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,,,CHEMBL1909046,,,"{'bei': '23.61', 'le': '0.42', 'lle': '2.09', 'sei': '209.42'}",CHEMBL516,CYPROHEPTADINE,CHEMBL516,6.79,0,http://www.openphacts.org/units/Nanomolar,1539664,=,15,1,=,,IC50,nM,,164.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.164
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708855,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1479,DANAZOL,CHEMBL1479,,0,,1539672,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708952,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,,,CHEMBL1909046,,,,CHEMBL384467,DEXAMETHASONE,CHEMBL384467,,0,,1539680,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7709458,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[S+](C)[O-],,,CHEMBL1909046,,,,CHEMBL504,DIMETHYL SULFOXIDE,CHEMBL504,,0,,1539705,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7709506,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,,,CHEMBL1909046,,,"{'bei': '20.14', 'le': '0.39', 'lle': '5.23', 'sei': '10.88'}",CHEMBL219916,DOMPERIDONE,CHEMBL219916,8.58,0,http://www.openphacts.org/units/Nanomolar,1539713,=,15,1,=,,IC50,nM,,2.647,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.002647
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7709604,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=NN(CCCl)C(=O)NCCCl,,,CHEMBL1909046,,,,CHEMBL513,CARMUSTINE,CHEMBL513,,0,,1539590,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710258,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL557555,CIPROFIBRATE,CHEMBL557555,,0,,1539623,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710348,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7711442,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O,,,CHEMBL1909046,,,,CHEMBL898,DIFLUNISAL,CHEMBL898,,0,,1539697,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7711918,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,,,CHEMBL1909046,,,"{'bei': '16.82', 'le': '0.31', 'lle': '3.10', 'sei': '9.03'}",CHEMBL723,CARVEDILOL,CHEMBL723,6.84,0,http://www.openphacts.org/units/Nanomolar,1539591,=,15,1,=,,IC50,nM,,146.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.146
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712027,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-],,,CHEMBL1909046,,,,CHEMBL334255,CETYLPYRIDINIUM BROMIDE,CHEMBL305906,,0,,1539599,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712085,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,,,CHEMBL1909046,,,,CHEMBL498,CHLORPROPAMIDE,CHEMBL498,,0,,1539607,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712230,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1200528,CHROMIC CHLORIDE,CHEMBL1200528,,0,,1539615,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712703,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1,,,CHEMBL1909046,,,,CHEMBL452,CLONAZEPAM,CHEMBL452,,0,,1539640,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7713365,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)CN1CCCC1=O,,,CHEMBL1909046,,,,CHEMBL36715,PIRACETAM,CHEMBL36715,,0,,1540061,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7713507,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCOc1ccc(OCCCN2CCOCC2)cc1,,,CHEMBL1909046,,,,CHEMBL1198,PRAMOXINE,CHEMBL1198,,0,,1540069,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7713627,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(NC(C)CCCN)c2ncccc2c1,,,CHEMBL1909046,,,,CHEMBL506,PRIMAQUINE,CHEMBL506,,0,,1540077,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7713729,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,,,CHEMBL1909046,,,,CHEMBL103,PROGESTERONE,CHEMBL103,,0,,1540085,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714174,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-],,,CHEMBL1909046,,,,CHEMBL54126,NEOSTIGMINE BROMIDE,CHEMBL278020,,0,,1539981,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714302,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O,,,CHEMBL1909046,,,,CHEMBL485549,NIFURSOL,CHEMBL485549,,0,,1539989,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714422,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1,,,CHEMBL1909046,,,,CHEMBL3183075,NIZATIDINE,CHEMBL3183075,,0,,1539997,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714502,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909071,,CHEMBL1909071,,0,,1540005,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714606,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccccc1C(OCCN(C)C)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL900,ORPHENADRINE,CHEMBL900,,0,,1540013,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714826,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1,,,CHEMBL1909046,,,,CHEMBL762,OXYMETAZOLINE,CHEMBL762,,0,,1540021,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7714949,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-],,,CHEMBL1909046,,,,CHEMBL458019,PARAQUAT DICHLORIDE,CHEMBL74469,,0,,1540029,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7715075,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,,,CHEMBL1909046,,,,CHEMBL29,BENZYLPENICILLIN,CHEMBL29,,0,,1540037,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7715159,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NNCCc1ccccc1,,,CHEMBL1909046,,,,CHEMBL1089,PHENELZINE,CHEMBL1089,,0,,1540045,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7715271,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1,,,CHEMBL1909046,,,,CHEMBL16,PHENYTOIN,CHEMBL16,,0,,1540053,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7716019,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCc1cc(=O)[nH]c(=S)[nH]1,,,CHEMBL1909046,,,,CHEMBL1518,PROPYLTHIOURACIL,CHEMBL1518,,0,,1540094,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7716097,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NC[C@@H](O)COc1cccc2ccccc12,,,CHEMBL1909046,,,,CHEMBL275742,DEXPROPRANOLOL,CHEMBL275742,,0,,1540104,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7717626,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C,,,CHEMBL1909046,,,,CHEMBL295416,PIRINIXIC ACID,CHEMBL295416,,0,,1540062,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7717769,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21,,,CHEMBL1909046,,,,CHEMBL1144,PRAVASTATIN,CHEMBL1144,,0,,1540070,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7717890,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC1(c2ccccc2)C(=O)NCNC1=O,,,CHEMBL1909046,,,,CHEMBL856,PRIMIDONE,CHEMBL856,,0,,1540078,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7717986,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL316561,PROGLUMIDE,CHEMBL316561,,0,,1540086,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7718220,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O,,,CHEMBL1909046,,,,CHEMBL1592,QUINAPRIL,CHEMBL1592,,0,,1540102,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7718432,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O,,,CHEMBL1909046,,,,CHEMBL1572,NETILMICIN,CHEMBL1572,,0,,1539982,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7718558,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1,,,CHEMBL1909046,,,,CHEMBL56367,NIMESULIDE,CHEMBL56367,,0,,1539990,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7718680,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)Nc1nc2cc(C(=O)c3cccs3)ccc2[nH]1,,,CHEMBL1909046,,,,CHEMBL9514,NOCODAZOLE,CHEMBL9514,,0,,1539998,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7718761,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O,,,CHEMBL1909046,,,,CHEMBL450895,NYSTATIN,CHEMBL450895,,0,,1540006,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7718848,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O,,,CHEMBL1909046,,,,CHEMBL222863,OUABAIN,CHEMBL222863,,0,,1540014,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7719055,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,,,CHEMBL1909046,,,,CHEMBL1200585,OXYMETHOLONE,CHEMBL1200585,,0,,1540022,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7719188,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,,,CHEMBL1909046,,,,CHEMBL490,PAROXETINE,CHEMBL490,,0,,1540030,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7719322,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1,,,CHEMBL1909046,,,,CHEMBL55,PENTAMIDINE,CHEMBL55,,0,,1540038,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7719419,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1c2ccccc2C(=O)C1c1ccccc1,,,CHEMBL1909046,,,,CHEMBL711,PHENINDIONE,CHEMBL711,,0,,1540046,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7719529,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C,,,CHEMBL1909046,,,,CHEMBL94,PHYSOSTIGMINE,CHEMBL94,,0,,1540054,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7720282,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O,,,CHEMBL1909046,,,,CHEMBL600325,PROSCILLARIDIN,CHEMBL600325,,0,,1540095,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7721886,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21,,,CHEMBL1909046,,,,CHEMBL311350,PIROMIDIC ACID,CHEMBL311350,,0,,1540063,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7722025,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1,,,CHEMBL1909046,,,,CHEMBL976,PRAZIQUANTEL,CHEMBL976,,0,,1540071,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7722147,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1,,,CHEMBL1909046,,,,CHEMBL897,PROBENECID,CHEMBL897,,0,,1540079,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7722236,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCCN1c2ccccc2Sc2ccccc21,,,CHEMBL1909046,,,"{'bei': '22.14', 'le': '0.43', 'lle': '2.06', 'sei': '97.17'}",CHEMBL564,PROMAZINE,CHEMBL564,6.30,0,http://www.openphacts.org/units/Nanomolar,1540087,=,15,1,=,,IC50,nM,,505.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.505
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7722495,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909075,,CHEMBL1909075,,0,,1540103,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7722708,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1,,,CHEMBL1909046,,,,CHEMBL57,NEVIRAPINE,CHEMBL57,,0,,1539983,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7722830,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21,,,CHEMBL1909046,,,,CHEMBL13341,NIMETAZEPAM,CHEMBL13341,,0,,1539991,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7722949,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1162,NORETHINDRONE,CHEMBL1162,,0,,1539999,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7723035,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccccc1N,,,CHEMBL1909046,,,,CHEMBL1612004,,CHEMBL1612004,,0,,1540007,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7723125,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL414804,OXALIPLATIN,CHEMBL414804,,0,,1540015,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7723331,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1cccc2cccnc12,,,CHEMBL1909046,,,,CHEMBL310555,OXYQUINOLINE,CHEMBL310555,,0,,1540023,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7723447,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21,,,CHEMBL1909046,,,,CHEMBL540445,PARTHENOLIDE,CHEMBL540445,,0,,1540031,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7723570,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,,,CHEMBL1909046,,,,CHEMBL628,PENTOXIFYLLINE,CHEMBL628,,0,,1540039,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7723671,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC1(c2ccccc2)C(=O)NC(=O)NC1=O,,,CHEMBL1909046,,,,CHEMBL40,PHENOBARBITAL,CHEMBL40,,0,,1540047,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7723781,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O,,,CHEMBL1909046,,,,CHEMBL1200656,NATAMYCIN,CHEMBL1200656,,0,,1540055,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7724548,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1,,,CHEMBL1909046,,,,CHEMBL469912,PUROMYCIN,CHEMBL469912,,0,,1540096,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7726151,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O,,,CHEMBL1909046,,,,CHEMBL527,PIROXICAM,CHEMBL527,,0,,1540064,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7726291,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,,,CHEMBL1909046,,,,CHEMBL2,PRAZOSIN,CHEMBL2,,0,,1540072,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7726421,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1,,,CHEMBL1909046,,,,CHEMBL608,PROBUCOL,CHEMBL608,,0,,1540080,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7726468,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,,,CHEMBL1909046,,,"{'bei': '21.48', 'le': '0.42', 'lle': '1.87', 'sei': '94.27'}",CHEMBL643,PROMETHAZINE,CHEMBL643,6.11,0,http://www.openphacts.org/units/Nanomolar,1540088,=,15,1,=,,IC50,nM,,779.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.779
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7726977,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cccnc1,,,CHEMBL1909046,,,,CHEMBL573,NIACIN,CHEMBL573,,0,,1539984,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7727097,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,,,CHEMBL1909046,,,,CHEMBL1428,NIMODIPINE,CHEMBL1428,,0,,1539992,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7727214,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1201146,NORETHINDRONE ACETATE,CHEMBL1201146,,0,,1540000,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7727306,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,,,CHEMBL1909046,,,,CHEMBL3350037,,CHEMBL3350037,,0,,1540008,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7727395,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,,,CHEMBL1909046,,,,CHEMBL1071,OXAPROZIN,CHEMBL1071,,0,,1540016,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7727601,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12,,,CHEMBL1909046,,,,CHEMBL1517,OXYTETRACYCLINE,CHEMBL1517,,0,,1540024,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7727718,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21,,,CHEMBL1909046,,,,CHEMBL267648,PEFLOXACIN,CHEMBL267648,,0,,1540032,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7727833,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,,,CHEMBL1909046,,,"{'bei': '22.11', 'le': '0.43', 'lle': '2.68', 'sei': '36.55'}",CHEMBL531,PERGOLIDE,CHEMBL531,6.96,0,http://www.openphacts.org/units/Nanomolar,1540040,=,15,1,=,,IC50,nM,,111.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.111
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7727951,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1ccccc1,,,CHEMBL1909046,,,,CHEMBL14060,PHENOL,CHEMBL14060,,0,,1540048,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7728057,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NCC(O)COc1cccc2[nH]ccc12,,,CHEMBL1909046,,,,CHEMBL500,PINDOLOL,CHEMBL500,,0,,1540056,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7728723,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1,,,CHEMBL1909046,,,,CHEMBL631,PROPAFENONE,CHEMBL631,,0,,1540089,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7728834,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)c1cnccn1,,,CHEMBL1909046,,,,CHEMBL614,PYRAZINAMIDE,CHEMBL614,,0,,1540097,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7728880,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O,,,CHEMBL1909046,,,,CHEMBL757,NANDROLONE,CHEMBL757,,0,,1539976,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7730439,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC,,,CHEMBL1909046,,,,CHEMBL61,PODOFILOX,CHEMBL61,,0,,1540065,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7730568,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,,CHEMBL1909046,,,,CHEMBL131,PREDNISOLONE,CHEMBL131,,0,,1540073,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7730706,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CCNC(=O)c1ccc(N)cc1,,,CHEMBL1909046,,,,CHEMBL640,PROCAINAMIDE,CHEMBL640,,0,,1540081,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731256,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)c1cccnc1,,,CHEMBL1909046,,,,CHEMBL1140,NIACINAMIDE,CHEMBL1140,,0,,1539985,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731369,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-],,,CHEMBL1909046,,,,CHEMBL1726,NISOLDIPINE,CHEMBL1726,,0,,1539993,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731487,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731582,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,,,CHEMBL1909046,,,,CHEMBL4,OFLOXACIN,CHEMBL4,,0,,1540009,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731671,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)N1c2ccccc2CC(=O)c2ccccc21,,,CHEMBL1909046,,,,CHEMBL1068,OXCARBAZEPINE,CHEMBL1068,,0,,1540017,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731876,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,,,CHEMBL1909046,,,,CHEMBL428647,PACLITAXEL,CHEMBL428647,,0,,1540025,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731995,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC1=NC(=O)C(c2ccccc2)O1,,,CHEMBL1909046,,,,CHEMBL1177,PEMOLINE,CHEMBL1177,,0,,1540033,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7732091,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,,,CHEMBL1909046,,,,CHEMBL75880,PERHEXILINE,CHEMBL75880,,0,,1540041,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7732223,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,c1ccc2c(c1)Nc1ccccc1S2,,,CHEMBL1909046,,,,CHEMBL828,PHENOTHIAZINE,CHEMBL828,,0,,1540049,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7732336,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,,,CHEMBL1909046,,,,CHEMBL595,PIOGLITAZONE,CHEMBL595,,0,,1540057,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7732973,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N,,,CHEMBL1909046,,,,CHEMBL1196,PROPARACAINE,CHEMBL1196,,0,,1540090,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733093,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,,,CHEMBL1909046,,,,CHEMBL511,PYRILAMINE,CHEMBL511,,0,,1540098,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733139,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,,,CHEMBL1909046,,,,CHEMBL154,NAPROXEN,CHEMBL154,,0,,1539977,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7734603,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,,CHEMBL1909046,,,"{'bei': '20.88', 'le': '0.42', 'lle': '3.86', 'sei': '16.93'}",CHEMBL1909072,PIPAMAZINE,CHEMBL1909072,8.39,0,http://www.openphacts.org/units/Nanomolar,1540058,=,15,1,=,,IC50,nM,,4.05,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.00405
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7734721,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL3559671,POLYVINYL ALCOHOL,CHEMBL3559671,,0,,1540066,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7734848,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,,,CHEMBL1909046,,,,CHEMBL635,PREDNISONE,CHEMBL635,,0,,1540074,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7734989,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CCOC(=O)c1ccc(N)cc1,,,CHEMBL1909046,,,,CHEMBL569,PROCAINE,CHEMBL569,,0,,1540082,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7735542,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCC[C@H]1c1cccnc1,,,CHEMBL1909046,,,,CHEMBL3,NICOTINE,CHEMBL3,,0,,1539986,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7735648,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1,,,CHEMBL1909046,,,,CHEMBL13209,NITRAZEPAM,CHEMBL13209,,0,,1539994,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7735768,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC,,,CHEMBL1909046,,,,CHEMBL2107797,NORGESTREL,CHEMBL2107797,,0,,1540002,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7735858,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,,,CHEMBL1909046,,,"{'bei': '22.17', 'le': '0.43', 'lle': '3.49', 'sei': '22.44'}",CHEMBL715,OLANZAPINE,CHEMBL715,6.93,0,http://www.openphacts.org/units/Nanomolar,1540010,=,15,1,=,,IC50,nM,,118.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.118
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7735965,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1,,,CHEMBL1909046,,,,CHEMBL42442,OXFENDAZOLE,CHEMBL42442,,0,,1540018,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7736164,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(CO)C(O)C(=O)NCCCO,,,CHEMBL1909046,,,,CHEMBL1371937,PANTHENOL,CHEMBL1371937,,0,,1540026,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7736286,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(O)c2ncn(CCC(CO)CO)c2n1,,,CHEMBL1909046,,,,CHEMBL1540,PENCICLOVIR,CHEMBL1540,,0,,1540034,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7736372,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,,CHEMBL1909046,,,,CHEMBL567,PERPHENAZINE,CHEMBL567,,0,,1540042,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7736494,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1,,,CHEMBL1909046,,,,CHEMBL597,PHENTOLAMINE,CHEMBL597,,0,,1540050,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7737262,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)c1cccc(C(C)C)c1O,,,CHEMBL1909046,,,,CHEMBL526,PROPOFOL,CHEMBL526,,0,,1540091,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7737373,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1cccc(O)c1O,,,CHEMBL1909046,,,,CHEMBL307145,PYROGALLOL,CHEMBL307145,,0,,1540099,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7737430,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1,,,CHEMBL1909046,,,,CHEMBL783,NATEGLINIDE,CHEMBL783,,0,,1539978,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7738233,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,,,CHEMBL1909046,,,,CHEMBL1262,OXICONAZOLE,CHEMBL1262,,0,,1540019,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7738876,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H]2SC(C)(C)[C@@H]3C(=O)O)c2ccccc2)C(=O)C1=O,,,CHEMBL1909046,,,,CHEMBL702,PIPERACILLIN,CHEMBL702,,0,,1540059,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7739011,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL2108139,POVIDONE,CHEMBL2108139,,0,,1540067,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7739135,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1400945,PREGNENOLONE CARBONITRILE ,CHEMBL1400945,,0,,1540075,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7739278,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNNCc1ccc(C(=O)NC(C)C)cc1,,,CHEMBL1909046,,,,CHEMBL1321,PROCARBAZINE,CHEMBL1321,,0,,1540083,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7739833,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],,,CHEMBL1909046,,,,CHEMBL193,NIFEDIPINE,CHEMBL193,,0,,1539987,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7739948,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1,,,CHEMBL1909046,,,,CHEMBL475534,NITRENDIPINE,CHEMBL475534,,0,,1539995,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7740067,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNCCC=C1c2ccccc2CCc2ccccc21,,,CHEMBL1909046,,,,CHEMBL445,NORTRIPTYLINE,CHEMBL445,,0,,1540003,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7740167,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1,,,CHEMBL1909046,,,,CHEMBL1503,OMEPRAZOLE,CHEMBL1503,,0,,1540011,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7740489,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC,,,CHEMBL1909046,,,,CHEMBL1502,PANTOPRAZOLE,CHEMBL1502,,0,,1540027,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7740611,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(S)[C@@H](N)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1430,PENICILLAMINE,CHEMBL1430,,0,,1540035,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7740695,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)NC(=O)Cc1ccccc1,,,CHEMBL1909046,,,,CHEMBL918,PHENACEMIDE,CHEMBL918,,0,,1540043,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7740809,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O,,,CHEMBL1909046,,,,CHEMBL101,PHENYLBUTAZONE,CHEMBL101,,0,,1540051,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7741564,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NCC(O)COc1cccc2ccccc12,,,CHEMBL1909046,,,,CHEMBL27,PROPRANOLOL,CHEMBL27,,0,,1540092,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7741681,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,,,CHEMBL1909046,,,"{'bei': '15.32', 'le': '0.30', 'lle': '3.02', 'sei': '12.17'}",CHEMBL716,QUETIAPINE,CHEMBL716,5.88,0,http://www.openphacts.org/units/Nanomolar,1540100,=,15,1,=,,IC50,nM,,1329.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.3299
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7741746,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,,,CHEMBL1909046,,,,CHEMBL584,NELFINAVIR,CHEMBL584,,0,,1539979,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7742547,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1,,,CHEMBL1909046,,,,CHEMBL1231,OXYBUTYNIN,CHEMBL1231,,0,,1540020,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743204,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-],,,CHEMBL1909046,,,,CHEMBL1909073,PIPERILATE ETHOBROMIDE,CHEMBL1889399,,0,,1540060,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743340,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[n+]1ccccc1/C=N/O.[Cl-],,,CHEMBL1909046,,,,CHEMBL748,PRALIDOXIME CHLORIDE,CHEMBL1420,,0,,1540068,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7743460,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCNC(C)C(=O)Nc1ccccc1C,,,CHEMBL1909046,,,,CHEMBL1194,PRILOCAINE,CHEMBL1194,,0,,1540076,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7743605,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,,CHEMBL1909046,,,"{'bei': '21.28', 'le': '0.43', 'lle': '3.38', 'sei': '81.88'}",CHEMBL728,PROCHLORPERAZINE,CHEMBL728,7.96,0,http://www.openphacts.org/units/Nanomolar,1540084,=,15,1,=,,IC50,nM,,11.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.011
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744056,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL184618,FRAMYCETIN,CHEMBL184618,,0,,1539980,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744189,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1,,,CHEMBL1909046,,,,CHEMBL63323,NIFLUMIC ACID,CHEMBL63323,,0,,1539988,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744307,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,,,CHEMBL1909046,,,,CHEMBL572,NITROFURANTOIN,CHEMBL572,,0,,1539996,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744388,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C,,,CHEMBL1909046,,,,CHEMBL364713,NOSCAPINE,CHEMBL364713,,0,,1540004,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744500,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O,,,CHEMBL1909046,,,,CHEMBL46,ONDANSETRON,CHEMBL46,,0,,1540012,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744827,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,,,CHEMBL1909046,,,,CHEMBL19224,PAPAVERINE,CHEMBL19224,,0,,1540028,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7744950,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C(C)C1(O)OC(=O)C=C1OC,,,CHEMBL1909046,,,,CHEMBL495778,PENICILLIC ACID,CHEMBL495778,,0,,1540036,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7745034,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOc1ccc(NC(C)=O)cc1,,,CHEMBL1909046,,,,CHEMBL16073,PHENACETIN,CHEMBL16073,,0,,1540044,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7745143,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NNc1ccccc1,,,CHEMBL1909046,,,,CHEMBL456807,PHENYLHYDRAZINE,CHEMBL456807,,0,,1540052,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7745916,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(O)CO,,,CHEMBL1909046,,,,CHEMBL286398,PROPYLENE GLYCOL,CHEMBL286398,,0,,1540093,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7746008,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,,,CHEMBL1909046,,,,CHEMBL7568,QUINACRINE,CHEMBL7568,,0,,1540101,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7747169,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cccc(Nc2ccccc2C(=O)O)c1C,,,CHEMBL1909046,,,,CHEMBL686,MEFENAMIC ACID,CHEMBL686,,0,,1539916,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7747282,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=S(=O)([O-])CCS.[Na+],,,CHEMBL1909046,,,,CHEMBL975,MESNA,CHEMBL1098319,,0,,1539924,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7747367,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c2occc2cc2ccc(=O)oc12,,,CHEMBL1909046,,,,CHEMBL416,METHOXSALEN,CHEMBL416,,0,,1539932,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7747484,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1,,,CHEMBL1909046,,,"{'bei': '17.24', 'le': '0.32', 'lle': '4.15', 'sei': '10.60'}",CHEMBL1065,METHYSERGIDE,CHEMBL1065,6.09,0,http://www.openphacts.org/units/Nanomolar,1539940,=,15,1,=,,IC50,nM,,807.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.807
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7747608,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cccc(C)c1OCC(C)N,,,CHEMBL1909046,,,,CHEMBL558,MEXILETINE,CHEMBL558,,0,,1539948,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748163,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1,,,CHEMBL1909046,,,,CHEMBL165790,IPRIFLAVONE,CHEMBL165790,,0,,1539851,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748299,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1,,,CHEMBL1909046,,,,CHEMBL547,ISOTRETINOIN,CHEMBL547,,0,,1539859,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748392,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,,,CHEMBL1909046,,,,CHEMBL534,KETOTIFEN,CHEMBL534,,0,,1539867,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7748964,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,,CHEMBL1909046,,,,CHEMBL191,LOSARTAN,CHEMBL191,,0,,1539900,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7749063,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNCCCC12CCC(c3ccccc31)c1ccccc12,,,CHEMBL1909046,,,"{'bei': '19.68', 'le': '0.36', 'lle': '1.25', 'sei': '45.39'}",CHEMBL21731,MAPROTILINE,CHEMBL21731,5.46,0,http://www.openphacts.org/units/Nanomolar,1539908,=,15,1,=,,IC50,nM,,3463.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,3.463
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7749904,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1,,,CHEMBL1909046,,,,CHEMBL86304,MOCLOBEMIDE,CHEMBL86304,,0,,1539957,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7750007,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CCOCCC1=CCC2CC1C2(C)C,,,CHEMBL1909046,,,,CHEMBL1630579,MYRTECAINE,CHEMBL1630579,,0,,1539965,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7750135,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5,,,CHEMBL1909046,,,,CHEMBL19019,NALTREXONE,CHEMBL19019,,0,,1539975,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7750767,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,,,CHEMBL1909046,,,,CHEMBL741,LAMOTRIGINE,CHEMBL741,,0,,1539876,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7750902,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O,,,CHEMBL1909046,,,,CHEMBL1201237,LEVOBUNOLOL,CHEMBL1201237,,0,,1539884,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7751037,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909064,LIPOPOLYSACCHARIDE E. COLI O55:B5,CHEMBL1909064,,0,,1539892,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7751458,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1201139,MEGESTROL ACETATE,CHEMBL1201139,,0,,1539917,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7751572,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1201151,MESTRANOL,CHEMBL1201151,,0,,1539925,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7751660,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@H]12.[Br-],,,CHEMBL1909046,,,,CHEMBL1201024,METHSCOPOLAMINE BROMIDE,CHEMBL1201268,,0,,1539933,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7751767,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,,,CHEMBL1909046,,,"{'bei': '23.00', 'le': '0.47', 'lle': '4.90', 'sei': '10.20'}",CHEMBL86,METOCLOPRAMIDE,CHEMBL86,6.90,0,http://www.openphacts.org/units/Nanomolar,1539941,=,15,1,=,,IC50,nM,,127.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.127
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7751895,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCN2c3ccccc3Cc3ccccc3C2C1,,,CHEMBL1909046,,,,CHEMBL6437,MIANSERIN,CHEMBL6437,,0,,1539949,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7752294,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5,,,CHEMBL1909046,,,,CHEMBL1618305,NALOXONAZINE,CHEMBL1618305,,0,,1539973,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7752468,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NNC(=O)c1ccncc1,,,CHEMBL1909046,,,,CHEMBL92401,IPRONIAZID,CHEMBL92401,,0,,1539852,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7752601,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,,,CHEMBL1909046,,,,CHEMBL64391,ITRACONAZOLE,CHEMBL64391,,0,,1539860,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7752678,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O,,,CHEMBL1909046,,,,CHEMBL2106399,KITASAMYCIN,CHEMBL2106399,,0,,1539868,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7753267,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,,,CHEMBL1909046,,,,CHEMBL503,LOVASTATIN,CHEMBL503,,0,,1539901,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7753350,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909067,,CHEMBL1909067,,0,,1539909,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7754155,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,,,CHEMBL1909046,,,"{'bei': '11.78', 'le': '0.27', 'lle': '-1.55', 'sei': '18.13'}",CHEMBL91,MICONAZOLE,CHEMBL91,4.90,0,http://www.openphacts.org/units/Nanomolar,1539950,=,15,1,=,,IC50,nM,,12504.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,12.504
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7754229,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL1373,MODAFINIL,CHEMBL1373,,0,,1539958,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7754332,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)N=O,,,CHEMBL1909046,,,,CHEMBL164290,N-NITROSODIETHYLAMINE,CHEMBL164290,,0,,1539966,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7755090,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1,,,CHEMBL1909046,,,,CHEMBL480,LANSOPRAZOLE,CHEMBL480,,0,,1539877,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7755218,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C,,,CHEMBL1909046,,,,CHEMBL1201193,LEVOBUPIVACAINE,CHEMBL1201193,,0,,1539885,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7755350,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O,,,CHEMBL1909046,,,,CHEMBL1237,LISINOPRIL,CHEMBL1237,,0,,1539893,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7755768,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,,,CHEMBL1909046,,,,CHEMBL45,MELATONIN,CHEMBL45,,0,,1539918,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7755880,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21,,,CHEMBL1909046,,,"{'bei': '17.84', 'le': '0.33', 'lle': '3.14', 'sei': '15.49'}",CHEMBL19215,METERGOLINE,CHEMBL19215,7.20,0,http://www.openphacts.org/units/Nanomolar,1539926,=,15,1,=,,IC50,nM,,63.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.063
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7755989,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COS(C)(=O)=O,,,CHEMBL1909046,,,,CHEMBL313493,METHANESULFONIC ACID METHYL ESTER,CHEMBL313493,,0,,1539934,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7756086,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C,,,CHEMBL1909046,,,,CHEMBL878,METOLAZONE,CHEMBL878,,0,,1539942,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7756638,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,,,CHEMBL1909046,,,,CHEMBL80,NALOXONE,CHEMBL80,,0,,1539974,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7756817,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,,,CHEMBL1909046,,,,CHEMBL1513,IRBESARTAN,CHEMBL1513,,0,,1539853,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7756942,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL1200633,IVERMECTIN,CHEMBL1200633,,0,,1539861,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7757028,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS,,,CHEMBL1909046,,,"{'bei': '12.15', 'le': '0.25', 'lle': '5.05', 'sei': '4.97'}",CHEMBL1221512,,CHEMBL1221512,6.80,0,http://www.openphacts.org/units/Nanomolar,1539869,=,15,1,=,,IC50,nM,,157.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.157
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7757615,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1,,,CHEMBL1909046,,,,CHEMBL19299,LOXOPROFEN,CHEMBL19299,,0,,1539902,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7757700,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909068,,CHEMBL1909068,,0,,1539910,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7758434,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1276308,MIFEPRISTONE,CHEMBL1276308,,0,,1539951,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7758548,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1ccc(OCc2ccccc2)cc1,,,CHEMBL1909046,,,,CHEMBL1388,MONOBENZONE,CHEMBL1388,,0,,1539959,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7758655,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)C=O,,,CHEMBL1909046,,,,CHEMBL268291,DIMETHYLFORMAMIDE,CHEMBL268291,,0,,1539967,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7759285,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2,,,CHEMBL1909046,,,,CHEMBL2252949,(-)-CAMPHOR,CHEMBL2252949,,0,,1539870,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7759402,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909062,LEAD (II) ACETATE,CHEMBL1909062,,0,,1539878,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7759531,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[N+](C)(C)C[C@H](O)CC(=O)[O-],,,CHEMBL1909046,,,,CHEMBL1149,LEVOCARNITINE,CHEMBL1149,,0,,1539886,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7759662,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,,,CHEMBL1909046,,,"{'bei': '25.24', 'le': '0.47', 'lle': '5.70', 'sei': '16.63'}",CHEMBL157138,LISURIDE,CHEMBL157138,8.54,0,http://www.openphacts.org/units/Nanomolar,1539894,=,15,1,=,,IC50,nM,,2.86,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.00286
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7760102,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,,,CHEMBL1909046,,,,CHEMBL599,MELOXICAM,CHEMBL599,,0,,1539919,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7760179,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)C(=N)NC(=N)N,,,CHEMBL1909046,,,,CHEMBL1431,METFORMIN,CHEMBL1431,,0,,1539927,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7760300,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)c1ccccc1O,,,CHEMBL1909046,,,,CHEMBL108545,METHYL SALICYLATE,CHEMBL108545,,0,,1539935,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7760395,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COCCc1ccc(OCC(O)CNC(C)C)cc1,,,CHEMBL1909046,,,,CHEMBL13,METOPROLOL,CHEMBL13,,0,,1539943,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7760980,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1,,,CHEMBL1909046,,,,CHEMBL406,INDAPAMIDE,CHEMBL406,,0,,1539846,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7761104,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC,,,CHEMBL1909046,,,,CHEMBL481,IRINOTECAN,CHEMBL481,,0,,1539854,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7761224,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL1384,KANAMYCIN,CHEMBL1384,,0,,1539862,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7761898,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,,,CHEMBL1909046,,,,CHEMBL98350,LY-294002,CHEMBL98350,,0,,1539903,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7761983,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909069,,CHEMBL1909069,,0,,1539911,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7762691,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1,,,CHEMBL1909046,,,,CHEMBL189,MILRINONE,CHEMBL189,,0,,1539952,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7762803,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,,,CHEMBL1909046,,,,CHEMBL787,MONTELUKAST,CHEMBL787,,0,,1539960,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7762925,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1,,,CHEMBL1909046,,,,CHEMBL1333512,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",CHEMBL1333512,,0,,1539968,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7763555,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL245416,L-MIMOSINE,CHEMBL245416,,0,,1539871,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7763669,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909063,LEAD(IV) ACETATE,CHEMBL1909063,,0,,1539879,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7763799,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1009,LEVODOPA,CHEMBL1009,,0,,1539887,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7763900,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21,,,CHEMBL1909046,,,,CHEMBL561,LOMEFLOXACIN,CHEMBL561,,0,,1539895,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7764360,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL852,MELPHALAN,CHEMBL852,,0,,1539920,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7764437,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)CCN(Cc1cccs1)c1ccccn1,,,CHEMBL1909046,,,,CHEMBL1411979,METHAPYRILENE,CHEMBL1411979,,0,,1539928,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7764569,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL459,METHYLDOPA,CHEMBL459,,0,,1539936,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7764665,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ncc([N+](=O)[O-])n1CCO,,,CHEMBL1909046,,,,CHEMBL137,METRONIDAZOLE,CHEMBL137,,0,,1539944,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7765243,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,,,CHEMBL1909046,,,,CHEMBL115,INDINAVIR,CHEMBL115,,0,,1539847,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7765365,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O,,,CHEMBL1909046,,,,CHEMBL1712923,IRSOGLADINE MALEATE,CHEMBL136497,,0,,1539855,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7765486,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNC1(c2ccccc2Cl)CCCCC1=O,,,CHEMBL1909046,,,,CHEMBL742,KETAMINE,CHEMBL742,,0,,1539863,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7766141,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C,,,CHEMBL1909046,,,"{'bei': '6.71', 'le': '0.13', 'lle': '1.83', 'sei': '2.95'}",CHEMBL1909065,MADURAMICIN,CHEMBL1909065,6.15,0,http://www.openphacts.org/units/Nanomolar,1539904,=,15,1,=,,IC50,nM,,702.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.702
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7766240,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1,,,CHEMBL1909046,,,,CHEMBL685,MEBENDAZOLE,CHEMBL685,,0,,1539912,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7766962,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],,,CHEMBL1909046,,,,CHEMBL802,MINOXIDIL,CHEMBL802,,0,,1539953,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7767058,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1,,,CHEMBL1909046,,,,CHEMBL60889,MOSAPRIDE,CHEMBL60889,,0,,1539961,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7767188,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2cc(CCC(C)=O)ccc2c1,,,CHEMBL1909046,,,,CHEMBL1070,NABUMETONE,CHEMBL1070,,0,,1539969,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7767830,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1,,,CHEMBL1909046,,,,CHEMBL429,LABETALOL,CHEMBL429,,0,,1539872,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7767953,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,,,CHEMBL1909046,,,,CHEMBL960,LEFLUNOMIDE,CHEMBL960,,0,,1539880,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768085,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,,,CHEMBL1909046,,,,CHEMBL33,LEVOFLOXACIN,CHEMBL33,,0,,1539888,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768190,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=NN(CCCl)C(=O)NC1CCCCC1,,,CHEMBL1909046,,,,CHEMBL514,LOMUSTINE,CHEMBL514,,0,,1539896,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768643,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1,,,CHEMBL1909046,,,,CHEMBL395110,MEPAZINE,CHEMBL395110,,0,,1539921,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768711,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cn1ccnc1S,,,CHEMBL1909046,,,,CHEMBL1515,METHIMAZOLE,CHEMBL1515,,0,,1539929,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7768846,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,,,CHEMBL1909046,,,"{'bei': '17.92', 'le': '0.33', 'lle': '4.16', 'sei': '8.90'}",CHEMBL1201356,METHYLERGONOVINE,CHEMBL1201356,6.08,0,http://www.openphacts.org/units/Nanomolar,1539937,=,15,1,=,,IC50,nM,,829.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.829
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7768952,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C(=O)c1cccnc1)c1cccnc1,,,CHEMBL1909046,,,,CHEMBL934,METYRAPONE,CHEMBL934,,0,,1539945,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7769522,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,,,CHEMBL1909046,,,,CHEMBL6,INDOMETHACIN,CHEMBL6,,0,,1539848,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7769649,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C/C=C\c1ccc(O)c(OC)c1,,,CHEMBL1909046,,,,CHEMBL445206,ISOEUGENOL,CHEMBL445206,,0,,1539856,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7769761,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,,,CHEMBL1909046,,,,CHEMBL157101,KETOCONAZOLE,CHEMBL157101,,0,,1539864,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770417,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C.N,,,CHEMBL1909046,,,,CHEMBL2105807,MADURAMICIN,CHEMBL1909065,,0,,1539905,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7770521,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl,,,CHEMBL1909046,,,,CHEMBL509,MECLOFENAMIC ACID,CHEMBL509,,0,,1539913,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7771254,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12,,,CHEMBL1909046,,,,CHEMBL105,MITOMYCIN,CHEMBL105,,0,,1539954,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7771340,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1nc(C)nc(Cl)c1NC1=NCCN1,,,CHEMBL1909046,,,,CHEMBL19236,MOXONIDINE,CHEMBL19236,,0,,1539962,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7771476,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2,,,CHEMBL1909046,,,,CHEMBL649,NADOLOL,CHEMBL649,,0,,1539970,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772103,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C,,,CHEMBL1909046,,,,CHEMBL460291,LACIDIPINE,CHEMBL460291,,0,,1539873,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772235,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,,,CHEMBL1909046,,,,CHEMBL1444,LETROZOLE,CHEMBL1444,,0,,1539881,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7772368,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,,,CHEMBL1909046,,,"{'bei': '20.19', 'le': '0.41', 'lle': '6.33', 'sei': '6.78'}",CHEMBL267044,LEVOSULPIRIDE,CHEMBL267044,6.89,0,http://www.openphacts.org/units/Nanomolar,1539889,=,15,1,=,,IC50,nM,,128.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.128
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772476,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL841,LOPERAMIDE,CHEMBL841,,0,,1539897,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772908,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cccc(C)c1NC(=O)C1CCCCN1C,,,CHEMBL1909046,,,,CHEMBL1087,MEPIVACAINE,CHEMBL1087,,0,,1539922,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7772993,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccccc1OCC(O)COC(N)=O,,,CHEMBL1909046,,,,CHEMBL1201117,METHOCARBAMOL,CHEMBL1201117,,0,,1539930,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7773115,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)c1ccc(O)cc1,,,CHEMBL1909046,,,,CHEMBL325372,METHYLPARABEN,CHEMBL325372,,0,,1539938,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7773227,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@](N)(Cc1ccc(O)cc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1200862,METYROSINE,CHEMBL1200862,,0,,1539946,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7773791,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1201631,INSULIN,CHEMBL1201631,,0,,1539849,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7773920,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NNC(=O)c1ccncc1,,,CHEMBL1909046,,,,CHEMBL64,ISONIAZID,CHEMBL64,,0,,1539857,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7774017,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1,,,CHEMBL1909046,,,,CHEMBL571,KETOPROFEN,CHEMBL571,,0,,1539865,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7774688,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1200693,MANGANESE CHLORIDE,CHEMBL1200693,,0,,1539906,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7774790,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL1390,,CHEMBL1390,,0,,1539914,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7775505,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1,,,CHEMBL1909046,,,,CHEMBL1670,MITOTANE,CHEMBL1670,,0,,1539955,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7775593,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,,,CHEMBL1909046,,,,CHEMBL1456,MYCOPHENOLATE MOFETIL,CHEMBL1456,,0,,1539963,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7775730,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1909070,NAFENOPIN,CHEMBL1909070,,0,,1539971,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7776341,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(O)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1200559,LACTIC ACID,CHEMBL1200559,,0,,1539874,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7776476,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O,,,CHEMBL1909046,,,,CHEMBL1679,LEUCOVORIN,CHEMBL1679,,0,,1539882,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7776606,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CC(=O)Nc1c(C)cccc1C,,,CHEMBL1909046,,,,CHEMBL79,LIDOCAINE,CHEMBL79,,0,,1539890,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7776694,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,,,CHEMBL1909046,,,,CHEMBL998,LORATADINE,CHEMBL998,,0,,1539898,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7777135,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,,,CHEMBL1909046,,,,CHEMBL127,MEROPENEM,CHEMBL127,,0,,1539923,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7777220,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,,,CHEMBL1909046,,,,CHEMBL34259,METHOTREXATE,CHEMBL34259,,0,,1539931,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7777342,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12,,,CHEMBL1909046,,,,CHEMBL650,METHYLPREDNISOLONE,CHEMBL650,,0,,1539939,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7777456,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,,,CHEMBL1909046,,,,CHEMBL54440,MEVASTATIN,CHEMBL54440,,0,,1539947,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7778020,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1c(I)cc(I)c2cccnc12,,,CHEMBL1909046,,,,CHEMBL86754,IODOQUINOL,CHEMBL86754,,0,,1539850,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7778151,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NCC(O)c1ccc(O)c(O)c1,,,CHEMBL1909046,,,,CHEMBL434,ISOPROTERENOL,CHEMBL434,,0,,1539858,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7778249,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O,,,CHEMBL1909046,,,,CHEMBL469,KETOROLAC,CHEMBL469,,0,,1539866,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7778915,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,,,CHEMBL1909046,,,,CHEMBL689,MANNITOL,CHEMBL689,,0,,1539907,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7779013,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL717,MEDROXYPROGESTERONE ACETATE,CHEMBL717,,0,,1539915,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7779731,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,,,CHEMBL1909046,,,,CHEMBL58,MITOXANTRONE,CHEMBL58,,0,,1539956,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7779829,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2,,,CHEMBL1909046,,,,CHEMBL866,MYCOPHENOLIC ACID,CHEMBL866,,0,,1539964,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7779964,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,,,CHEMBL1909046,,,,CHEMBL895,NALBUPHINE,CHEMBL895,,0,,1539972,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7780590,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,,,CHEMBL1909046,,,,CHEMBL141,LAMIVUDINE,CHEMBL141,,0,,1539875,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7780725,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,c1ccc([C@H]2CN3CCSC3=N2)cc1,,,CHEMBL1909046,,,,CHEMBL1454,LEVAMISOLE,CHEMBL1454,,0,,1539883,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7780855,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1,,,CHEMBL1909046,,,,CHEMBL1447,LINCOMYCIN,CHEMBL1447,,0,,1539891,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7780938,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O,,,CHEMBL1909046,,,,CHEMBL580,LORAZEPAM,CHEMBL580,,0,,1539899,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7781039,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)OCC(COC(C)=O)OC(C)=O,,,CHEMBL1909046,,,,CHEMBL1489254,TRIACETIN,CHEMBL1489254,,0,,1540239,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7781170,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,,,CHEMBL1909046,,,,CHEMBL422,TRIFLUOPERAZINE,CHEMBL422,,0,,1540247,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7781286,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1c[nH]c3ccccc13)C2,,,CHEMBL1909046,,,,CHEMBL56564,TROPISETRON,CHEMBL56564,,0,,1540255,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7781760,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,,,CHEMBL1909046,,,,CHEMBL603,ZAFIRLUKAST,CHEMBL603,,0,,1540279,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7782328,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-],,,CHEMBL1909046,,,,CHEMBL2107687,VALETHAMATE BROMIDE,CHEMBL2111176,,0,,1540264,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7782444,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,,,CHEMBL1909046,,,,CHEMBL90555,VINCRISTINE,CHEMBL90555,,0,,1540272,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7782639,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F,,,CHEMBL1909046,,,,CHEMBL1451,TRIAMCINOLONE,CHEMBL1451,,0,,1540240,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7782769,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1,,,CHEMBL1909046,,,,CHEMBL1490,TRIHEXYPHENIDYL,CHEMBL1490,,0,,1540248,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7782885,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12,,,CHEMBL1909046,,,,CHEMBL428,TROVAFLOXACIN,CHEMBL428,,0,,1540256,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7783360,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1,,,CHEMBL1909046,,,,CHEMBL1521,ZALEPLON,CHEMBL1521,,0,,1540280,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7783928,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCC(CCC)C(=O)O,,,CHEMBL1909046,,,,CHEMBL109,VALPROIC ACID,CHEMBL109,,0,,1540265,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7784049,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,,,CHEMBL1909046,,,,CHEMBL238071,VINDESINE,CHEMBL238071,,0,,1540273,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7784236,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,,,CHEMBL1909046,,,,CHEMBL1504,TRIAMCINOLONE ACETONIDE,CHEMBL1504,,0,,1540241,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7784357,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(CN2CCNCC2)c(OC)c1OC,,,CHEMBL1909046,,,,CHEMBL203266,TRIMETAZIDINE,CHEMBL203266,,0,,1540249,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7784475,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC,,,CHEMBL1909046,,,,CHEMBL1566956,TROXIPIDE,CHEMBL1566956,,0,,1540257,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7784943,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1,,,CHEMBL1909046,,,,CHEMBL28079,ZAPRINAST,CHEMBL28079,,0,,1540281,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7785506,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C,,,CHEMBL1909046,,,,CHEMBL1069,VALSARTAN,CHEMBL1069,,0,,1540266,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7785627,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,,,CHEMBL1909046,,,,CHEMBL553025,VINORELBINE,CHEMBL553025,,0,,1540274,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7785833,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1CC[C@H](C(=O)O)CC1,,,CHEMBL1909046,,,,CHEMBL877,TRANEXAMIC ACID,CHEMBL877,,0,,1540234,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7785944,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,,,CHEMBL1909046,,,,CHEMBL585,TRIAMTERENE,CHEMBL585,,0,,1540242,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7786067,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C(=O)OC(C)(C)C1=O,,,CHEMBL1909046,,,,CHEMBL695,TRIMETHADIONE,CHEMBL695,,0,,1540250,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7786184,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N#CC(C#N)=Cc1ccc(O)c(O)c1,,,CHEMBL1909046,,,,CHEMBL76904,TYRPHOSTIN 23,CHEMBL76904,,0,,1540258,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7786652,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O,,,CHEMBL1909046,,,,CHEMBL129,ZIDOVUDINE,CHEMBL129,,0,,1540282,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7787354,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O,,,CHEMBL1909046,,,,CHEMBL262777,VANCOMYCIN,CHEMBL262777,,0,,1540267,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7787474,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,,,CHEMBL1909046,,,,CHEMBL119385,NEFLAMAPIMOD,CHEMBL119385,,0,,1540275,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7787691,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC,,,CHEMBL1909046,,,,CHEMBL415324,TRANILAST,CHEMBL415324,,0,,1540235,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7787799,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O,,,CHEMBL1909046,,,,CHEMBL24944,TRIBROMSALAN,CHEMBL24944,,0,,1540243,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7787926,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1,,,CHEMBL1909046,,,,CHEMBL1475,TRIOXSALEN,CHEMBL1475,,0,,1540251,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7788040,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2,,,CHEMBL1909046,,,"{'bei': '9.17', 'le': '0.17', 'lle': '0.57', 'sei': '7.00'}",CHEMBL141343,,CHEMBL141343,4.78,0,http://www.openphacts.org/units/Nanomolar,1540259,=,15,1,=,,IC50,nM,,16760.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,16.76
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7788528,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(c1cc2ccccc2s1)N(O)C(N)=O,,,CHEMBL1909046,,,,CHEMBL93,ZILEUTON,CHEMBL93,,0,,1540283,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7789103,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL29292,UBENIMEX,CHEMBL29292,,0,,1540260,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7789237,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-],,,CHEMBL1909046,,,,CHEMBL1200629,VECURONIUM BROMIDE,CHEMBL1201219,,0,,1540268,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7789343,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,,,CHEMBL1909046,,,,CHEMBL1464,WARFARIN,CHEMBL1464,,0,,1540276,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7789561,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1386,TRANSPLATIN,CHEMBL1386,,0,,1540236,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7789665,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O,,,CHEMBL1909046,,,,CHEMBL1054,TRICHLORMETHIAZIDE,CHEMBL1054,,0,,1540244,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7789792,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2,,,CHEMBL1909046,,,,CHEMBL408,TROGLITAZONE,CHEMBL408,,0,,1540252,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7790382,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,[Cl-].[Cl-].[Zn+2],,,CHEMBL1909046,,,,CHEMBL1200679,ZINC CHLORIDE,CHEMBL1200679,,0,,1540284,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7790959,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(N)=O,,,CHEMBL1909046,,,,CHEMBL462547,URETHANE,CHEMBL462547,,0,,1540261,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7791093,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,,,CHEMBL1909046,,,,CHEMBL637,VENLAFAXINE,CHEMBL637,,0,,1540269,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7791200,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,,,CHEMBL1909046,,,,CHEMBL559147,Y-27632,CHEMBL559147,,0,,1540277,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7791409,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,,,CHEMBL1909046,,,,CHEMBL621,TRAZODONE,CHEMBL621,,0,,1540237,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7791527,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)C(Cl)(Cl)Cl,,,CHEMBL1909046,,,,CHEMBL14053,TRICHLOROACETIC ACID,CHEMBL14053,,0,,1540245,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7791650,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(CO)(CO)CO,,,CHEMBL1909046,,,,CHEMBL1200391,TROMETHAMINE,CHEMBL1200391,,0,,1540253,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7792236,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909083,ZIRCONIUM(IV) CHLORIDE,CHEMBL1909083,,0,,1540285,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7792815,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21,,,CHEMBL1909046,,,,CHEMBL1349,VALACYCLOVIR,CHEMBL1349,,0,,1540262,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7792948,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC,,,CHEMBL1909046,,,,CHEMBL6966,VERAPAMIL,CHEMBL6966,,0,,1540270,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7793064,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O,,,CHEMBL1909046,,,"{'bei': '16.04', 'le': '0.30', 'lle': '3.04', 'sei': '8.67'}",CHEMBL15245,YOHIMBINE,CHEMBL15245,5.69,0,http://www.openphacts.org/units/Nanomolar,1540278,=,15,1,=,,IC50,nM,,2060.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.06
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7793260,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,,,CHEMBL1909046,,,,CHEMBL38,TRETINOIN,CHEMBL38,,0,,1540238,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7793389,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,ClCC(Cl)Cl,,,CHEMBL1909046,,,,CHEMBL43882,TRICHLOROETHANE,CHEMBL43882,,0,,1540246,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7793512,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1,,,CHEMBL1909046,,,,CHEMBL1200604,TROPICAMIDE,CHEMBL1200604,,0,,1540254,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7794558,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1,,,CHEMBL1909046,,,,CHEMBL865,VALDECOXIB,CHEMBL865,,0,,1540263,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7794677,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1,,,CHEMBL1909046,,,,CHEMBL159,VINBLASTINE,CHEMBL159,,0,,1540271,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7794748,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,,,CHEMBL1909046,,,,CHEMBL1393,SPIRONOLACTONE,CHEMBL1393,,0,,1540158,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7794883,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46,,,CHEMBL1909046,,,,CHEMBL227934,STRYCHNINE,CHEMBL227934,,0,,1540166,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7795000,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1,,,CHEMBL1909046,,,,CHEMBL446,SULFAMETHAZINE,CHEMBL446,,0,,1540174,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7795140,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C,,,CHEMBL1909046,,,,CHEMBL453,SULFISOXAZOLE,CHEMBL453,,0,,1540182,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7795614,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12,,,CHEMBL1909046,,,,CHEMBL1440,TETRACYCLINE,CHEMBL1440,,0,,1540207,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7795744,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc2[nH]cnc2c(=S)[nH]1,,,CHEMBL1909046,,,,CHEMBL727,THIOGUANINE,CHEMBL727,,0,,1540215,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7795816,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1,,,CHEMBL1909046,,,,CHEMBL1630578,TIRILAZAD,CHEMBL1630578,,0,,1540223,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7795943,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1,,,CHEMBL1909046,,,,CHEMBL1148,TORSEMIDE,CHEMBL1148,,0,,1540231,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7796163,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,,,CHEMBL1909046,,,,CHEMBL413,SIROLIMUS,CHEMBL413,,0,,1540110,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7796293,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(N)C12CC3CC(CC(C3)C1)C2,,,CHEMBL1909046,,,,CHEMBL959,RIMANTADINE,CHEMBL959,,0,,1540118,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7796400,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O,,,CHEMBL1909046,,,,CHEMBL1321154,ROXARSONE,CHEMBL1321154,,0,,1540126,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7796516,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)c1ccccc1O,,,CHEMBL1909046,,,,CHEMBL27577,SALICYLAMIDE,CHEMBL27577,,0,,1540134,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7796632,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O,,,CHEMBL1909046,,,,CHEMBL447,SECOBARBITAL,CHEMBL447,,0,,1540142,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7796729,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=[As][O-].[Na+],,,CHEMBL1909046,,,,CHEMBL1909078,SODIUM ARSENITE,CHEMBL1909222,,0,,1540150,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7797474,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,,,CHEMBL1909046,,,,CHEMBL269732,TACROLIMUS,CHEMBL269732,,0,,1540191,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7797537,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O,,,CHEMBL1909046,,,,CHEMBL302795,TENOXICAM,CHEMBL302795,,0,,1540199,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7798978,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL1909079,STANNOUS FLUORIDE,CHEMBL1909079,,0,,1540159,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7799113,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,,,CHEMBL1909046,,,,CHEMBL403,SULBACTAM,CHEMBL403,,0,,1540167,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7799230,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,,,CHEMBL1909046,,,,CHEMBL1191,SULFAMETHIZOLE,CHEMBL1191,,0,,1540175,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7799367,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1,,,CHEMBL1909046,,,,CHEMBL15770,SULINDAC,CHEMBL15770,,0,,1540183,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7799845,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,,,CHEMBL1909046,,,,CHEMBL468,THALIDOMIDE,CHEMBL468,,0,,1540208,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7799971,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,,,CHEMBL1909046,,,"{'bei': '20.12', 'le': '0.41', 'lle': '1.57', 'sei': '115.06'}",CHEMBL479,THIORIDAZINE,CHEMBL479,7.46,0,http://www.openphacts.org/units/Nanomolar,1540216,=,15,1,=,,IC50,nM,,35.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.035
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800055,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1540224,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800408,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,,,CHEMBL1909046,,,,CHEMBL772,RESERPINE,CHEMBL772,,0,,1540111,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800649,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1214185,ROXITHROMYCIN,CHEMBL1214185,,0,,1540127,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800766,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1ccccc1O,,,CHEMBL1909046,,,,CHEMBL424,SALICYLIC ACID,CHEMBL424,,0,,1540135,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800881,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#CCN(C)[C@H](C)Cc1ccccc1,,,CHEMBL1909046,,,,CHEMBL972,SELEGILINE,CHEMBL972,,0,,1540143,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7800984,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL136478,SODIUM NITROPRUSSIDE,CHEMBL2097081,,0,,1540151,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7801733,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,,,CHEMBL1909046,,,"{'bei': '13.07', 'le': '0.24', 'lle': '-1.14', 'sei': '38.95'}",CHEMBL83,TAMOXIFEN,CHEMBL83,4.86,0,http://www.openphacts.org/units/Nanomolar,1540192,=,15,1,=,,IC50,nM,,13885.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,13.885
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7801814,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC,,,CHEMBL1909046,,,,CHEMBL611,TERAZOSIN,CHEMBL611,,0,,1540200,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802358,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1,,,CHEMBL1909046,,,,CHEMBL273348,TOSUFLOXACIN,CHEMBL273348,,0,,1540232,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7802574,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O,,,CHEMBL1909046,,,,CHEMBL923,RISEDRONIC ACID,CHEMBL923,,0,,1540119,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7803275,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,,,CHEMBL1909046,,,,CHEMBL27769,STANOLONE,CHEMBL27769,,0,,1540160,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7803404,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,,,CHEMBL1909046,,,,CHEMBL1221,SULCONAZOLE,CHEMBL1221,,0,,1540168,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7803541,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,,,CHEMBL1909046,,,,CHEMBL443,SULFAMETHOXAZOLE,CHEMBL443,,0,,1540176,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7803676,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1,,,CHEMBL1909046,,,,CHEMBL18797,SULINDAC SULFIDE,CHEMBL18797,,0,,1540184,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7804196,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cn1c(=O)c2[nH]cnc2n(C)c1=O,,,CHEMBL1909046,,,,CHEMBL190,THEOPHYLLINE,CHEMBL190,,0,,1540209,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7804278,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC,,,CHEMBL1909046,,,"{'bei': '17.99', 'le': '0.37', 'lle': '4.74', 'sei': '7.81'}",CHEMBL84158,TIAPRIDE,CHEMBL84158,5.91,0,http://www.openphacts.org/units/Nanomolar,1540217,=,15,1,=,,IC50,nM,,1232.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.232
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7804388,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cccc(C)c1NC(=O)C(C)N,,,CHEMBL1909046,,,,CHEMBL1762,TOCAINIDE,CHEMBL1762,,0,,1540225,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7804736,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,,,CHEMBL1909046,,,,CHEMBL165,RESVERATROL,CHEMBL165,,0,,1540112,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7804879,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,,,CHEMBL1909046,,,"{'bei': '18.76', 'le': '0.35', 'lle': '4.11', 'sei': '12.00'}",CHEMBL85,RISPERIDONE,CHEMBL85,7.70,0,http://www.openphacts.org/units/Nanomolar,1540120,=,15,1,=,,IC50,nM,,20.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.02
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7804996,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2,,,CHEMBL1909046,,,,CHEMBL115769,,CHEMBL115769,,0,,1540128,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7805120,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C,,,CHEMBL1909046,,,,CHEMBL1208572,SALINOMYCIN,CHEMBL1208572,,0,,1540136,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7805230,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1CCC(NC(=O)N(CCCl)N=O)CC1,,,CHEMBL1909046,,,,CHEMBL12948,SEMUSTINE,CHEMBL12948,,0,,1540144,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7805335,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL179166,SODIUM ORTHOVANAD,CHEMBL179166,,0,,1540152,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7806029,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1,,,CHEMBL1909046,,,,CHEMBL506247,TANNIC ACID,CHEMBL506247,,0,,1540193,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7806151,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12,,,CHEMBL1909046,,,,CHEMBL822,TERBINAFINE,CHEMBL822,,0,,1540201,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7806675,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cccc(C2(O)CCCCC2CN(C)C)c1,,,CHEMBL1909046,,,,CHEMBL1237044,TRAMADOL,CHEMBL1237044,,0,,1540233,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7807603,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,,,CHEMBL1909046,,,,CHEMBL2079587,STANOZOLOL,CHEMBL2079587,,0,,1540161,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7807717,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1,,,CHEMBL1909046,,,,CHEMBL1243,SULFABENZAMIDE,CHEMBL1243,,0,,1540169,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7807863,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccc(S(N)(=O)=O)cc1,,,CHEMBL1909046,,,,CHEMBL21,SULFANILAMIDE,CHEMBL21,,0,,1540177,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7807988,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1,,,CHEMBL1909046,,,,CHEMBL488025,EXISULIND,CHEMBL488025,,0,,1540185,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7808482,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,c1ccc2[nH]c(-c3cscn3)nc2c1,,,CHEMBL1909046,,,,CHEMBL625,THIABENDAZOLE,CHEMBL625,,0,,1540210,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7808562,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C,,,CHEMBL1909046,,,,CHEMBL2103774,TIBOLONE,CHEMBL2103774,,0,,1540218,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7808675,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1,,,CHEMBL1909046,,,,CHEMBL817,TOLAZAMIDE,CHEMBL817,,0,,1540226,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7809021,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1,,,CHEMBL1909046,,,,CHEMBL1643,RIBAVIRIN,CHEMBL1643,,0,,1540113,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7809143,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1,,,CHEMBL1909046,,,,CHEMBL163,RITONAVIR,CHEMBL163,,0,,1540121,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7809265,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NC[C@H](O)COc1cccc2ccccc12,,,CHEMBL1909046,,,,CHEMBL452861,(-)-PROPANOLOL ,CHEMBL452861,,0,,1540129,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7809395,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(Oc1ccccc1C(=O)O)c1ccccc1O,,,CHEMBL1909046,,,,CHEMBL154111,SALSALATE,CHEMBL154111,,0,,1540137,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7809500,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21,,,CHEMBL1909046,,,,CHEMBL809,SERTRALINE,CHEMBL809,,0,,1540145,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7809621,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1,,,CHEMBL1909046,,,,CHEMBL471,SOTALOL,CHEMBL471,,0,,1540153,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7810299,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O,,,CHEMBL1909046,,,,CHEMBL404,TAZOBACTAM,CHEMBL404,,0,,1540194,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7810425,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NCC(O)c1cc(O)cc(O)c1,,,CHEMBL1909046,,,,CHEMBL1760,TERBUTALINE,CHEMBL1760,,0,,1540202,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7810946,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1,,,CHEMBL1909046,,,,CHEMBL427526,(R)-IBUPROPHEN,CHEMBL427526,,0,,1540105,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7811889,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,,,CHEMBL1909046,,,,CHEMBL991,STAVUDINE,CHEMBL991,,0,,1540162,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7812005,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1,,,CHEMBL1909046,,,,CHEMBL439,SULFADIAZINE,CHEMBL439,,0,,1540170,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7812151,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1,,,CHEMBL1909046,,,,CHEMBL1109,SULFAPHENAZOLE,CHEMBL1109,,0,,1540178,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7812264,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1,,,CHEMBL1909046,,,,CHEMBL588119,SULOCTIDIL,CHEMBL588119,,0,,1540186,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7812781,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1,,,CHEMBL1909046,,,,CHEMBL1236282,THIAMPHENICOL,CHEMBL1236282,,0,,1540211,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7812851,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Clc1ccccc1CN1CCc2sccc2C1,,,CHEMBL1909046,,,,CHEMBL833,TICLOPIDINE,CHEMBL833,,0,,1540219,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7812972,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1,,,CHEMBL1909046,,,,CHEMBL1020,TOLMETIN,CHEMBL1020,,0,,1540227,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7813316,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,,,CHEMBL1909046,,,,CHEMBL444633,RIFABUTIN,CHEMBL444633,,0,,1540114,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7813432,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCOc1cc(CC2CNC(=O)N2)ccc1OC,,,CHEMBL1909046,,,,CHEMBL18701,RO-201724,CHEMBL18701,,0,,1540122,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7813548,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,N[C@H](CSC(=S)NCc1ccccc1)C(=O)O,,,CHEMBL1909046,,,,CHEMBL1909076,,CHEMBL1909076,,0,,1540130,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7813688,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1,,,CHEMBL1909046,,,,CHEMBL114,SAQUINAVIR,CHEMBL114,,0,,1540138,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7813770,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1,,,CHEMBL1909046,,,,CHEMBL1419,SIBUTRAMINE,CHEMBL1419,,0,,1540146,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7813907,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1,,,CHEMBL1909046,,,,CHEMBL850,SPARFLOXACIN,CHEMBL850,,0,,1540154,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7814528,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,,,CHEMBL1909046,,,"{'bei': '19.59', 'le': '0.40', 'lle': '6.13', 'sei': '6.57'}",CHEMBL26,SULPIRIDE,CHEMBL26,6.69,0,http://www.openphacts.org/units/Nanomolar,1540187,=,15,1,=,,IC50,nM,,205.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.205
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7814586,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=c1[nH]c(=O)n(C2CCCO2)cc1F,,,CHEMBL1909046,,,,CHEMBL20883,TEGAFUR,CHEMBL20883,,0,,1540195,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7814699,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,,,CHEMBL1909046,,,,CHEMBL1306,TERCONAZOLE,CHEMBL1306,,0,,1540203,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7815240,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C,,,CHEMBL1909046,,,,CHEMBL1219,RABEPRAZOLE,CHEMBL1219,,0,,1540106,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7816182,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O,,,CHEMBL1909046,,,,CHEMBL372795,STREPTOMYCIN,CHEMBL372795,,0,,1540163,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7816298,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1,,,CHEMBL1909046,,,,CHEMBL62193,SULFADIMETHOXINE,CHEMBL62193,,0,,1540171,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7816442,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O,,,CHEMBL1909046,,,,CHEMBL421,SULFASALAZINE,CHEMBL421,,0,,1540179,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7817068,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,,,,CHEMBL1909046,,,,CHEMBL508338,THIMEROSAL,CHEMBL508338,,0,,1540212,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7817141,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl,,,CHEMBL1909046,,,,CHEMBL267744,TICRYNAFEN,CHEMBL267744,,0,,1540220,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7817264,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,,,CHEMBL1909046,,,,CHEMBL83668,TOLNAFTATE,CHEMBL83668,,0,,1540228,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7817622,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,,,CHEMBL1909046,,,,CHEMBL374478,RIFAMPIN,CHEMBL374478,,0,,1540115,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7817732,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1,,,CHEMBL1909046,,,,CHEMBL122,ROFECOXIB,CHEMBL122,,0,,1540123,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7817850,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O,,,CHEMBL1909046,,,,CHEMBL1200748,CARBIDOPA,CHEMBL1201236,,0,,1540131,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7817976,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1909046,,,,CHEMBL37858,SARAFLOXACIN,CHEMBL37858,,0,,1540139,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7818060,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,,,CHEMBL1909046,,,,CHEMBL192,SILDENAFIL,CHEMBL192,,0,,1540147,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7818202,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@@H]34)[C@H]2C1,,,CHEMBL1909046,,,,CHEMBL412873,SPARTEINE,CHEMBL412873,,0,,1540155,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7818815,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,,,CHEMBL1909046,,,,CHEMBL128,SUMATRIPTAN,CHEMBL128,,0,,1540188,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7818873,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL2367892,TEICOPLANIN,CHEMBL2367892,,0,,1540196,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7818952,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,,,CHEMBL1909046,,,"{'bei': '11.05', 'le': '0.20', 'lle': '-1.24', 'sei': '11.92'}",CHEMBL17157,TERFENADINE,CHEMBL17157,5.21,0,http://www.openphacts.org/units/Nanomolar,1540204,=,15,1,=,,IC50,nM,,6167.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,6.167
,,7819508,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12,,,CHEMBL1909046,,,"{'bei': '12.52', 'le': '0.24', 'lle': '-0.15', 'sei': '8.47'}",CHEMBL81,RALOXIFENE,CHEMBL81,5.93,0,http://www.openphacts.org/units/Nanomolar,1540107,=,15,1,=,,IC50,nM,,1174.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.174
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7820463,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,,,CHEMBL1909046,,,,CHEMBL1651906,STREPTOZOCIN,CHEMBL1651906,,0,,1540164,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7820578,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,,,CHEMBL1909046,,,,CHEMBL1539,SULFADOXINE,CHEMBL1539,,0,,1540172,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7820718,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1ccc(S(=O)(=O)Nc2nccs2)cc1,,,CHEMBL1909046,,,,CHEMBL437,SULFATHIAZOLE,CHEMBL437,,0,,1540180,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7821204,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,,,CHEMBL1909046,,,,CHEMBL386630,TESTOSTERONE,CHEMBL386630,,0,,1540205,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7821327,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(=N)S,,,CHEMBL1909046,,,,CHEMBL38737,THIOACETAMIDE,CHEMBL38737,,0,,1540213,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7821400,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1,,,CHEMBL1909046,,,,CHEMBL499,TIMOLOL,CHEMBL499,,0,,1540221,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7821523,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1,,,CHEMBL1909046,,,,CHEMBL1076211,TOLPERISONE,CHEMBL1076211,,0,,1540229,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7821752,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,,,CHEMBL1909046,,,,CHEMBL1168,RAMIPRIL,CHEMBL1168,,0,,1540108,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7821879,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C,,,CHEMBL1909046,,,,CHEMBL1660,RIFAPENTINE,CHEMBL1660,,0,,1540116,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7821989,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,,,CHEMBL1909046,,,,CHEMBL121,ROSIGLITAZONE,CHEMBL121,,0,,1540124,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7822105,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=CCc1ccc2c(c1)OCO2,,,CHEMBL1909046,,,,CHEMBL242273,SAFROLE,CHEMBL242273,,0,,1540132,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7822233,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,,,CHEMBL1909046,,,,CHEMBL10,SB-203580,CHEMBL10,,0,,1540140,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7822324,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,,,CHEMBL1909046,,,,CHEMBL1064,SIMVASTATIN,CHEMBL1064,,0,,1540148,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7822467,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O,,,CHEMBL1909046,,,,CHEMBL1167,SPECTINOMYCIN,CHEMBL1167,,0,,1540156,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7823074,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-],,,CHEMBL1909046,,,,CHEMBL983,SUCCINYLCHOLINE CHLORIDE,CHEMBL703,,0,,1540189,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7823135,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1,,,CHEMBL1909046,,,,CHEMBL277100,TEMAFLOXACIN,CHEMBL277100,,0,,1540197,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7824707,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2],,,CHEMBL1909046,,,,CHEMBL1909080,STRONTIUM CHLORIDE HEXAHYDRATE,CHEMBL2219640,,0,,1540165,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7824822,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1,,,CHEMBL1909046,,,,CHEMBL438,SULFAMERAZINE,CHEMBL438,,0,,1540173,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7824962,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1,,,CHEMBL1909046,,,,CHEMBL832,SULFINPYRAZONE,CHEMBL832,,0,,1540181,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7825437,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCCCNc1ccc(C(=O)OCCN(C)C)cc1,,,CHEMBL1909046,,,,CHEMBL698,TETRACAINE,CHEMBL698,,0,,1540206,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7825561,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,O=C(O)CCCC[C@@H]1CCSS1,,,CHEMBL1909046,,,,CHEMBL134342,THIOCTIC ACID,CHEMBL134342,,0,,1540214,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7825633,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C,,,CHEMBL1909046,,,,CHEMBL1220,TINIDAZOLE,CHEMBL1220,,0,,1540222,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7825755,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,,,CHEMBL1909046,,,,CHEMBL84,TOPOTECAN,CHEMBL84,,0,,1540230,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7826102,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1nc2ccc(OC(F)(F)F)cc2s1,,,CHEMBL1909046,,,,CHEMBL744,RILUZOLE,CHEMBL744,,0,,1540117,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7826212,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1,,,CHEMBL1909046,,,,CHEMBL429023,ROTENONE,CHEMBL429023,,0,,1540125,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7826329,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,,,CHEMBL1909046,,,,CHEMBL714,ALBUTEROL,CHEMBL714,,0,,1540133,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7826444,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Cc1ncc([N+](=O)[O-])n1CC(C)O,,,CHEMBL1909046,,,,CHEMBL498847,SECNIDAZOLE,CHEMBL498847,,0,,1540141,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7826541,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL221886,SISOMICIN,CHEMBL221886,,0,,1540149,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7826684,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1,,,CHEMBL1909046,,,,CHEMBL70586,SPIRADOLINE,CHEMBL70586,,0,,1540157,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7827293,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,Nc1c2c(nc3ccccc13)CCCC2,,,CHEMBL1909046,,,,CHEMBL95,TACRINE,CHEMBL95,,0,,1540190,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7827359,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21,,,CHEMBL1909046,,,,CHEMBL1908355,TENIDAP,CHEMBL1908355,,0,,1540198,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7827963,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1,,,CHEMBL1909046,,,,CHEMBL1790041,RANITIDINE,CHEMBL1790041,,0,,1540109,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,7929956,[],CHEMBL1919022,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCOC(=O)N1CCC(NCCNC(=O)c2ccccc2C)CC1,,,CHEMBL1914417,Bioorg Med Chem Lett,2011.0,,CHEMBL1624037,,CHEMBL1624037,5.35,0,http://www.openphacts.org/units/Nanomolar,1558621,=,1,1,=,,IC50,nM,,4500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,4.5
,,7929957,[],CHEMBL1919022,Antagonist activity at dopamine D2 receptor,F,,,BAO_0000190,BAO_0000019,assay format,CCOC(=O)N1CCC(N2CCC[C@@H](NC(=O)c3ccccc3C)C2)CC1,,,CHEMBL1914417,Bioorg Med Chem Lett,2011.0,,CHEMBL1916224,,CHEMBL1916224,,0,http://www.openphacts.org/units/Nanomolar,1558630,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,30.0
,,7989732,[],CHEMBL1936809,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1CC2(CCN(Cc3ccc4[nH]c5ccc(Cl)cc5c4c3)CC2)c2ccccc21,,,CHEMBL1932960,Bioorg Med Chem Lett,2012.0,"{'bei': '13.76', 'le': '0.26', 'lle': '0.21', 'sei': '13.09'}",CHEMBL1934127,,CHEMBL1934127,6.30,0,http://www.openphacts.org/units/Nanomolar,1568082,=,1,1,=,,IC50,nM,,500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.5
,,7989759,[],CHEMBL1936809,Inhibition of dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)N[C@@H]1CC2(CCN(Cc3ccc4c(c3)c3ccccc3n4C(N)=O)CC2)c2ccccc21,,,CHEMBL1932960,Bioorg Med Chem Lett,2012.0,"{'bei': '12.48', 'le': '0.23', 'lle': '0.98', 'sei': '7.25'}",CHEMBL1934130,,CHEMBL1934130,5.82,0,http://www.openphacts.org/units/Nanomolar,1568085,=,1,1,=,,IC50,nM,,1500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.5
,,8023024,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.39', 'le': '0.26', 'lle': '1.80', 'sei': '6.78'}",CHEMBL1947157,,CHEMBL1947157,6.60,0,http://www.openphacts.org/units/Nanomolar,1576620,=,1,1,=,,IC50,nM,,251.19,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.6
,,8023025,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '11.27', 'le': '0.23', 'lle': '1.20', 'sei': '6.16'}",CHEMBL1944689,,CHEMBL1944689,6.00,0,http://www.openphacts.org/units/Nanomolar,1573530,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,8023026,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.45', 'le': '0.25', 'lle': '2.05', 'sei': '6.37'}",CHEMBL1944690,,CHEMBL1944690,6.20,0,http://www.openphacts.org/units/Nanomolar,1573531,=,1,1,=,,IC50,nM,,630.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.2
,,8023027,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '13.29', 'le': '0.26', 'lle': '2.77', 'sei': '6.57'}",CHEMBL1944691,,CHEMBL1944691,6.40,0,http://www.openphacts.org/units/Nanomolar,1573532,=,1,1,=,,IC50,nM,,398.11,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.4
,,8023028,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '11.84', 'le': '0.23', 'lle': '2.07', 'sei': '5.85'}",CHEMBL1944692,,CHEMBL1944692,5.70,0,http://www.openphacts.org/units/Nanomolar,1573533,=,1,1,=,,IC50,nM,,1995.26,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.7
,,8023029,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,,CHEMBL1944693,,CHEMBL1944693,,0,http://www.openphacts.org/units/Nanomolar,1573534,<,1,1,>,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,8023030,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.56', 'le': '0.24', 'lle': '2.70', 'sei': '5.82'}",CHEMBL1944694,,CHEMBL1944694,6.20,0,http://www.openphacts.org/units/Nanomolar,1573535,=,1,1,=,,IC50,nM,,630.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.2
,,8023031,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.30', 'le': '0.24', 'lle': '2.21', 'sei': '5.85'}",CHEMBL1944695,,CHEMBL1944695,5.70,0,http://www.openphacts.org/units/Nanomolar,1573536,=,1,1,=,,IC50,nM,,1995.26,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.7
,,8023032,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.39', 'le': '0.24', 'lle': '2.12', 'sei': '5.66'}",CHEMBL1945031,,CHEMBL1945031,6.40,0,http://www.openphacts.org/units/Nanomolar,1573950,=,1,1,=,,IC50,nM,,398.11,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.4
,,8023033,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cccc2c(CCNCc3ccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)cc3)c[nH]c12,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,,CHEMBL1945032,,CHEMBL1945032,,0,http://www.openphacts.org/units/Nanomolar,1573951,<,1,1,>,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,8023034,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.48', 'le': '0.24', 'lle': '2.91', 'sei': '5.26'}",CHEMBL1945033,,CHEMBL1945033,5.80,0,http://www.openphacts.org/units/Nanomolar,1573952,=,1,1,=,,IC50,nM,,1584.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.8
,,8023035,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccn4)cc3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.05', 'le': '0.23', 'lle': '2.71', 'sei': '5.08'}",CHEMBL1945034,,CHEMBL1945034,5.60,0,http://www.openphacts.org/units/Nanomolar,1573953,=,1,1,=,,IC50,nM,,2511.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.6
,,8023036,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.67', 'le': '0.25', 'lle': '2.47', 'sei': '6.26'}",CHEMBL1945035,,CHEMBL1945035,6.10,0,http://www.openphacts.org/units/Nanomolar,1573954,=,1,1,=,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,8023037,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '11.72', 'le': '0.22', 'lle': '1.55', 'sei': '5.75'}",CHEMBL1945036,,CHEMBL1945036,5.60,0,http://www.openphacts.org/units/Nanomolar,1573955,=,1,1,=,,IC50,nM,,2511.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.6
,,8023038,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '13.61', 'le': '0.26', 'lle': '2.62', 'sei': '6.67'}",CHEMBL1945037,,CHEMBL1945037,6.50,0,http://www.openphacts.org/units/Nanomolar,1573956,=,1,1,=,,IC50,nM,,316.23,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.5
,,8023039,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccn4)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,,CHEMBL1945038,,CHEMBL1945038,,0,http://www.openphacts.org/units/Nanomolar,1573957,<,1,1,>,,IC50,nM,,2511.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.6
,,8023040,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.51', 'le': '0.24', 'lle': '2.54', 'sei': '5.63'}",CHEMBL1945039,,CHEMBL1945039,6.00,0,http://www.openphacts.org/units/Nanomolar,1573958,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,8023041,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '11.68', 'le': '0.22', 'lle': '2.14', 'sei': '5.25'}",CHEMBL1945040,,CHEMBL1945040,5.60,0,http://www.openphacts.org/units/Nanomolar,1573959,=,1,1,=,,IC50,nM,,2511.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.6
,,8023042,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '13.64', 'le': '0.27', 'lle': '2.50', 'sei': '6.78'}",CHEMBL1945041,,CHEMBL1945041,6.60,0,http://www.openphacts.org/units/Nanomolar,1573960,=,1,1,=,,IC50,nM,,251.19,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.6
,,8023043,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '13.26', 'le': '0.26', 'lle': '2.61', 'sei': '6.37'}",CHEMBL1945042,,CHEMBL1945042,6.20,0,http://www.openphacts.org/units/Nanomolar,1573961,=,1,1,=,,IC50,nM,,630.96,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.2
,,8023044,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '11.76', 'le': '0.23', 'lle': '2.45', 'sei': '4.81'}",CHEMBL1945043,,CHEMBL1945043,5.30,0,http://www.openphacts.org/units/Nanomolar,1573962,=,1,1,=,,IC50,nM,,5011.87,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.3
,,8023045,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.72', 'le': '0.25', 'lle': '2.64', 'sei': '5.72'}",CHEMBL1945044,,CHEMBL1945044,6.10,0,http://www.openphacts.org/units/Nanomolar,1573963,=,1,1,=,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,8023046,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.72', 'le': '0.25', 'lle': '2.64', 'sei': '5.72'}",CHEMBL1945289,,CHEMBL1945289,6.10,0,http://www.openphacts.org/units/Nanomolar,1574341,=,1,1,=,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,8023047,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '11.95', 'le': '0.23', 'lle': '2.05', 'sei': '5.53'}",CHEMBL1945290,,CHEMBL1945290,5.90,0,http://www.openphacts.org/units/Nanomolar,1574342,=,1,1,=,,IC50,nM,,1258.93,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.9
,,8023048,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.15', 'le': '0.23', 'lle': '2.20', 'sei': '6.13'}",CHEMBL1945291,,CHEMBL1945291,6.00,0,http://www.openphacts.org/units/Nanomolar,1574343,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,8023049,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '14.61', 'le': '0.29', 'lle': '4.20', 'sei': '5.72'}",CHEMBL1945292,,CHEMBL1945292,6.10,0,http://www.openphacts.org/units/Nanomolar,1574344,=,1,1,=,,IC50,nM,,794.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.1
,,8023050,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,,CHEMBL1945293,,CHEMBL1945293,,0,http://www.openphacts.org/units/Nanomolar,1574345,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,8023051,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '13.30', 'le': '0.26', 'lle': '2.74', 'sei': '6.21'}",CHEMBL1945294,,CHEMBL1945294,5.50,0,http://www.openphacts.org/units/Nanomolar,1574346,=,1,1,=,,IC50,nM,,3162.28,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.5
,,8023053,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.99', 'le': '0.27', 'lle': '1.91', 'sei': '7.29'}",CHEMBL1945296,,CHEMBL1945296,7.10,0,http://www.openphacts.org/units/Nanomolar,1574348,=,1,1,=,,IC50,nM,,79.43,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.1
,,8023054,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.63', 'le': '0.26', 'lle': '1.71', 'sei': '7.09'}",CHEMBL1945297,,CHEMBL1945297,6.90,0,http://www.openphacts.org/units/Nanomolar,1574349,=,1,1,=,,IC50,nM,,125.89,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.9
,,8023055,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.86', 'le': '0.25', 'lle': '2.93', 'sei': '6.00'}",CHEMBL1945298,,CHEMBL1945298,6.40,0,http://www.openphacts.org/units/Nanomolar,1574350,=,1,1,=,,IC50,nM,,398.11,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.4
,,8023056,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '12.15', 'le': '0.23', 'lle': '2.50', 'sei': '5.63'}",CHEMBL1945299,,CHEMBL1945299,6.00,0,http://www.openphacts.org/units/Nanomolar,1574351,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,8023057,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,OCc1cc([C@@H](O)CNCCc2ccc(CNCCc3ccccc3)cc2)ccc1O,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,,CHEMBL1945300,,CHEMBL1945300,,0,http://www.openphacts.org/units/Nanomolar,1574352,<,1,1,>,,IC50,nM,,7943.28,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.1
,,8023058,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,O=c1ccc2c([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)ccc(O)c2[nH]1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,,CHEMBL1945503,,CHEMBL1945503,,0,http://www.openphacts.org/units/Nanomolar,1574609,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,8023059,[],CHEMBL1947794,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,,,CHEMBL1944599,Bioorg Med Chem Lett,2012.0,"{'bei': '11.88', 'le': '0.23', 'lle': '2.24', 'sei': '5.35'}",CHEMBL1945504,,CHEMBL1945504,5.70,0,http://www.openphacts.org/units/Nanomolar,1574610,=,1,1,=,,IC50,nM,,1995.26,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.7
,,10858697,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016621,,CHEMBL2016621,,0,http://www.openphacts.org/units/Nanomolar,1634046,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858698,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016620,,CHEMBL2016620,,0,http://www.openphacts.org/units/Nanomolar,1634045,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858699,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016619,,CHEMBL2016619,,0,http://www.openphacts.org/units/Nanomolar,1634044,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858700,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016618,,CHEMBL2016618,,0,http://www.openphacts.org/units/Nanomolar,1634043,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858701,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016617,,CHEMBL2016617,,0,http://www.openphacts.org/units/Nanomolar,1634042,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858702,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '6.83', 'le': '0.13', 'lle': '-2.04', 'sei': '5.48'}",CHEMBL2016616,,CHEMBL2016616,5.61,0,http://www.openphacts.org/units/Nanomolar,1634041,=,1,1,=,,IC50,nM,,2440.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2440.0
,,10858703,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '7.16', 'le': '0.14', 'lle': '-1.19', 'sei': '5.55'}",CHEMBL2016615,,CHEMBL2016615,5.68,0,http://www.openphacts.org/units/Nanomolar,1634040,=,1,1,=,,IC50,nM,,2078.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2078.0
,,10858704,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '10.18', 'le': '0.20', 'lle': '-1.24', 'sei': '9.86'}",CHEMBL2016614,,CHEMBL2016614,5.05,0,http://www.openphacts.org/units/Nanomolar,1634039,=,1,1,=,,IC50,nM,,8939.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8939.0
,,10858705,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016613,,CHEMBL2016613,,0,http://www.openphacts.org/units/Nanomolar,1634038,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858706,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016612,,CHEMBL2016612,,0,http://www.openphacts.org/units/Nanomolar,1634037,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858707,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016611,,CHEMBL2016611,,0,http://www.openphacts.org/units/Nanomolar,1634036,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858708,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016610,,CHEMBL2016610,,0,http://www.openphacts.org/units/Nanomolar,1634035,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858709,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016609,,CHEMBL2016609,,0,http://www.openphacts.org/units/Nanomolar,1634034,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10858710,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '7.04', 'le': '0.14', 'lle': '-3.07', 'sei': '7.12'}",CHEMBL2016608,,CHEMBL2016608,5.58,0,http://www.openphacts.org/units/Nanomolar,1634033,=,1,1,=,,IC50,nM,,2662.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2662.0
,,10858711,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '12.70', 'le': '0.25', 'lle': '-0.67', 'sei': '15.61'}",CHEMBL2016607,,CHEMBL2016607,6.11,0,http://www.openphacts.org/units/Nanomolar,1634032,=,1,1,=,,IC50,nM,,776.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,776.0
,,10858712,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '20.46', 'le': '0.40', 'lle': '2.97', 'sei': '21.66'}",CHEMBL42,CLOZAPINE,CHEMBL42,6.69,0,http://www.openphacts.org/units/Nanomolar,1634031,=,1,1,=,,IC50,nM,,206.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,206.0
,,10858723,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016632,,CHEMBL2016632,,0,http://www.openphacts.org/units/Nanomolar,1634057,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858724,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '5.02', 'le': None, 'lle': None, 'sei': None}",CHEMBL2016631,,CHEMBL2016631,5.11,0,http://www.openphacts.org/units/Nanomolar,1634056,=,1,1,=,,IC50,nM,,7762.47,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.11
,,10858725,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '5.17', 'le': '0.10', 'lle': '-5.92', 'sei': '4.14'}",CHEMBL2016630,,CHEMBL2016630,4.97,0,http://www.openphacts.org/units/Nanomolar,1634055,=,1,1,=,,IC50,nM,,10715.19,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,4.97
,,10858726,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '6.38', 'le': '0.12', 'lle': '-4.15', 'sei': '4.97'}",CHEMBL2016629,,CHEMBL2016629,5.96,0,http://www.openphacts.org/units/Nanomolar,1634054,=,1,1,=,,IC50,nM,,1096.48,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.96
,,10858727,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '8.11', 'le': '0.16', 'lle': '-1.98', 'sei': '6.13'}",CHEMBL2016628,,CHEMBL2016628,7.35,0,http://www.openphacts.org/units/Nanomolar,1634053,=,1,1,=,,IC50,nM,,44.67,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.35
,,10858728,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '8.69', 'le': '0.17', 'lle': '-0.92', 'sei': '6.36'}",CHEMBL2016627,,CHEMBL2016627,7.63,0,http://www.openphacts.org/units/Nanomolar,1634052,=,1,1,=,,IC50,nM,,23.44,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.63
,,10858729,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '8.31', 'le': '0.16', 'lle': '-0.71', 'sei': '5.89'}",CHEMBL2016626,,CHEMBL2016626,7.06,0,http://www.openphacts.org/units/Nanomolar,1634051,=,1,1,=,,IC50,nM,,87.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.06
,,10858730,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '11.14', 'le': '0.22', 'lle': '-0.90', 'sei': '9.74'}",CHEMBL2016625,,CHEMBL2016625,5.84,0,http://www.openphacts.org/units/Nanomolar,1634050,=,1,1,=,,IC50,nM,,1445.44,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.84
,,10858731,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)OCCOC(=O)CCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '6.18', 'le': '0.12', 'lle': '-0.34', 'sei': '3.63'}",CHEMBL2016624,,CHEMBL2016624,5.62,0,http://www.openphacts.org/units/Nanomolar,1634049,=,1,1,=,,IC50,nM,,2398.83,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.62
,,10858732,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCC(=O)N3CCN(C(=O)CCCC(=O)N4CCN(C(=O)CCCC(=O)NN5c6ccc(Cl)cc6N=C(N6CCN(C)CC6)c6ccccc65)CC4)CC3)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '4.88', 'le': None, 'lle': None, 'sei': None}",CHEMBL2016623,,CHEMBL2016623,5.58,0,http://www.openphacts.org/units/Nanomolar,1634048,=,1,1,=,,IC50,nM,,2630.27,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.58
,,10858733,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)N3CCN(C(=O)CCC(=O)NN4c5ccc(Cl)cc5N=C(N5CCN(C)CC5)c5ccccc54)CC3)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '6.20', 'le': '0.12', 'lle': '0.25', 'sei': '4.05'}",CHEMBL2016622,,CHEMBL2016622,5.79,0,http://www.openphacts.org/units/Nanomolar,1634047,=,1,1,=,,IC50,nM,,1621.81,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.79
,,10858734,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016621,,CHEMBL2016621,,0,http://www.openphacts.org/units/Nanomolar,1634046,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858735,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016620,,CHEMBL2016620,,0,http://www.openphacts.org/units/Nanomolar,1634045,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858736,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016619,,CHEMBL2016619,,0,http://www.openphacts.org/units/Nanomolar,1634044,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858737,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016618,,CHEMBL2016618,,0,http://www.openphacts.org/units/Nanomolar,1634043,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858738,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016617,,CHEMBL2016617,,0,http://www.openphacts.org/units/Nanomolar,1634042,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858739,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '6.83', 'le': '0.13', 'lle': '-2.04', 'sei': '5.48'}",CHEMBL2016616,,CHEMBL2016616,5.61,0,http://www.openphacts.org/units/Nanomolar,1634041,=,1,1,=,,IC50,nM,,2454.71,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.61
,,10858740,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '7.17', 'le': '0.14', 'lle': '-1.18', 'sei': '5.56'}",CHEMBL2016615,,CHEMBL2016615,5.69,0,http://www.openphacts.org/units/Nanomolar,1634040,=,1,1,=,,IC50,nM,,2041.74,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.69
,,10858741,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '10.18', 'le': '0.20', 'lle': '-1.24', 'sei': '9.87'}",CHEMBL2016614,,CHEMBL2016614,5.05,0,http://www.openphacts.org/units/Nanomolar,1634039,=,1,1,=,,IC50,nM,,8912.51,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.05
,,10858742,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016613,,CHEMBL2016613,,0,http://www.openphacts.org/units/Nanomolar,1634038,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858743,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016612,,CHEMBL2016612,,0,http://www.openphacts.org/units/Nanomolar,1634037,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858744,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016611,,CHEMBL2016611,,0,http://www.openphacts.org/units/Nanomolar,1634036,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858745,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016610,,CHEMBL2016610,,0,http://www.openphacts.org/units/Nanomolar,1634035,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858746,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016609,,CHEMBL2016609,,0,http://www.openphacts.org/units/Nanomolar,1634034,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,10858747,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '7.26', 'le': '0.14', 'lle': '-2.89', 'sei': '7.34'}",CHEMBL2016608,,CHEMBL2016608,5.75,0,http://www.openphacts.org/units/Nanomolar,1634033,=,1,1,=,,IC50,nM,,1778.28,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.75
,,10858748,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '12.70', 'le': '0.25', 'lle': '-0.67', 'sei': '15.61'}",CHEMBL2016607,,CHEMBL2016607,6.11,0,http://www.openphacts.org/units/Nanomolar,1634032,=,1,1,=,,IC50,nM,,776.25,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.11
,,10858749,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '20.47', 'le': '0.40', 'lle': '2.97', 'sei': '21.67'}",CHEMBL42,CLOZAPINE,CHEMBL42,6.69,0,http://www.openphacts.org/units/Nanomolar,1634031,=,1,1,=,,IC50,nM,,204.17,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.69
,,10858750,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)N3CCN(C(=O)CCC(=O)NN4c5ccc(Cl)cc5N=C(N5CCN(C)CC5)c5ccccc54)CC3)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '6.20', 'le': '0.12', 'lle': '0.25', 'sei': '4.05'}",CHEMBL2016622,,CHEMBL2016622,5.79,0,http://www.openphacts.org/units/Nanomolar,1634047,=,1,1,=,,IC50,nM,,1617.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1617.0
,,10858751,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCC(=O)N3CCN(C(=O)CCCC(=O)N4CCN(C(=O)CCCC(=O)NN5c6ccc(Cl)cc6N=C(N6CCN(C)CC6)c6ccccc65)CC4)CC3)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '4.88', 'le': None, 'lle': None, 'sei': None}",CHEMBL2016623,,CHEMBL2016623,5.58,0,http://www.openphacts.org/units/Nanomolar,1634048,=,1,1,=,,IC50,nM,,2633.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2633.0
,,10858752,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)OCCOC(=O)CCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '6.17', 'le': '0.12', 'lle': '-0.34', 'sei': '3.63'}",CHEMBL2016624,,CHEMBL2016624,5.62,0,http://www.openphacts.org/units/Nanomolar,1634049,=,1,1,=,,IC50,nM,,2412.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2412.0
,,10858753,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '11.14', 'le': '0.22', 'lle': '-0.90', 'sei': '9.73'}",CHEMBL2016625,,CHEMBL2016625,5.84,0,http://www.openphacts.org/units/Nanomolar,1634050,=,1,1,=,,IC50,nM,,1455.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1455.0
,,10858754,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '8.31', 'le': '0.16', 'lle': '-0.71', 'sei': '5.89'}",CHEMBL2016626,,CHEMBL2016626,7.06,0,http://www.openphacts.org/units/Nanomolar,1634051,=,1,1,=,,IC50,nM,,87.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,87.0
,,10858755,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '8.70', 'le': '0.17', 'lle': '-0.91', 'sei': '6.37'}",CHEMBL2016627,,CHEMBL2016627,7.64,0,http://www.openphacts.org/units/Nanomolar,1634052,=,1,1,=,,IC50,nM,,23.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,23.0
,,10858756,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '8.12', 'le': '0.16', 'lle': '-1.97', 'sei': '6.13'}",CHEMBL2016628,,CHEMBL2016628,7.36,0,http://www.openphacts.org/units/Nanomolar,1634053,=,1,1,=,,IC50,nM,,44.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,44.0
,,10858757,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '6.37', 'le': '0.12', 'lle': '-4.16', 'sei': '4.96'}",CHEMBL2016629,,CHEMBL2016629,5.95,0,http://www.openphacts.org/units/Nanomolar,1634054,=,1,1,=,,IC50,nM,,1119.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1119.0
,,10858758,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '5.15', 'le': '0.10', 'lle': '-5.93', 'sei': '4.13'}",CHEMBL2016630,,CHEMBL2016630,4.96,0,http://www.openphacts.org/units/Nanomolar,1634055,=,1,1,=,,IC50,nM,,11000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11000.0
,,10858759,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,"{'bei': '5.02', 'le': None, 'lle': None, 'sei': None}",CHEMBL2016631,,CHEMBL2016631,5.11,0,http://www.openphacts.org/units/Nanomolar,1634056,=,1,1,=,,IC50,nM,,7800.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7800.0
,,10858760,[],CHEMBL2020816,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL2016514,J Med Chem,2012.0,,CHEMBL2016632,,CHEMBL2016632,,0,http://www.openphacts.org/units/Nanomolar,1634057,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,10959447,[],CHEMBL2060922,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,,,CHEMBL2057072,Bioorg Med Chem,2012.0,"{'bei': '22.49', 'le': '0.42', 'lle': '5.68', 'sei': '16.90'}",CHEMBL267930,SPIPERONE,CHEMBL267930,8.90,0,http://www.openphacts.org/units/Nanomolar,1655115,=,1,1,=,,IC50,nM,,1.27,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.27
,,10959448,[],CHEMBL2060922,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,,,CHEMBL2057072,Bioorg Med Chem,2012.0,"{'bei': '21.31', 'le': '0.40', 'lle': '4.21', 'sei': '11.22'}",CHEMBL487387,STEPHOLIDINE,CHEMBL487387,6.98,0,http://www.openphacts.org/units/Nanomolar,1655113,=,1,1,=,,IC50,nM,,105.41,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,105.41
,,10959449,[],CHEMBL2060922,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,,,CHEMBL2057072,Bioorg Med Chem,2012.0,"{'bei': '20.49', 'le': '0.38', 'lle': '2.67', 'sei': '19.39'}",CHEMBL2057457,,CHEMBL2057457,6.34,1,http://www.openphacts.org/units/Nanomolar,1655112,=,1,1,=,,IC50,nM,,456.13,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,456.13
,,10959450,[],CHEMBL2060922,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2,,,CHEMBL2057072,Bioorg Med Chem,2012.0,"{'bei': '16.93', 'le': '0.32', 'lle': '3.72', 'sei': '8.81'}",CHEMBL2057456,,CHEMBL2057456,6.29,0,http://www.openphacts.org/units/Nanomolar,1655111,=,1,1,=,,IC50,nM,,514.46,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,514.46
,,10959451,[],CHEMBL2060922,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,,,CHEMBL2057072,Bioorg Med Chem,2012.0,"{'bei': '19.46', 'le': '0.36', 'lle': '3.00', 'sei': '14.45'}",CHEMBL2057453,,CHEMBL2057453,6.06,0,http://www.openphacts.org/units/Nanomolar,1655108,=,1,1,=,,IC50,nM,,873.14,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,873.14
,,10959452,[],CHEMBL2060922,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,,,CHEMBL2057072,Bioorg Med Chem,2012.0,"{'bei': '18.36', 'le': '0.34', 'lle': '1.96', 'sei': '27.36'}",CHEMBL2057451,,CHEMBL2057451,5.94,1,http://www.openphacts.org/units/Nanomolar,1655106,=,1,1,=,,IC50,nM,,1155.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1155.3
,,12164984,[],CHEMBL2182829,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirol-induced mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCCCCN(CCc1ccccc1)CCc1cccc(O)c1,,,CHEMBL2177058,J Med Chem,2012.0,,CHEMBL2180641,,CHEMBL2180641,5.90,0,http://www.openphacts.org/units/Nanomolar,1753932,=,1,1,=,,IC50,nM,,1252.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1252.0
,,12164985,[],CHEMBL2182829,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirol-induced mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Oc1cccc(CCN(CCc2ccccc2)CC2CCC2)c1,,,CHEMBL2177058,J Med Chem,2012.0,,CHEMBL2180639,,CHEMBL2180639,5.78,0,http://www.openphacts.org/units/Nanomolar,1753930,=,1,1,=,,IC50,nM,,1647.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1647.0
,,12174025,[],CHEMBL2211561,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCCN1CCC(n2cnc3ccccc32)CC1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL2203152,J Med Chem,2012.0,,CHEMBL2207492,,CHEMBL2207492,,0,http://www.openphacts.org/units/Nanomolar,1761244,>,1,1,>,,IC50,nM,,580000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,580000.0
,,12652678,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)n1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326473,,CHEMBL2326473,5.36,0,http://www.openphacts.org/units/Nanomolar,1852954,=,1,1,=,,IC50,nM,,4400.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,4.4
,,12652679,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(CN2CCc3cc4nc(N)sc4cc3CC2)cn1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326472,,CHEMBL2326472,6.06,0,http://www.openphacts.org/units/Nanomolar,1852953,=,1,1,=,,IC50,nM,,870.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.87
,,12652680,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1ncon1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326471,,CHEMBL2326471,5.00,0,http://www.openphacts.org/units/Nanomolar,1852952,=,1,1,=,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,12652681,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1cnc[nH]1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326470,,CHEMBL2326470,5.82,0,http://www.openphacts.org/units/Nanomolar,1852951,=,1,1,=,,IC50,nM,,1500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.5
,,12652682,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1cscn1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326469,,CHEMBL2326469,5.92,0,http://www.openphacts.org/units/Nanomolar,1852950,=,1,1,=,,IC50,nM,,1200.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.2
,,12652683,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1cnco1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326468,,CHEMBL2326468,5.60,0,http://www.openphacts.org/units/Nanomolar,1852949,=,1,1,=,,IC50,nM,,2500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.5
,,12652684,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1ccncc1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326485,,CHEMBL2326485,5.35,0,http://www.openphacts.org/units/Nanomolar,1852966,=,1,1,=,,IC50,nM,,4500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,4.5
,,12652685,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1cccnc1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326484,,CHEMBL2326484,5.77,0,http://www.openphacts.org/units/Nanomolar,1852965,=,1,1,=,,IC50,nM,,1700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.7
,,12652686,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccn1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326483,,CHEMBL2326483,5.10,0,http://www.openphacts.org/units/Nanomolar,1852964,=,1,1,=,,IC50,nM,,8000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,8.0
,,12652687,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)c1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326482,,CHEMBL2326482,6.00,0,http://www.openphacts.org/units/Nanomolar,1852963,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.0
,,12652688,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)c1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326481,,CHEMBL2326481,6.52,0,http://www.openphacts.org/units/Nanomolar,1852962,=,1,1,=,,IC50,nM,,300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.3
,,12652689,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326480,,CHEMBL2326480,6.05,0,http://www.openphacts.org/units/Nanomolar,1852961,=,1,1,=,,IC50,nM,,900.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.9
,,12652690,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326479,,CHEMBL2326479,6.40,0,http://www.openphacts.org/units/Nanomolar,1852960,=,1,1,=,,IC50,nM,,400.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.4
,,12652691,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1cccc(F)c1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326478,,CHEMBL2326478,6.40,0,http://www.openphacts.org/units/Nanomolar,1852959,=,1,1,=,,IC50,nM,,400.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.4
,,12652692,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1ccc(F)cc1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326477,,CHEMBL2326477,6.22,0,http://www.openphacts.org/units/Nanomolar,1852958,=,1,1,=,,IC50,nM,,600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.6
,,12652693,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(Cc1ccccc1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326476,,CHEMBL2326476,5.54,0,http://www.openphacts.org/units/Nanomolar,1852957,=,1,1,=,,IC50,nM,,2900.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.9
,,12652694,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(C(=O)c1ccccc1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326475,,CHEMBL2326475,5.00,0,http://www.openphacts.org/units/Nanomolar,1852956,=,1,1,=,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,12652695,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(CCO)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326474,,CHEMBL2326474,5.00,0,http://www.openphacts.org/units/Nanomolar,1852955,=,1,1,=,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,12652696,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)CN1CCc2cc3nc(N)sc3cc2CC1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326492,,CHEMBL2326492,5.11,0,http://www.openphacts.org/units/Nanomolar,1852976,=,1,1,=,,IC50,nM,,7800.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,7.8
,,12652697,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(CC(F)(F)F)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326491,,CHEMBL2326491,4.52,0,http://www.openphacts.org/units/Nanomolar,1852975,=,1,1,=,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,30.0
,,12652698,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCN(C1CC1)CC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326490,,CHEMBL2326490,5.35,0,http://www.openphacts.org/units/Nanomolar,1852974,=,1,1,=,,IC50,nM,,4500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,4.5
,,12652699,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCN1CCc2cc3nc(N)sc3cc2CC1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326489,,CHEMBL2326489,4.72,0,http://www.openphacts.org/units/Nanomolar,1852973,=,1,1,=,,IC50,nM,,19000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,19.0
,,12652700,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cc3nc(N)sc3cc2CC1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326488,,CHEMBL2326488,5.85,0,http://www.openphacts.org/units/Nanomolar,1852972,=,1,1,=,,IC50,nM,,1400.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.4
,,12652701,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Nc1nc2cc3c(cc2s1)CCNCC3,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326487,,CHEMBL2326487,5.12,0,http://www.openphacts.org/units/Nanomolar,1852971,=,1,1,=,,IC50,nM,,7600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,7.6
,,12652702,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCN[C@H]1CCc2nc(N)sc2C1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL301265,PRAMIPEXOLE,CHEMBL301265,,0,http://www.openphacts.org/units/Nanomolar,1852970,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,12652703,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCN[C@@H]1Cc2cc3nc(N)sc3cc2C1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL2326486,,CHEMBL2326486,6.17,0,http://www.openphacts.org/units/Nanomolar,1852969,=,1,1,=,,IC50,nM,,670.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,670.0
,,12652704,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL218166,BIFEPRUNOX,CHEMBL218166,8.54,0,http://www.openphacts.org/units/Nanomolar,1852968,=,1,1,=,,IC50,nM,,2.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.9
,,12652705,[],CHEMBL2328744,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,,,CHEMBL2321835,Bioorg Med Chem Lett,2013.0,,CHEMBL1112,ARIPIPRAZOLE,CHEMBL1112,8.12,0,http://www.openphacts.org/units/Nanomolar,1852967,=,1,1,=,,IC50,nM,,7.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.6
,,12659408,[],CHEMBL2330406,Inhibition of dopamine receptor D2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1,,,CHEMBL2321744,J Med Chem,2013.0,"{'bei': '19.56', 'le': '0.38', 'lle': '4.96', 'sei': '11.63'}",CHEMBL245621,HALOPEMIDE,CHEMBL245621,8.15,0,http://www.openphacts.org/units/Nanomolar,1851800,=,1,1,=,,IC50,nM,,7.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.0
,,12698252,[],CHEMBL2342830,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,,,CHEMBL2331343,Bioorg Med Chem,2013.0,,CHEMBL448891,,CHEMBL448891,4.73,0,http://www.openphacts.org/units/Nanomolar,1869386,=,1,1,=,,IC50,nM,,18730.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,18.73
,,12698257,[],CHEMBL2342830,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,,,CHEMBL2331343,Bioorg Med Chem,2013.0,,CHEMBL1457510,,CHEMBL1457510,6.00,0,http://www.openphacts.org/units/Nanomolar,1869352,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.0
,,12698260,[],CHEMBL2342830,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL2331343,Bioorg Med Chem,2013.0,,CHEMBL54,HALOPERIDOL,CHEMBL54,6.26,0,http://www.openphacts.org/units/Nanomolar,1869370,=,1,1,=,,IC50,nM,,550.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.55
,Not Determined,12701189,[],CHEMBL2342830,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Oc1cc2c(cc1O)C(c1ccccc1)CNCC2,,,CHEMBL2331343,Bioorg Med Chem,2013.0,,CHEMBL286080,SKF-38393,CHEMBL286080,,0,,1869369,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,12701190,[],CHEMBL2342830,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,F,,,BAO_0000190,BAO_0000219,cell-based format,NCCc1c[nH]c2ccc(O)cc12,,,CHEMBL2331343,Bioorg Med Chem,2013.0,,CHEMBL39,SEROTONIN,CHEMBL39,,0,,1869368,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,12701191,[],CHEMBL2342830,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1,,,CHEMBL2331343,Bioorg Med Chem,2013.0,,CHEMBL13668,,CHEMBL13668,,0,,1869366,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,12707021,[],CHEMBL2346209,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)CCN1CC[C@@](O)(c3ccc(Cl)cc3)C[C@H]21,,,CHEMBL2331372,Bioorg Med Chem Lett,2013.0,,CHEMBL2335739,,CHEMBL2335739,,0,,1870446,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,12707022,[],CHEMBL2346209,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2,,,CHEMBL2331372,Bioorg Med Chem Lett,2013.0,,CHEMBL2335740,,CHEMBL2335740,,0,,1870447,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,12707028,[],CHEMBL2346209,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1)CCN1CC[C@](O)(c3ccc(Cl)cc3)C[C@H]21,,,CHEMBL2331372,Bioorg Med Chem Lett,2013.0,,CHEMBL2335738,,CHEMBL2335738,6.00,0,http://www.openphacts.org/units/Nanomolar,1870445,=,1,1,=,,IC50,nM,,1010.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1010.0
,,12707030,[],CHEMBL2346209,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,,,CHEMBL2331372,Bioorg Med Chem Lett,2013.0,,CHEMBL2335741,,CHEMBL2335741,6.42,0,http://www.openphacts.org/units/Nanomolar,1870448,=,1,1,=,,IC50,nM,,380.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,380.0
,,12707033,[],CHEMBL2346209,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2,,,CHEMBL2331372,Bioorg Med Chem Lett,2013.0,,CHEMBL2335737,,CHEMBL2335737,6.66,0,http://www.openphacts.org/units/Nanomolar,1870443,=,1,1,=,,IC50,nM,,220.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,220.0
,,12707035,[],CHEMBL2346209,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,F,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,,,CHEMBL2331372,Bioorg Med Chem Lett,2013.0,,CHEMBL2331599,,CHEMBL2331599,6.82,0,http://www.openphacts.org/units/Nanomolar,1870444,=,1,1,=,,IC50,nM,,150.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,150.0
,,12707057,[],CHEMBL2346209,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(OC(F)(F)F)cc3)CCN1CC2,,,CHEMBL2331372,Bioorg Med Chem Lett,2013.0,,CHEMBL2335736,,CHEMBL2335736,8.22,0,http://www.openphacts.org/units/Nanomolar,1870442,=,1,1,=,,IC50,nM,,6.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6.0
,,12720296,[],CHEMBL2352923,Displacement of [3H]raclopride from D2 receptor in human corpus striatum after 30 mins by scintillation counting,B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,,,CHEMBL2346662,Bioorg Med Chem Lett,2013.0,"{'bei': '25.60', 'le': '0.50', 'lle': '4.56', 'sei': '25.92'}",CHEMBL715,OLANZAPINE,CHEMBL715,8.00,0,http://www.openphacts.org/units/Nanomolar,1874851,=,1,1,=,,IC50,nM,,10.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10.0
,,13317546,[],CHEMBL2390217,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 assessed as inhibition of agonist-induced response incubated for 60 mins in incubator followed by 15 mins at room temperature by FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,,,CHEMBL2385071,J Med Chem,2013.0,"{'bei': '23.57', 'le': '0.48', 'lle': '5.58', 'sei': '31.80'}",CHEMBL567,PERPHENAZINE,CHEMBL567,9.52,0,http://www.openphacts.org/units/Nanomolar,1897843,=,1,1,=,,IC50,nM,,0.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.3
,,13317547,[],CHEMBL2390217,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 assessed as inhibition of agonist-induced response incubated for 60 mins in incubator followed by 15 mins at room temperature by FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(=O)oc2c(Cl)c(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12,,,CHEMBL2385071,J Med Chem,2013.0,"{'bei': '15.63', 'le': '0.30', 'lle': '1.51', 'sei': '11.03'}",CHEMBL2387229,,CHEMBL2387229,7.58,0,http://www.openphacts.org/units/Nanomolar,1897828,=,1,1,=,,IC50,nM,,26.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,26.3
,,13334286,[],CHEMBL2396124,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,B,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1.Cl,,,CHEMBL2390866,Eur J Med Chem,2013.0,"{'bei': '18.83', 'le': '0.34', 'lle': '3.28', 'sei': '11.49'}",CHEMBL2393246,,CHEMBL3040325,6.79,0,http://www.openphacts.org/units/Nanomolar,1901469,=,1,1,=,,IC50,nM,,162.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,162.8
,,13334289,[],CHEMBL2396124,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1,,,CHEMBL2390866,Eur J Med Chem,2013.0,"{'bei': '20.68', 'le': '0.37', 'lle': '3.33', 'sei': '13.71'}",CHEMBL2393243,,CHEMBL3040324,6.83,0,http://www.openphacts.org/units/Nanomolar,1901466,=,1,1,=,,IC50,nM,,146.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,146.7
,,13335060,[],CHEMBL2396124,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.Clc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1,,,CHEMBL2390866,Eur J Med Chem,2013.0,"{'bei': '19.37', 'le': '0.37', 'lle': '2.92', 'sei': '14.18'}",CHEMBL2393245,,CHEMBL3040361,7.07,0,http://www.openphacts.org/units/Nanomolar,1901468,=,1,1,=,,IC50,nM,,85.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,85.8
,,13335094,[],CHEMBL2396124,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,B,,,BAO_0000190,BAO_0000357,single protein format,Cl.Fc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1,,,CHEMBL2390866,Eur J Med Chem,2013.0,"{'bei': '20.66', 'le': '0.38', 'lle': '3.56', 'sei': '14.44'}",CHEMBL2393244,,CHEMBL3040288,7.20,0,http://www.openphacts.org/units/Nanomolar,1901467,=,1,1,=,,IC50,nM,,63.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,63.3
,,13336205,[],CHEMBL2395588,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,,,CHEMBL2390917,Bioorg Med Chem,2013.0,"{'bei': '24.49', 'le': '0.45', 'lle': '4.01', 'sei': '37.72'}",CHEMBL1255588,,CHEMBL1255588,8.85,0,http://www.openphacts.org/units/Nanomolar,1898828,=,1,1,=,,IC50,nM,,1.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.4
,,13340390,[],CHEMBL2395274,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells after 2 hrs,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,,,CHEMBL2390918,Bioorg Med Chem Lett,2013.0,"{'bei': '24.28', 'le': '0.45', 'lle': '6.38', 'sei': '18.24'}",CHEMBL267930,SPIPERONE,CHEMBL267930,9.60,0,http://www.openphacts.org/units/Nanomolar,1899744,=,1,1,=,,IC50,nM,,0.25,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.25
,,13342109,[],CHEMBL2395699,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,,,CHEMBL2390830,Eur J Med Chem,2013.0,"{'bei': '23.95', 'le': '0.44', 'lle': '3.82', 'sei': '36.89'}",CHEMBL1255588,,CHEMBL1255588,8.66,0,http://www.openphacts.org/units/Nanomolar,1900387,=,1,1,=,,IC50,nM,,2.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,10'-9M,UO_0000065,,2.2
,,13342175,[],CHEMBL2395897,Inhibition of human recombinant dopamine D2S receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCCCN2Cc3c(Cl)nc4ccccc4c3C2=O)CC1,,,CHEMBL2390830,Eur J Med Chem,2013.0,,CHEMBL2392351,,CHEMBL2392351,,0,http://www.openphacts.org/units/Nanomolar,1900370,>,1,1,>,,IC50,nM,,100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100.0
,,13342176,[],CHEMBL2395897,Inhibition of human recombinant dopamine D2S receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCCCN2Cc3ccc4ccccc4c3C2=O)CC1,,,CHEMBL2390830,Eur J Med Chem,2013.0,"{'bei': '19.06', 'le': '0.35', 'lle': '3.66', 'sei': '23.48'}",CHEMBL2392349,,CHEMBL2392349,8.46,0,http://www.openphacts.org/units/Nanomolar,1900368,=,1,1,=,,IC50,nM,,3.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.5
,,13828622,[],CHEMBL3090831,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,,,CHEMBL3085767,J Med Chem,2013.0,"{'bei': '24.61', 'le': '0.48', 'lle': '2.76', 'sei': '108.02'}",CHEMBL643,PROMETHAZINE,CHEMBL643,7.00,0,http://www.openphacts.org/units/Nanomolar,1950245,=,1,1,=,,IC50,nM,,100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.1
,,13828625,[],CHEMBL3090831,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,,CHEMBL3085767,J Med Chem,2013.0,"{'bei': '24.84', 'le': '0.52', 'lle': '3.03', 'sei': '122.23'}",CHEMBL71,CHLORPROMAZINE,CHEMBL71,7.92,0,http://www.openphacts.org/units/Nanomolar,1950244,=,1,1,=,,IC50,nM,,12.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.012
,,13828629,[],CHEMBL3090831,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,B,,,BAO_0000190,BAO_0000357,single protein format,CN(C)CCCN1c2ccccc2CCc2ccccc21,,,CHEMBL3085767,J Med Chem,2013.0,"{'bei': '22.78', 'le': '0.42', 'lle': '2.51', 'sei': '98.57'}",CHEMBL11,IMIPRAMINE,CHEMBL11,6.39,0,http://www.openphacts.org/units/Nanomolar,1950053,=,1,1,=,,IC50,nM,,410.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.41
,,13863459,[],CHEMBL3101864,Binding affinity to dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1,,,CHEMBL3098003,ACS Med Chem Lett,2013.0,,CHEMBL3099716,,CHEMBL3099716,,0,http://www.openphacts.org/units/Nanomolar,1956958,>,1,1,>,,IC50,nM,,48500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,48.5
,,13915675,[],CHEMBL3117738,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.NCCc1ccc(O)c(O)c1,,,CHEMBL3112461,J Med Chem,2014.0,"{'bei': '26.11', 'le': '0.50', 'lle': '3.40', 'sei': '6.02'}",CHEMBL1557,DOPAMINE HYDROCHLORIDE,CHEMBL59,4.00,0,http://www.openphacts.org/units/Nanomolar,1966714,=,1,1,=,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,10'-4M,UO_0000065,,1.0
,,13915676,[],CHEMBL3117739,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,Cl.NCCc1ccc(O)c(O)c1,,,CHEMBL3112461,J Med Chem,2014.0,"{'bei': '39.17', 'le': '0.74', 'lle': '5.40', 'sei': '9.03'}",CHEMBL1557,DOPAMINE HYDROCHLORIDE,CHEMBL59,6.00,0,http://www.openphacts.org/units/Nanomolar,1966714,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.0
,,13920837,[],CHEMBL3117964,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2oc(=O)c(CN3CCCC3)cc2c1,,,CHEMBL3112537,Eur J Med Chem,2014.0,,CHEMBL3113646,,CHEMBL3113646,,0,http://www.openphacts.org/units/Nanomolar,1964360,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30000.0
,,13920838,[],CHEMBL3117964,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Nc1ccc2oc(=O)c(CN3CCCC3)cc2c1,,,CHEMBL3112537,Eur J Med Chem,2014.0,"{'bei': '19.60', 'le': '0.36', 'lle': '2.82', 'sei': '8.05'}",CHEMBL3113644,,CHEMBL3113644,4.79,0,http://www.openphacts.org/units/Nanomolar,1964358,=,1,1,=,,IC50,nM,,16280.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,16280.0
,,13920839,[],CHEMBL3117964,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1oc2ccc(OC(F)(F)F)cc2cc1CN1CCCC1,,,CHEMBL3112537,Eur J Med Chem,2014.0,,CHEMBL3113643,,CHEMBL3113643,,0,http://www.openphacts.org/units/Nanomolar,1964357,>,1,1,>,,IC50,nM,,26000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,26000.0
,,13920840,[],CHEMBL3117964,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1oc2ccc(C(F)(F)F)cc2cc1CN1CCCC1,,,CHEMBL3112537,Eur J Med Chem,2014.0,,CHEMBL3113642,,CHEMBL3113642,,0,http://www.openphacts.org/units/Nanomolar,1964356,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30000.0
,,13920841,[],CHEMBL3117964,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=c1oc2ccc([N+](=O)[O-])cc2cc1CN1CCCC1,,,CHEMBL3112537,Eur J Med Chem,2014.0,,CHEMBL3113641,,CHEMBL3113641,,0,http://www.openphacts.org/units/Nanomolar,1964355,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30000.0
,,13920842,[],CHEMBL3117964,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCNCc1cc2ccccc2oc1=O,,,CHEMBL3112537,Eur J Med Chem,2014.0,,CHEMBL3113639,,CHEMBL3113639,,0,http://www.openphacts.org/units/Nanomolar,1964352,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30000.0
,,13965370,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '6.08', 'le': '0.11', 'lle': '-6.28', 'sei': '4.70'}",CHEMBL3134071,,CHEMBL3134071,5.81,0,http://www.openphacts.org/units/Nanomolar,1975970,=,1,1,=,,IC50,nM,,1550.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1550.0
,,13965371,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '6.01', 'le': '0.11', 'lle': '-5.74', 'sei': '4.51'}",CHEMBL3134070,,CHEMBL3134070,5.57,0,http://www.openphacts.org/units/Nanomolar,1975969,=,1,1,=,,IC50,nM,,2680.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2680.0
,Not Determined,13965372,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,,CHEMBL3134069,,CHEMBL3134069,,0,,1975968,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,13965373,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '7.99', 'le': '0.15', 'lle': '-2.23', 'sei': '5.45'}",CHEMBL3134068,,CHEMBL3134068,6.74,0,http://www.openphacts.org/units/Nanomolar,1975967,=,1,1,=,,IC50,nM,,183.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,183.0
,,13965374,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '7.20', 'le': '0.13', 'lle': '-2.32', 'sei': '4.75'}",CHEMBL3134067,,CHEMBL3134067,5.87,0,http://www.openphacts.org/units/Nanomolar,1975966,=,1,1,=,,IC50,nM,,1350.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1350.0
,,13965375,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '6.92', 'le': '0.13', 'lle': '-1.97', 'sei': '4.40'}",CHEMBL3134066,,CHEMBL3134066,5.44,0,http://www.openphacts.org/units/Nanomolar,1975965,=,1,1,=,,IC50,nM,,3600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3600.0
,,13965376,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '6.95', 'le': '0.13', 'lle': '-1.36', 'sei': '4.27'}",CHEMBL3134065,,CHEMBL3134065,5.27,0,http://www.openphacts.org/units/Nanomolar,1975964,=,1,1,=,,IC50,nM,,5320.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5320.0
,,13965377,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '7.33', 'le': '0.14', 'lle': '-0.49', 'sei': '4.34'}",CHEMBL3134064,,CHEMBL3134064,5.36,0,http://www.openphacts.org/units/Nanomolar,1975963,=,1,1,=,,IC50,nM,,4360.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4360.0
,,13965378,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCNC(=O)OC(C)(C)C)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '9.64', 'le': '0.18', 'lle': '0.07', 'sei': '5.18'}",CHEMBL3134063,,CHEMBL3134063,5.18,0,http://www.openphacts.org/units/Nanomolar,1975962,=,1,1,=,,IC50,nM,,6540.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6540.0
,,13965379,[],CHEMBL3136959,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,,CHEMBL3132795,Medchemcomm,2013.0,"{'bei': '25.93', 'le': '0.47', 'lle': '4.08', 'sei': '15.86'}",CHEMBL53,APOMORPHINE,CHEMBL53,6.93,0,http://www.openphacts.org/units/Nanomolar,1975959,=,1,1,=,,IC50,nM,,117.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,117.0
,,14734343,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '17.73', 'le': '0.36', 'lle': '3.09', 'sei': '17.74'}",CHEMBL1112,ARIPIPRAZOLE,CHEMBL1112,7.95,0,http://www.openphacts.org/units/Nanomolar,2114714,=,1,1,=,,IC50,nM,,11.22,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.95
,,14734344,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '20.54', 'le': '0.43', 'lle': '4.44', 'sei': '22.62'}",CHEMBL2028019,CARIPRAZINE,CHEMBL2028019,8.78,0,http://www.openphacts.org/units/Nanomolar,2114715,=,1,1,=,,IC50,nM,,1.66,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.78
,,14734345,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '14.40', 'le': '0.29', 'lle': '2.01', 'sei': '12.86'}",CHEMBL3287397,,CHEMBL3287397,6.44,0,http://www.openphacts.org/units/Nanomolar,2114723,=,1,1,=,,IC50,nM,,363.08,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.44
,,14734346,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '16.85', 'le': '0.34', 'lle': '3.11', 'sei': '15.06'}",CHEMBL3287402,,CHEMBL3287402,7.54,0,http://www.openphacts.org/units/Nanomolar,2114728,=,1,1,=,,IC50,nM,,28.84,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.54
,,14734347,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '18.21', 'le': '0.37', 'lle': '3.99', 'sei': '12.84'}",CHEMBL3287403,,CHEMBL3287403,8.42,0,http://www.openphacts.org/units/Nanomolar,2114730,=,1,1,=,,IC50,nM,,3.802,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.42
,,14734348,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '24.34', 'le': '0.48', 'lle': '4.72', 'sei': '22.57'}",CHEMBL54,HALOPERIDOL,CHEMBL54,9.15,0,http://www.openphacts.org/units/Nanomolar,2114735,=,1,1,=,,IC50,nM,,0.7079,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,9.15
,,14734349,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '17.75', 'le': '0.36', 'lle': '3.10', 'sei': '17.76'}",CHEMBL1112,ARIPIPRAZOLE,CHEMBL1112,7.96,0,http://www.openphacts.org/units/Nanomolar,2114714,=,1,1,=,,IC50,nM,,11.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11.0
,,14734350,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '20.52', 'le': '0.43', 'lle': '4.43', 'sei': '22.59'}",CHEMBL2028019,CARIPRAZINE,CHEMBL2028019,8.77,0,http://www.openphacts.org/units/Nanomolar,2114715,=,1,1,=,,IC50,nM,,1.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.7
,,14734351,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '14.40', 'le': '0.29', 'lle': '2.01', 'sei': '12.87'}",CHEMBL3287397,,CHEMBL3287397,6.44,0,http://www.openphacts.org/units/Nanomolar,2114723,=,1,1,=,,IC50,nM,,360.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,360.0
,,14734352,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '17.12', 'le': '0.35', 'lle': '3.23', 'sei': '15.29'}",CHEMBL3287402,,CHEMBL3287402,7.66,0,http://www.openphacts.org/units/Nanomolar,2114728,=,1,1,=,,IC50,nM,,22.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,22.0
,,14734353,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '18.21', 'le': '0.37', 'lle': '3.99', 'sei': '12.84'}",CHEMBL3287403,,CHEMBL3287403,8.42,0,http://www.openphacts.org/units/Nanomolar,2114730,=,1,1,=,,IC50,nM,,3.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.8
,,14734354,[],CHEMBL3293231,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL3286313,J Med Chem,2014.0,"{'bei': '24.36', 'le': '0.48', 'lle': '4.72', 'sei': '22.58'}",CHEMBL54,HALOPERIDOL,CHEMBL54,9.15,0,http://www.openphacts.org/units/Nanomolar,2114735,=,1,1,=,,IC50,nM,,0.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.7
,,14738674,[],CHEMBL3295410,Antagonist activity at human recombinant at D2S receptor assessed as inhibition of dopamine-induced cAMP accumulation,F,,,BAO_0000190,BAO_0000019,assay format,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,,,CHEMBL3286108,J Med Chem,2014.0,,CHEMBL8514,BUTACLAMOL,CHEMBL8514,8.30,0,http://www.openphacts.org/units/Nanomolar,2117908,=,1,1,=,,IC50,nM,,5.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.0
,,14741975,[],CHEMBL3294209,Inhibition of D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCc1ccccc1NC(=O)N1C[C@@H](C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,,,CHEMBL3286266,ACS Med Chem Lett,2014.0,,CHEMBL3287898,,CHEMBL3287898,,0,http://www.openphacts.org/units/Nanomolar,2115332,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,14755262,[],CHEMBL3300164,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCNCC1,,,CHEMBL3297649,J Med Chem,2014.0,,CHEMBL9666,,CHEMBL9666,,0,http://www.openphacts.org/units/Nanomolar,2121438,>,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1000.0
,,14755263,[],CHEMBL3300164,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCNC(=O)OC(C)(C)C)CC1,,,CHEMBL3297649,J Med Chem,2014.0,"{'bei': '20.96', 'le': '0.40', 'lle': '4.69', 'sei': '13.01'}",CHEMBL3299093,,CHEMBL3299093,7.03,0,http://www.openphacts.org/units/Nanomolar,2121439,=,1,1,=,,IC50,nM,,93.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,93.3
,,14755264,[],CHEMBL3300164,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCCCCNC(=O)OC(C)(C)C)CC1,,,CHEMBL3297649,J Med Chem,2014.0,"{'bei': '21.45', 'le': '0.41', 'lle': '4.50', 'sei': '15.54'}",CHEMBL3299097,,CHEMBL3299097,8.40,0,http://www.openphacts.org/units/Nanomolar,2121443,=,1,1,=,,IC50,nM,,3.98,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.98
,,14755265,[],CHEMBL3300164,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCNCC1,,,CHEMBL3297649,J Med Chem,2014.0,,CHEMBL9666,,CHEMBL9666,,0,http://www.openphacts.org/units/Nanomolar,2121438,<,1,1,>,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.0
,,14755266,[],CHEMBL3300164,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCNC(=O)OC(C)(C)C)CC1,,,CHEMBL3297649,J Med Chem,2014.0,"{'bei': '20.96', 'le': '0.40', 'lle': '4.69', 'sei': '13.01'}",CHEMBL3299093,,CHEMBL3299093,7.03,0,http://www.openphacts.org/units/Nanomolar,2121439,=,1,1,=,,IC50,nM,,93.33,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.03
,,14755267,[],CHEMBL3300164,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCCCCNC(=O)OC(C)(C)C)CC1,,,CHEMBL3297649,J Med Chem,2014.0,"{'bei': '21.45', 'le': '0.41', 'lle': '4.50', 'sei': '15.54'}",CHEMBL3299097,,CHEMBL3299097,8.40,0,http://www.openphacts.org/units/Nanomolar,2121443,=,1,1,=,,IC50,nM,,3.981,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.4
,,14988034,[],CHEMBL3379090,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,O=C(NCCN1CCC(n2c(=O)[nH]c3ccccc32)C(F)C1)c1ccc(F)c(F)c1,,,CHEMBL3352006,Bioorg Med Chem Lett,2014.0,,CHEMBL3357315,,CHEMBL3357315,,0,http://www.openphacts.org/units/Nanomolar,2258782,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,14996152,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '18.61', 'le': '0.35', 'lle': '4.91', 'sei': '12.21'}",CHEMBL3322993,,CHEMBL3322993,7.58,0,http://www.openphacts.org/units/Nanomolar,2263896,=,1,1,=,,IC50,nM,,26.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,26.0
,,14996153,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '16.26', 'le': '0.33', 'lle': '3.29', 'sei': '13.73'}",CHEMBL3322994,,CHEMBL3322994,7.26,0,http://www.openphacts.org/units/Nanomolar,2263897,=,1,1,=,,IC50,nM,,55.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,55.0
,Not Determined,14996154,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,,,CHEMBL3351252,J Med Chem,2014.0,,CHEMBL3322998,,CHEMBL3322998,,0,,2265976,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Determined,14996155,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1,,,CHEMBL3351252,J Med Chem,2014.0,,CHEMBL3323003,,CHEMBL3323003,,0,,2265981,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,14996156,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '11.20', 'le': '0.21', 'lle': '1.87', 'sei': '7.17'}",CHEMBL3323011,,CHEMBL3323011,5.64,0,http://www.openphacts.org/units/Nanomolar,2265989,=,1,1,=,,IC50,nM,,2300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2300.0
,,14996157,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3nc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '12.53', 'le': '0.24', 'lle': '2.31', 'sei': '7.01'}",CHEMBL3323013,,CHEMBL3323013,6.31,0,http://www.openphacts.org/units/Nanomolar,2265991,=,1,1,=,,IC50,nM,,490.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,490.0
,,14996158,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '13.26', 'le': '0.25', 'lle': '3.52', 'sei': '7.31'}",CHEMBL3323015,,CHEMBL3323015,6.69,0,http://www.openphacts.org/units/Nanomolar,2265993,=,1,1,=,,IC50,nM,,205.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,205.0
,,14996159,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '12.64', 'le': '0.24', 'lle': '3.21', 'sei': '6.97'}",CHEMBL3323016,,CHEMBL3323016,6.38,0,http://www.openphacts.org/units/Nanomolar,2265994,=,1,1,=,,IC50,nM,,420.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,420.0
,,14996160,[],CHEMBL3379904,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '11.01', 'le': '0.22', 'lle': '2.12', 'sei': '6.48'}",CHEMBL3323017,,CHEMBL3323017,5.94,0,http://www.openphacts.org/units/Nanomolar,2265995,=,1,1,=,,IC50,nM,,1160.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1160.0
,,14996267,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '20.07', 'le': '0.37', 'lle': '5.50', 'sei': '13.17'}",CHEMBL3322993,,CHEMBL3322993,8.18,0,http://www.openphacts.org/units/Nanomolar,2263896,=,1,1,=,,IC50,nM,,6.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6.6
,,14996268,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '15.77', 'le': '0.32', 'lle': '3.07', 'sei': '13.31'}",CHEMBL3322994,,CHEMBL3322994,7.04,0,http://www.openphacts.org/units/Nanomolar,2263897,=,1,1,=,,IC50,nM,,91.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,91.0
,,14996269,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cn2ccccc2n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '16.21', 'le': '0.31', 'lle': '3.53', 'sei': '13.66'}",CHEMBL3322995,,CHEMBL3322995,7.22,0,http://www.openphacts.org/units/Nanomolar,2265973,=,1,1,=,,IC50,nM,,60.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,60.0
,,14996270,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '15.85', 'le': '0.29', 'lle': '3.58', 'sei': '10.33'}",CHEMBL3322998,,CHEMBL3322998,6.79,0,http://www.openphacts.org/units/Nanomolar,2265976,=,1,1,=,,IC50,nM,,161.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,161.0
,,14996271,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '15.38', 'le': '0.28', 'lle': '4.00', 'sei': '8.40'}",CHEMBL3323003,,CHEMBL3323003,6.61,0,http://www.openphacts.org/units/Nanomolar,2265981,=,1,1,=,,IC50,nM,,248.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,248.0
,,14996272,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '13.07', 'le': '0.25', 'lle': '2.81', 'sei': '8.37'}",CHEMBL3323011,,CHEMBL3323011,6.58,0,http://www.openphacts.org/units/Nanomolar,2265989,=,1,1,=,,IC50,nM,,261.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,261.0
,,14996273,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '12.69', 'le': '0.24', 'lle': '1.77', 'sei': '8.27'}",CHEMBL3323012,,CHEMBL3323012,6.38,0,http://www.openphacts.org/units/Nanomolar,2265990,=,1,1,=,,IC50,nM,,418.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,418.0
,,14996274,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3nc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '12.95', 'le': '0.25', 'lle': '2.52', 'sei': '7.24'}",CHEMBL3323013,,CHEMBL3323013,6.52,0,http://www.openphacts.org/units/Nanomolar,2265991,=,1,1,=,,IC50,nM,,301.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,301.0
,,14996275,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '14.73', 'le': '0.28', 'lle': '4.26', 'sei': '8.12'}",CHEMBL3323015,,CHEMBL3323015,7.43,0,http://www.openphacts.org/units/Nanomolar,2265993,=,1,1,=,,IC50,nM,,37.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,37.0
,,14996276,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '14.49', 'le': '0.28', 'lle': '4.14', 'sei': '7.98'}",CHEMBL3323016,,CHEMBL3323016,7.31,0,http://www.openphacts.org/units/Nanomolar,2265994,=,1,1,=,,IC50,nM,,49.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,49.0
,,14996277,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '14.21', 'le': '0.28', 'lle': '3.84', 'sei': '8.36'}",CHEMBL3323017,,CHEMBL3323017,7.66,0,http://www.openphacts.org/units/Nanomolar,2265995,=,1,1,=,,IC50,nM,,22.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,22.0
,,14996278,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)[nH]c2ccccc12,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '11.63', 'le': '0.22', 'lle': '1.84', 'sei': '8.09'}",CHEMBL3323019,,CHEMBL3323019,6.51,0,http://www.openphacts.org/units/Nanomolar,2265997,=,1,1,=,,IC50,nM,,311.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,311.0
,,14996279,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '11.88', 'le': '0.23', 'lle': '2.83', 'sei': '8.14'}",CHEMBL3323112,,CHEMBL3323112,6.66,0,http://www.openphacts.org/units/Nanomolar,2265998,=,1,1,=,,IC50,nM,,217.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,217.0
,,14996280,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '11.68', 'le': '0.22', 'lle': '2.72', 'sei': '8.00'}",CHEMBL3323114,,CHEMBL3323114,6.55,0,http://www.openphacts.org/units/Nanomolar,2266000,=,1,1,=,,IC50,nM,,281.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,281.0
,,14996281,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)[C@H]3CC[C@H](c4ccccc4)CC3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,,CHEMBL3323117,,CHEMBL3323117,,0,http://www.openphacts.org/units/Nanomolar,2266003,>,1,1,>,,IC50,nM,,500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,500.0
,,14996282,[],CHEMBL3372144,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL3351252,J Med Chem,2014.0,"{'bei': '26.06', 'le': '0.51', 'lle': '5.37', 'sei': '24.16'}",CHEMBL54,HALOPERIDOL,CHEMBL54,9.80,1,http://www.openphacts.org/units/Nanomolar,2266004,=,1,1,=,,IC50,nM,,0.16,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.16
,,14996314,[],CHEMBL3372150,Antagonist activity against human D2LR expressed in CHO cells assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by dopamine potency shift assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,,,CHEMBL3351252,J Med Chem,2014.0,,CHEMBL3322994,,CHEMBL3322994,8.96,0,http://www.openphacts.org/units/Nanomolar,2263897,=,1,1,=,,IC50,nM,,1.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.1
,,14996315,[],CHEMBL3372150,Antagonist activity against human D2LR expressed in CHO cells assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by dopamine potency shift assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,,CHEMBL3323011,,CHEMBL3323011,6.96,0,http://www.openphacts.org/units/Nanomolar,2265989,=,1,1,=,,IC50,nM,,111.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,111.0
,,14996316,[],CHEMBL3372150,Antagonist activity against human D2LR expressed in CHO cells assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by dopamine potency shift assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,,CHEMBL3323016,,CHEMBL3323016,7.60,0,http://www.openphacts.org/units/Nanomolar,2265994,=,1,1,=,,IC50,nM,,25.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,25.0
,Not Determined,15000400,[],CHEMBL3372150,Antagonist activity against human D2LR expressed in CHO cells assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by dopamine potency shift assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)[C@H]3CC[C@H](c4ccccc4)CC3)CC2)cc(C(F)(F)F)n1,,,CHEMBL3351252,J Med Chem,2014.0,,CHEMBL3323117,,CHEMBL3323117,,0,,2266003,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,15040050,[],CHEMBL3362291,Antagonist activity at human dopamine D2 receptor by GTPgS SPA/summary (Abse5) assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1,,,CHEMBL3351646,Bioorg Med Chem Lett,2014.0,,CHEMBL3311308,,CHEMBL3311308,,0,http://www.openphacts.org/units/Nanomolar,2252753,<,1,1,>,,IC50,nM,,31622.78,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,4.5
,,15040055,[],CHEMBL3362290,Antagonist activity at human dopamine D2 receptor by GTPgS SPA assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1,,,CHEMBL3351646,Bioorg Med Chem Lett,2014.0,,CHEMBL3311308,,CHEMBL3311308,,0,http://www.openphacts.org/units/Nanomolar,2252753,<,1,1,>,,IC50,nM,,30199.52,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,4.52
,,15078471,[],CHEMBL3387745,Antagonist activity at D2 receptor (unknown origin) after 40 mins by [35S]GTP-gammaS binding assay in presence of quinpirole,F,,,BAO_0000190,BAO_0000019,assay format,CCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,,,CHEMBL3351714,Bioorg Med Chem,2014.0,,CHEMBL3344458,,CHEMBL3344458,6.04,0,http://www.openphacts.org/units/Nanomolar,2243497,=,1,1,=,,IC50,nM,,910.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.91
,,15078472,[],CHEMBL3387745,Antagonist activity at D2 receptor (unknown origin) after 40 mins by [35S]GTP-gammaS binding assay in presence of quinpirole,F,,,BAO_0000190,BAO_0000019,assay format,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)C)cc3CN1CC2,,,CHEMBL3351714,Bioorg Med Chem,2014.0,,CHEMBL3344459,,CHEMBL3344459,6.80,0,http://www.openphacts.org/units/Nanomolar,2243498,=,1,1,=,,IC50,nM,,160.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.16
,,15078473,[],CHEMBL3387745,Antagonist activity at D2 receptor (unknown origin) after 40 mins by [35S]GTP-gammaS binding assay in presence of quinpirole,F,,,BAO_0000190,BAO_0000019,assay format,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,,,CHEMBL3351714,Bioorg Med Chem,2014.0,,CHEMBL487387,STEPHOLIDINE,CHEMBL487387,5.36,0,http://www.openphacts.org/units/Nanomolar,2243510,=,1,1,=,,IC50,nM,,4380.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,4.38
,,15078474,[],CHEMBL3387745,Antagonist activity at D2 receptor (unknown origin) after 40 mins by [35S]GTP-gammaS binding assay in presence of quinpirole,F,,,BAO_0000190,BAO_0000019,assay format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL3351714,Bioorg Med Chem,2014.0,,CHEMBL54,HALOPERIDOL,CHEMBL54,6.39,0,http://www.openphacts.org/units/Nanomolar,2243512,=,1,1,=,,IC50,nM,,410.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.41
,,15119276,[],CHEMBL3383656,Inhibition of human dopamine D2L receptor,B,,,BAO_0000190,BAO_0000357,single protein format,COc1ccc(CN2CCOC(CCc3ccccc3)C2)cc1,,,CHEMBL3352711,ACS Med Chem Lett,2014.0,"{'bei': '15.36', 'le': '0.28', 'lle': '1.25', 'sei': '22.04'}",CHEMBL3335539,,CHEMBL3335539,4.78,0,http://www.openphacts.org/units/Nanomolar,2251543,=,1,1,=,,IC50,nM,,16500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,16.5
,,15119278,[],CHEMBL3383656,Inhibition of human dopamine D2L receptor,B,,,BAO_0000190,BAO_0000357,single protein format,Oc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1,,,CHEMBL3352711,ACS Med Chem Lett,2014.0,"{'bei': '16.08', 'le': '0.30', 'lle': '1.55', 'sei': '14.63'}",CHEMBL3335555,,CHEMBL3335555,4.78,0,http://www.openphacts.org/units/Nanomolar,2251559,=,1,1,=,,IC50,nM,,16500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,16.5
,,15119308,[],CHEMBL3383110,Inhibition of human dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CCC2CN(Cc3nc4ccccc4[nH]3)CCO2)cc1,,,CHEMBL3352711,ACS Med Chem Lett,2014.0,,CHEMBL3335535,,CHEMBL3335535,,0,http://www.openphacts.org/units/Nanomolar,2251539,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,100.0
,,15119309,[],CHEMBL3383110,Inhibition of human dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CC[C@H]2CN(Cc3nc4ccccc4[nH]3)CCO2)cc1,,,CHEMBL3352711,ACS Med Chem Lett,2014.0,,CHEMBL3335536,,CHEMBL3335536,,0,http://www.openphacts.org/units/Nanomolar,2251540,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,100.0
,,15119310,[],CHEMBL3383110,Inhibition of human dopamine D2 receptor,B,,,BAO_0000190,BAO_0000357,single protein format,c1ccc(CC[C@@H]2CN(Cc3nc4ccccc4[nH]3)CCO2)cc1,,,CHEMBL3352711,ACS Med Chem Lett,2014.0,,CHEMBL3335537,,CHEMBL3335537,,0,http://www.openphacts.org/units/Nanomolar,2251541,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,100.0
,,15186915,[],CHEMBL3414320,Antagonist activity against human recombinant dopmaine D2L receptor expressed in CHOK1 cells assessed as reduction in apomorphine-induced increase in intracellular Ca2+ levels by aequorin based radiometric and luminescence plate counting method,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,,CHEMBL3407464,Eur J Med Chem,2015.0,,CHEMBL71,CHLORPROMAZINE,CHEMBL71,9.00,0,http://www.openphacts.org/units/Nanomolar,2287756,=,1,1,=,,IC50,nM,,1.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.0
,,15187892,[],CHEMBL3413551,Antagonist activity at human dopamine D2 receptor expressed in CHOK1 cells assessed as inhibition of apomorphine-induced calcium mobilization by radiometric and luminescence plate counting method,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,,CHEMBL3407464,Eur J Med Chem,2015.0,,CHEMBL71,CHLORPROMAZINE,CHEMBL71,9.00,0,http://www.openphacts.org/units/Nanomolar,2287756,=,1,1,=,,IC50,nM,,1.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.0
,,15187893,[],CHEMBL3413550,Agonist activity at human dopamine D2 receptor expressed in CHOK1 cells assessed as calcium mobilization by radiometric and luminescence plate counting method,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,,,CHEMBL3407464,Eur J Med Chem,2015.0,,CHEMBL53,APOMORPHINE,CHEMBL53,8.38,0,http://www.openphacts.org/units/Nanomolar,2287755,=,1,1,=,,IC50,nM,,4.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.2
,inactive,15473004,[],CHEMBL3561985,"PubChem BioAssay. Counterscreening of D4 Antagonists against Dopamine 2L (Human), Confirmatory Assay.   (Class of assay: confirmatory) ",F,,,BAO_0000190,BAO_0000019,assay format,Clc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1,,,CHEMBL1201862,,,,CHEMBL3335556,,CHEMBL3335556,,0,http://www.openphacts.org/units/Nanomolar,2475804,,7,1,,,IC50,nM,,20000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,20.0
,active,15473005,[],CHEMBL3561985,"PubChem BioAssay. Counterscreening of D4 Antagonists against Dopamine 2L (Human), Confirmatory Assay.   (Class of assay: confirmatory) ",F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(CN2CCO[C@@H](CCc3ccccc3)C2)cc1,,,CHEMBL1201862,,,,CHEMBL3561555,,CHEMBL3561555,,0,http://www.openphacts.org/units/Nanomolar,2476834,,7,1,,,IC50,nM,,16500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,16.5
,inactive,15527085,[],CHEMBL3562090,"PubChem BioAssay. Counterscreening of D4 Antagonists against Dopamine 2S (Human), Confirmatory Assay.   (Class of assay: confirmatory) ",F,,,BAO_0000190,BAO_0000019,assay format,Clc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1,,,CHEMBL1201862,,,,CHEMBL3335556,,CHEMBL3335556,,0,http://www.openphacts.org/units/Nanomolar,2475804,,7,1,,,IC50,nM,,20000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,20.0
,inactive,15527086,[],CHEMBL3562090,"PubChem BioAssay. Counterscreening of D4 Antagonists against Dopamine 2S (Human), Confirmatory Assay.   (Class of assay: confirmatory) ",F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc(CN2CCO[C@@H](CCc3ccccc3)C2)cc1,,,CHEMBL1201862,,,,CHEMBL3561555,,CHEMBL3561555,,0,http://www.openphacts.org/units/Nanomolar,2476834,,7,1,,,IC50,nM,,20000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,20.0
,,15657946,[],CHEMBL3599945,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,,,CHEMBL3596172,J Med Chem,2015.0,"{'bei': '11.61', 'le': '0.24', 'lle': '1.58', 'sei': '7.48'}",CHEMBL1627305,,CHEMBL1627305,5.36,0,http://www.openphacts.org/units/Nanomolar,2491002,=,1,1,=,,IC50,nM,,4400.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4400.0
,,15657947,[],CHEMBL3599945,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1,,,CHEMBL3596172,J Med Chem,2015.0,"{'bei': '16.55', 'le': '0.30', 'lle': '2.41', 'sei': '13.74'}",CHEMBL3597643,,CHEMBL3597643,7.06,0,http://www.openphacts.org/units/Nanomolar,2491005,=,1,1,=,,IC50,nM,,87.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,87.0
,,15657948,[],CHEMBL3599945,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(F)ccc2[nH]1,,,CHEMBL3596172,J Med Chem,2015.0,"{'bei': '13.48', 'le': '0.28', 'lle': '1.30', 'sei': '12.16'}",CHEMBL68740,,CHEMBL68740,6.25,0,http://www.openphacts.org/units/Nanomolar,2491009,=,1,1,=,,IC50,nM,,564.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,564.4
,Not Determined,15657949,[],CHEMBL3599945,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccccc3c2)CC1,,,CHEMBL3596172,J Med Chem,2015.0,,CHEMBL3597649,,CHEMBL3597649,,0,,2491015,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,15657950,[],CHEMBL3599945,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,,,CHEMBL3596172,J Med Chem,2015.0,"{'bei': '17.19', 'le': '0.31', 'lle': '2.82', 'sei': '15.55'}",CHEMBL3597635,,CHEMBL3597635,7.54,0,http://www.openphacts.org/units/Nanomolar,2490994,=,1,1,=,,IC50,nM,,29.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,29.0
,,15657951,[],CHEMBL3599945,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(NCCC(O)CN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,,,CHEMBL3596172,J Med Chem,2015.0,"{'bei': '13.51', 'le': '0.25', 'lle': '2.45', 'sei': '8.94'}",CHEMBL3597636,,CHEMBL3597636,6.14,0,http://www.openphacts.org/units/Nanomolar,2490995,=,1,1,=,,IC50,nM,,720.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,720.0
,,15657952,[],CHEMBL3599945,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cnc3ccccc3c2)CC1,,,CHEMBL3596172,J Med Chem,2015.0,"{'bei': '15.90', 'le': '0.31', 'lle': '2.97', 'sei': '12.48'}",CHEMBL3597637,,CHEMBL3597637,7.20,0,http://www.openphacts.org/units/Nanomolar,2490996,=,1,1,=,,IC50,nM,,63.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,63.0
,,15745912,[],CHEMBL3624486,Inhibition of recombinant D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,,,CHEMBL3621142,J Med Chem,2015.0,"{'bei': '13.26', 'le': '0.26', 'lle': '1.79', 'sei': '7.64'}",CHEMBL3623290,AZD-3759,CHEMBL3623290,6.10,0,http://www.openphacts.org/units/Nanomolar,2505818,=,1,1,=,,IC50,nM,,797.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,797.0
,,16387419,[],CHEMBL3738649,Antagonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as dopamine-induced cAMP by HTRF assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)NCC(O)COc1cccc2ccccc12,,,CHEMBL3734721,J Med Chem,2015.0,,CHEMBL27,PROPRANOLOL,CHEMBL27,,0,http://www.openphacts.org/units/Nanomolar,2735487,<,1,1,>,,IC50,nM,,5011.87,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.3
,,16387420,[],CHEMBL3738649,Antagonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as dopamine-induced cAMP by HTRF assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CB1C=Cc2cccc(OCC(O)CN(C)C)c2N1,,,CHEMBL3734721,J Med Chem,2015.0,,CHEMBL3736433,,CHEMBL3736433,,0,http://www.openphacts.org/units/Nanomolar,2735488,<,1,1,>,,IC50,nM,,5011.87,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.3
,,16387421,[],CHEMBL3738649,Antagonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as dopamine-induced cAMP by HTRF assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CB1C=Cc2c(cccc2OCC(O)CN(C)C)N1,,,CHEMBL3734721,J Med Chem,2015.0,,CHEMBL3736156,,CHEMBL3736156,,0,http://www.openphacts.org/units/Nanomolar,2735489,<,1,1,>,,IC50,nM,,5011.87,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.3
,,16501827,[],CHEMBL3779713,Displacement of [3H]methylspiperone from human recombinant Dopamine D2S receptor expressed in HEK293 cells,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,,,CHEMBL3774372,Bioorg Med Chem,2016.0,"{'bei': '24.78', 'le': '0.45', 'lle': '4.12', 'sei': '38.17'}",CHEMBL8514,BUTACLAMOL,CHEMBL8514,8.96,0,http://www.openphacts.org/units/Nanomolar,2762827,=,1,1,=,,IC50,nM,,1.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.1
,,16587937,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805518,,CHEMBL3805518,7.64,0,http://www.openphacts.org/units/Nanomolar,2776859,=,1,1,=,,IC50,nM,,23.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,23.0
,,16587953,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805559,,CHEMBL3805559,8.07,0,http://www.openphacts.org/units/Nanomolar,2776858,=,1,1,=,,IC50,nM,,8.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8.5
,,16587956,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805376,,CHEMBL3805376,7.16,0,http://www.openphacts.org/units/Nanomolar,2776857,=,1,1,=,,IC50,nM,,70.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,70.0
,,16587959,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccccc1OCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3804954,,CHEMBL3804954,6.78,0,http://www.openphacts.org/units/Nanomolar,2776856,=,1,1,=,,IC50,nM,,167.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,167.0
,,16587962,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CC(=O)Nc1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805600,,CHEMBL3805600,7.01,0,http://www.openphacts.org/units/Nanomolar,2776710,=,1,1,=,,IC50,nM,,98.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,98.4
,,16587973,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL1112,ARIPIPRAZOLE,CHEMBL1112,7.76,0,http://www.openphacts.org/units/Nanomolar,2776709,=,1,1,=,,IC50,nM,,17.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,17.2
,,16587983,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(OCCCCN2CCN(c3nsc4ccccc34)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805860,,CHEMBL3805860,8.00,0,http://www.openphacts.org/units/Nanomolar,2776860,=,1,1,=,,IC50,nM,,10.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10.0
,,16587986,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccc1F,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805099,,CHEMBL3805099,7.92,0,http://www.openphacts.org/units/Nanomolar,2776861,=,1,1,=,,IC50,nM,,12.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,12.0
,,16587991,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4sccc34)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805704,,CHEMBL3805704,7.04,0,http://www.openphacts.org/units/Nanomolar,2776862,=,1,1,=,,IC50,nM,,91.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,91.0
,,16587994,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccc1F,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805649,,CHEMBL3805649,7.37,0,http://www.openphacts.org/units/Nanomolar,2776863,=,1,1,=,,IC50,nM,,43.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,43.0
,,16587999,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4c3OC(F)(F)O4)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805165,,CHEMBL3805165,8.39,0,http://www.openphacts.org/units/Nanomolar,2776864,=,1,1,=,,IC50,nM,,4.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.1
,,16588002,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4c3OC(F)(F)O4)CC2)ccc1F,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3804965,,CHEMBL3804965,7.52,0,http://www.openphacts.org/units/Nanomolar,2776865,=,1,1,=,,IC50,nM,,30.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30.0
,,16588005,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805077,,CHEMBL3805077,7.50,0,http://www.openphacts.org/units/Nanomolar,2776711,=,1,1,=,,IC50,nM,,32.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,32.0
,,16588008,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,NC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3806169,,CHEMBL3806169,7.26,0,http://www.openphacts.org/units/Nanomolar,2776712,=,1,1,=,,IC50,nM,,55.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,55.0
,,16588011,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CCNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805772,,CHEMBL3805772,6.94,0,http://www.openphacts.org/units/Nanomolar,2776713,=,1,1,=,,IC50,nM,,116.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,116.0
,,16588014,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CCCCCNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805826,,CHEMBL3805826,7.78,0,http://www.openphacts.org/units/Nanomolar,2776714,=,1,1,=,,IC50,nM,,16.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,16.8
,,16588314,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1C,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805120,,CHEMBL3805120,8.01,0,http://www.openphacts.org/units/Nanomolar,2776715,=,1,1,=,,IC50,nM,,9.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.8
,,16588317,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1F,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805884,,CHEMBL3805884,7.41,0,http://www.openphacts.org/units/Nanomolar,2776716,=,1,1,=,,IC50,nM,,39.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,39.4
,,16588320,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3806091,,CHEMBL3806091,5.44,0,http://www.openphacts.org/units/Nanomolar,2776717,=,1,1,=,,IC50,nM,,3600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3600.0
,,16588323,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccc(OC)c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3804943,,CHEMBL3804943,7.92,0,http://www.openphacts.org/units/Nanomolar,2776718,=,1,1,=,,IC50,nM,,12.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,12.0
,,16588326,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1Cl,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3806224,,CHEMBL3806224,7.46,0,http://www.openphacts.org/units/Nanomolar,2776719,=,1,1,=,,IC50,nM,,34.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,34.9
,,16588329,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(C)cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3806047,,CHEMBL3806047,7.05,0,http://www.openphacts.org/units/Nanomolar,2776720,=,1,1,=,,IC50,nM,,89.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,89.8
,,16588332,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(C(C)=O)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805434,,CHEMBL3805434,7.42,0,http://www.openphacts.org/units/Nanomolar,2776721,=,1,1,=,,IC50,nM,,37.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,37.7
,,16588335,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1ccc(Cl)c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805327,,CHEMBL3805327,7.23,0,http://www.openphacts.org/units/Nanomolar,2776722,=,1,1,=,,IC50,nM,,58.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,58.5
,,16588338,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cc(F)cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805262,,CHEMBL3805262,5.80,0,http://www.openphacts.org/units/Nanomolar,2776723,=,1,1,=,,IC50,nM,,1580.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1580.0
,,16588341,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1OC,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805515,,CHEMBL3805515,6.70,0,http://www.openphacts.org/units/Nanomolar,2776724,=,1,1,=,,IC50,nM,,202.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,202.0
,,16588344,[],CHEMBL3806800,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1F,,,CHEMBL3804825,Bioorg Med Chem Lett,2016.0,,CHEMBL3805046,,CHEMBL3805046,6.77,0,http://www.openphacts.org/units/Nanomolar,2776855,=,1,1,=,,IC50,nM,,171.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,171.0
,,16772093,[],CHEMBL3863997,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCCN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2,,,CHEMBL3862037,J Med Chem,2016.0,,CHEMBL11493,,CHEMBL11493,,0,http://www.openphacts.org/units/Nanomolar,2804090,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,16772094,[],CHEMBL3863997,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,Fc1ccc(C(SCCNCCCc2ccccc2)c2ccc(F)cc2)cc1,,,CHEMBL3862037,J Med Chem,2016.0,"{'bei': '14.34', 'le': '0.28', 'lle': '-0.31', 'sei': '47.37'}",CHEMBL3126735,,CHEMBL3126735,5.70,0,http://www.openphacts.org/units/Nanomolar,2804091,=,1,1,=,,IC50,nM,,2000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2000.0
,,16772095,[],CHEMBL3863997,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(O)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,,,CHEMBL3862037,J Med Chem,2016.0,,CHEMBL3916231,,CHEMBL3916231,,0,http://www.openphacts.org/units/Nanomolar,2804095,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,16772096,[],CHEMBL3863997,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(O)CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,,,CHEMBL3862037,J Med Chem,2016.0,,CHEMBL3931765,,CHEMBL3931765,,0,http://www.openphacts.org/units/Nanomolar,2804104,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,16772097,[],CHEMBL3863997,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,[O-][S+](CCN1CCN(CC(O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,,,CHEMBL3862037,J Med Chem,2016.0,,CHEMBL3918282,,CHEMBL3918282,,0,http://www.openphacts.org/units/Nanomolar,2804113,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,16772098,[],CHEMBL3863997,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O,,,CHEMBL3862037,J Med Chem,2016.0,,CHEMBL8946,ETICLOPRIDE,CHEMBL8946,,0,http://www.openphacts.org/units/Nanomolar,2804128,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,16772099,[],CHEMBL3863997,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1,,,CHEMBL3862037,J Med Chem,2016.0,"{'bei': '31.74', 'le': '0.62', 'lle': '6.67', 'sei': '13.12'}",CHEMBL1201192,ARMODAFINIL,CHEMBL1201192,8.68,0,http://www.openphacts.org/units/Nanomolar,2804129,=,1,1,=,,IC50,nM,,2.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.1
,,16819979,[],CHEMBL3872774,Antagonistic activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 assessed as inhibition of dopamine-induced calcium flux by fluo-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,,,CHEMBL3872208,Eur J Med Chem,2016.0,,CHEMBL3946995,,CHEMBL3946995,7.21,0,http://www.openphacts.org/units/Nanomolar,2812770,=,1,1,=,,IC50,nM,,61.45,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,61.45
,,16819980,[],CHEMBL3872774,Antagonistic activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 assessed as inhibition of dopamine-induced calcium flux by fluo-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,,,CHEMBL3872208,Eur J Med Chem,2016.0,,CHEMBL243712,AMISULPRIDE,CHEMBL243712,8.52,0,http://www.openphacts.org/units/Nanomolar,2812787,=,1,1,=,,IC50,nM,,3.04,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.04
,,16838416,[],CHEMBL3876354,Displacement of [3H]methyl-spiperone from human recombinant dopamine D2S receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)[C@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,,,CHEMBL3875185,Bioorg Med Chem,2017.0,"{'bei': '24.78', 'le': '0.45', 'lle': '4.12', 'sei': '38.17'}",CHEMBL3885419,,CHEMBL3885419,8.96,0,http://www.openphacts.org/units/Nanomolar,2815524,=,1,1,=,,IC50,nM,,1.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,10'-9M,UO_0000065,,1.1
,252914,17635864,[],CHEMBL3705175,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,,,BAO_0000190,BAO_0000019,assay format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,,,CHEMBL3638880,,2014.0,"{'bei': '14.85', 'le': '0.30', 'lle': '2.93', 'sei': '10.79'}",CHEMBL244562,,CHEMBL244562,7.39,0,http://www.openphacts.org/units/Nanomolar,2551475,=,37,1,=,,IC50,nM,,41.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,41.0
,252915,17635865,[],CHEMBL3705175,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1,,,CHEMBL3638880,,2014.0,"{'bei': '11.88', 'le': '0.24', 'lle': '0.42', 'sei': '12.14'}",CHEMBL398175,,CHEMBL398175,5.89,0,http://www.openphacts.org/units/Nanomolar,2551471,=,37,1,=,,IC50,nM,,1300.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1300.0
,252916,17635866,[],CHEMBL3705175,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,,,BAO_0000190,BAO_0000019,assay format,Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,,,CHEMBL3638880,,2014.0,"{'bei': '12.99', 'le': '0.26', 'lle': '0.96', 'sei': '13.27'}",CHEMBL244773,,CHEMBL244773,6.43,0,http://www.openphacts.org/units/Nanomolar,2551474,=,37,1,=,,IC50,nM,,368.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,368.0
,252917,17635867,[],CHEMBL3705175,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,,,BAO_0000190,BAO_0000019,assay format,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,,,CHEMBL3638880,,2014.0,"{'bei': '15.36', 'le': '0.31', 'lle': '3.24', 'sei': '12.22'}",CHEMBL244774,,CHEMBL244774,7.64,0,http://www.openphacts.org/units/Nanomolar,2551456,=,37,1,=,,IC50,nM,,22.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,22.9
,252918,17635868,[],CHEMBL3705175,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1,,,CHEMBL3638880,,2014.0,"{'bei': '15.27', 'le': '0.28', 'lle': '2.89', 'sei': '11.71'}",CHEMBL394541,,CHEMBL394541,6.76,0,http://www.openphacts.org/units/Nanomolar,2551472,=,37,1,=,,IC50,nM,,175.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,175.0
,252919,17635869,[],CHEMBL3705175,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,,,BAO_0000190,BAO_0000019,assay format,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,,,CHEMBL3638880,,2014.0,"{'bei': '14.87', 'le': '0.27', 'lle': '2.38', 'sei': '15.06'}",CHEMBL244989,,CHEMBL244989,6.75,0,http://www.openphacts.org/units/Nanomolar,2551473,=,37,1,=,,IC50,nM,,179.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,179.0
,252920,17635870,[],CHEMBL3705175,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,,,BAO_0000190,BAO_0000019,assay format,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,,,CHEMBL3638880,,2014.0,"{'bei': '15.62', 'le': '0.31', 'lle': '3.44', 'sei': '11.36'}",CHEMBL244990,,CHEMBL244990,7.80,0,http://www.openphacts.org/units/Nanomolar,2551458,=,37,1,=,,IC50,nM,,15.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,15.8
,252921,17635871,[],CHEMBL3705175,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",B,,,BAO_0000190,BAO_0000019,assay format,O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,,,CHEMBL3638880,,2014.0,"{'bei': '14.12', 'le': '0.28', 'lle': '2.69', 'sei': '10.27'}",CHEMBL390253,,CHEMBL390253,7.05,0,http://www.openphacts.org/units/Nanomolar,2551463,=,37,1,=,,IC50,nM,,88.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,88.3
,410729,17775533,[],CHEMBL3888598,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2,,,CHEMBL3886775,,2016.0,"{'bei': '16.21', 'le': '0.30', 'lle': '2.38', 'sei': '14.35'}",CHEMBL3982119,,CHEMBL3982119,5.76,0,http://www.openphacts.org/units/Nanomolar,2885296,=,37,1,=,,IC50,nM,,1727.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1727.6
,410730,17775535,[],CHEMBL3888598,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,,,BAO_0000190,BAO_0000219,cell-based format,c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,,,CHEMBL3886775,,2016.0,"{'bei': '18.27', 'le': '0.34', 'lle': '3.11', 'sei': '14.71'}",CHEMBL3903297,,CHEMBL3903297,5.91,0,http://www.openphacts.org/units/Nanomolar,2885297,=,37,1,=,,IC50,nM,,1239.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1239.4
,410731,17775537,[],CHEMBL3888598,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4,,,CHEMBL3886775,,2016.0,"{'bei': '16.50', 'le': '0.31', 'lle': '2.51', 'sei': '13.95'}",CHEMBL3897805,,CHEMBL3897805,5.60,0,http://www.openphacts.org/units/Nanomolar,2885298,=,37,1,=,,IC50,nM,,2508.05,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2508.05
,410732,17775539,[],CHEMBL3888598,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,,,CHEMBL3886775,,2016.0,"{'bei': '18.36', 'le': '0.34', 'lle': '1.96', 'sei': '27.36'}",CHEMBL2057451,,CHEMBL2057451,5.94,0,http://www.openphacts.org/units/Nanomolar,2885300,=,37,1,=,,IC50,nM,,1155.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1155.3
,410733,17775541,[],CHEMBL3888598,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4,,,CHEMBL3886775,,2016.0,"{'bei': '21.64', 'le': '0.40', 'lle': '4.25', 'sei': '13.76'}",CHEMBL2334893,,CHEMBL2334893,7.04,0,http://www.openphacts.org/units/Nanomolar,2885305,=,37,1,=,,IC50,nM,,91.11,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,91.11
,410734,17775543,[],CHEMBL3888598,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,,,CHEMBL3886775,,2016.0,"{'bei': '20.49', 'le': '0.38', 'lle': '2.67', 'sei': '19.39'}",CHEMBL2057457,,CHEMBL2057457,6.34,0,http://www.openphacts.org/units/Nanomolar,2885307,=,37,1,=,,IC50,nM,,456.13,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,456.13
,410735,17775545,[],CHEMBL3888598,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,,,CHEMBL3886775,,2016.0,"{'bei': '21.72', 'le': '0.40', 'lle': '5.37', 'sei': '16.32'}",CHEMBL267930,SPIPERONE,CHEMBL267930,8.59,0,http://www.openphacts.org/units/Nanomolar,2885317,=,37,1,=,,IC50,nM,,2.56,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.56
,410743,17775553,[],CHEMBL3888599,"Affinity Assay: Each medicament was dissolved in serum-free F12 culture medium containing 100 μM of IBMX. CHO cells which can stably express D2 receptor were pre-incubated at 37° C. for 10 min, and then 10 μM Forskoline and 10 μM Dopanie were added at the same time to react for 10 min. 100 μL, of pre-cooled 1 M of HClO4 was added and the reaction was terminated at 4° C. for 1 hour. 20 μL of 2 M K2CO3 was added to neutralize the reaction. The resulting mixture was centrifugated at 3000 rpm for 15 min, and the precipitate KClO4 was discarded. A certain amount of the supernatant was taken for cAMP detection. Spiperone and Quinpirole were used as positive control.",F,,,BAO_0000190,BAO_0000219,cell-based format,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,,,CHEMBL3886775,,2016.0,,CHEMBL240773,QUINPIROLE,CHEMBL240773,6.33,0,http://www.openphacts.org/units/Nanomolar,2885318,=,37,1,=,,IC50,nM,,462.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,462.0
,,17995171,[],CHEMBL4001156,Displacement of [3H]methyl-spiperone from human recombinant D2S receptor in HEK293 cells after 60 mins by scintillation counting,B,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,,,CHEMBL4000185,J Med Chem,2017.0,"{'bei': '25.15', 'le': '0.46', 'lle': '4.25', 'sei': '38.74'}",CHEMBL8514,BUTACLAMOL,CHEMBL8514,9.09,0,http://www.openphacts.org/units/Nanomolar,2981397,=,1,1,=,,IC50,nM,,0.81,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.81
,,18049298,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4097572,,CHEMBL4097572,,0,http://www.openphacts.org/units/Nanomolar,2991124,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049397,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4076129,,CHEMBL4076129,,0,http://www.openphacts.org/units/Nanomolar,2991125,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049398,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4077430,,CHEMBL4077430,,0,http://www.openphacts.org/units/Nanomolar,2991127,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049399,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4100734,,CHEMBL4100734,,0,http://www.openphacts.org/units/Nanomolar,2991128,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049400,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4068455,,CHEMBL4068455,,0,http://www.openphacts.org/units/Nanomolar,2991130,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049401,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4100322,,CHEMBL4100322,,0,http://www.openphacts.org/units/Nanomolar,2991131,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049402,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4085282,,CHEMBL4085282,,0,http://www.openphacts.org/units/Nanomolar,2991132,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049403,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4095452,,CHEMBL4095452,,0,http://www.openphacts.org/units/Nanomolar,2991133,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049404,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4093477,,CHEMBL4093477,,0,http://www.openphacts.org/units/Nanomolar,2991136,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049405,[],CHEMBL4011216,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(CCCCOc1ccc2c(c1)NC(=O)CC2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4096422,,CHEMBL4096422,,0,http://www.openphacts.org/units/Nanomolar,2991138,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049449,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '21.56', 'le': '0.40', 'lle': '3.54', 'sei': '22.55'}",CHEMBL3797209,,CHEMBL3797209,6.80,0,http://www.openphacts.org/units/Nanomolar,2991119,=,1,1,=,,IC50,nM,,157.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,157.8
,,18049450,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4097572,,CHEMBL4097572,,0,http://www.openphacts.org/units/Nanomolar,2991124,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049451,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4076129,,CHEMBL4076129,,0,http://www.openphacts.org/units/Nanomolar,2991125,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049452,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4077430,,CHEMBL4077430,,0,http://www.openphacts.org/units/Nanomolar,2991127,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049453,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4100734,,CHEMBL4100734,,0,http://www.openphacts.org/units/Nanomolar,2991128,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049454,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '12.61', 'le': '0.23', 'lle': '1.61', 'sei': '8.19'}",CHEMBL4068455,,CHEMBL4068455,6.15,0,http://www.openphacts.org/units/Nanomolar,2991130,=,1,1,=,,IC50,nM,,712.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,712.9
,,18049455,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4100322,,CHEMBL4100322,,0,http://www.openphacts.org/units/Nanomolar,2991131,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049456,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4085282,,CHEMBL4085282,,0,http://www.openphacts.org/units/Nanomolar,2991132,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049457,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4095452,,CHEMBL4095452,,0,http://www.openphacts.org/units/Nanomolar,2991133,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049458,[],CHEMBL4011220,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4093477,,CHEMBL4093477,,0,http://www.openphacts.org/units/Nanomolar,2991136,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049504,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '19.12', 'le': '0.36', 'lle': '2.77', 'sei': '19.99'}",CHEMBL3797209,,CHEMBL3797209,6.03,0,http://www.openphacts.org/units/Nanomolar,2991119,=,1,1,=,,IC50,nM,,931.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,931.1
,,18049505,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4097572,,CHEMBL4097572,,0,http://www.openphacts.org/units/Nanomolar,2991124,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049506,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '10.88', 'le': '0.20', 'lle': '-0.76', 'sei': '11.10'}",CHEMBL4076129,,CHEMBL4076129,5.35,0,http://www.openphacts.org/units/Nanomolar,2991125,=,1,1,=,,IC50,nM,,4487.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4487.5
,,18049507,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '12.81', 'le': '0.24', 'lle': '2.70', 'sei': '6.97'}",CHEMBL4077430,,CHEMBL4077430,5.39,0,http://www.openphacts.org/units/Nanomolar,2991127,=,1,1,=,,IC50,nM,,4102.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4102.0
,,18049508,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4100734,,CHEMBL4100734,,0,http://www.openphacts.org/units/Nanomolar,2991128,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049509,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '11.15', 'le': '0.21', 'lle': '0.90', 'sei': '7.24'}",CHEMBL4068455,,CHEMBL4068455,5.44,0,http://www.openphacts.org/units/Nanomolar,2991130,=,1,1,=,,IC50,nM,,3647.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3647.5
,,18049510,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4100322,,CHEMBL4100322,,0,http://www.openphacts.org/units/Nanomolar,2991131,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049511,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4085282,,CHEMBL4085282,,0,http://www.openphacts.org/units/Nanomolar,2991132,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049512,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4095452,,CHEMBL4095452,,0,http://www.openphacts.org/units/Nanomolar,2991133,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049513,[],CHEMBL4011224,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '11.33', 'le': '0.21', 'lle': '0.99', 'sei': '7.36'}",CHEMBL4093477,,CHEMBL4093477,5.53,0,http://www.openphacts.org/units/Nanomolar,2991136,=,1,1,=,,IC50,nM,,2971.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2971.7
,,18049559,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '22.21', 'le': '0.42', 'lle': '3.74', 'sei': '23.22'}",CHEMBL3797209,,CHEMBL3797209,7.00,0,http://www.openphacts.org/units/Nanomolar,2991119,=,1,1,=,,IC50,nM,,98.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,98.9
,,18049560,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4097572,,CHEMBL4097572,,0,http://www.openphacts.org/units/Nanomolar,2991124,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049561,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '12.40', 'le': '0.23', 'lle': '-0.01', 'sei': '12.65'}",CHEMBL4076129,,CHEMBL4076129,6.10,0,http://www.openphacts.org/units/Nanomolar,2991125,=,1,1,=,,IC50,nM,,801.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,801.7
,,18049562,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4077430,,CHEMBL4077430,,0,http://www.openphacts.org/units/Nanomolar,2991127,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049563,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4100734,,CHEMBL4100734,,0,http://www.openphacts.org/units/Nanomolar,2991128,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049564,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '11.68', 'le': '0.22', 'lle': '1.16', 'sei': '7.59'}",CHEMBL4068455,,CHEMBL4068455,5.70,0,http://www.openphacts.org/units/Nanomolar,2991130,=,1,1,=,,IC50,nM,,2013.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2013.7
,,18049565,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4100322,,CHEMBL4100322,,0,http://www.openphacts.org/units/Nanomolar,2991131,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049566,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4085282,,CHEMBL4085282,,0,http://www.openphacts.org/units/Nanomolar,2991132,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049567,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1,,,CHEMBL4007493,J Med Chem,2017.0,,CHEMBL4095452,,CHEMBL4095452,,0,http://www.openphacts.org/units/Nanomolar,2991133,>,1,1,>,,IC50,nM,,5000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.0
,,18049568,[],CHEMBL4011228,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,,,CHEMBL4007493,J Med Chem,2017.0,"{'bei': '10.96', 'le': '0.20', 'lle': '0.80', 'sei': '7.12'}",CHEMBL4093477,,CHEMBL4093477,5.34,0,http://www.openphacts.org/units/Nanomolar,2991136,=,1,1,=,,IC50,nM,,4529.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4529.0
,,18208526,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2c(O)cccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4102561,,CHEMBL4102561,7.57,0,http://www.openphacts.org/units/Nanomolar,3021004,=,1,1,=,,IC50,nM,,26.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,26.7
,,18208527,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCC=C2.Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4074326,,CHEMBL4116465,8.03,0,http://www.openphacts.org/units/Nanomolar,3021003,=,1,1,=,,IC50,nM,,9.44,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.44
,,18208528,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2ccccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4094825,,CHEMBL4094825,8.48,0,http://www.openphacts.org/units/Nanomolar,3021002,=,1,1,=,,IC50,nM,,3.29,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.29
,,18208529,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(C)O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4065710,,CHEMBL4065710,7.50,0,http://www.openphacts.org/units/Nanomolar,3021001,=,1,1,=,,IC50,nM,,31.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,31.5
,,18208530,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(F)F.Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4087132,,CHEMBL4116744,8.46,0,http://www.openphacts.org/units/Nanomolar,3021000,=,1,1,=,,IC50,nM,,3.51,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.51
,,18208531,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2=O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4103509,,CHEMBL4103509,7.39,0,http://www.openphacts.org/units/Nanomolar,3020999,=,1,1,=,,IC50,nM,,40.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,40.5
,,18208532,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4079251,,CHEMBL4079251,8.26,0,http://www.openphacts.org/units/Nanomolar,3020998,=,1,1,=,,IC50,nM,,5.49,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.49
,,18208533,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2F,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4104261,,CHEMBL4104261,8.48,0,http://www.openphacts.org/units/Nanomolar,3020997,=,1,1,=,,IC50,nM,,3.32,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.32
,,18208534,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2(C)O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4061068,,CHEMBL4061068,8.62,0,http://www.openphacts.org/units/Nanomolar,3020996,=,1,1,=,,IC50,nM,,2.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.4
,,18208535,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2(F)F,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4062992,,CHEMBL4062992,8.28,0,http://www.openphacts.org/units/Nanomolar,3020995,=,1,1,=,,IC50,nM,,5.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.2
,,18208536,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2=O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4084663,,CHEMBL4084663,8.12,0,http://www.openphacts.org/units/Nanomolar,3020994,=,1,1,=,,IC50,nM,,7.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.6
,,18208537,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4101115,,CHEMBL4101115,8.08,0,http://www.openphacts.org/units/Nanomolar,3020993,=,1,1,=,,IC50,nM,,8.29,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8.29
,,18208538,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2F,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4074373,,CHEMBL4074373,8.11,0,http://www.openphacts.org/units/Nanomolar,3020992,=,1,1,=,,IC50,nM,,7.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.8
,,18208539,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1ccc(Sc2ccccc2N2CCN(CCc3c(C)nc4n(c3=O)CCCC4O)CC2)c(C)c1.Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4082150,,CHEMBL4117087,6.06,0,http://www.openphacts.org/units/Nanomolar,3020991,=,1,1,=,,IC50,nM,,875.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,875.0
,,18208540,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4100152,,CHEMBL4100152,7.57,0,http://www.openphacts.org/units/Nanomolar,3020990,=,1,1,=,,IC50,nM,,27.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,27.0
,,18208541,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2.Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4077006,,CHEMBL4117235,7.44,0,http://www.openphacts.org/units/Nanomolar,3020989,=,1,1,=,,IC50,nM,,36.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,36.6
,,18208542,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3ncnc4sccc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4064609,,CHEMBL4064609,5.18,0,http://www.openphacts.org/units/Nanomolar,3020988,=,1,1,=,,IC50,nM,,6660.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6660.0
,,18208543,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3ncnc4sccc34)CC1)CCCC2,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4063748,,CHEMBL4063748,5.26,0,http://www.openphacts.org/units/Nanomolar,3020987,=,1,1,=,,IC50,nM,,5530.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5530.0
,,18208544,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cncc4sccc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4091554,,CHEMBL4091554,6.02,0,http://www.openphacts.org/units/Nanomolar,3020986,=,1,1,=,,IC50,nM,,960.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,960.0
,,18208545,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3nccc4sccc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4097395,,CHEMBL4097395,7.70,0,http://www.openphacts.org/units/Nanomolar,3020985,=,1,1,=,,IC50,nM,,20.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,20.0
,,18208546,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3nccc4sccc34)CC1)CCCC2,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4079365,,CHEMBL4079365,7.42,0,http://www.openphacts.org/units/Nanomolar,3020984,=,1,1,=,,IC50,nM,,37.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,37.6
,,18208547,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4scnc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4105102,,CHEMBL4105102,,0,http://www.openphacts.org/units/Nanomolar,3020983,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,18208548,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3CCS4)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4087246,,CHEMBL4087246,7.93,0,http://www.openphacts.org/units/Nanomolar,3020982,=,1,1,=,,IC50,nM,,11.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11.8
,,18208549,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3csc4ccsc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4067506,,CHEMBL4067506,6.80,0,http://www.openphacts.org/units/Nanomolar,3020981,=,1,1,=,,IC50,nM,,157.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,157.0
,,18208550,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4094926,,CHEMBL4094926,7.12,0,http://www.openphacts.org/units/Nanomolar,3020980,=,1,1,=,,IC50,nM,,75.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,75.4
,,18208551,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2.Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4078409,,CHEMBL4117823,7.98,0,http://www.openphacts.org/units/Nanomolar,3020979,=,1,1,=,,IC50,nM,,10.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10.4
,,18208552,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4102670,,CHEMBL4102670,8.48,0,http://www.openphacts.org/units/Nanomolar,3020978,=,1,1,=,,IC50,nM,,3.31,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.31
,,18208553,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4083333,,CHEMBL4083333,8.58,0,http://www.openphacts.org/units/Nanomolar,3020977,=,1,1,=,,IC50,nM,,2.61,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.61
,,18208554,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4060678,,CHEMBL4060678,8.29,0,http://www.openphacts.org/units/Nanomolar,3020976,=,1,1,=,,IC50,nM,,5.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.1
,,18208555,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCN(c3noc4cc(F)ccc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4098594,,CHEMBL4098594,8.02,0,http://www.openphacts.org/units/Nanomolar,3020975,=,1,1,=,,IC50,nM,,9.65,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.65
,,18208556,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL1621,PALIPERIDONE,CHEMBL1621,8.08,0,http://www.openphacts.org/units/Nanomolar,3020974,=,1,1,=,,IC50,nM,,8.28,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8.28
,,18208557,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL85,RISPERIDONE,CHEMBL85,8.15,0,http://www.openphacts.org/units/Nanomolar,3020973,=,1,1,=,,IC50,nM,,7.09,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.09
,,18208558,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(C)O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4082084,,CHEMBL4082084,7.10,0,http://www.openphacts.org/units/Nanomolar,3020972,=,1,1,=,,IC50,nM,,80.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,80.0
,,18208559,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(F)F.Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4096467,,CHEMBL4117548,8.30,0,http://www.openphacts.org/units/Nanomolar,3020971,=,1,1,=,,IC50,nM,,5.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.0
,,18208560,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2=O,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4077702,,CHEMBL4077702,8.04,0,http://www.openphacts.org/units/Nanomolar,3020970,=,1,1,=,,IC50,nM,,9.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.1
,,18208561,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2Cl,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4090872,,CHEMBL4090872,8.54,0,http://www.openphacts.org/units/Nanomolar,3020969,=,1,1,=,,IC50,nM,,2.87,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.87
,,18208562,[],CHEMBL4045104,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2F,,,CHEMBL4043141,Bioorg Med Chem,2017.0,,CHEMBL4062936,,CHEMBL4062936,8.21,0,http://www.openphacts.org/units/Nanomolar,3020968,=,1,1,=,,IC50,nM,,6.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6.2
,,18286241,[],CHEMBL4121476,Displacement of [3H]7-OH-DPAT from human recombinant dopamine D2S receptor after 60 mins by scintillation counting analysis,B,,,BAO_0000190,BAO_0000357,single protein format,CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12,,,CHEMBL4118122,Bioorg Med Chem Lett,2018.0,"{'bei': '14.98', 'le': '0.30', 'lle': '2.98', 'sei': '6.97'}",CHEMBL4128926,,CHEMBL4128926,8.74,0,http://www.openphacts.org/units/Nanomolar,3035290,=,1,1,=,,IC50,nM,,1.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.8
,,18494659,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4210030,,CHEMBL4210030,7.22,0,http://www.openphacts.org/units/Nanomolar,3069793,=,1,1,=,,IC50,nM,,59.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,59.8
,,18494660,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CCNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4210637,,CHEMBL4210637,7.42,0,http://www.openphacts.org/units/Nanomolar,3069794,=,1,1,=,,IC50,nM,,37.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,37.6
,,18494661,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(NC1CC1)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4212622,,CHEMBL4212622,7.27,0,http://www.openphacts.org/units/Nanomolar,3069795,=,1,1,=,,IC50,nM,,53.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,53.5
,,18494662,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4213342,,CHEMBL4213342,7.94,0,http://www.openphacts.org/units/Nanomolar,3069796,=,1,1,=,,IC50,nM,,11.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11.4
,,18494663,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,NC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4217986,,CHEMBL4217986,7.37,0,http://www.openphacts.org/units/Nanomolar,3069797,=,1,1,=,,IC50,nM,,42.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,42.6
,,18494664,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(NC1CC1)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4202871,,CHEMBL4202871,7.19,0,http://www.openphacts.org/units/Nanomolar,3069798,=,1,1,=,,IC50,nM,,65.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,65.2
,,18494665,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4214528,,CHEMBL4214528,7.58,0,http://www.openphacts.org/units/Nanomolar,3069799,=,1,1,=,,IC50,nM,,26.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,26.5
,,18494666,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4209188,,CHEMBL4209188,7.62,0,http://www.openphacts.org/units/Nanomolar,3069800,=,1,1,=,,IC50,nM,,24.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,24.0
,,18494667,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sc(F)cc34)CC2)ccn1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4217182,,CHEMBL4217182,8.10,0,http://www.openphacts.org/units/Nanomolar,3069801,=,1,1,=,,IC50,nM,,8.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8.0
,,18494668,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4213586,,CHEMBL4213586,6.91,0,http://www.openphacts.org/units/Nanomolar,3069802,=,1,1,=,,IC50,nM,,123.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,123.0
,,18494669,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CCNC(=O)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4218526,,CHEMBL4218526,7.23,0,http://www.openphacts.org/units/Nanomolar,3069803,=,1,1,=,,IC50,nM,,59.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,59.0
,,18494670,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(NC1CC1)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4217039,,CHEMBL4217039,7.37,0,http://www.openphacts.org/units/Nanomolar,3069804,=,1,1,=,,IC50,nM,,42.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,42.5
,,18494671,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cncc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)c1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4205326,,CHEMBL4205326,7.07,0,http://www.openphacts.org/units/Nanomolar,3069805,=,1,1,=,,IC50,nM,,85.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,85.0
,,18494672,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4204832,,CHEMBL4204832,6.52,0,http://www.openphacts.org/units/Nanomolar,3069806,=,1,1,=,,IC50,nM,,299.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,299.0
,,18494673,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CCNC(=O)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4209705,,CHEMBL4209705,7.18,0,http://www.openphacts.org/units/Nanomolar,3069807,=,1,1,=,,IC50,nM,,65.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,65.5
,,18494674,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C(NC1CC1)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4210128,,CHEMBL4210128,7.29,0,http://www.openphacts.org/units/Nanomolar,3069808,=,1,1,=,,IC50,nM,,51.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,51.7
,,18494675,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1ccnc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)c1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4215048,,CHEMBL4215048,7.05,0,http://www.openphacts.org/units/Nanomolar,3069809,=,1,1,=,,IC50,nM,,89.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,89.1
,,18494676,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)n1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4205772,,CHEMBL4205772,8.03,0,http://www.openphacts.org/units/Nanomolar,3069810,=,1,1,=,,IC50,nM,,9.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.3
,,18494677,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cccc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)n1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4214642,,CHEMBL4214642,7.94,0,http://www.openphacts.org/units/Nanomolar,3069811,=,1,1,=,,IC50,nM,,11.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11.4
,,18494678,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4207328,,CHEMBL4207328,7.29,0,http://www.openphacts.org/units/Nanomolar,3069812,=,1,1,=,,IC50,nM,,51.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,51.1
,,18494679,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4sccc34)CC2)n1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4202443,,CHEMBL4202443,7.07,0,http://www.openphacts.org/units/Nanomolar,3069813,=,1,1,=,,IC50,nM,,86.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,86.1
,,18494680,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CNC(=O)c1cccc(OCCCCN2CCN(c3ccc4ccsc4c3)CC2)n1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL4211473,,CHEMBL4211473,6.38,0,http://www.openphacts.org/units/Nanomolar,3069814,=,1,1,=,,IC50,nM,,412.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,412.0
,,18494681,[],CHEMBL4187998,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,,,CHEMBL4184238,Bioorg Med Chem Lett,2018.0,,CHEMBL1112,ARIPIPRAZOLE,CHEMBL1112,7.50,0,http://www.openphacts.org/units/Nanomolar,3069815,=,1,1,=,,IC50,nM,,32.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,32.0
,,18530269,[],CHEMBL4195154,Antagonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as decrease in apomorphine-induced calcium mobilization preincubated for 30 mins followed by apomorphine challenge measured for 30 secs by aequorin-derived luminescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1.Cl,,,CHEMBL4190389,Bioorg Med Chem Lett,2018.0,,CHEMBL4209888,,CHEMBL4300899,7.75,0,http://www.openphacts.org/units/Nanomolar,3076639,=,1,1,=,,IC50,nM,,17.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,17.7
,,18530270,[],CHEMBL4195154,Antagonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as decrease in apomorphine-induced calcium mobilization preincubated for 30 mins followed by apomorphine challenge measured for 30 secs by aequorin-derived luminescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1.Cl.Cl,,,CHEMBL4190389,Bioorg Med Chem Lett,2018.0,,CHEMBL4213352,,CHEMBL4300399,7.11,0,http://www.openphacts.org/units/Nanomolar,3076645,=,1,1,=,,IC50,nM,,78.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,78.5
,,18530271,[],CHEMBL4195154,Antagonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as decrease in apomorphine-induced calcium mobilization preincubated for 30 mins followed by apomorphine challenge measured for 30 secs by aequorin-derived luminescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1.Cl.Cl,,,CHEMBL4190389,Bioorg Med Chem Lett,2018.0,,CHEMBL4207653,,CHEMBL4302655,7.09,0,http://www.openphacts.org/units/Nanomolar,3076647,=,1,1,=,,IC50,nM,,82.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,82.0
,,18530272,[],CHEMBL4195154,Antagonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as decrease in apomorphine-induced calcium mobilization preincubated for 30 mins followed by apomorphine challenge measured for 30 secs by aequorin-derived luminescence assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,,,CHEMBL4190389,Bioorg Med Chem Lett,2018.0,,CHEMBL71,CHLORPROMAZINE,CHEMBL71,8.52,0,http://www.openphacts.org/units/Nanomolar,3076661,=,1,1,=,,IC50,nM,,3.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.0
,,18700520,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCC(c2noc3cc(F)ccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4280940,,CHEMBL4280940,8.32,0,http://www.openphacts.org/units/Nanomolar,3105704,=,1,1,=,,IC50,nM,,4.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.8
,,18700521,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ccc3ccsc3c2)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4292250,,CHEMBL4292250,7.10,0,http://www.openphacts.org/units/Nanomolar,3105705,=,1,1,=,,IC50,nM,,80.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,80.2
,,18700522,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4284346,,CHEMBL4284346,8.21,0,http://www.openphacts.org/units/Nanomolar,3105706,=,1,1,=,,IC50,nM,,6.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6.1
,,18700523,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4sccc34)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4277101,,CHEMBL4277101,8.19,0,http://www.openphacts.org/units/Nanomolar,3105707,=,1,1,=,,IC50,nM,,6.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6.4
,,18700524,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4scnc34)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4287752,,CHEMBL4287752,8.02,0,http://www.openphacts.org/units/Nanomolar,3105708,=,1,1,=,,IC50,nM,,9.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.6
,,18700525,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4sc(F)cc34)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4289238,,CHEMBL4289238,8.60,0,http://www.openphacts.org/units/Nanomolar,3105709,=,1,1,=,,IC50,nM,,2.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.5
,,18700526,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4ccsc34)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4278581,,CHEMBL4278581,8.28,0,http://www.openphacts.org/units/Nanomolar,3105710,=,1,1,=,,IC50,nM,,5.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5.3
,,18700527,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4c3OCCO4)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4285839,,CHEMBL4285839,8.01,0,http://www.openphacts.org/units/Nanomolar,3105711,=,1,1,=,,IC50,nM,,9.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.8
,,18700528,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4293718,,CHEMBL4293718,8.70,0,http://www.openphacts.org/units/Nanomolar,3105712,=,1,1,=,,IC50,nM,,2.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.0
,,18700529,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3nsc4ccccc34)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4277532,,CHEMBL4277532,8.38,0,http://www.openphacts.org/units/Nanomolar,3105713,=,1,1,=,,IC50,nM,,4.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.2
,,18700530,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCN1CCN(c3cccc4sccc34)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4285479,,CHEMBL4285479,6.92,0,http://www.openphacts.org/units/Nanomolar,3105714,=,1,1,=,,IC50,nM,,119.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,119.0
,,18700531,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCN1CCN(c3cccc4sccc34)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4292655,,CHEMBL4292655,7.49,0,http://www.openphacts.org/units/Nanomolar,3105715,=,1,1,=,,IC50,nM,,32.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,32.4
,,18700532,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@H](C(=O)N1CCCCCN1CCN(c3cccc4sccc34)CC1)[C@H]1C=C[C@@H]2C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4282051,,CHEMBL4282051,7.55,0,http://www.openphacts.org/units/Nanomolar,3105716,=,1,1,=,,IC50,nM,,28.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,28.0
,,18700533,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)C2C(=O)N(CCCCN3CCN(c4cccc5sccc45)CC3)C(=O)C21,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4284353,,CHEMBL4284353,8.08,0,http://www.openphacts.org/units/Nanomolar,3105717,=,1,1,=,,IC50,nM,,8.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8.4
,,18700534,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,Cc1ccc(C23CC2C(=O)N(CCCCN2CCN(c4cccc5sccc45)CC2)C3=O)cc1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4292254,,CHEMBL4292254,7.09,0,http://www.openphacts.org/units/Nanomolar,3105718,=,1,1,=,,IC50,nM,,80.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,80.6
,,18700535,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C2CCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4291387,,CHEMBL4291387,7.89,0,http://www.openphacts.org/units/Nanomolar,3105719,=,1,1,=,,IC50,nM,,13.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,13.0
,,18700536,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4283546,,CHEMBL4283546,8.37,0,http://www.openphacts.org/units/Nanomolar,3105720,=,1,1,=,,IC50,nM,,4.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.3
,,18700537,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C2CC=CCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4287980,,CHEMBL4287980,8.07,0,http://www.openphacts.org/units/Nanomolar,3105721,=,1,1,=,,IC50,nM,,8.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8.5
,,18700538,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1C2CC(O)C(O)CC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4280084,,CHEMBL4280084,8.03,0,http://www.openphacts.org/units/Nanomolar,3105722,=,1,1,=,,IC50,nM,,9.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.4
,,18700539,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1[C@@H]2[C@@H]3C[C@@H]([C@@H](O)[C@H]3O)[C@@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4279645,,CHEMBL4279645,7.85,0,http://www.openphacts.org/units/Nanomolar,3105723,=,1,1,=,,IC50,nM,,14.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,14.1
,,18700540,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CC(=O)O[C@@H]1[C@@H]2C[C@H]([C@@H]1OC(C)=O)[C@H]1C(=O)N(CCCCN3CCN(c4cccc5sccc45)CC3)C(=O)[C@@H]21,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4290309,,CHEMBL4290309,7.35,0,http://www.openphacts.org/units/Nanomolar,3105724,=,1,1,=,,IC50,nM,,44.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,44.6
,,18700541,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4294797,,CHEMBL4294797,6.88,0,http://www.openphacts.org/units/Nanomolar,3105725,=,1,1,=,,IC50,nM,,131.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,131.0
,,18700542,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1c2cccc(F)c2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4286905,,CHEMBL4286905,7.42,0,http://www.openphacts.org/units/Nanomolar,3105726,=,1,1,=,,IC50,nM,,38.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,38.1
,,18700543,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1c2ccc(F)cc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4277751,,CHEMBL4277751,6.67,0,http://www.openphacts.org/units/Nanomolar,3105727,=,1,1,=,,IC50,nM,,213.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,213.0
,,18700544,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1c2cccc(Cl)c2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4288388,,CHEMBL4288388,7.52,0,http://www.openphacts.org/units/Nanomolar,3105728,=,1,1,=,,IC50,nM,,30.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30.1
,,18700545,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1c2ccc(Cl)cc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4283369,,CHEMBL4283369,6.26,0,http://www.openphacts.org/units/Nanomolar,3105729,=,1,1,=,,IC50,nM,,543.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,543.0
,,18700546,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4291215,,CHEMBL4291215,8.14,0,http://www.openphacts.org/units/Nanomolar,3105730,=,1,1,=,,IC50,nM,,7.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.2
,,18700547,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4286717,,CHEMBL4286717,7.96,0,http://www.openphacts.org/units/Nanomolar,3105731,=,1,1,=,,IC50,nM,,10.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10.9
,,18700548,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4294617,,CHEMBL4294617,7.61,0,http://www.openphacts.org/units/Nanomolar,3105732,=,1,1,=,,IC50,nM,,24.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,24.4
,,18700549,[],CHEMBL4254801,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,F,,,BAO_0000190,BAO_0000019,assay format,O=C1CC2(CCCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4251643,Eur J Med Chem,2018.0,,CHEMBL4295055,,CHEMBL4295055,7.96,0,http://www.openphacts.org/units/Nanomolar,3105733,=,1,1,=,,IC50,nM,,11.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11.0
,,18813982,[],CHEMBL4276601,Antagonist activity at dopamine D2 receptor long isoform (unknown origin) expressed in HEK293 cells assessed as inhibition of dopamine-induced calcium flux after 15 mins by calcium 4-dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,,,CHEMBL4270672,J Med Chem,2018.0,,CHEMBL4293999,,CHEMBL4293999,8.04,0,http://www.openphacts.org/units/Nanomolar,3126078,=,1,1,=,,IC50,nM,,9.02,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9.02
,,18813983,[],CHEMBL4276601,Antagonist activity at dopamine D2 receptor long isoform (unknown origin) expressed in HEK293 cells assessed as inhibition of dopamine-induced calcium flux after 15 mins by calcium 4-dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,,,CHEMBL4270672,J Med Chem,2018.0,,CHEMBL62,SCH-23390,CHEMBL62,7.51,0,http://www.openphacts.org/units/Nanomolar,3126056,=,1,1,=,,IC50,nM,,31.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,31.0
,,18872068,[],CHEMBL4310164,Antagonist activity at human dopamine D2 receptor expressed in CHO cells co-expressing A2A receptor assessed as reduction in sumanirole-induced response after 90 mins by DMR analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)CN(CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1)CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1,,,CHEMBL4308850,J Med Chem,2018.0,"{'bei': '4.72', 'le': None, 'lle': None, 'sei': None}",CHEMBL4515776,,CHEMBL4515776,7.82,0,http://www.openphacts.org/units/Nanomolar,3149217,=,1,1,=,,IC50,nM,,15.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,15.0
,,18872069,[],CHEMBL4310164,Antagonist activity at human dopamine D2 receptor expressed in CHO cells co-expressing A2A receptor assessed as reduction in sumanirole-induced response after 90 mins by DMR analysis,B,,,BAO_0000190,BAO_0000219,cell-based format,COC(=O)CN(CC(=O)NCCOCCOCCNC(C)=O)CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1,,,CHEMBL4308850,J Med Chem,2018.0,"{'bei': '5.93', 'le': None, 'lle': None, 'sei': None}",CHEMBL4542935,,CHEMBL4542935,6.55,0,http://www.openphacts.org/units/Nanomolar,3149219,=,1,1,=,,IC50,nM,,280.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,280.0
,,18985475,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL487182,TETRAHYDROPALMATINE,CHEMBL487182,6.35,0,http://www.openphacts.org/units/Nanomolar,3167114,=,1,1,=,,IC50,nM,,450.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.45
,,18985476,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)C1Cc3ccc(OC)c(O)c3CN1CC2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL2314745,,CHEMBL2314745,5.51,0,http://www.openphacts.org/units/Nanomolar,3167115,=,1,1,=,,IC50,nM,,3110.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,3.11
,,18985477,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC(C)=O)CN1CCc3cc4c(cc3C1C2)OCO4,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL2314734,,CHEMBL2314734,6.38,0,http://www.openphacts.org/units/Nanomolar,3167116,=,1,1,=,,IC50,nM,,420.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.42
,,18985478,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc(/C=C/C(=O)Oc2c(OC)ccc3c2CN2CCc4cc5c(cc4C2C3)OCO5)ccc1OC(C)=O,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL2314740,,CHEMBL2314740,5.10,0,http://www.openphacts.org/units/Nanomolar,3167117,=,1,1,=,,IC50,nM,,7960.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,7.96
,,18985479,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)CN1CCc3cc(O)c(O)cc3C1C2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL2314747,,CHEMBL2314747,7.40,0,http://www.openphacts.org/units/Nanomolar,3167118,=,1,1,=,,IC50,nM,,40.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.04
,,18985480,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1O)CN1CCc3cc(O)c(O)cc3C1C2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4438471,,CHEMBL4438471,7.12,0,http://www.openphacts.org/units/Nanomolar,3167119,=,1,1,=,,IC50,nM,,76.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.076
,,18985481,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)CC1c3cc(OC)c(OC)cc3CCN1C2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4521450,,CHEMBL4521450,5.59,0,http://www.openphacts.org/units/Nanomolar,3167120,=,1,1,=,,IC50,nM,,2590.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.59
,,18985482,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)C1Cc3ccc(O)cc3CN1CC2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4561303,,CHEMBL4561303,5.82,0,http://www.openphacts.org/units/Nanomolar,3167121,=,1,1,=,,IC50,nM,,1530.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.53
,,18985483,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)C1Cc3c(cc(O)c(OC)c3OC)CN1CC2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4453330,,CHEMBL4453330,5.05,0,http://www.openphacts.org/units/Nanomolar,3167122,=,1,1,=,,IC50,nM,,8810.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,8.81
,,18985484,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)CC1c3cc4c(cc3CCN1C2)OCO4,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4551037,,CHEMBL4551037,5.31,0,http://www.openphacts.org/units/Nanomolar,3167123,=,1,1,=,,IC50,nM,,4940.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,4.94
,,18985485,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Oc1cccc2c1CC1c3cc4c(cc3CCN1C2)OCO4,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4582377,,CHEMBL4582377,6.72,0,http://www.openphacts.org/units/Nanomolar,3167124,=,1,1,=,,IC50,nM,,190.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.19
,,18985486,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,Oc1ccc2c(c1)CN1CCc3cc4c(cc3C1C2)OCO4,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4476383,,CHEMBL4476383,6.30,0,http://www.openphacts.org/units/Nanomolar,3167125,=,1,1,=,,IC50,nM,,500.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,0.5
,,18985487,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(c(OC)c1O)CC1c3cc4c(cc3CCN1C2)OCO4,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4544045,,CHEMBL4544045,5.97,0,http://www.openphacts.org/units/Nanomolar,3167126,=,1,1,=,,IC50,nM,,1080.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.08
,,18985488,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,c1ccc(COc2cccc3c2CC2c4cc5c(cc4CCN2C3)OCO5)cc1,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4435291,,CHEMBL4435291,,0,http://www.openphacts.org/units/Nanomolar,3167127,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,18985489,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL2314741,,CHEMBL2314741,,0,http://www.openphacts.org/units/Nanomolar,3167128,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,18985490,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)CN1CCc3cc4c(cc3[C@H]1C2)OCO4,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL2314742,,CHEMBL2314742,,0,http://www.openphacts.org/units/Nanomolar,3167129,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,18985491,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1O)C1Cc3cc(OC)c(OC)cc3CN1CC2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4528264,,CHEMBL4528264,5.45,0,http://www.openphacts.org/units/Nanomolar,3167130,=,1,1,=,,IC50,nM,,3580.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,3.58
,,18985492,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1cc2c(cc1OC)C1Cc3c(cc(OC)c(O)c3OC)CN1CC2,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL4585730,,CHEMBL4585730,5.20,0,http://www.openphacts.org/units/Nanomolar,3167131,=,1,1,=,,IC50,nM,,6360.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,6.36
,,18985493,[],CHEMBL4339971,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,,,CHEMBL4339211,Bioorg Med Chem,2019.0,,CHEMBL62,SCH-23390,CHEMBL62,5.69,0,http://www.openphacts.org/units/Nanomolar,3167132,=,1,1,=,,IC50,nM,,2050.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,2.05
,,19010059,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '20.09', 'le': '0.45', 'lle': '3.30', 'sei': '34.65'}",CHEMBL4467483,,CHEMBL4467483,7.52,0,http://www.openphacts.org/units/Nanomolar,3172275,=,1,1,=,,IC50,nM,,30.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.52
,,19010060,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '17.37', 'le': '0.39', 'lle': '2.28', 'sei': '29.95'}",CHEMBL4564103,,CHEMBL4564103,6.50,0,http://www.openphacts.org/units/Nanomolar,3172276,=,1,1,=,,IC50,nM,,316.23,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.5
,,19010061,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '19.64', 'le': '0.44', 'lle': '3.13', 'sei': '33.87'}",CHEMBL4579687,,CHEMBL4579687,7.35,0,http://www.openphacts.org/units/Nanomolar,3172277,=,1,1,=,,IC50,nM,,44.67,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.35
,,19010062,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '15.26', 'le': '0.34', 'lle': '1.49', 'sei': '26.31'}",CHEMBL4513262,,CHEMBL4513262,5.71,0,http://www.openphacts.org/units/Nanomolar,3172278,=,1,1,=,,IC50,nM,,1949.84,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.71
,,19010063,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '23.34', 'le': '0.43', 'lle': '3.53', 'sei': '34.79'}",CHEMBL4439029,,CHEMBL4439029,7.55,0,http://www.openphacts.org/units/Nanomolar,3172279,=,1,1,=,,IC50,nM,,28.18,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.55
,,19010064,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '22.85', 'le': '0.42', 'lle': '3.37', 'sei': '34.06'}",CHEMBL4442011,,CHEMBL4442011,7.39,0,http://www.openphacts.org/units/Nanomolar,3172280,=,1,1,=,,IC50,nM,,40.74,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.39
,,19010065,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '17.58', 'le': '0.32', 'lle': '1.68', 'sei': '25.07'}",CHEMBL4589737,,CHEMBL4589737,5.44,0,http://www.openphacts.org/units/Nanomolar,3172281,=,1,1,=,,IC50,nM,,3630.78,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.44
,,19010066,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '25.17', 'le': '0.54', 'lle': '5.82', 'sei': '14.14'}",CHEMBL8809,RACLOPRIDE,CHEMBL8809,8.74,0,http://www.openphacts.org/units/Nanomolar,3172283,=,1,1,=,,IC50,nM,,1.82,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,8.74
,,19010067,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '20.09', 'le': '0.45', 'lle': '3.30', 'sei': '34.64'}",CHEMBL4467483,,CHEMBL4467483,7.52,0,http://www.openphacts.org/units/Nanomolar,3172275,=,1,1,=,,IC50,nM,,30.35,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30.35
,,19010068,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '17.29', 'le': '0.38', 'lle': '2.25', 'sei': '29.82'}",CHEMBL4564103,,CHEMBL4564103,6.47,0,http://www.openphacts.org/units/Nanomolar,3172276,=,1,1,=,,IC50,nM,,337.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,337.5
,,19010069,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '19.63', 'le': '0.44', 'lle': '3.13', 'sei': '33.85'}",CHEMBL4579687,,CHEMBL4579687,7.35,0,http://www.openphacts.org/units/Nanomolar,3172277,=,1,1,=,,IC50,nM,,45.07,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,45.07
,,19010070,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '15.25', 'le': '0.34', 'lle': '1.49', 'sei': '26.31'}",CHEMBL4513262,,CHEMBL4513262,5.71,0,http://www.openphacts.org/units/Nanomolar,3172278,=,1,1,=,,IC50,nM,,1957.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1957.0
,,19010071,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '23.34', 'le': '0.43', 'lle': '3.53', 'sei': '34.79'}",CHEMBL4439029,,CHEMBL4439029,7.55,0,http://www.openphacts.org/units/Nanomolar,3172279,=,1,1,=,,IC50,nM,,28.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,28.2
,,19010072,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '22.85', 'le': '0.42', 'lle': '3.37', 'sei': '34.05'}",CHEMBL4442011,,CHEMBL4442011,7.39,0,http://www.openphacts.org/units/Nanomolar,3172280,=,1,1,=,,IC50,nM,,40.77,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,40.77
,,19010073,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '17.58', 'le': '0.32', 'lle': '1.68', 'sei': '25.07'}",CHEMBL4589737,,CHEMBL4589737,5.44,0,http://www.openphacts.org/units/Nanomolar,3172281,=,1,1,=,,IC50,nM,,3629.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3629.0
,,19010074,[],CHEMBL4345338,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,"{'bei': '25.16', 'le': '0.54', 'lle': '5.82', 'sei': '14.14'}",CHEMBL8809,RACLOPRIDE,CHEMBL8809,8.74,0,http://www.openphacts.org/units/Nanomolar,3172283,=,1,1,=,,IC50,nM,,1.83,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.83
,,19010107,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4467483,,CHEMBL4467483,9.91,0,http://www.openphacts.org/units/Nanomolar,3172275,=,1,1,=,,IC50,nM,,0.123,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,9.91
,,19010108,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4564103,,CHEMBL4564103,6.44,0,http://www.openphacts.org/units/Nanomolar,3172276,=,1,1,=,,IC50,nM,,363.08,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.44
,,19010109,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4579687,,CHEMBL4579687,5.49,0,http://www.openphacts.org/units/Nanomolar,3172277,=,1,1,=,,IC50,nM,,3235.94,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.49
,,19010110,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4513262,,CHEMBL4513262,5.05,0,http://www.openphacts.org/units/Nanomolar,3172278,=,1,1,=,,IC50,nM,,8912.51,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.05
,,19010111,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4442011,,CHEMBL4442011,,0,http://www.openphacts.org/units/Nanomolar,3172280,<,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,5.0
,,19010112,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL8809,RACLOPRIDE,CHEMBL8809,7.00,0,http://www.openphacts.org/units/Nanomolar,3172283,=,1,1,=,,IC50,nM,,100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.0
,,19010113,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4467483,,CHEMBL4467483,9.91,0,http://www.openphacts.org/units/Nanomolar,3172275,=,1,1,=,,IC50,nM,,0.124,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.124
,,19010114,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4564103,,CHEMBL4564103,6.44,0,http://www.openphacts.org/units/Nanomolar,3172276,=,1,1,=,,IC50,nM,,365.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,365.2
,,19010115,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4579687,,CHEMBL4579687,5.49,0,http://www.openphacts.org/units/Nanomolar,3172277,=,1,1,=,,IC50,nM,,3222.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3222.0
,,19010116,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4513262,,CHEMBL4513262,5.05,0,http://www.openphacts.org/units/Nanomolar,3172278,=,1,1,=,,IC50,nM,,8900.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,8900.0
,,19010117,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL4442011,,CHEMBL4442011,,0,http://www.openphacts.org/units/Nanomolar,3172280,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,19010118,[],CHEMBL4345342,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,,,CHEMBL4342494,ACS Med Chem Lett,2020.0,,CHEMBL8809,RACLOPRIDE,CHEMBL8809,6.98,0,http://www.openphacts.org/units/Nanomolar,3172283,=,1,1,=,,IC50,nM,,104.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,104.2
,,19086937,[],CHEMBL4365013,Displacement of [3H]7-OH-DPAT from recombinant human D2s receptor after 60 mins by scintillation counting analysis,B,,,BAO_0000190,BAO_0000357,single protein format,O=C(Nc1ccc(OC(F)F)nc1)NC1CCN(c2ncnc3c2nc(-c2ccccc2Cl)n3-c2ccc(Cl)cc2)CC1,,,CHEMBL4364254,J Med Chem,2019.0,,CHEMBL4563408,,CHEMBL4563408,,0,http://www.openphacts.org/units/Nanomolar,3184343,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,19205473,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL375596,,CHEMBL375596,,0,http://www.openphacts.org/units/Nanomolar,3205452,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19205474,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCC(c3ccccc3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL216393,,CHEMBL216393,4.78,0,http://www.openphacts.org/units/Nanomolar,3205453,=,1,1,=,,IC50,nM,,16447.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,16447.0
,,19205475,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(C2CCN(CC(=O)Nc3cccc(C)c3)CC2)cc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4473792,,CHEMBL4473792,4.35,0,http://www.openphacts.org/units/Nanomolar,3205454,=,1,1,=,,IC50,nM,,44834.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,44834.0
,,19205476,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCC(c3ccc(Cl)cc3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4436479,,CHEMBL4436479,4.15,0,http://www.openphacts.org/units/Nanomolar,3205455,=,1,1,=,,IC50,nM,,71437.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,71437.0
,,19205477,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(C2CCN(CC(=O)Nc3cccc(C)c3)CC2)nc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4587925,,CHEMBL4587925,4.15,0,http://www.openphacts.org/units/Nanomolar,3205456,=,1,1,=,,IC50,nM,,71065.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,71065.0
,,19205478,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4448320,,CHEMBL4448320,,0,http://www.openphacts.org/units/Nanomolar,3205457,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205479,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCN(c3ncccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4443054,,CHEMBL4443054,,0,http://www.openphacts.org/units/Nanomolar,3205458,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205480,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCN(c3ccc(Cl)cn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4572245,,CHEMBL4572245,4.18,0,http://www.openphacts.org/units/Nanomolar,3205459,=,1,1,=,,IC50,nM,,66077.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,66077.0
,,19205481,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCN(c3cccc4ccccc34)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4473652,,CHEMBL4473652,4.17,0,http://www.openphacts.org/units/Nanomolar,3205460,=,1,1,=,,IC50,nM,,68329.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,68329.0
,,19205482,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CCN2CCC(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4464861,,CHEMBL4464861,,0,http://www.openphacts.org/units/Nanomolar,3205461,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205483,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CCN2CCN(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4454068,,CHEMBL4454068,,0,http://www.openphacts.org/units/Nanomolar,3205462,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205484,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CCN2CCN(c3ncccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4588808,,CHEMBL4588808,,0,http://www.openphacts.org/units/Nanomolar,3205463,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205485,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4437912,,CHEMBL4437912,4.79,0,http://www.openphacts.org/units/Nanomolar,3205464,=,1,1,=,,IC50,nM,,16278.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,16278.0
,,19205486,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4442548,,CHEMBL4442548,4.39,0,http://www.openphacts.org/units/Nanomolar,3205465,=,1,1,=,,IC50,nM,,40466.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,40466.0
,,19205487,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cccc(NC(=O)CN2CCN(c3ccc(Cl)cn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4443848,,CHEMBL4443848,4.33,0,http://www.openphacts.org/units/Nanomolar,3205466,=,1,1,=,,IC50,nM,,46795.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,46795.0
,,19205488,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1CCN(c2ccccn2)CC1)Nc1cccnc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4592753,,CHEMBL4592753,,0,http://www.openphacts.org/units/Nanomolar,3205467,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205489,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1CCN(c2ccc(Cl)cn2)CC1)Nc1cccnc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4591118,,CHEMBL4591118,4.06,0,http://www.openphacts.org/units/Nanomolar,3205468,=,1,1,=,,IC50,nM,,86617.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,86617.0
,,19205490,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1CCN(c2ccccn2)CC1)Nc1cncnc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4453069,,CHEMBL4453069,4.03,0,http://www.openphacts.org/units/Nanomolar,3205469,=,1,1,=,,IC50,nM,,94255.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,94255.0
,,19205491,[],CHEMBL4392176,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1CCN(c2ccc(Cl)cn2)CC1)Nc1cncnc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4456754,,CHEMBL4456754,4.14,0,http://www.openphacts.org/units/Nanomolar,3205470,=,1,1,=,,IC50,nM,,72516.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,72516.0
,,19205663,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL375596,,CHEMBL375596,5.23,0,http://www.openphacts.org/units/Nanomolar,3205452,=,1,1,=,,IC50,nM,,5846.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5846.0
,,19205664,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCC(c3ccccc3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL216393,,CHEMBL216393,5.11,0,http://www.openphacts.org/units/Nanomolar,3205453,=,1,1,=,,IC50,nM,,7692.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7692.0
,,19205665,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(C2CCN(CC(=O)Nc3cccc(C)c3)CC2)cc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4473792,,CHEMBL4473792,4.05,0,http://www.openphacts.org/units/Nanomolar,3205454,=,1,1,=,,IC50,nM,,89153.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,89153.0
,,19205666,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCC(c3ccc(Cl)cc3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4436479,,CHEMBL4436479,,0,http://www.openphacts.org/units/Nanomolar,3205455,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205667,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(C2CCN(CC(=O)Nc3cccc(C)c3)CC2)nc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4587925,,CHEMBL4587925,,0,http://www.openphacts.org/units/Nanomolar,3205456,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205668,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4448320,,CHEMBL4448320,4.80,0,http://www.openphacts.org/units/Nanomolar,3205457,=,1,1,=,,IC50,nM,,16010.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,16010.0
,,19205669,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCN(c3ncccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4443054,,CHEMBL4443054,4.60,0,http://www.openphacts.org/units/Nanomolar,3205458,=,1,1,=,,IC50,nM,,25008.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,25008.0
,,19205670,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCN(c3ccc(Cl)cn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4572245,,CHEMBL4572245,,0,http://www.openphacts.org/units/Nanomolar,3205459,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205671,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CN2CCN(c3cccc4ccccc34)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4473652,,CHEMBL4473652,,0,http://www.openphacts.org/units/Nanomolar,3205460,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19205672,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CCN2CCC(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4464861,,CHEMBL4464861,5.12,0,http://www.openphacts.org/units/Nanomolar,3205461,=,1,1,=,,IC50,nM,,7627.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7627.0
,,19205673,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CCN2CCN(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4454068,,CHEMBL4454068,5.15,0,http://www.openphacts.org/units/Nanomolar,3205462,=,1,1,=,,IC50,nM,,7067.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7067.0
,,19205674,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc(NC(=O)CCN2CCN(c3ncccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4588808,,CHEMBL4588808,4.93,0,http://www.openphacts.org/units/Nanomolar,3205463,=,1,1,=,,IC50,nM,,11847.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11847.0
,,19205675,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4437912,,CHEMBL4437912,4.17,0,http://www.openphacts.org/units/Nanomolar,3205464,=,1,1,=,,IC50,nM,,67613.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,67613.0
,,19205676,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4442548,,CHEMBL4442548,4.05,0,http://www.openphacts.org/units/Nanomolar,3205465,=,1,1,=,,IC50,nM,,88447.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,88447.0
,,19205677,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1cccc(NC(=O)CN2CCN(c3ccc(Cl)cn3)CC2)c1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4443848,,CHEMBL4443848,4.15,0,http://www.openphacts.org/units/Nanomolar,3205466,=,1,1,=,,IC50,nM,,70703.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,70703.0
,Not Active,19205678,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1CCN(c2ccccn2)CC1)Nc1cccnc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4592753,,CHEMBL4592753,,0,,3205467,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19205679,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1CCN(c2ccc(Cl)cn2)CC1)Nc1cccnc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4591118,,CHEMBL4591118,,0,,3205468,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19205680,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1CCN(c2ccccn2)CC1)Nc1cncnc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4453069,,CHEMBL4453069,,0,,3205469,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19205681,[],CHEMBL4392186,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CN1CCN(c2ccc(Cl)cn2)CC1)Nc1cncnc1,,,CHEMBL4390675,J Med Chem,2019.0,,CHEMBL4456754,,CHEMBL4456754,,0,,3205470,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19218544,[],CHEMBL4394479,Antagonist activity at D2L receptor (unknown origin) expressed in human HTLA cells assessed as inhibition of dopamine-stimulated beta-arrestin2 recruitment measured after 20 to 22 hrs by brightglo-luciferase reporter gene assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(Cl)c3C2)CC1,,,CHEMBL4393669,J Med Chem,2019.0,"{'bei': '19.64', 'le': '0.39', 'lle': '3.23', 'sei': '20.09'}",CHEMBL4451797,,CHEMBL4451797,7.15,0,http://www.openphacts.org/units/Nanomolar,3208083,=,1,1,=,,IC50,nM,,71.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,71.0
,,19218545,[],CHEMBL4394479,Antagonist activity at D2L receptor (unknown origin) expressed in human HTLA cells assessed as inhibition of dopamine-stimulated beta-arrestin2 recruitment measured after 20 to 22 hrs by brightglo-luciferase reporter gene assay,B,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,,,CHEMBL4393669,J Med Chem,2019.0,"{'bei': '20.97', 'le': '0.41', 'lle': '3.13', 'sei': '22.20'}",CHEMBL42,CLOZAPINE,CHEMBL42,6.85,0,http://www.openphacts.org/units/Nanomolar,3208089,=,1,1,=,,IC50,nM,,140.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,140.0
,,19231546,[],CHEMBL4397362,Antagonist activity at recombinant human D2 receptor expressed in CHOK1 cells assessed as inhibition of quinpirole-induced beta arrestin2 recruitment preincubated for 30 mins followed by quinpirole addition and measured after 90 mins by coelenterazine-based beta-galactosidase reporter gene assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1,,,CHEMBL4396871,J Med Chem,2019.0,,CHEMBL4084262,,CHEMBL4084262,5.79,0,http://www.openphacts.org/units/Nanomolar,3210235,=,1,1,=,,IC50,nM,,1616.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1616.0
,,19231547,[],CHEMBL4397362,Antagonist activity at recombinant human D2 receptor expressed in CHOK1 cells assessed as inhibition of quinpirole-induced beta arrestin2 recruitment preincubated for 30 mins followed by quinpirole addition and measured after 90 mins by coelenterazine-based beta-galactosidase reporter gene assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCSc2nnc(-c3ccccc3)n2C)CC1,,,CHEMBL4396871,J Med Chem,2019.0,,CHEMBL4083252,,CHEMBL4083252,6.48,0,http://www.openphacts.org/units/Nanomolar,3210260,=,1,1,=,,IC50,nM,,328.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,328.3
,,19231548,[],CHEMBL4397362,Antagonist activity at recombinant human D2 receptor expressed in CHOK1 cells assessed as inhibition of quinpirole-induced beta arrestin2 recruitment preincubated for 30 mins followed by quinpirole addition and measured after 90 mins by coelenterazine-based beta-galactosidase reporter gene assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,,,CHEMBL4396871,J Med Chem,2019.0,,CHEMBL54,HALOPERIDOL,CHEMBL54,9.80,0,http://www.openphacts.org/units/Nanomolar,3210281,=,1,1,=,,IC50,nM,,0.16,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,0.16
,,19270076,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL1700053,,CHEMBL1700053,4.80,0,http://www.openphacts.org/units/Nanomolar,3217837,=,1,1,=,,IC50,nM,,15700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,16.0,15.7
,,19270077,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3ccccc3OC)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4449219,,CHEMBL4449219,5.05,0,http://www.openphacts.org/units/Nanomolar,3217733,=,1,1,=,,IC50,nM,,9000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9000.0
,,19270078,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3cccc(OC)c3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4552311,,CHEMBL4552311,5.17,0,http://www.openphacts.org/units/Nanomolar,3217734,=,1,1,=,,IC50,nM,,6800.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6800.0
,,19270079,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc(OCCN2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4436562,,CHEMBL4436562,,0,http://www.openphacts.org/units/Nanomolar,3217796,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270080,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3ccc(Cl)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL3262809,,CHEMBL3262809,,0,http://www.openphacts.org/units/Nanomolar,3217797,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,19270081,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3ccc(OC(F)(F)F)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4519519,,CHEMBL4519519,,0,http://www.openphacts.org/units/Nanomolar,3217798,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270082,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3cc(OC)cc(OC)c3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4444245,,CHEMBL4444245,,0,http://www.openphacts.org/units/Nanomolar,3217799,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270083,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3ccccc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL3262808,,CHEMBL3262808,,0,http://www.openphacts.org/units/Nanomolar,3217800,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270084,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3ccc4c(c3)OCO4)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4450129,,CHEMBL4450129,,0,http://www.openphacts.org/units/Nanomolar,3217801,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,19270085,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3cccnc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4563661,,CHEMBL4563661,,0,http://www.openphacts.org/units/Nanomolar,3217802,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270086,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccccc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4471690,,CHEMBL4471690,,0,http://www.openphacts.org/units/Nanomolar,3217803,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270087,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccccc3OC)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4526308,,CHEMBL4526308,,0,http://www.openphacts.org/units/Nanomolar,3217804,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270088,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cccc(OC)c3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4577943,,CHEMBL4577943,,0,,3217805,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270089,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccc(Cl)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4513935,,CHEMBL4513935,5.05,0,http://www.openphacts.org/units/Nanomolar,3217806,=,1,1,=,,IC50,nM,,9000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9000.0
,,19270090,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc(C(=O)N2CCN(CCOc3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4451542,,CHEMBL4451542,5.22,0,http://www.openphacts.org/units/Nanomolar,3217807,=,1,1,=,,IC50,nM,,6000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6000.0
,Not Active,19270091,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccncc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4474673,,CHEMBL4474673,,0,,3217808,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270092,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccc(OC)cn3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4526466,,CHEMBL4526466,,0,http://www.openphacts.org/units/Nanomolar,3217809,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270093,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccc4[nH]ccc4c3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4472813,,CHEMBL4472813,5.34,0,http://www.openphacts.org/units/Nanomolar,3217810,=,1,1,=,,IC50,nM,,4600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4600.0
,,19270094,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3c[nH]c4ccccc34)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4533633,,CHEMBL4533633,5.55,0,http://www.openphacts.org/units/Nanomolar,3217811,=,1,1,=,,IC50,nM,,2800.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2800.0
,,19270095,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4476784,,CHEMBL4476784,,0,http://www.openphacts.org/units/Nanomolar,3217812,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,19270096,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4cccc(OC)c4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4548345,,CHEMBL4548345,,0,http://www.openphacts.org/units/Nanomolar,3217813,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,Not Active,19270097,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccc(OC)cc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4540693,,CHEMBL4540693,,0,,3217814,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270098,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4cc(OC)ccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4589125,,CHEMBL4589125,,0,http://www.openphacts.org/units/Nanomolar,3217815,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270099,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4c(OC)cccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4440776,,CHEMBL4440776,,0,http://www.openphacts.org/units/Nanomolar,3217816,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270100,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4cccc(C)c4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4542423,,CHEMBL4542423,,0,http://www.openphacts.org/units/Nanomolar,3217817,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270101,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccc(C)cc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4470213,,CHEMBL4470213,,0,,3217818,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270102,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4cc(C)ccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4514648,,CHEMBL4514648,,0,http://www.openphacts.org/units/Nanomolar,3217819,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270103,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4c(C)cccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4460818,,CHEMBL4460818,6.13,0,http://www.openphacts.org/units/Nanomolar,3217820,=,1,1,=,,IC50,nM,,744.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,744.0
,,19270104,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4cccc(Cl)c4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4587372,,CHEMBL4587372,,0,http://www.openphacts.org/units/Nanomolar,3217821,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270105,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccc(Cl)cc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4466748,,CHEMBL4466748,,0,http://www.openphacts.org/units/Nanomolar,3217822,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270106,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4cc(Cl)ccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4545654,,CHEMBL4545654,,0,,3217823,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270107,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4c(Cl)cccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4474192,,CHEMBL4474192,,0,http://www.openphacts.org/units/Nanomolar,3217824,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270108,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4n3C)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4530116,,CHEMBL4530116,5.02,0,http://www.openphacts.org/units/Nanomolar,3217825,=,1,1,=,,IC50,nM,,9600.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9600.0
,,19270109,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3[nH]c4ccccc4c3C)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4562300,,CHEMBL4562300,,0,http://www.openphacts.org/units/Nanomolar,3217826,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270110,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4cccnc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4471655,,CHEMBL4471655,,0,,3217827,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270111,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccncc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4575347,,CHEMBL4575347,,0,http://www.openphacts.org/units/Nanomolar,3217828,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270112,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4cnccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4455487,,CHEMBL4455487,,0,http://www.openphacts.org/units/Nanomolar,3217829,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270113,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ncccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4519354,,CHEMBL4519354,,0,,3217830,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270114,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3nc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4443579,,CHEMBL4443579,,0,http://www.openphacts.org/units/Nanomolar,3217831,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270115,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4o3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4577889,,CHEMBL4577889,5.11,0,http://www.openphacts.org/units/Nanomolar,3217832,=,1,1,=,,IC50,nM,,7700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7700.0
,,19270116,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4s3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4472861,,CHEMBL4472861,5.29,0,http://www.openphacts.org/units/Nanomolar,3217833,=,1,1,=,,IC50,nM,,5100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,5100.0
,,19270117,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)C3CCCCC3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4581806,,CHEMBL4581806,,0,http://www.openphacts.org/units/Nanomolar,3217834,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,Not Active,19270118,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(C)=O)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4553903,,CHEMBL4553903,,0,,3217835,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270119,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(S(=O)(=O)c3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4436824,,CHEMBL4436824,,0,,3217836,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270120,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(c3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4559117,,CHEMBL4559117,,0,http://www.openphacts.org/units/Nanomolar,3217730,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270121,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCC(C)N2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4564115,,CHEMBL4564115,,0,http://www.openphacts.org/units/Nanomolar,3217731,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270122,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OC(C)CN2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4585248,,CHEMBL4585248,4.75,0,http://www.openphacts.org/units/Nanomolar,3217732,=,1,1,=,,IC50,nM,,18000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,18000.0
,,19270123,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccc(OC)cc3)CC2C)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4438465,,CHEMBL4438465,,0,http://www.openphacts.org/units/Nanomolar,3217764,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270124,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccc(OC)cc3)C(C)C2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4461742,,CHEMBL4461742,,0,http://www.openphacts.org/units/Nanomolar,3217765,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270125,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCC2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4463707,,CHEMBL4463707,,0,,3217766,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270126,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN(C)CCN(C)C(=O)c2ccc(OC)cc2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4459353,,CHEMBL4459353,4.75,0,http://www.openphacts.org/units/Nanomolar,3217767,=,1,1,=,,IC50,nM,,18000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,18000.0
,Not Active,19270127,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(OCCN2CCN(C(=O)c3cc4cccnc4[nH]3)CC2)c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4567332,,CHEMBL4567332,,0,,3217768,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270128,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(OCCN2CCN(C(=O)c3cc4cnccc4[nH]3)CC2)c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4594046,,CHEMBL4594046,5.13,0,http://www.openphacts.org/units/Nanomolar,3217769,=,1,1,=,,IC50,nM,,7400.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7400.0
,,19270129,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4472566,,CHEMBL4472566,,0,http://www.openphacts.org/units/Nanomolar,3217770,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270130,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(OCCN2CCN(C(=O)c3cc4cc(OC)ccc4[nH]3)CC2)c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4448833,,CHEMBL4448833,,0,,3217771,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270131,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1cccc(OCCN2CCN(C(=O)c3nc4ccccc4[nH]3)CC2)c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4471623,,CHEMBL4471623,5.70,0,http://www.openphacts.org/units/Nanomolar,3217772,=,1,1,=,,IC50,nM,,2000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2000.0
,,19270132,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(C(=O)N2CCN(CCOc3cccnc3)CC2)c(C)c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4514438,,CHEMBL4514438,,0,http://www.openphacts.org/units/Nanomolar,3217773,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270133,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2cc(C(=O)N3CCN(CCOc4cccnc4)CC3)[nH]c2c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4458958,,CHEMBL4458958,,0,,3217774,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270134,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc2[nH]c(C(=O)N3CCN(CCOc4cccnc4)CC3)cc2c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4591958,,CHEMBL4591958,,0,,3217775,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270135,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc2cc(C(=O)N3CCN(CCOc4cccnc4)CC3)[nH]c12,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4470786,,CHEMBL4470786,,0,,3217776,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270136,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2cc(C(=O)N3CCN(CCOc4cccnc4)CC3)[nH]c2c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4459426,,CHEMBL4459426,,0,,3217777,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270137,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc2[nH]c(C(=O)N3CCN(CCOc4cccnc4)CC3)cc2c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4551448,,CHEMBL4551448,,0,,3217778,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270138,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cccc2[nH]c(C(=O)N3CCN(CCOc4cccnc4)CC3)cc12,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4575155,,CHEMBL4575155,,0,,3217779,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270139,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1c(C(=O)N2CCN(CCOc3cccnc3)CC2)[nH]c2ccccc12,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4468192,,CHEMBL4468192,,0,,3217780,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270140,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cn1c(C(=O)N2CCN(CCOc3cccnc3)CC2)cc2ccccc21,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4548340,,CHEMBL4548340,,0,,3217781,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270141,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cn1cc(C(=O)N2CCN(CCOc3cccnc3)CC2)c2ccccc21,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4435730,,CHEMBL4435730,,0,,3217782,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270142,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2cccc(Cl)c2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4518951,,CHEMBL4518951,,0,,3217783,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270143,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccc(Cl)cc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4455456,,CHEMBL4455456,,0,,3217784,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270144,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2cc(Cl)ccc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4466214,,CHEMBL4466214,,0,,3217785,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270145,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2c(Cl)cccc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4472628,,CHEMBL4472628,,0,,3217786,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270146,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2cccnc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4447103,,CHEMBL4447103,,0,,3217787,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270147,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccncc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4556267,,CHEMBL4556267,,0,,3217788,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270148,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2cnccc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4437215,,CHEMBL4437215,,0,,3217789,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270149,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ncccc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4587874,,CHEMBL4587874,,0,,3217790,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270150,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1nc2ccccc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4566746,,CHEMBL4566746,,0,,3217791,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270151,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1n[nH]c2ccccc12)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4538239,,CHEMBL4538239,,0,,3217792,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270152,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2o1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4473910,,CHEMBL4473910,,0,,3217793,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270153,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2s1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4470996,,CHEMBL4470996,5.68,0,http://www.openphacts.org/units/Nanomolar,3217794,=,1,1,=,,IC50,nM,,2100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2100.0
,,19270154,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccc[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4525545,,CHEMBL4525545,,0,http://www.openphacts.org/units/Nanomolar,3217795,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270155,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4574338,,CHEMBL4574338,6.27,0,http://www.openphacts.org/units/Nanomolar,3217728,=,1,1,=,,IC50,nM,,535.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,535.0
,,19270156,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc3c(c2)OCO3)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4578060,,CHEMBL4578060,,0,http://www.openphacts.org/units/Nanomolar,3217729,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270157,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(SCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4446051,,CHEMBL4446051,,0,http://www.openphacts.org/units/Nanomolar,3217735,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270158,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CSc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4446145,,CHEMBL4446145,,0,http://www.openphacts.org/units/Nanomolar,3217736,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270159,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCOc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4442016,,CHEMBL4442016,,0,http://www.openphacts.org/units/Nanomolar,3217737,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270160,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc(OC(F)(F)F)cc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4471346,,CHEMBL4471346,,0,http://www.openphacts.org/units/Nanomolar,3217738,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270161,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4461237,,CHEMBL4461237,,0,http://www.openphacts.org/units/Nanomolar,3217739,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270162,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4435184,,CHEMBL4435184,,0,http://www.openphacts.org/units/Nanomolar,3217740,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270163,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)(C)c1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4439612,,CHEMBL4439612,,0,http://www.openphacts.org/units/Nanomolar,3217741,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270164,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc(F)cc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4456795,,CHEMBL4456795,5.01,0,http://www.openphacts.org/units/Nanomolar,3217742,=,1,1,=,,IC50,nM,,9700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,9700.0
,,19270165,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc(Cl)cc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4574586,,CHEMBL4574586,,0,http://www.openphacts.org/units/Nanomolar,3217743,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270166,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc(Br)cc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4581907,,CHEMBL4581907,,0,http://www.openphacts.org/units/Nanomolar,3217744,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270167,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc([N+](=O)[O-])cc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4518079,,CHEMBL4518079,,0,,3217745,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270168,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1OC,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4473158,,CHEMBL4473158,,0,http://www.openphacts.org/units/Nanomolar,3217746,>,1,1,>,,IC50,nM,,50000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,50000.0
,,19270169,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1C,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4519087,,CHEMBL4519087,4.89,0,http://www.openphacts.org/units/Nanomolar,3217747,=,1,1,=,,IC50,nM,,13000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,13000.0
,Not Active,19270170,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1Cl,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4443381,,CHEMBL4443381,,0,,3217748,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270171,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,Cc1cc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)ccc1Cl,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4462053,,CHEMBL4462053,5.42,0,http://www.openphacts.org/units/Nanomolar,3217749,=,1,1,=,,IC50,nM,,3800.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3800.0
,,19270172,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)c(Cl)c1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4445988,,CHEMBL4445988,,0,http://www.openphacts.org/units/Nanomolar,3217750,>,1,1,>,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10000.0
,,19270173,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccn2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4522768,,CHEMBL4522768,,0,http://www.openphacts.org/units/Nanomolar,3217751,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270174,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2cccnc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4538010,,CHEMBL4538010,,0,,3217752,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270175,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccncc2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4585651,,CHEMBL4585651,,0,http://www.openphacts.org/units/Nanomolar,3217753,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,Not Active,19270176,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2cncc(Cl)c2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4554045,,CHEMBL4554045,,0,,3217754,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270177,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OC(C)CN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4585649,,CHEMBL4585649,,0,,3217755,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270178,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC(CN1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)Oc1ccc(Cl)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4522471,,CHEMBL4522471,,0,,3217756,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270179,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(N(C)CCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4471482,,CHEMBL4471482,,0,http://www.openphacts.org/units/Nanomolar,3217757,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,100000.0
,,19270180,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc3[nH]ccc3c2)CC1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4550539,,CHEMBL4550539,6.36,0,http://www.openphacts.org/units/Nanomolar,3217758,=,1,1,=,,IC50,nM,,440.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,440.0
,,19270181,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4442293,,CHEMBL4442293,6.16,0,http://www.openphacts.org/units/Nanomolar,3217759,=,1,1,=,,IC50,nM,,691.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,691.0
,,19270182,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4580359,,CHEMBL4580359,5.92,0,http://www.openphacts.org/units/Nanomolar,3217760,=,1,1,=,,IC50,nM,,1200.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1200.0
,Not Active,19270183,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCC2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4545637,,CHEMBL4545637,,0,,3217761,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,19270184,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(CC(=O)c3cc4ccccc4[nH]3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL4471242,,CHEMBL4471242,,0,,3217762,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,,19270185,[],CHEMBL4406527,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL26,SULPIRIDE,CHEMBL26,7.38,0,http://www.openphacts.org/units/Nanomolar,3217839,=,1,1,=,,IC50,nM,,42.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,42.0
,,19270190,[],CHEMBL4406530,Displacement of [3H]-methylspiperon from human D2RL expressed in HEK293 cell membranes measured after 90 mins by topcount assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccc(OCCN2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,,,CHEMBL4402608,J Med Chem,2020.0,,CHEMBL1700053,,CHEMBL1700053,,0,http://www.openphacts.org/units/Nanomolar,3217837,>,1,1,>,,IC50,nM,,100000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,100.0
,,20667699,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4638599,,CHEMBL4638599,7.91,0,http://www.openphacts.org/units/Nanomolar,3480135,=,1,1,=,,IC50,nM,,12.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,12.4
,,20667700,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccc(F)cn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4647011,,CHEMBL4647011,7.58,0,http://www.openphacts.org/units/Nanomolar,3480136,=,1,1,=,,IC50,nM,,26.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,26.3
,,20667701,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4644352,,CHEMBL4644352,7.52,0,http://www.openphacts.org/units/Nanomolar,3480137,=,1,1,=,,IC50,nM,,30.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,30.2
,,20667702,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cc(F)cn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4635414,,CHEMBL4635414,7.20,0,http://www.openphacts.org/units/Nanomolar,3480138,=,1,1,=,,IC50,nM,,62.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,62.8
,,20667703,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccc(Cl)cn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4633978,,CHEMBL4633978,6.87,0,http://www.openphacts.org/units/Nanomolar,3480139,=,1,1,=,,IC50,nM,,135.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,135.0
,,20667704,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Cl)cccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4636321,,CHEMBL4636321,7.02,0,http://www.openphacts.org/units/Nanomolar,3480140,=,1,1,=,,IC50,nM,,94.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,94.7
,,20667705,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Cl)cc(Cl)cn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4648027,,CHEMBL4648027,6.39,0,http://www.openphacts.org/units/Nanomolar,3480141,=,1,1,=,,IC50,nM,,406.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,406.0
,,20667706,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Br)cccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4640409,,CHEMBL4640409,6.98,0,http://www.openphacts.org/units/Nanomolar,3480142,=,1,1,=,,IC50,nM,,105.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,105.0
,,20667707,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,COc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4634009,,CHEMBL4634009,7.91,0,http://www.openphacts.org/units/Nanomolar,3480143,=,1,1,=,,IC50,nM,,12.4,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,12.4
,,20667708,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,COc1cccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4644500,,CHEMBL4644500,6.99,0,http://www.openphacts.org/units/Nanomolar,3480144,=,1,1,=,,IC50,nM,,102.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,102.0
,,20667709,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4644742,,CHEMBL4644742,7.37,0,http://www.openphacts.org/units/Nanomolar,3480145,=,1,1,=,,IC50,nM,,42.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,42.6
,,20667710,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n2c1,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4644391,,CHEMBL4644391,8.99,0,http://www.openphacts.org/units/Nanomolar,3480146,=,1,1,=,,IC50,nM,,1.03,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.03
,,20667711,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1ccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc2c1,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4648979,,CHEMBL4648979,6.84,0,http://www.openphacts.org/units/Nanomolar,3480147,=,1,1,=,,IC50,nM,,146.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,146.0
,,20667712,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,N#Cc1cccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4638430,,CHEMBL4638430,8.82,0,http://www.openphacts.org/units/Nanomolar,3480148,=,1,1,=,,IC50,nM,,1.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.5
,,20667713,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL621,TRAZODONE,CHEMBL621,5.35,0,http://www.openphacts.org/units/Nanomolar,3480134,=,1,1,=,,IC50,nM,,4485.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4485.0
,,20667744,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2ccccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4635890,,CHEMBL4635890,6.93,0,http://www.openphacts.org/units/Nanomolar,3480149,=,1,1,=,,IC50,nM,,117.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,117.0
,,20667745,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCC(c3cc(F)cc4oncc34)CC2)nc2ccccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4636764,,CHEMBL4636764,7.39,0,http://www.openphacts.org/units/Nanomolar,3480150,=,1,1,=,,IC50,nM,,40.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,40.5
,,20667746,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2c(F)cccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4633397,,CHEMBL4633397,8.15,0,http://www.openphacts.org/units/Nanomolar,3480151,=,1,1,=,,IC50,nM,,7.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,7.0
,,20667747,[],CHEMBL4619928,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,F,,,BAO_0000190,BAO_0000357,single protein format,O=c1n(CCCCN2CCN(c3cccc4sc(F)cc34)CC2)nc2c(F)cccn12,,,CHEMBL4619707,Bioorg Med Chem Lett,2020.0,,CHEMBL4649106,,CHEMBL4649106,7.96,0,http://www.openphacts.org/units/Nanomolar,3480152,=,1,1,=,,IC50,nM,,11.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11.1
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475586,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,N#Cc1ccc(S(=O)(=O)N(CCCN2CCC(c3noc4cc(F)ccc34)CC2)C2COC2)cc1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4747208,,CHEMBL4747208,8.44,0,http://www.openphacts.org/units/Nanomolar,3522673,=,1,1,=,,IC50,nM,,3.6,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.6
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475587,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(c1ccc(C(F)(F)F)cc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4746981,,CHEMBL4746981,8.64,0,http://www.openphacts.org/units/Nanomolar,3522672,=,1,1,=,,IC50,nM,,2.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.3
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475588,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(c1ccc(Cl)cc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4759817,,CHEMBL4759817,8.70,0,http://www.openphacts.org/units/Nanomolar,3522671,=,1,1,=,,IC50,nM,,2.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,2.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475589,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(c1ccc(F)cc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4787495,,CHEMBL4787495,8.52,0,http://www.openphacts.org/units/Nanomolar,3522670,=,1,1,=,,IC50,nM,,3.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475590,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=S(=O)(c1ccccc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4776840,,CHEMBL4776840,8.72,0,http://www.openphacts.org/units/Nanomolar,3522669,=,1,1,=,,IC50,nM,,1.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1.9
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475591,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4749144,,CHEMBL4749144,6.81,0,http://www.openphacts.org/units/Nanomolar,3522668,=,1,1,=,,IC50,nM,,156.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,156.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475592,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)CC1CC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4751911,,CHEMBL4751911,7.97,0,http://www.openphacts.org/units/Nanomolar,3522667,=,1,1,=,,IC50,nM,,10.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,10.8
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475593,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C(=O)c1ccccc1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4794013,,CHEMBL4794013,7.23,0,http://www.openphacts.org/units/Nanomolar,3522666,=,1,1,=,,IC50,nM,,59.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,59.3
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475594,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C(=O)c1ccccc1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4761441,,CHEMBL4761441,7.73,0,http://www.openphacts.org/units/Nanomolar,3522665,=,1,1,=,,IC50,nM,,18.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,18.5
,Not Active,22475595,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N(CCCN1CCN(c2ccccn2)CC1)C1COC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4777749,,CHEMBL4777749,,0,,3522664,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,22475596,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N(CCCN1CCN(c2ccccn2)CC1)CC1CC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4787394,,CHEMBL4787394,,0,,3522663,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
,Not Active,22475597,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(CCCN1CCN(c2ccccn2)CC1)C(=O)c1ccccc1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4800109,,CHEMBL4800109,,0,,3522662,,1,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,,,,
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475598,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCCN1CCN(c2ccccn2)CC1)C(=O)c1ccccc1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4754651,,CHEMBL4754651,5.16,0,http://www.openphacts.org/units/Nanomolar,3522661,=,1,1,=,,IC50,nM,,6935.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6935.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475599,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCN(C(=O)c2ccccc2)C2COC2)CC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4778957,,CHEMBL4778957,5.42,0,http://www.openphacts.org/units/Nanomolar,3522660,=,1,1,=,,IC50,nM,,3765.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3765.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475600,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCN(CC2CC2)C(=O)c2ccccc2)CC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4753512,,CHEMBL4753512,6.54,0,http://www.openphacts.org/units/Nanomolar,3522659,=,1,1,=,,IC50,nM,,288.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,288.7
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475601,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1ccccc1N1CCN(CCCN(C(=O)c2ccccc2)C(C)C)CC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4787658,,CHEMBL4787658,6.08,0,http://www.openphacts.org/units/Nanomolar,3522658,=,1,1,=,,IC50,nM,,823.5,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,823.5
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475602,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCCN1CCN(c2ccccc2OC)CC1)C(=O)c1ccccc1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4746563,,CHEMBL4746563,6.33,0,http://www.openphacts.org/units/Nanomolar,3522657,=,1,1,=,,IC50,nM,,466.9,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,466.9
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475603,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1COC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4800286,,CHEMBL4800286,5.73,0,http://www.openphacts.org/units/Nanomolar,3522656,=,1,1,=,,IC50,nM,,1878.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,1878.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475604,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,O=C(c1ccccc1)N(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)CC1CC1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4777207,,CHEMBL4777207,6.34,0,http://www.openphacts.org/units/Nanomolar,3522655,=,1,1,=,,IC50,nM,,459.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,459.2
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475605,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CC(C)N(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)C(=O)c1ccccc1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4752859,,CHEMBL4752859,6.28,0,http://www.openphacts.org/units/Nanomolar,3522654,=,1,1,=,,IC50,nM,,528.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,528.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22475607,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '60.0'}]",CHEMBL4686220,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCCN(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)C(=O)c1ccccc1,,,CHEMBL4680230,Eur J Med Chem,2020.0,,CHEMBL4745192,,CHEMBL4745192,6.32,0,http://www.openphacts.org/units/Nanomolar,3522653,=,1,1,=,,IC50,nM,,484.7,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,484.7
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22788349,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '120.0'}]",CHEMBL4708967,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,F,,,BAO_0000190,BAO_0000019,assay format,O=C1COc2ccccc2N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4706522,Eur J Med Chem,2020.0,,CHEMBL4741908,,CHEMBL4741908,6.67,0,http://www.openphacts.org/units/Nanomolar,3538409,=,1,1,=,,IC50,nM,,216.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,216.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22788350,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '120.0'}]",CHEMBL4708967,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,F,,,BAO_0000190,BAO_0000019,assay format,O=C1NCC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)c2cc(F)ccc21,,,CHEMBL4706522,Eur J Med Chem,2020.0,,CHEMBL4763837,,CHEMBL4763837,7.46,0,http://www.openphacts.org/units/Nanomolar,3538410,=,1,1,=,,IC50,nM,,34.67,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.46
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22788351,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '120.0'}]",CHEMBL4708967,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,F,,,BAO_0000190,BAO_0000019,assay format,COc1ccc2ncc(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)c2c1,,,CHEMBL4706522,Eur J Med Chem,2020.0,,CHEMBL4749223,,CHEMBL4749223,7.11,0,http://www.openphacts.org/units/Nanomolar,3538411,=,1,1,=,,IC50,nM,,77.62,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.11
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22788352,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '120.0'}]",CHEMBL4708967,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,F,,,BAO_0000190,BAO_0000019,assay format,CN1CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc2C1=O,,,CHEMBL4706522,Eur J Med Chem,2020.0,,CHEMBL4777098,,CHEMBL4777098,6.91,0,http://www.openphacts.org/units/Nanomolar,3538412,=,1,1,=,,IC50,nM,,123.03,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,6.91
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22788353,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '120.0'}]",CHEMBL4708967,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,F,,,BAO_0000190,BAO_0000019,assay format,O=c1[nH]c(=O)n(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc12,,,CHEMBL4706522,Eur J Med Chem,2020.0,,CHEMBL4777475,,CHEMBL4777475,7.54,0,http://www.openphacts.org/units/Nanomolar,3538413,=,1,1,=,,IC50,nM,,28.84,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.54
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22788354,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '120.0'}]",CHEMBL4708967,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,F,,,BAO_0000190,BAO_0000019,assay format,O=S1(=O)CCc2ccc(O)cc2N1CCCCN1CCN(c2cccc3sccc23)CC1,,,CHEMBL4706522,Eur J Med Chem,2020.0,,CHEMBL4759331,,CHEMBL4759331,7.70,0,http://www.openphacts.org/units/Nanomolar,3538414,=,1,1,=,,IC50,nM,,19.95,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.7
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22788355,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '120.0'}]",CHEMBL4708967,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,F,,,BAO_0000190,BAO_0000019,assay format,Nc1ccc2c(c1)N(CCCCN1CCN(c3cccc4sccc34)CC1)S(=O)(=O)CC2,,,CHEMBL4706522,Eur J Med Chem,2020.0,,CHEMBL4751542,,CHEMBL4751542,7.17,0,http://www.openphacts.org/units/Nanomolar,3538415,=,1,1,=,,IC50,nM,,67.61,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,pIC50,,UO_0000065,,7.17
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22792359,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.25', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '75.0'}]",CHEMBL4709853,Antagonist activity at human D2 receptor expressed in CHO-K1 cells assessed as inhibition of dopamine-induced calcium flux incubated for 60 mins at 37 degC followed by 15 mins incubation at room temperature and subsequent dopamine addition by calcium 4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2C1=O,,,CHEMBL4706549,Eur J Med Chem,2020.0,,CHEMBL4764679,,CHEMBL4764679,8.20,0,http://www.openphacts.org/units/Nanomolar,3539165,=,1,1,=,,IC50,nM,,6.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,6.3
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22792360,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.25', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '75.0'}]",CHEMBL4709853,Antagonist activity at human D2 receptor expressed in CHO-K1 cells assessed as inhibition of dopamine-induced calcium flux incubated for 60 mins at 37 degC followed by 15 mins incubation at room temperature and subsequent dopamine addition by calcium 4 dye based FLIPR assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.O=C(O)/C=C\C(=O)O,,,CHEMBL4706549,Eur J Med Chem,2020.0,,CHEMBL1814790,,CHEMBL62,7.59,0,http://www.openphacts.org/units/Nanomolar,3539148,=,1,1,=,,IC50,nM,,25.8,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,25.8
"{'action_type': 'PARTIAL AGONIST', 'description': 'Binds to and only partially activates a receptor (relative to the response to a full agonist)', 'parent_type': 'POSITIVE MODULATOR'}",,22795665,[],CHEMBL4710573,Partial agonist activity at presynaptic D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12,,,CHEMBL4706566,Eur J Med Chem,2020.0,"{'bei': '21.31', 'le': '0.39', 'lle': '4.47', 'sei': '31.31'}",CHEMBL3306803,LUMATEPERONE,CHEMBL3306803,8.39,0,http://www.openphacts.org/units/Nanomolar,3539659,=,1,1,=,,IC50,nM,,4.1,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,4.1
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,22795666,[],CHEMBL4710574,Antagonist activity at postsynaptic D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12,,,CHEMBL4706566,Eur J Med Chem,2020.0,"{'bei': '21.59', 'le': '0.40', 'lle': '4.57', 'sei': '31.71'}",CHEMBL3306803,LUMATEPERONE,CHEMBL3306803,8.49,0,http://www.openphacts.org/units/Nanomolar,3539659,=,1,1,=,,IC50,nM,,3.2,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,3.2
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,23202365,[],CHEMBL4821086,Antagonist activity at D2 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,Fc1ccc2c(C3CCN(CCCOc4ccc(CCN5CCOCC5)cc4)CC3)noc2c1,,,CHEMBL4819047,Bioorg Med Chem Lett,2021.0,,CHEMBL4867978,,CHEMBL4867978,7.95,0,http://www.openphacts.org/units/Nanomolar,3608423,=,1,1,=,,IC50,nM,,11.3,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,nM,UO_0000065,,11.3
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24421254,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21,,,CHEMBL5046278,J Med Chem,2022.0,"{'bei': '14.39', 'le': '0.27', 'lle': '2.03', 'sei': '9.68'}",CHEMBL3091687,,CHEMBL3091687,5.24,0,http://www.openphacts.org/units/Nanomolar,3784580,=,1,1,=,,IC50,nM,,5700.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,5.7
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24421255,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NCCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21,,,CHEMBL5046278,J Med Chem,2022.0,"{'bei': '13.75', 'le': '0.25', 'lle': '2.42', 'sei': '7.49'}",CHEMBL5070958,,CHEMBL5070958,5.03,0,http://www.openphacts.org/units/Nanomolar,3784581,=,1,1,=,,IC50,nM,,9400.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,9.4
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24421256,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NCCCCN(C[C@H]1Cc2cccnc2CN1)[C@H]1CCCc2cccnc21,,,CHEMBL5046278,J Med Chem,2022.0,"{'bei': '13.68', 'le': '0.25', 'lle': '2.39', 'sei': '7.45'}",CHEMBL5076569,,CHEMBL5076569,5.00,0,http://www.openphacts.org/units/Nanomolar,3784583,=,1,1,=,,IC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,10.0
,,24421257,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCC(F)(F)CC1,,,CHEMBL5046278,J Med Chem,2022.0,,CHEMBL5093818,,CHEMBL5093818,,0,http://www.openphacts.org/units/Nanomolar,3784598,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,30.0
,,24421258,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,c1cnc2c(c1)CN[C@@H](CN(CCCCNC1CCOCC1)[C@H]1CCCc3cccnc31)C2,,,CHEMBL5046278,J Med Chem,2022.0,,CHEMBL5085511,,CHEMBL5085511,,0,http://www.openphacts.org/units/Nanomolar,3784599,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,30.0
,,24421259,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CN(CCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21)C1CCOCC1,,,CHEMBL5046278,J Med Chem,2022.0,,CHEMBL5077132,,CHEMBL5077132,,0,http://www.openphacts.org/units/Nanomolar,3784600,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,30.0
,,24421260,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,c1cnc2c(c1)CN[C@@H](CN(CCCCNC1COC1)[C@H]1CCCc3cccnc31)C2,,,CHEMBL5046278,J Med Chem,2022.0,,CHEMBL5083458,,CHEMBL5083458,,0,http://www.openphacts.org/units/Nanomolar,3784601,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,30.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24421261,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,c1cnc2c(c1)CN[C@@H](CN(CCCC1CCNCC1)[C@H]1CCCc3cccnc31)C2,,,CHEMBL5046278,J Med Chem,2022.0,"{'bei': '11.94', 'le': '0.22', 'lle': '1.36', 'sei': '9.44'}",CHEMBL5081505,,CHEMBL5081505,5.01,0,http://www.openphacts.org/units/Nanomolar,3784603,=,1,1,=,,IC50,nM,,9800.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,9.8
,,24421262,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,c1cnc2c(c1)CN[C@@H](CN(CCCCN1CCOCC1)[C@H]1CCCc3cccnc31)C2,,,CHEMBL5046278,J Med Chem,2022.0,,CHEMBL5082142,,CHEMBL5082142,,0,http://www.openphacts.org/units/Nanomolar,3784604,>,1,1,>,,IC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,30.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24421263,[],CHEMBL5048805,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,,,CHEMBL5046278,J Med Chem,2022.0,"{'bei': '15.41', 'le': '0.28', 'lle': '1.81', 'sei': '7.61'}",CHEMBL518924,MAVORIXAFOR,CHEMBL518924,5.39,0,http://www.openphacts.org/units/Nanomolar,3784605,=,1,1,=,,IC50,nM,,4100.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,4.1
,,24647173,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Compound concentration', 'standard_units': 'µM', 'standard_value': '10.0', 'text_value': None, 'type': 'Compound concentration', 'units': 'µM', 'value': '10.0'}]",CHEMBL5058713,DRD2S Eurofins SafetyScan (Receptor),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1cn([C@H](C)CC#N)c(=O)c2cc(Cn3nc(C(F)F)cc3Cl)nn12,,,CHEMBL5058641,,2022.0,,CHEMBL5092058,,CHEMBL5092058,,0,,3839895,>,54,0,>,,IC50,µM,,10.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,µM,,,10.0
"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24749333,[],CHEMBL5120437,Inhibition of dopamine D2 receptor (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cc1c(C#Cc2ccc(CN3CCC(CO)CC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3CCC43CC3)nc12,,,CHEMBL5113538,J Med Chem,2022.0,"{'bei': '8.80', 'le': '0.17', 'lle': '-0.20', 'sei': '5.93'}",CHEMBL5177023,,CHEMBL5177023,6.00,0,http://www.openphacts.org/units/Nanomolar,3860936,=,1,1,=,,IC50,nM,,1000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,1.0
"{'action_type': 'ANTAGONIST', 'description': 'Binds to a receptor and prevents activation by an agonist through competing for the binding site', 'parent_type': 'NEGATIVE MODULATOR'}",,24768417,[],CHEMBL5125561,Antagonist activity at D2 receptor (unknown origin),F,,,BAO_0000190,BAO_0000019,assay format,CC(=O)N1CCN([C@H]2CCC[C@@H](NC(=O)c3cc4c(F)ccc(C)c4[nH]3)C2)CC1,,,CHEMBL5120931,ACS Med Chem Lett,2022.0,,CHEMBL5095235,EZM-0414,CHEMBL5095235,4.89,0,http://www.openphacts.org/units/Nanomolar,3864603,=,1,1,=,,IC50,nM,,13000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606,,,IC50,uM,UO_0000065,,13.0
